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Schizophrenia is a severe psychiatric disorder that affects more than twenty-
one million people worldwide, contributing significantly to the global burden of 
disease. A growing body of genetic, epigenetic and epidemiological evidence 
suggests that schizophrenia has its origins during neurodevelopment and that 
dysregulation of the immune system and infection may play a role in disease 
etiology. Twin and family studies have highlighted a considerable heritable 
component to schizophrenia; however the role of genetic variation in the 
etiology of the disorder is complex. In the majority of cases, susceptibility is 
attributed to the combined action of multiple common genetic risk variants of 
low penetrance. 
Improved understanding about the biology of the genome has led to increased 
interest in the role of non-sequence-based variation in the etiology of 
neurodevelopmental phenotypes, including schizophrenia. The notion that 
epigenetic processes and gene expression dysregulation are involved in the 
onset of schizophrenia is supported by recent studies of disease-discordant 
monozygotic twins, clinical sample cohorts, and post-mortem brain tissue. To 
date, however, studies characterizing schizophrenia-associated methylomic and 
transcriptomic variation in the brain have been limited by small sample number 
or the assessment of a single brain region. 
The main aim of this thesis was to undertake a comprehensive study of 
genomic variation across four brain regions in schizophrenia. The results 
provide further support for a neurodevelopmental origin to schizophrenia, as 
well as a role of the immune system on schizophrenia etiology. My analyses 
also suggest that epigenetic variation associated with polygenic burden for 
schizophrenia might play a role in the disease. 
In summary, the work presented in this thesis represents the first analysis of 
epigenetic and gene expression variation associated with schizophrenia across 
multiple brain regions and highlights the utility of polygenic risk scores for 
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Chapter 1 - General Introduction 
 Schizophrenia 1.1.
1.1.1. Clinical manifestation 
Schizophrenia is a severe psychiatric disorder with neurodevelopmental origins 
that affects more than twenty-one million people worldwide, and contributes 
significantly to the global burden of disease (World Health Organization, 2013, 
World Health Organization, 2015). Schizophrenia onset occurs typically during 
adolescence or early adulthood, generally later in females than males (Hafner 
et al., 1994). Incidence rates are higher in males compared to females with a 
relative risk of approximately 1.4 (Aleman et al., 2003, McGrath et al., 2008). 
The term schizophrenia was first used in 1908 by the Swiss psychiatrist Eugen 
Bleuler and over the last century the diagnostic criteria for schizophrenia has 
been the subject of considerable debate. The disorder is primarily defined by 
both ‘positive’ symptoms, such as hallucinations, delusions and interference 
with thought processes, and ‘negative’ symptoms, such as dysfunctional 
affective responses including apathy, lack of drive and social isolation, and 
altered cognition (Burmeister et al., 2008). Positive symptoms refer to 
symptoms present in affected individuals and absent in unaffected individuals, 
whereas negative symptoms are features absent in affected individuals and 
present in unaffected individuals. The wide range of symptoms means that 
multiple different clinical presentations are possible, with two schizophrenia 
patients potentially having few diagnosed symptoms in common.  
This heterogeneity has led to multiple attempts to identify diagnostic subtypes 
within schizophrenia, not only to improve understanding of its aetiology and 
pathophysiology, but also improve therapy for these patients (Kendell, 1987). 
Despite these attempts to refine diagnosis, schizophrenia remains a broad 
clinical syndrome defined by reported subjective experiences (symptoms), loss 
of function (behavioural impairments) and variable patterns of course 
(Jablensky, 2010). Until 2013, according to the Diagnostic and Statistical 
Manual of Mental Disorders (DSM) IV, (American Psychiatric Association, 
1994), schizophrenia was categorised into five different subtypes: paranoid, 




these subtypes were eliminated from the updated DSM-5 (American Psychiatric 
Association, 2013) because they provided a poor description of the 
heterogeneity of schizophrenia, had low diagnostic stability, did not exhibit 
distinctive patterns of treatment response or longitudinal course, and were not 
heritable (Tandon et al., 2013). Table 1.1 - taken from Tandon et al. (2013) -
describes the updates in schizophrenia diagnostic criteria from DSM-IV 
(American Psychiatric Association, 1994) to DSM-5 (American Psychiatric 
Association, 2013). Despite these changes the core of diagnostic criteria in the 
latest DSM was maintained; schizophrenia remains within the schizophrenia 
disorders spectrum, which includes schizophreniform disorder, schizoaffective 
disorder and delusional disorder. 
1.1.2. Neuropathology of schizophrenia 
In this thesis my research focuses primarily on molecular alterations in the 
prefrontal cortex (PFC), striatum (STR), hippocampus (HC) and cerebellum 
(CER) in the context of schizophrenia. Figures 3.1. to 3.4 in Chapter 3 show 
the location of each of the regions in the human brain. Next I give an overview 
of the function of each brain region and their involvement in schizophrenia: 
 The PFC is located in the anterior part of the frontal lobe (Chapter 3 
Figure 3.1). It coordinates a broad range of functions including attention and 
the planning of motor and behavioural responses to internal and external 
stimuli, working with other brain regions to play a role in learning and memory 
and working memory (Tamminga and Buchsbaum, 2004). Decades of clinical, 
neuropathological, functional and brain connectivity research implicate it as one 
of the primary brain regions affected in schizophrenia (Shenton et al., 2001). 
 The STR is composed by a group of contiguous subcortical structures 
located in the forebrain: the caudate, putamen and nucleus accumbens, and is 
part of the basal ganglia (Chapter 3 Figure 3.2). The basal ganglia are best 
known by their role in facilitating voluntary movement. The STR is one of the 
main components of the basal ganglia; it is connected and receives input from 
the cerebral cortex. It is therefore thought to be involved in several cortical 
functions, including cognition, motor and action planning, decision-making, 
motivation, reinforcement, and reward perception (Balleine et al., 2007). 




context of schizophrenia, emerging evidence suggests that the STR might be 
involved in generating the cognitive symptoms observed in the disease. For an 
overview of the function of the STR and its possible involvement in 
schizophrenia see Simpson et al. (2010). 
 The HC is located in the medial temporal lobe, under the cerebral cortex 
(Chapter 3 Figure 3.3). It is part of the limbic system and is involved in spatial 
navigation and the consolidation of information from short-term memory to long-
term memory. The observation that schizophrenia patients can experience 
episodic memory loss (Ranganath et al., 2008) led to the suggestion that the 
HC could be involved in the disorder. Several neuroimaging, behavioural and 
molecular studies have implicated hippocampal dysfunction in schizophrenia 
(Heckers, 2001, Preston et al., 2005, Lodge and Grace, 2008, Tamminga et al., 
2010). 
 The CER is located in the hindbrain (Chapter 3 Figure 3.4). Its primary 
function is to coordinate motor activity; however mounting evidence suggests 
that the CER also plays a role in cognition (Rapoport et al., 2000). This concurs 
with evidence showing that cerebellar dysfunction is important in schizophrenia 
and neuropathological studies showing that patients with schizophrenia have 
cerebellar abnormalities, including a decrease in the density and size of 
Purkinje cells. For a detailed overview of the role of the CER in schizophrenia 




























































































1.1.3. Genetics of schizophrenia 
1.1.3.1. Heritability and evidence from twin studies 
Twin and family studies have highlighted a notable heritable component to 
schizophrenia, currently estimated at ~85% (Craddock et al., 2005). 
Concordance rates for diagnosed schizophrenia in monozygotic twins have 
been shown to be consistently higher (~50%) than in dizygotic twins (~17%), 
and adoption studies have provided further evidence that relatives of 
schizophrenia patients have an increased risk of developing the disorder (Riley 
and Kendler, 2006). 
1.1.3.2. Rare and de novo mutations 
Although schizophrenia genetic susceptibility is believed to be predominantly 
due to a polygenic burden of common genetic variants (see section 1.1.3.3), 
rare but highly penetrant inherited genomic alterations, such as copy number 
variants (Stefansson et al., 2014), de novo mutations (Xu et al., 2011, Purcell et 
al., 2014), and genetic translocations (St Clair et al., 1990), have been 
implicated in some cases of the disease. Furthermore, a recent study reported 
an increased retrotransposition of long interspersed nuclear element-1 (L1) 
copy number in brains of schizophrenia patients compared to controls, as well 
as in iPS-derived neurons of schizophrenia patients (Bundo et al., 2014). 
1.1.3.3. Schizophrenia as a polygenic disorder 
Initial genetic studies looking for genetic variants associated with schizophrenia 
took a candidate gene approach, selecting genes for study due to their 
presumed biological function. However, in these studies effect sizes are small 
and researchers have often been unable to replicate initial associations  
(Burmeister et al., 2008). Today, it is clear that schizophrenia susceptibility is 
predominantly attributed to the action of common genetic variants of low 
penetrance. The revolution precipitated by the onset of genome-wide 
association studies (GWAS) facilitated the identification of thousands of genes 
and genetic variants that contribute to complex diseases in humans. However, 
such studies need large sample sizes to increase the chance of detecting 
disease-associated variants, especially in heterogeneous disorders such as 
schizophrenia. In 2007 the Psychiatric Genomics Consortium (PGC) was 




and mega-analyses of genome-wide genomic data for psychiatric disorders’, 
including now 800 investigators from 38 countries (Psychiatric Genomics 
Consortium, 2016) and is an exemplar for collaboration in genetic studies 
across the biomedical sciences. The most recent schizophrenia GWAS carried 
out by the Schizophrenia Working Group of the PGC identified 128 common 
variants in 108 loci associated with schizophrenia (Schizophrenia Working 
Group of the Psychiatric Genomics, 2014). Despite these advances in 
understanding the genetic epidemiology of schizophrenia, little is known about 
the mechanisms by which schizophrenia risk variants mediate disease 
susceptibility in the brain (Fullard et al., 2016, Psych et al., 2015). 
1.1.4. Schizophrenia polygenic risk score  
In complex disorders such as schizophrenia, the variants reaching stringent 
genome-wide significance thresholds explain a limited amount of the observed 
heritability (International Schizophrenia, 2009, Schizophrenia Working Group of 
the Psychiatric Genomics, 2014), limiting their predictive power for clinical and 
aetiological applications. Polygenic risk scores (PRS) have recently generated 
interest as a way of using the information of nominally associated alleles with 
very small individual effects that collectively account for a substantial proportion 
of variation in disease risk (Dudbridge, 2013). This approach ideally involves 
combining multiple genetic markers into a single score for predicting disease 
risk.  
A common method to calculate PRS is to count the number of risk alleles 
present in an individual’s genome weighted by their effect size in the GWAS 
analysis in which they were identified. The most recent schizophrenia GWAS 
(Schizophrenia Working Group of the Psychiatric Genomics, 2014) calculated a 
schizophrenia PRS derived from all independent nominally significant 
associated alleles (association P-value < 0.05) that captures about 7% of total 
liability for the disorder in an European population. Although this is still not 
useful for clinical risk predication, it is possible that it may be predictive of 
chronicity, treatment resistance or useful in the stratification of patients 




1.1.5. Neurodevelopmental origins of schizophrenia 
The neurodevelopmental hypothesis of schizophrenia posits that the disease 
results from deficits arising during neurodevelopment. Mounting evidence from 
brain imaging, genetic, epigenetic and epidemiological studies support a 
neurodevelopmental origin of schizophrenia (for a comprehensive review on the 
neurodevelopmental model of schizophrenia see Rapoport et al. (2012) and 
Fatemi and Folsom (2009)). For example, several of the most robustly 
supported schizophrenia susceptibility genes identified in GWAS have known 
roles in early brain development and appear to impact on schizophrenia risk 
during this period (Kirov et al., 2009, Hill and Bray, 2012). Furthermore, several 
prenatal environmental insults including maternal stress (Khashan et al., 2008), 
hypoxia (Cannon et al., 2002), maternal infection (Brown and Derkits, 2010) and 
maternal malnutrition or famine (Susser et al., 1996) are well established 
associations with increased schizophrenia risk.  
1.1.6. Immunity and inflammation in schizophrenia 
Epidemiological studies have long suggested a role for dysregulation of the 
immune system and infection in schizophrenia (Sorensen et al., 2009, Benros et 
al., 2011, Nielsen et al., 2013). For example, an increased maternal level of the 
pro-inflammatory cytokine interleukin-8 during pregnancy is associated with an 
increased risk for schizophrenia in offspring (Brown et al., 2004) (for a review on 
maternal infection and schizophrenia risk see Brown and Derkits (2010)). This 
hypothesis is supported by schizophrenia transcriptomic studies which show 
enrichment of immune-related pathways in genes dysregulated in schizophrenia 
patients (Mistry et al., 2013, Roussos et al., 2012). Furthermore, genetic 
variants in the major histocompatibility complex (MHC) locus have been 
strongly associated with schizophrenia in recent GWAS studies (International 
Schizophrenia et al., 2009, Schizophrenia Working Group of the Psychiatric 
Genomics, 2014). The MHC locus spans several megabases on chromosome 6 
and contains 18 highly polymorphic human leukocyte antigen (HLA) genes that 





 Gene  expression and regulation 1.2.
Understanding the molecular mechanisms that mediate gene regulation in a 
living organism is a central challenge of modern biology. The DNA sequence of 
an individual is identical across all somatic cells in the human body (except 
when rare somatic mutations occur), holding instructions for synthesising all the 
molecules that form the human body (Encode Project Consortium et al., 2007).  
However not all of this genetic information is required at all points during 
development or by all cells; it is estimated that only half of the ~19,000 protein 
coding genes within the mammalian genome are expressed in any cell type 
(Ezkurdia et al., 2014).  
Figure 1.1 shows a simplified diagram of the gene expression process from 
DNA to protein. During transcription, a coding portion of the DNA (i.e. a protein 
coding gene) is used by a RNA polymerase as a template to generate a 
messenger RNA (mRNA) molecule. The mRNA molecules contain sequences 
called introns that are removed before the mature mRNA leaves the nucleus in 
a process called splicing. The remaining regions of the transcript, which include 
the protein-coding regions, are called exons, which are spliced together to 
produce the mature mRNA. After the mature mRNA leaves the nucleus it is 
used as a template to synthesise proteins in a process called translation.  
The fine-scale temporal and spatial control of gene transcription (DNA to RNA) 
is regulated by the presence, absence and interplay of transcription factors and 
other co-factors as well as epigenetic marks. These marks include DNA 
modifications, histone modifications and the action of non-coding RNA (ncRNA) 
(Allis et al., 2015). In the next sections I describe some of the epigenetic 
modifications involved in transcriptional regulation, with particular focus on DNA 
methylation, and present supporting evidence for the dysregulation of gene 





Figure 1.1. A simplified overview of the flow of information from DNA to 






1.2.1. Introduction to epigenetics 
The term ‘epigenetics’ was introduced in 1942 by the embryologist Conrad 
Waddington to define the emerging branch of biology that ‘…studies the causal 
interactions between genes and their products which bring the phenotype into 
being…’ (Waddington, 1942). Waddington illustrated his concept as an 
‘Epigenetic Landscape’ (Figure 1.2), representing a metaphor for how gene 
regulation modulates cell fate during development. The figure shows a cell 
represented as a marble which is initially phenotypically plural, but becomes 
increasingly differentiated as it traverses down specific ridges and valleys within 
the landscape (Waddington, 1957). In modern usage epigenetics refers to the 
study of mitotically heritable, but reversible, changes in gene expression that 
occur independently of the genomic DNA sequence (Henikoff and Matzke, 
1997). As such, epigenetic processes are critical for normal cellular 
development, tissue differentiation and the long-term regulation of gene 
function. For a glossary of key epigenetic terms used in this thesis see Table 
1.2. 
 
Figure 1.2. Waddington’s epigenetic landscape. This figure represents the 
process of cellular differentiation during development; the marble represents a 
cell which has to follow a pathway through the different ‘valleys’ and ‘peaks’ of 
genetic regulation and the specific trajectory taken determines the cell fate. 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.2.2. Epigenetic mechanisms 
Epigenetic mechanisms are integral to normal cellular differentiation and play a 
key role in the regulation of gene expression, X-chromosome inactivation 
(Avner and Heard, 2001), genomic imprinting (Morison et al., 2005) and the 
silencing of retroviral transposable elements (Walsh et al., 1998). Epigenetic 
mechanisms show distinct tissue-specific patterns and are highly dynamic 
during development (Rakyan et al., 2008). Once established during 
development, the epigenetic marks defining cellular phenotype are mitotically 
inherited, although evidence suggests epigenetic alterations can arise across 
the life span as a result of environmental influences or stochastic changes 
(Egger et al., 2004). There are several different forms of epigenetic processes 
including DNA or histone modifications and non-coding RNAs, which are each 
described in the following sections. 
1.2.2.1. DNA modifications 
DNA methylation is the most well characterised and stable epigenetic 
mechanism (Jirtle and Skinner, 2007) and plays a key role in the transcriptional 
regulation of the mammalian genome. In eukaryotes DNA methylation involves 
the transfer of a methyl group to the 5th position of the cytosine pyrimidine ring, 
usually (but not exclusively) at a CpG site (Figure 1.3). The reaction uses S-
adenosylmethionine (SAM) as a methyl donor and is catalysed by a group of 
enzymes called DNA methyltransferases (DNMTs) (Klose and Bird, 2006). 
DNMT3a and DNMT3b are de novo methytransferases which are responsible 
for establishing DNA methylation at unmethylated cytosines, whilst DNMT1 acts 
to maintain existing DNA methylation patterns (Lyko et al., 1999). 
 
Figure 1.3. DNA methylation involves the transfer of a methyl group to the 





Although it is widely accepted that DNA methylation can be both actively and 
passively removed from methylated cytosines (Tahiliani et al., 2009, Chen et al., 
2003), the specific mechanisms driving active DNA demethylation have only 
recently been described. It has recently been shown that methyl groups can be 
removed by sequential oxidation of DNA methylation mediated by TET proteins 
via three intermediate modifications; 5-hydroxymethlcytosine (5hmC), 5-
formylcytosine (5fC) and finally 5-carboxylcytosine (5caC) (He et al., 2011, Ito et 
al., 2011), which can then be removed by thymine DNA glycosylase (Zhang et 
al., 2012, Yu et al., 2012). Figure 1.4 taken from Tan and Shi (2012) shows the 
proposed mechanisms of cytosine demethylation in the literature. 
Although the 5hmC, 5fC and 5caC species were initially considered to be 
intermediate by-products of active 5mC demethylation, recent evidence 
suggests they may be epigenetic marks on their own (Booth et al., 2014, Booth 
et al., 2013, Booth et al., 2012, Bachman et al., 2015, Bachman et al., 2014). 
5hmc in particular has gained recent attention given its potentially important role 
in the human brain and implication in neurological disorders (Cheng et al., 2015, 
Lunnon et al., 2016a). Furthermore, TET proteins have been implicated in 
meiosis, development, imprinting maintenance and stem-cell reprogramming 
(Yamaguchi et al., 2012, Gu et al., 2011, Ficz et al., 2011, Dawlaty et al., 2013), 
suggesting wide-ranging functional roles for other products of active DNA 
demethylation. 
Since methylated cytosines are more liable to spontaneous deamination than 
unmethylated cytosines, CpG dinucleotides are less common in the genome 
than would be predicted by chance, and primarily occur in conserved clusters 
called ‘CpG islands’ (see Table 1.2 for a definition) which are often located in 
gene promoters and are typically unmethylated (Bird, 1986). Epigenetic 
epidemiological research has primarily focused on DNA methylation at these 
CpG islands, although recent research highlights the functional importance of 
DNA methylation in other genomic regions (Jones, 2012). For example, exciting 
new research supports the hypothesis that intergenic DNA methylation might 
modulate alternative splicing (Maunakea et al., 2013). Furthermore, DNA 
methylation changes during brain development are overrepresented in regions 






Figure 1.4. Potential mechanisms of active demethylation of DNA 
regulated by ten-eleven-translocation (TET) family protein.  Figure taken 
and legend adapted from Tan and Shi (2012). TET proteins catalyse 5mC 
oxidation to 5hmC and further conversion into 5fC and 5caC. These may be 
recognized and excised by thymine DNA glycosylase (TDG) to generate 
cytosine and therefore complete demethylation. Alternatively, because 5hmC is 
more sensitive than 5mC to deamination (via activation-induced deaminase, 
AID), it can be converted to 5-hydroxymethyluracil (5hmU), which can in turn be 





1.2.2.2. Histone modifications 
Histone proteins package and order eukaryotic DNA into structural units 
called nucleosomes within the cell nucleus and are the primary protein 
component of chromatin (Figure 1.5). The nucleosome (see Table 1.2 for a 
definition) is the building unit of chromatin and is comprised of DNA wrapped 
around histone proteins forming a ‘spool’-like structure. Four types of histone 
protein – H2A, H2B, H3, H4 – combine to form the nucleosome’s histone 
octamer core (Spencer and Davie, 1999). The N-terminal tails of the histone 
particles extend out from the nucleosome and are subject to post-synthesis 
modifications (Spencer and Davie, 1999).  
A growing number of post-translational covalent histone modifications have 
been described (including acetylation, methylation, phosphorylation, 
SUMOylation, and ubiquitylation) (for a review on histone modifications see 
Kouzarides (2007)). Together these modifications form a complex, 
combinatorial ‘histone code’ which plays a role in gene expression regulation 
via alterations in chromatin structure (Berger, 2007). These alterations affect the 
access of the cell’s transcriptional machinery to the DNA. In the condensed 
chromatin state (heterochromatin), in which the DNA and histone proteins are 
tightly packed, the access to DNA of transcription factors and other co-factors is 
blocked, repressing transcription. Conversely, an open chromatin state 
(euchromatin) allows the transcriptional machinery to access DNA and drive 





Figure 1.5. Scheme of chromatin structure. Figure adapted from Felsenfeld 
and Groudine (2003). The nucleosome is the most building unit of chromatin 
organisation. The “beads on a string” structure folds into a fibre 30nm in 




1.2.2.3. Non-coding RNA 
Small non-coding RNAs (ncRNA) can take several forms, namely small 
interfering RNAs (siRNA), small temporal RNAs (stRNA), small nuclear RNAs 
(snRNAs), small nucleolar RNAs (snoRNAs), piwi-interacting RNAs (piRNA) 
and microRNAs (miRNAs) (Barry, 2014, Mattick and Makunin, 2006). Small 
ncRNAs are present in all life kingdoms and play diverse roles in regulating 
gene expression, epigenetic processes and defence against viruses (Finnegan 
and Matzke, 2003). Long noncoding RNAs (lncRNAs) appeared later in 
evolution and are present in invertebrates, vertebrates and plants and are 
particularly enriched in the cell nucleus. LncRNA forms are highly specific to 
each cell type and maintain certain features seen in coding RNAs, like promoter 
regions and intro-exon boundaries (Barry, 2014). The function of these long 
RNAs is still subject to debate, but they appear to play a role in chromatin 
regulation and shaping nuclear organization (Quinodoz et al., 2014) and have 
been implicated in neuronal differentiation and brain development and evolution 
(Lv et al., 2015, Ng and Stanton, 2013, Qureshi and Mehler, 2012). 
1.2.2.4. Interaction of different epigenetic mechanisms and 
gene expression regulation 
The epigenetic landscape of a given cell and the associated gene expression 
profile are established during development and maintained down the cell 
lineage through complex interactions that involve transcription factors, 
chromatin regulators, histone modifications, DNA modifications and ncRNA. 
Examples of interaction between DNA methylation and histone modifications 
include recruitment of histone deacetylases (HDACs) by DMNTs and methyl-
CpG binding protein 2 (MECP2) (Nan et al., 1998, Saha and Pahan, 2006, Fuks 
et al., 2000, Fuks et al., 2001, Bachman et al., 2001). ncRNAs have also been 
found to interact with specific histone modifications (Dinger et al., 2008) and can 
function as modular scaffolds for histone modifying enzymes (Tsai et al., 2010).  
However, the full extent of interactions between different epigenetic 
mechanisms to regulate gene expression in mammals remain largely poorly 
understood (Bernstein et al., 2010). One of the reasons is because the different 
epigenetic modifications discussed in sections 1.2.2.1 to 1.2.2.3 are frequently 




combinatorial epigenomic signatures across the genome in a diverse range of 
cell types. The National Institutes of Health (NIH) Roadmap Epigenomics 
Consortium has set out to extensively examine these mechanisms in an 
integrative analysis of reference epigenomes and transcriptomes of over 100 
human tissue types and provide a publicly accessible resource of epigenomic 
maps in stem cells and primary ex vivo tissues (Bernstein et al., 2010, 
Romanoski et al., 2015, Roadmap Epigenomics Consortium et al., 2015) 
(Figure 1.6).  
 
Figure 1.6. Epigenomic information across tissues and marks profiled in 
the NIH Roadmap Epigenomics Consortium. Adapted from Roadmap 
Epigenomics Consortium et al. (2015). A) Individual marks datasets across all 
epigenomes in which they are available; B) Relationship of figure panels 






1.2.2.5. Genetic mediation of the epigenome 
Genetic variation has been shown to influence epigenetic modifications at 
specific sites across multiple tissues (Kasowski et al., 2013, Kilpinen et al., 
2013, McVicker et al., 2013, Gutierrez-Arcelus et al., 2013) including the brain 
(Gibbs et al., 2010, Gamazon et al., 2013). This can occur in two ways; firstly, 
alterations in genome sequence may influence the establishment of epigenetic 
marks, for example a SNP located within the cytosine or guanine of a CpG site 
(a “CpG-SNP”) may potentially remove or introduce that CpG site; secondly, 
genetic polymorphisms may alter the epigenetic machinery directly. Genetic 
variants associated with changes in DNA methylation levels are denoted 
methylation quantitative trait loci (mQTLs). These frequently overlap genetic 
variants associated with gene expression changes, which are denoted 
expression quantitative trait loci (eQTLs). Therefore, it is possible that genetic 
mediation of the methylome provides a link between genetic variation and the 
establishment of complex phenotypes (Wagner et al., 2014, Gutierrez-Arcelus 
et al., 2013). Recent publications have studied the implication of eQTLs 
(Schizophrenia Working Group of the Psychiatric Genomics, 2014, Richards et 
al., 2012) and mQTLs (Hannon et al., 2016, Jaffe et al., 2016) in schizophrenia, 
providing support for the hypothesis that common variants associated with 
schizophrenia may function through influencing gene regulation to affect the 
disease phenotype. 
 Profiling the methylome 1.3.
DNA modifications are erased by standard molecular biology approaches, 
including polymerase chain reaction (PCR). Therefore, the detection of DNA 
methylation requires exposure of the    DNA to a methylation sensitive pre-
treatment prior to DNA sequence analysis, of which the most commonly used is 
sodium bisulfite conversion (see Chapter 2 section 2.3.1 for details). Whole 
genome bisulfite sequencing is considered the gold standard technique to 
profile DNA methylation, allowing the coverage of ~28 million CpG sites across 
the human genome. However, the high read depth needed to quantify the small 
DNA methylation changes that are commonly associated with complex 
disorders such as schizophrenia makes it, to this date, economically unfeasible 




HumanMethylation450 BeadChip (Illumina, San Diego, CA, USA; 450K array), 
and more recently the Illumina EPIC array, have become popular tools for 
screening  over 450,000 CpG sites across the human genome (Dedeurwaerder 
et al., 2011). This approach represents the best compromise between coverage 
and cost, enabling DNA methylation quantification across the genome in a large 
number of samples. Furthermore, the widespread use of the 450K array has 
driven development of many novel bioinformatic methods and pipelines specific 
for this platform (Wilhelm-Benartzi et al., 2013), which has fostered its popularity 
and facilitated cross-study comparisons of findings and meta-analyses. 
One limitation of standard bisulfite conversion-based approaches is that they do 
not distinguish between DNA methylation and other DNA modifications (Booth 
et al., 2012). Recent publications have described new methods of quantifying 5-
methylcytosine, 5fC and 5hmC (Booth et al., 2012, Booth et al., 2014, Booth et 
al., 2013). Although these methods grant the comparison between levels of the 
three modifications in one same sample, they require three times the amount of 
screening in parallel. Single, non-modified and non-amplified molecule 
sequencing methods promise to overcome some of the problems faced by 
bisulfite conversion and amplification-based methods of epigenetic marks 
profiling. Single-molecule real-time (SMRT) sequencing allows the direct 
sequencing of different DNA modifications (Flusberg et al., 2010). This 
sequencing-by-synthesis method distinguishes between the several modified 
nucleotides by reading the different durations of fluorescently labelled 
nucleotides incorporation. Nanopore sequencing, on the other hand, involves 
translocating a single DNA molecule through a protein nanopore and 
sequencing it as the molecule passes through the pore, allowing the 
identification of different DNA modifications (Laszlo et al., 2013, Li et al., 2013, 
Ahmed et al., 2014). However, these single-cell sequencing techniques are 





 Epigenetic and gene expression studies in schizophrenia 1.4.
Fully understanding the regulatory genomic changes associated with 
schizophrenia will enable researchers to develop molecular assays for 
improving clinical prognostic, disease subtyping and drug development. 
Schizophrenia is known to have a substantial genetic component, with several 
of the most robustly supported schizophrenia susceptibility genes playing 
important roles in early brain development (see section 1.1.5). Furthermore, 
epidemiological research suggests that prenatal environmental insults are also 
important (see section 1.1.5). These observations have led to a growing 
interest in the role of developmentally regulated epigenetic variation in the 
molecular etiology of schizophrenia (Dempster et al., 2013). The notion that 
epigenetic processes are involved in the onset of schizophrenia is supported by 
recent methylomic studies of disease-discordant monozygotic twins (Dempster 
et al., 2011), clinical sample cohorts (Aberg et al., 2014), and post-mortem brain 
tissue (Mill et al., 2008, Pidsley et al., 2014). In the following sections I describe 
and discuss epigenomic and transcriptomic research of schizophrenia 
developed to date. 
1.4.1. Epigenetics of schizophrenia 
It is being increasingly recognised that epigenetic dysregulation plays an 
important role in human health and disease (Egger et al., 2004).  For example, 
aberrant promoter hypermethylation and associated with inappropriate gene 
silencing are well stablished mechanisms of cancer initiation and progression 
(Jones and Baylin, 2002). Furthermore, a growing number of studies provide 
evidence for epigenetic dysregulation in several complex psychiatric disorders 
(for a review see Labrie et al. (2012)). Although the last decade has witnessed 
tremendous advances in our understanding about the genetic basis of 
schizophrenia, a large amount of the variance in disease risk remains to be 
explained (see section 1.1.3). In this section I discuss the main evidence for 
epigenetic dysregulation in schizophrenia. This section is an updated version of 




1.4.1.1. Epigenetic studies of schizophrenia using post-
mortem brain tissue 
As discussed above, different cell types in the human body express specific 
subsets of genes, regulated by cell-specific epigenetic factors including DNA 
methylation and histone modifications (Weber et al., 2005, Eckhardt et al., 
2006, Doi et al., 2009). One of the major challenges in studying epigenetic 
changes in neuropsychiatric disorders is availability of samples of the primary 
target tissue (i.e., the brain). Since it is not possible to perform in vivo epigenetic 
studies in the brain, only retrospective study designs using post-mortem brain 
samples are viable. These experiments are limited by access to high-quality, 
well-phenotyped samples. There are a number of potential confounders that 
could influence epigenetic analyses of such samples, including post-mortem 
interval, storage time, pH, and cellular heterogeneity (Pidsley and Mill, 2011). 
The small number of brain samples available for schizophrenia epigenetic 
research means that many investigations are limited in terms of their power to 
detect significant associations, especially given the small absolute changes that 
are likely to be uncovered and the heterogeneous cellular composition of the 
cerebral cortex. Ultimately, given the cell-specific differences identified in 
epigenetic gene regulation, it may be optimal to isolate specific cell types (e.g., 
neurons, glia, and astrocytes) from brain tissue via processes such as laser 
capture microdissection. 
Despite these limitations, in the last few years, researchers have made an effort 
to investigate epigenetic dysregulation in the schizophrenia brain. Table 1.3 
summarises DNA methylation studies on schizophrenia using post-mortem 
brain samples. These studies have primarily focused on only DNA methylation 
using small numbers of samples across very specific genomic regions (i.e., 
promoter CpG islands associated with a priori candidate genes). A plethora of 
different methodological approaches have been used to interrogate epigenetic 
variation. The first studies were marked by little validation of disease-associated 
differences using alternative approaches or replication in additional samples. 
The most recent DNA methylation studies in schizophrenia have used the 
Illumina 450K array or its predecessor, the Illumina Infinium 




1.3), with larger sample sizes and some effort to replicate (and validate) 
schizophrenia-associated differences. 
Recently, we published a study that identified several differently methylated 
positions (DMP) and regions (DMR) in the PFC of individuals with 
schizophrenia. The top schizophrenia-associated DMPs were enriched for CpG 
sites that show dynamic DNA methylation changes during neurodevelopment 
(Pidsley et al., 2014, Spiers et al., 2015). Additionally, we identified modules of 
co-methylated CpG sites enriched for neuropsychiatric- and 
neurodevelopmental-linked genes. In another recent study we identified a 
significant enrichment of schizophrenia-associated GWAS variants in fetal brain 
mQTLs (Hannon et al., 2016). Similarly, Jaffe et al. (2016) identified an 
enrichment of DMPs associated with prenatal-postnatal transition in 
schizophrenia GWAS regions. Together this evidence supports the hypothesis 
that schizophrenia has an important, potentially epigenetic-mediated 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.4.1.2. Epigenetic studies of schizophrenia using peripheral 
tissues 
Although understanding epigenetic dysregulation in the brain is crucial, 
investigating epigenetic changes in peripheral tissues of schizophrenia patients 
may be useful in the context of identifying disease biomarkers. Biomarkers are 
biological measures (e.g. molecular, physiological, anatomical measures) that 
can predict diagnosis, determine patient-specific aetiology and monitor the 
progress of disease. Clinical application of epigenetic biomarkers is close to be 
a reality in diseases where genetic regulation mechanisms undergo dramatic 
changes, such as cancer (Bock, 2009). Different areas of research such as 
transcriptomics, proteomics, immunology and epigenetics have aimed to identify 
molecular biomarkers for schizophrenia (Pickard, 2015).  
Table 1.4 shows an overview of DNA methylation studies of schizophrenia 
using peripheral tissues. Aberg et al. (2014) identified several DMPs associated 
with disease using whole blood from a large number of schizophrenia patients 
and controls and a replication cohort, implicating genes relevant to neuronal 
differentiation, hypoxia and infection pathways. However this study did not 
account for cell composition heterogeneity. Recently, another study using whole 
blood from a large cohort identified several schizophrenia-associated DMPs 
with the Illumina 450K array, but failed to replicate any previously identified 
associations (Montano et al., 2016). Despite these advances, so far the different 
studies profiling DNA methylation changes in peripheral tissues of 
schizophrenia patients have failed to find consistent changes that could be used 
as biomarkers for the disease. As in post-mortem brain studies (section 
1.4.1.1), we will need larger cohorts to achieve the replicative power needed to 
detect suitable biomarkers. Furthermore, these studies can be confounded with 
factors such as medication and smoking, which are sometimes difficult to 
account for. Before determining a clinical use of potential epigenetic biomarkers 
of schizophrenia, we first need to better understand which pathways are 
dysregulated in the disorder, as well which mechanisms are targeted by current 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.4.2. Transcriptomic variation in schizophrenia 
Early gene expression studies of schizophrenia primarily targeted GABAergic 
genes that are thought to be involved in the disease (Benes and Berretta, 
2001), in particular RELN and GAD67 (Guidotti et al., 2000). Several studies 
have reported decreased expression of these genes in post-mortem brain tissue 
of schizophrenia patients (Guidotti et al., 2000, Impagnatiello et al., 1998). In 
the last decade, several gene expression studies using microarrays have 
implicated immune and inflammatory, neurodevelopment and 
neurotransmission pathways in schizophrenia-associated transcriptomic 
abnormalities in the brain (Bowden et al., 2008, Narayan et al., 2008, Maycox et 
al., 2009, Torkamani et al., 2010, Schmitt et al., 2011). For a comprehensive 
review of gene expression analysis in schizophrenia using microarray 
technology see Kumarasinghe et al. (2012).  
The advances in RNA sequencing (RNA-seq) techniques and analysis pipelines 
provide an opportunity to characterise the full extent of transcriptomic 
dysregulation in disease (Ozsolak and Milos, 2011). Table 1.5 summarises the 
most recent transcriptomic studies in schizophrenia and their findings. It is 
notable that, despite general lack of replication of previous microarray findings, 
these novel studies largely implicate neurodevelopmental processes, 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1.4.3. Antipsychotic medication and the implications of 
epigenetic studies    
Before the 1950s the treatment for schizophrenia consisted of electroconvulsive 
therapy. The first generation antipsychotics (FGAs) were discovered in the 
1950s and the second generation antipsychotics (SGAs) were developed in the 
1970s. The SGAs, contrary to FGAs, are less likely to cause extrapyramidal 
symptoms such as Parkinson-like movements (for a review on antipsychotic 
drugs see Miyamoto et al. (2005)). However, they introduced a new range of 
side-effects, such as weight gain and metabolic side effects (Hert et al., 2009). 
About 20% of the patients are resistant to current antipsychotic drugs and 40 to 
70% of patients treated with clozapine (a commonly used antipsychotic drug) 
show an inadequate response (Bosia et al., 2015). Furthermore, most 
antipsychotic drugs act on reversing the symptoms rather than prevent the 
development of molecular dysfunction that underlies the disorder. They have 
poor effect on cognitive impairment and are not an efficient therapeutic of long 
term disability. Furthermore, even when effective, the molecular mechanism of 
action of several of these drugs remains elusive (Miyamoto et al., 2005) and 
understanding this would inform us about molecular pathways involved in 
schizophrenia itself. 
Several studies have offered evidence that antipsychotic drugs might act 
through changes in epigenetic processes. The majority of the commonly used 
antipsychotics target serotonin and dopamine receptors and have been shown 
to induce changes in histone marks or DNA methylation, particularly in 
promoters of genes involved in GABAergic mechanisms (for a review of 
epigenetic effects of antipsychotic drugs see Bosia et al. (2015)). Figure 1.7 
summarises the epigenetic changes induced by a number of commonly-used 
antipsychotic medications (Boks et al., 2012). Assessing the effects of 
antipsychotic medication on epigenetic modifications in the brain is currently 
very difficult to achieve because most samples have poorly described 
medication information. Furthermore, even when this information is available is 
often impossible to distinguish between medication intake and disease status as 
all schizophrenia patients are usually prescribed some type of antipsychotic 
medication during their lifetime. The ideal study design would be to 




individuals’ transition into disease, although such a study is clearly unfeasible at 
present. My current work is aiming to explore these mechanisms using animal 
models and will be the focus of my initial postdoctoral studies. 
 
Figure 1.7. Influence of neuropsychiatric drugs on the epigenome. Image 
taken from Boks et al. (2012). 
 Klinefelter syndrome 1.5.
As part of our first integrated “-omics” study of schizophrenia (Pidsley et al., 
2014), we examined genome-wide patterns of DNA methylation, gene 
expression, and genetic variation in post-mortem CER and PFC brain tissue 
samples from schizophrenia patients and controls. During quality control steps 
on these data we identified an individual as having a Klinefelter syndrome (KS; 
47,XXY karyotype). Klinefelter syndrome is the most common sex chromosome 
disorder, affecting approximately 1 in 400 to 800 men (van Rijn et al., 2006). Of 
note, comorbidity of schizophrenia-spectrum pathology have been reported in 
individuals with KS (van Rijn et al., 2006). For this reason, I decided to explore 
genomic variation in KS as part of my PhD; Chapter 7 describes the first study 
to examine genome-wide patterns of DNA methylation and gene expression in 




karyotype. We identified widespread tissue-specific epigenomic and 
transcriptomic alterations, providing potential clues about the molecular 
consequences of KS. Further details on the clinical manifestation and evidence 
for epigenomic dysregulation in KS can be found in Chapter 7. 
 General aims of my thesis  1.6.
Increased understanding about the functional complexity of the genome has led 
to growing recognition about the role of epigenetic variation in the aetiology of 
schizophrenia. Epigenetic processes act to dynamically control gene expression 
and are known to regulate key neurobiological and cognitive processes in the 
brain. Furthermore, mounting evidence suggests that genetic mediation of 
epigenetic processes and gene regulation may play a role in disease etiology. 
To date, our knowledge about dysregulation of transcriptomic and epigenomic 
mechanisms in the schizophrenia brain is limited and based on analyses of 
small numbers of samples obtained from a range of different cell and tissue 
types. The general aim of this thesis was to further our knowledge about the 
extent of methylomic and transcriptomic variation in the schizophrenia brain. 
 In the first empirical chapter (Chapter 3) I aim to systematically 
investigate genome-wide methylomic variation associated with schizophrenia in 
four different brain regions; PFC, STR, HC and CER. The analyses were 
performed in a unique collection of two post-mortem brain cohorts using the 
Illumina 450K array. I identified multiple disease-associated DMPs and DMRs, 
many residing in the vicinity of genes previously implicated in schizophrenia.  
 In the second empirical chapter (Chapter 4) I investigate DNA 
methylation variation associated with increased polygenic burden for 
schizophrenia. I identified multiple schizophrenia PRS-associated DMPs and 
DMRs in the PFC, STR, HC and CER, as well as associations across different 
brain regions. This study highlights the utility of PRS for identifying molecular 
pathways associated with etiological variation in complex disease. 
 In the third empirical chapter (Chapter 5) I utilise a systems-level 
approach to explore the correlation structure of the schizophrenia methylome in 
each of the brain regions. This chapter describes my exploration of weighted 




several modules of co-methylated probes associated with schizophrenia in the 
PFC. Furthermore, I provide evidence that supports a neurodevelopmental 
origin of schizophrenia.  
 In the fourth empirical chapter (Chapter 6) I profiled the transcriptome of 
the PFC of schizophrenia patients and controls using RNA-seq. In this chapter I 
describe the stringent quality control and analyses methods using to handle this 
dataset. I identified several differentially expressed genes associated with 
schizophrenia and provide evidence of schizophrenia-associated methylomic 
variation overlapping some of these genes. 
 In the fifth empirical chapter (Chapter 7) I present the first study to 
examine genome-wide patterns of DNA methylation and gene expression in two 
regions of the post-mortem brain obtained from a patient with a 47,XXY 
karyotype. This chapter is presented in the format of a peered-review 
publication (Viana et al., 2014).  
Figure 1.8 describes the integration of the schizophrenia-relevant Chapters 3 















































Chapter 2 - Materials and Methods 
In this chapter I describe the general materials and methods used throughout 
my thesis in multiple chapters. Detailed descriptions of individual sample 
cohorts and methods specific to each analysis section are given in each of the 
empirical chapters 
 Human sample cohorts  2.1.
I used tissue from the MRC London Neurodegenerative Diseases Brain Bank 
(LNDBB), Douglas-Bell Canada Brain Bank (DBCBB) and Edinburgh Brain and 
Tissue Banks (EBTB) to study genomic variation associated with schizophrenia. 
Each cohort comprises of multiple brain regions from schizophrenia patients 
and non-psychiatric controls. The use of these samples in the research 
presented in my thesis was approved by the University of Exeter Medical 
School Research Ethics Committee (reference number 13/02/009). Detailed 
information of each sample cohort is given in Chapter 3 section 3.2.1. Detailed 
information on the specific subset of samples used for individual analyses is 
given in each chapter.  
 Nucleic acid extraction 2.2.
In this section I describe the methods used throughout my thesis to isolate 
nucleic acids (i.e. genomic DNA and total RNA) from tissue samples dissected 
from human brain tissue. All plastic-ware used during these procedures was 
sterile and RNase-free. Before starting experimental procedures, all the 
surfaces and materials were cleaned using ethanol and/or RNaseZap (Thermo 
Fisher Scientific, Waltham, MA, United States of America (USA)) to remove 
RNases present and avoid RNA degradation. Table 2.1 describes the specific 
nucleic acid extraction methods used in each chapter. 
Table 2.1. Nucleic acid extraction methods used in this thesis. 
Chapters Human brain regions 
Nucleic 
acid 
Extraction method Protocol 
3,4 & 5 
Prefrontal cortex, striatum, 
hippocampus, cerebellum 
DNA Phenol-chloroform section 2.2.1 
6 Prefrontal cortex RNA 











2.2.1. Genomic DNA isolation using phenol-chloroform  
This section describes the isolation of genomic DNA from post-mortem human 
brain tissue. Figure 2.1 shows an overview of the experimental procedure. 
~50mg of frozen human brain tissue was excised from each sample using a 
sterile scalpel blade on a petri dish over dry ice and transferred to a sterile 
1.5ml microcentrifuge tube. The tissue was homogenised in 500μl of lysis buffer 
(75mM NaCl, 10Mm TRIS-Cl pH=8, 0.1M EDTA pH=8, 0.5% SDS) using a 
DNAse free, sterile plastic pestle. 1μl of DNase free RNase-A. 5μl of proteinase 
K (20mg/ml) (Thermo Fisher Scientific, Waltham, MA, USA) was added and the 
samples incubated in a water bath at 50ºC overnight. After overnight incubation 
the samples were transferred to a water bath at 65°C for 20 minutes to 
deactivate the proteinase K, and then cooled to room temperature. 
Phase-lock tubes were prepared in advance by adding a small amount of high 
vacuum grease (Dow Corning, Midland, Michigan (MI), USA) to a 2ml 
microcentrifuge tube and centrifuging for 5 minutes. The samples were 
transferred to these tubes and 500µl of phenol:chloroform:isoamyl alcohol 
(Thermo Fisher Scientific, Waltham, MA, USA) was added.  The samples were 
mixed by inverting the tubes ~20 times and centrifuged at 13,000 rpm for 20 
minutes. The upper layer of each sample was transferred to a new tube. 500µl 
of chloroform (Sigma-Aldrich Corporation, St. Louis, MO, USA) were added and 
the samples centrifuged at 13,000 rpm for 15 minutes. The upper layer was 
transferred to a new tube, another 500µl of chloroform added, and the samples 
centrifuged again at 13,000 rpm for 15 minutes. The upper layer was 
transferred with a pipette into new tubes. 1ml of cooled 100% ethanol (Sigma-
Aldrich Corporation, St. Louis, MO, USA) was added and the samples slowly 
mixed by inverting to precipitate the DNA. The samples were centrifuged at 
13,000 rpm for 15 minutes and the supernatant removed carefully and 
discarded. 500µl of 70% ethanol were added and the samples centrifuged at 
13,000 rpm for 5 minutes. The supernatant was removed and the samples were 
left to air dry for 30 minutes or until dry. The DNA was resuspended in 100µl of 











2.2.2. Total RNA isolation from post-mortem human brain tissue 
This section describes the isolation of total RNA from post-mortem human brain 
tissue. Total RNA was extracted using the miRNeasy Mini Kit (Qiagen, Venlo, 
Holland). Figure 2.2  shows an overview of the experimental procedure (taken 
from the miRNeasy Mini Kit Handbook (Qiagen, 2014)). All the reagents are 
provided with the kit unless otherwise stated. Before starting, the lysophilised 
RNase-Free DNase I (Qiagen, Venlo, Holland) was prepared by adding 550µl of 
RNAse-free water, and 100% ethanol (Sigma-Aldrich Corporation, St. Louis, 
MO, USA) was added to the RPE and RWT buffers as indicated in the 
manufacturer instructions. 
~30mg of frozen human brain tissue was excised from each sample using a 
sterile scalpel blade on a petri dish over dry ice and transferred into a sterile 
1.5ml microcentrifuge tube. The tissue was homogenised in 350µl of QIAzol and 
using an RNase free, sterile plastic pestle. Another 350µl of QIAzol were added 
to each tube. The total 700µl of lysate were transferred into a QIAshredder 
column (Qiagen, Venlo, Holland) and centrifuged at 13,000rpm for 2 minutes. 
The samples were transferred to new microcentrifuge tubes and incubated at 
room temperature for 5 minutes. 140µl of chloroform (Sigma-Aldrich 
Corporation, St. Louis, MO, USA) was added and the samples mixed by 
shaking for 15 seconds. The samples were again incubated at room 
temperature for 2 minutes and then centrifuged at 13,000rpm at 4ºC for 15 
minutes. 
The upper layer of each sample was transferred to a new microcentrifuge tube 
and 525µl of 100% ethanol added and mixed by pipetting. The samples were 
transferred to RNeasy Mini spin columns, centrifuged at 10,000rpm for 15 
seconds and the flow-through discarded. 350μl of RWT buffer were added to 
each column, the samples were centrifuged at 10,000rpm for 15 seconds and 
the flow-through discarded. For each sample, 10μl of DNase I solution was 
added to 70μl of RDD buffer I (Qiagen, Venlo, Holland). 80µl of this solution 
was added to the centre of each column and the samples incubated at room 
temperature for 15 minutes. After incubation, 350μl of RWT buffer were added 
to each column, the samples were centrifuged at 10,000rpm for 15 seconds and 




the samples were centrifuged at 10,000rpm for 15 seconds and the flow-
through discarded. Another 500μl of RPE buffer were added to each column, 
the samples were centrifuged at 10,000rpm for 2 minutes and the flow-through 
discarded. The columns were placed in new collection tubes and centrifuged at 
13,000rpm for 1 minute to dry. The columns were placed in the microcentrifuge 
tubes. 15μl of RNAse-free water were added to the centre of each column and 
the samples centrifuged at 10,000rpm for 1 minute to elute the RNA. Another 
15μl of RNAse-free water were added to the centre of each column and the 
samples centrifuged at 10,000rpm for 1 minute to elute the remaining RNA. 
2.2.3. Total RNA clean-up  
From each of the total RNA samples isolated as described in section 2.2.2, 
10µl were purified using the RNeasy MinElute Cleanup Kit (Qiagen, Venlo, 
Holland). Figure 2.3  shows an overview of the experimental procedure (taken 
from the RNeasy MinElute Cleanup Kit Handbook (Qiagen, 2010)). All the 
reagents are provided with the kit unless otherwise stated. Before starting 100% 
ethanol (Sigma-Aldrich Corporation, St. Louis, MO, USA) was added to the RPE 
buffer as indicated in the manufacturer instructions. 80% ethanol was prepared 
using RNase-free water and 10µl of β-Mercaptoethanol (Sigma-Aldrich 
Corporation, St. Louis, MO, USA) was added per each 1ml of RLT buffer.  
90µl of RNAse-free water was added to 10µl of each RNA sample. 350µl of RLT 
buffer were added to each sample and mixed by pipetting, followed by 250µl of 
100% ethanol (Sigma-Aldrich Corporation, St. Louis, MO, USA). The samples 
were transferred to an RNeasy MinElute spin columns, centrifuged at 10,000 
rpm for 15 seconds and the flow-through discarded. The columns were placed 
into new tubes and 500µl of RPE buffer added to each. The samples were 
centrifuged at 10,000 rpm for 15 seconds and the flow-through discarded. 500µl 
of 80% ethanol were added, the columns centrifuged at 10,000rpm for 2 
minutes and the flow-through discarded. The columns were placed in new 
tubes, the lids opened and centrifuged for at 13,000 rpm for 5 minutes. The 
tubes were rotated 180º from their previous position in the centrifuge and then 
spun again at 13,000rpm for 1 minute. The columns were then placed in new 
centrifuge tubes, 14µl of RNAse-free water were added to the centre of the 





Figure 2.2. Overview of the total RNA extraction experimental procedure. 






Figure 2.3. Overview of the RNA clean-up experimental procedure. Figure 




2.2.4. Determining the quality and quantity of isolated nucleic 
acids 
After extraction, DNA and RNA samples were quantified and checked for purity 
by spectrophotometry using a Nanodrop ND-8000 (Thermo Fisher Scientific, 
MA, USA). Nucleic acids absorb UV light at a wavelength of 260nm, whereas 
proteins absorb UV light at a wavelength of 280nm and other compounds such 
as ethylenediamine tetraacetic acid (EDTA), carbohydrates and phenol, at a 
wavelength of ~230nm. Therefore, the absorbency rations of 260/280 and 
260/280 indicate the presence of protein and other contaminants in the DNA 
and RNA samples. A 260/280 ratio of ~1.8 (for DNA) and ~2.0 (for RNA), and a 
260/230 ratio between 1.8 and 2.2 is indicative of high purity sample. Figure 2.4 
shows an example of a typical nucleic acid nanodrop profile.  
 
Figure 2.4. A typical nucleic acid sample will have a very characteristic 
profile. 
The purity and integrity of RNA samples was further assessed using an Agilent 
2100 Bioanalyzer Instrument (Agilent Technologies, Santa Clara, CA, USA) in 
conjunction with the Agilent RNA 6000 Nano Kit (Agilent Technologies, Santa 
Clara, CA, USA). The Bioanalyzer uses a fluorescent dye that binds to RNA on 
a gel electrophoresis chip. The Agilent Bioanalyzer software analyses the 
resulting electrophoresis gel and calculates an RNA integrity number (RIN), that 
can range between 1 (suggesting the RNA is highly degraded) and 10 
(indicating the RNA has perfect integrity). Figure 2.5 shows an 
electropherogram detailing the regions that are indicative of RNA quality (taken 




electrophoresis images  and electropherogram of RNA samples that were 
degraded for different periods of time, respectively (taken from Muelle et al. 
(2004)). Examples of good and poor quality RNA samples from the post-mortem 
brain tissues used in my work can be seen in example traces in Figure 2.8. 
 
Figure 2.5. Electropherogram detailing the regions that are indicative of 
RNA quality. Figure and legend taken from the RNA Integrity Number (RIN) – 
Standardization of RNA Quality Control guide, Agilent Technologies (Muelle et 
al., 2004). 
 
Figure 2.6. A total RNA sample was degraded for varying times and the 
resulting samples were analyzed on the Agilent 2100 Bioanalyzer System 
using the Eukaryote Total RNA Nano assay. A shift towards shorter fragment 
sizes (left to right) can be observed with progressing degradation. Figure taken 
and legend adapted from the RNA Integrity Number (RIN) – Standardization of 





Figure 2.7. Electropherograms from samples ranging from intact (RNA 
Integrity Number (RIN) = 10), to degraded (RIN = 2). Figure taken and legend 
adapted from the RNA Integrity Number (RIN) – Standardization of RNA Quality 
Control guide, Agilent Technologies (Muelle et al., 2004). 
 
Figure 2.8. Bioanalyzer electropherograms and gel eleptrophoresis 
images from a good quality (A) and a degraded sample (B). Shown are the 
bioanalyzer results for the prefrontal cortex sample MS20 from the Douglas-Bell 
Canada Brain Bank with a RIN=8 (A; good quality) and the prefrontal cortex 
sample 50 from the MRC London Neurodegenerative Diseases Brain Bank with 






RNA samples were run on the Bioanalyzer before and after clean-up (Figure 
2.9) (see Section 2.2.3), in general confirming that the clean-up procedure 
improved the quality of the samples by removing heavily degraded RNA 
molecules. Final RIN numbers ranged between 1.9 and 8.3. The samples were 
characterized by relatively low RIN numbers, which is expected from post-
mortem brain tissue that has variable post-mortem interval before dissection, 
and which has been stored for several decades and potentially subjected to 
several freeze-thaw cycles (Pidsley and Mill, 2011). The post-mortem human 
brain samples were prioritized for RNA sequencing based on RIN and 
concentration and the final cohort of samples used in the sequencing 
experiment had RIN numbers ranging between 4.2 and 8.3. The detailed quality 
and quantity information for each sample is further described in Chapter 6 
section 6.2.1. 
 
Figure 2.9. Bioanalyzer electropherograms and gel eleptrophoresis 
images from a sample which was successfully rescued in the clean-up 
process (see section 2.2.3). Shown are the bioanalyzer results for the 
prefrontal cortex sample 33 from the MRC London Neurodegenerative Diseases 




 DNA methylation profiling  2.3.
The mostly common used sequencing technologies are unable to distinguish 
between methylated and unmethylated cytosine residues due to their similar 
base-pairing characteristics. Sodium bisulfite (NaHSO3) treatment of DNA 
molecules enables quantification of this modification through the deamination of 
non-methylated cytosines to uracil, which is then replaced by thymine during 
downstream procedures such as polymerase chain reaction (PCR). Methylated 
cytosines are protected from deamination, remaining as cytosines (Wang et al., 
1980, Paul and Clark, 1996). Figure 2.10 taken from the New England Biolabs 
(Ipswich, MA, USA) webpage (New England Biolabs, 2016) summarises the 
sodium bisulfite conversion process. A range of technologies can be 
subsequently used to quantify DNA methylation through comparison of 
expected and observed DNA sequences (Frommer et al., 1992). In this section I 
describe sodium bisulfite conversion followed by the different methods I utilised 
to profile DNA methylation across the research undertaken in this thesis.   
 
Figure 2.10. DNA sodium bisulfite treatment. Taken from New England 




2.3.1. Sodium bisulfite conversion  
Genomic human DNA was treated with sodium bisulfite using the EZ DNA 
Methylation-Gold Kit (Zymo Research, Irvine, CA, USA), according to 
manufacturer’s instructions. Figure 2.11 shows an overview of the experimental 
procedure (taken from Zymo Research webpage (2016). Sodium bisulfite 




Figure 2.11. Overview of the sodium bisulfite treatment experimental 




2.3.2. Infinium HumanMethylation450 BeadChip 
Following sodium bisulfite conversion, the human DNA samples used in this 
thesis were profiled using the Infinium HumanMethylation450 BeadChip 
(Illumina 450K array), scanned on an iScan Microarray Scanner (Illumina, San 
Diego, CA, USA) according to the manufacturer’s instructions. The Illumina 
450K array enables the quantification of DNA methylation levels at 485,577 
CpG sites, covering 99% of RefSeq genes. The array also covers important 
regulatory regions such as CpG islands (96% covered), island shores and 
shelfs, 5′ and 3′ UTRs, and promoters and gene bodies (Bibikova et al., 2011). 
The array uses two different types of chemistry, termed Infinium I and Infinium II 
probes. The first incorporates one of two probe types per CpG site with the 
same dye colour, one for the methylated (M) and the other for the unmethylated 
(U) state. The type I probe design is based on the assumption that the 
methylation status of CpG sites within 50bp are correlated with the query CpG 
(Illumina, 2015). This could be a source of bias when CpGs underlying the 
probe are not co-methylated with the query site.  
The Infinium II probes use a single bead type with the DNA methylation state 
determined at the single base extension step after hybridization by two different 
dye colours (green for methylated sites and red for unmethylated sites). This 
design includes the addition of a degenerate R [A/G] base at underlying CpG 
sites, and therefore is less influenced by co-methylation patterns across nearby 
CpG sites.  
2.3.2.1. Infinium HumanMethylation450 BeadChip data 
analysis 
The DNA methylation level at each CpG site is determined by calculating the 
ratio of the intensity of the fluorescent signal for M (methylated) and U 
(unmethylated), which gives a β (DNA methylation) value for each site ranging 
from 0 (i.e. all cytosines at that site are unmethylated) to 1 (i.e. all cytosines at 
that site are methylated). The β value is calculated by the following equation: 
𝛽 =
𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑀
𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑀 + 𝐼𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 𝑈 + 100
 
The Illumina 450K array has become one of the most popular methodologies to 




have been put into understanding the advantages and pitfalls of the technology. 
One of the disadvantages of using two types of probes is that they perform 
differently (Dedeurwaerder et al., 2011). For example, Infinium II probes are 
less accurate at detecting extreme levels of DNA methylation and present a 
larger variation across replicates than Infinium I probes. This realization led to 
the development of several normalisation methods and an ongoing debate 
about which analysis method is most suitable (Wang et al., 2015). Our research 
group has developed the wateRmelon package in R (Pidsley et al., 2013) which 
offers a range of normalisation function and tools that were used to pre-process 
and normalise the DNA methylation data presented in this thesis. Details on 
pre-processing and normalisation steps used in the DNA methylation datasets 
are described in Chapter 3 sections 3.2.2 and 3.2.3. 
An additional issue is the presence of SNP variation within close proximity (10 
base pairs (bp)) of the query CpG site. The DNA methylation data at these sites 
might be confounded by the polymorphism in the underlying genetic sequence 
(Chen et al., 2013, Price et al., 2013). Additionally, 6-8% of the probes in the 
array were found to cross-hybridise with other locations in the genome, not 
accurately estimating the DNA methylation levels at the annotated site (Chen et 
al., 2013, Price et al., 2013). Given these issues, two different research groups 
have developed additional annotation for the Illumina 450K array that allows the 
exclusion of cross-reactive and polymorphic probes from analysis. Details on 
the probe exclusion criteria and final number of probes included in the various 
analyses are present in Chapter 3 section 3.2.3.  
A big confounder in epigenetic studies is the diverse (and variable) cell 
composition of different tissues or different samples (Jaffe and Irizarry, 2014). 
Even when working within the same brain region, different samples will have a 
different composition of neurons and other brain cells. Over recent years, 
researchers in the field have become increasingly more aware of the need to 
control for such differences. In 2013, our collaborators Guintivano and co-
workers developed an algorithm to estimate neuronal composition from Illumina 
450k human brain data (Guintivano et al., 2013). They identified cell 
epigenotype specific (CETS) markers based on DNA methylation differences 
between fluorescence-activated cell sorted (FACS) neuronal and non-neuronal 




to quantify the proportions of neurons and non-neurons as a proxy for cellular 
proportions. I used this approach to estimate neuronal to glia proportions in my 
datasets (and incorporated these estimates as covariates in subsequent 
analyses to control for cell composition differences across different samples 
with the exception of the cerebellum – see Chapter 3 section 3.2.5). The 
details on neuronal proportion estimates are presented in Chapter 3 section 
3.2.4. 
2.3.3. Bisulfite-PCR-pyrosequencing 
In this thesis I used bisulfite-PCR-pyrosequencing to quantify DNA methylation 
across targeted regions and specific genomic regions identified using the 450K 
array (see section 2.3.2). The first step of this process is to treat the genomic 
DNA using sodium bisulfite (see section 2.3.1), followed by PCR to amplify 
specific target regions and pyrosequencing to quantify site-specific levels of 
DNA methylation. 
 
2.3.3.1. Polymerase chain reaction 
PCR is a method used to amplify a segment of DNA to generate thousands to 
millions copies of the same segment. These components are combined 
together and subject to cycles of heating and cooling in a thermocycler. During 
the first PCR step the mix is heated to a high temperature to activate the heat-
sensitive polymerase taq. This is followed by three steps:  
1) A denaturation step, where the mix is heated to 95ºC to denature the 
double-stranded DNA;  
2) An annealing step where the mix is cooled to a primer-specific 
temperature (usually between 50ºC and 65ºC) to allow the primers to 
anneal with high specificity to the correct annealing sequence in the 
DNA;  
3) An elongation step at 72ºC to allow the taq polymerase to synthetize the 
complementary strand of DNA using the deoxynucleotides (dNTPs).  
These three steps are repeated for a number of cycles to allow the synthesis of 
an exponential number of DNA amplicons. The final number of amplicons will 
be 2n, where n is the number of cycles. A final step at 72ºC is added to allow a 




Bisulfite-PCR uses bisulfite-converted genomic DNA as the reaction template 
(see section 2.3.1), which presents more of a challenge than using standard 
unconverted genomic DNA (Neumann, 2007) for a several reasons : i) extended 
sodium bisulfite incubations can lead to extensive damage to the DNA template; 
ii) bisulfite treatment leads to reduced sequence complexity (the DNA largely 
comprises three bases rather than four), leading to a higher redundancy of the 
target sequence; and iii) regions of interest often lie within CG-rich sequences, 
which become long stretches of thymines following bisulfite conversion, which 
can cause polymerase slippage. Together these consequences of sodium 
bisulfite treatment give a higher chance of mispriming and non-specific PCR 
amplification. This issue can be addressed with careful primer design, using the 
following criteria which are widely reported to be optimal for successful bisulfite-
PCR:  
1) Primers should not contain any CpG sites within their sequence to 
avoid discrimination between methylated or unmethylated DNA.  
2) Primers should not be placed in a repetitive region.  
3) Primers should contain non-CpG cytosines within their sequence to 
ensure exclusive amplification of bisulfite-converted DNA.  
4) Primer length should be at least 20 bases long, to prevent non-specific 
amplification. 
The cycling conditions, primer sequences and PCR reagents used in this thesis 
are presented in Chapter 3 section 3.2.10. The reagents used in the PCR 
reactions in this thesis, together with their description and quantities in a 
standard PCR reaction, are described in Table 2.2. Table 2.3 describes the 




Table 2.2. Polymerase chain reaction (PCR) reagents and quantities used 
in this thesis.  





Single-stranded sodium bisulfite 
converted genomic DNA provides the 







Short, single-stranded oligonucleotides 






Nucleotide bases required for the 
sythesis of new DNA strands 
dNTPs (2.5mM) 0.4 
Taq DNA polymerase 
Heat-resistant enzyme that extends 
primers to synthesize new DNA strands 
complementary to the target sequence 








Buffer that maintains optimal pH for 
PCR reaction 
10 x PCR buffer 2 
Magnesium Chloride 
(MgCl2) 
Required for Taq DNA polymerase 
function 
MgCl2 (25mM) 0.4 
Rnase/Dnase free 
water 
Ensures consistent reaction volume 
Water to a final 
volume of 20µl 
13.05 
 
Table 2.3. Standard polymerase chain reaction thermocycling conditions. 




DNA mix is heated to activate the 
Taq. Hot-start Taq reduces 
mispriming and primer-dimer 
formation 
95 15 minutes 
2. Denaturation 
High temperatures denature the 








Lower temperatures allow the 
primers to anneal. Annealing 
temperature is selected carefully - 
too high and the primers are 
unable to anneal, too low and non-
specific amplification occurs. 




Taq DNA polymerase uses dNTPs 
to build the complementary DNA 
strand 
72 1 minute 
5. Final extension 
Remaining single stranded DNA is 
fully extended 
72 3 minutes 
6. Finish 






2.3.3.2. Agarose gel electrophoresis 
Agarose gel electrophoresis is a commonly used technique for the separation of 
DNA molecules based on their size. It is most commonly used to assess the 
quality and quantity of DNA and determining the success of molecular biology 
techniques such as PCR amplification. An agarose gel is a three-dimensional 
matrix containing pores through which molecules can pass. The gel is obtained 
by melting agarose powder at a concentration that can typically range from 0.8 
to 1.0%, in tris-borate EDTA (TBE) buffer. The concentration of agarose 
influences the size of the pores in the matrix; therefore the concentration of 
agarose selected is dependent on the size of molecule to be separated. After 
addition of a DNA sample to the gel matrix, an electrical charge is applied 
across it, causing the negatively charged DNA to migrate towards the positive 
terminal, at a speed determined by the DNA fragment size. Smaller molecules 
are able to move through the matrix faster, and move further through the gel. 
The separated DNA is then viewed using a stain, most commonly ethidium 
bromide, which intercalates into the DNA structure allowing it to be visualised 
under UV light. The UV light is absorbed by the ethidium bromide and re-
emitted as visible light, allowing the fragments the DNA to be observed. In this 
thesis, agarose gel electrophoresis was used for the inspection of PCR 
products (see section 2.3.3.1) using a 1.5% gel. Figure 2.12 shows an 





Figure 2.12. Example of an agarose gel used to inspect polymerase chain 
reaction (PCR) amplification products. All samples amplified successfully 
during PCR except for sample 3. L, 1,000bp ladder, W, water (negative control). 
2.3.3.3. Bisulfite-pyrosequencing 
Pyrosequencing is a highly-sensitive ‘sequencing-by-synthesis’ technique often 
used to quantify DNA methylation at individual CpG sites in short DNA 
fragments (<200bp). The method works by monitoring the real-time 
incorporation of nucleotides via detection of the light signal resulting from the 
release of pyrophosphate molecules (PPi) during DNA elongation (Tost and 
Gut, 2007). DNA methylation analysis by pyrosequencing uses single-stranded, 
biotin-labelled bisulfite-PCR amplicons as a template (see section 2.3.3.1). 
Figure 2.13 adapted from the Qiagen website (Qiagen, 2016) illustrates the 
principles of pyrosequencing. In summary: 
1) A sequencing primer is hybridised to the template and incubated with 
DNA polymerase, ATP sulfurylase, luciferase, and apyrases, substrates, 
adenosine 5‘ phosphosulphate (APS) and luciferin.  
2) dNTPs are then dispensed sequentially, and release PPi molecules 
when incorporated into the DNA elongation strand, in a quantity equimolar to 
the amount of incorporated nucleotide. 
3) In the presence of APS, ATP-sulfurylase converts PPi to ATP which 
provides energy for luciferase to generate visible light in amounts that are 




couple device chip and visualised as a peak in the raw data output with a height 
proportional to the number of nucleotides incorporated.  
4) Unincorporated dNTPs and ATPs are continuously degraded by a nucleotide-
degrading enzyme, apyrase.  
In the work carried out in this thesis, bisulfite-pyrosequencing primers (specific 
to bisulfite-converted DNA) were designed using the PyroMarkQ24 Assay 
Design Software version 2.0 (Qiagen, Venlo, Holland). A biotin label was 
incorporated into the primer to allow capture of single-strands of DNA. For each 
sample, PCR was performed in duplicated as described in section 2.3.3.1. 
Subsequently, 10μl of each PCR duplicate were mixed to make a total of 20μl 
PCR product for each sample. The PCR products were incubated for 10 
minutes with Streptavidin Sepharose beads (Qiagen, Venlo, Holland) to 
immobilise and capture the biotin-labelled DNA strands. This was followed by 
washes in 70% ethanol (Sigma-Aldrich Corporation, St. Louis, MO, USA), 
denaturation solution (0.2M NaOH), and Pyromark wash buffer (Qiagen, Venlo, 
Holland). Denatured PCR products were then sequenced using 0.3μM 
sequencing primer and Qiagen Pyromark enzyme and substrate in a PyroMark 
Q24 Instument (Qiagen, Venlo, Holland). Details about the assays, primers and 
conditions used for pyrosequencing are presented in Chapters 3 section 
3.2.10 and Chapter 7 Materials and Methods. For an example of a pyrogram 





Figure 2.13. The principles of pyrosequencing. Figure adapted from the 




 Genome-wide SNP profiling 2.4.
In this section I describe the method used to profile common genetic common 
variation and calculate schizophrenia polygenic risk score in the samples used 
in Chapters 3 to 6. The samples were genotyped using the Infinium HTS 
HumanOmniExpress-24 BeadChip Kit v1-0 and processed on an iScan 
Microarray Scanner (Illumina, San Diego, CA, USA), according to 
manufacturer’s instructions. The array was designed to analyse up to 750,000 
SNPs and copy number variant (CNV) markers across the genome. Similarly to 
the 450K array described above, the Illumina OmniExpress SNP array uses two 
different types of Infinium probes. In the type I probe, the 3' end of the primer 
overlaps with the SNP site and the intensity signal is only generated is there is a 
perfect match and extension occurs. In the type II probe, the 3' end of the 
primer is positioned directly adjacent to the SNP site, or in the case of a non-
polymorphic probe, directly adjacent to the non-polymorphic site (Illumina, 
2013). Allele-specific single base extension of the primer incorporates a biotin 
nucleotide (in case of a C or G) or a dinitrophenyl labelled nucleotide (in case of 
a n A or T). The overall signal-to-noise ratio is improved by signal amplification 
of the incorporated label. The details of SNP array data quality control and 
analysis are described in Chapter 4 section 4.2.1.  
 Transcriptome profiling  2.5.
In this section I describe the methods used to profile the transcriptome of the 
samples used in Chapter 6 using highly-parallel RNA sequencing (RNA-seq). 
The first step of RNA-seq is to create libraries of double stranded DNA (cDNA) 
complementary to messenger RNA (mRNA) molecules. Before library 
preparation it is necessary to remove all ribosomal RNA (rRNA) present in the 
sample that could confound the quantification of mRNA modules. The method 
used for this step depends primarily on the quality of the sample. I used rRNA 
depletion given the low quality of RNA retrieved from a number of the post-
mortem brain samples (see Chapter 6 section 6.2.1). RNA depletion enables 
subsequent sequencing of all non-rRNA molecules including mRNA molecules 
that are not intact, being ideal for partially-degraded RNA samples. I will first 
describe the method used for complementary DNA (cDNA) library preparation 




2.5.1. Complementary DNA libraries preparation 
To prepare cDNA libraries from total RNA from post-mortem brain tissue, I used 
the TruSeq Stranded Total RNA with Ribo-Zero Gold Library Preparation LT kit 
(Illumina, San Diego, CA, USA). The protocol was carried following 
manufacturer’s instructions. The human cDNA libraries were prepared by 
myself in conjunction with Audrey Farbos, a research technician from the Exeter 
Sequencing Service.  
 The protocol consists in the following six steps (Figure 2.14): 
1) Deplete and fragment RNA – this step aims to remove rRNA using 
biotinylated, target-specific oligos combined with Ribo-Zero rRNA removal 
beads. The specific kit used in my analyses (Gold) depletes samples of 
both cytoplasmic and mitochondrial rRNA. After the rRNA is depleted, the 
remaining RNA is purified, fragmented, and primed for cDNA synthesis. 
2) First strand cDNA synthesis – in this step the cleaved RNA fragments 
are copied into first strand cDNA using reverse transcriptase and random 
primers.  
3) Second strand cDNA synthesis - this process removes the RNA 
template and synthesizes a replacement strand, incorporating dUTP in 
place of dTTP to generate double stranded cDNA. At the end of this step 
we have blunt ended DNA. 
4) Adenylate 3’ ends - A single ‘A’ nucleotide is added to the 3’ ends of the 
blunt cDNA fragments to prevent them from ligating to each other during 
the ligation of the adapter. A corresponding single ‘T’ nucleotide on the 3’ 
end of the adapter provides a complementary overhang for ligating the 
adapter to the fragment. This strategy ensures a low rate of chimera 
(concatenated template) formation.  
5) Ligate adapters - this process ligates multiple indexing adapters to the 
ends of the cDNA. The adapters are known barcode DNA sequences that 
allow the labelling and posterior identification of individual samples. 
6) PCR amplification - the labelled cDNA fragments are then purified and 





Figure 2.14. Overview of the complementary DNA libraries preparation 
protocol. 
2.5.2. cDNA libraries quantification and pooling 
After preparation, the cDNA libraries were quantified using D1000 ScreenTapes 
(Agilent Technologies, Santa Clara, CA, USA) processed on a 2200 
TapeStation Instrument (Agilent Technologies, Santa Clara, CA, USA), 
according to manufacturer’s instructions. The TapeStation uses an 
electrophoresis-based approach to analyse DNA or RNA, giving an accurate 
measure of quality and fragment size. The tape used allows the analysis of 
DNA fragments ranging from 35 to 1000bp. The cDNA libraries prepared should 
have an average fragment size of 260-300bp. Figure 2.15 shows an example of 
the tape gel electrophoresis and electropherogram of a cDNA library. To 
quantify cDNA molarity and fragment size I isolated the region from 150 to 
900bp (red in Figure 2.15 B) in the TapeStation Instrument software. I also 
isolated the region from 50 to 150bp (green in Figure 2.15 B) to make sure 




quantification of the resulting cDNA libraries are presented in Chapter 6 
section 6.2.2.  
2.5.3. RNA sequencing 
The sequencing of the libraries was performed using the Illumina HiSeq 2500 
Ultra-High-Throughput Sequencing System (Illumina, San Diego, CA, USA), 
which performs next generation sequencing (NGS). NGS allows the massive 
parallel sequencing of millions of DNA molecules at the same time and 
developed from Sanger sequencing, a gold-standard method developed by 
Frederick Sanger in the 1970s (Sanger et al., 1977).  
Following the library preparation steps described above (section 2.5.1), the 
libraries were loaded into a flow cell for cluster generation by bridge 
amplification. In the flow cell, the cDNA fragments are captured on a lawn of 
surface-bound oligos complementary to the library adapters. Each fragment is 
then amplified into distinct clonal fragments and ready for sequencing. Each 
cluster of clonal molecules will act as an individual sequencing reaction.  
Illumina NGS chemistry is a sequencing-by-synthesis method (SBS). Briefly, a 
fluorescently labelled reversible terminator is imaged as each dNTP is added, 
and then cleaved to allow incorporation of the next base. Since all 4 reversible 
terminator-bound dNTPs are present during each sequencing cycle, natural 
competition minimizes incorporation bias. We performed paired-end 
sequencing, which involves sequencing both the forward and reverse template 
strands of each cDNA fragment. This increases the accuracy when aligning the 
data to a reference genome, especially in repetitive areas of the genome. 
Figure 2.16. taken from Martin and Wang (2011) show the workflow of a typical 
RNA-sequencing experiment. Details on RNA-sequencing and data analysis 

































































































































































































































































































































































































Figure 2.16. The data generation and analysis steps of a typical RNA 





Chapter 3 - Methylomic profiling of  
schizophrenia in the brain 
 Introduction 3.1.
Schizophrenia is a severe neurodevelopmental disorder, characterized by 
episodic psychosis, hallucinations, delusion and altered cognitive function 
(Burmeister et al., 2008). The disorder affects more than twenty-one million 
people worldwide contributing significantly to the global burden of disease 
(World Health Organization, 2013, World Health Organization, 2015). Twin and 
family studies have highlighted a notable heritable component to schizophrenia 
(Craddock et al., 2005), however the role of genetic variation in the etiology of 
the disorder is complex. Rare, highly penetrant mutations have been implicated 
in some cases of schizophrenia; these include copy number variants 
(Stefansson et al., 2014), de novo coding mutations (Xu et al., 2011, Purcell et 
al., 2014), or genomic translocations (St Clair et al., 1990). In most cases of 
schizophrenia, however, susceptibility is attributed to the combined action of 
multiple common genetic variants of low penetrance (Schizophrenia Working 
Group of the Psychiatric Genomics, 2014). 
A growing body of evidence suggest that schizophrenia has its origins during 
neurodevelopment. Several of the most robustly supported schizophrenia 
susceptibility genes have known roles in early brain development and appear to 
impact on schizophrenia risk during this period (Kirov et al., 2009, Hill and Bray, 
2012). Furthermore, epidemiological studies have shown that prenatal 
environmental insults are also important, with established associations between 
hypoxia (Cannon et al., 2002), maternal infection (Brown and Derkits, 2010), 
maternal stress (Khashan et al., 2008), and maternal malnutrition or famine 
(Susser et al., 1996) and risk for developing schizophrenia. These observations 
have led to a growing interest in the role of developmentally regulated 
epigenetic variation in the molecular etiology of schizophrenia (Dempster et al., 
2013). Despite the advances in understanding the genetic and environmental 
epidemiology of schizophrenia, little is known about the mechanisms by which 





Improved understanding of the biology of the genome has led to increased 
interest in the role of non-DNA sequence-based variation in the etiology of 
neurodevelopmental phenotypes, including schizophrenia. Epigenetic 
processes have been hypothesised to mediate associations between genetic 
risk burden, environmental risk exposure and phenotype. Furthermore, a 
growing number of studies provide evidence for the dysregulation of epigenetic 
mechanisms in complex psychiatric disorders (Labrie et al., 2012, Pidsley and 
Mill, 2011, Dempster et al., 2013, Fullard et al., 2016). The notion that 
epigenetic processes are involved in the onset of schizophrenia is supported by 
recent methylomic studies of disease-discordant monozygotic twins (Dempster 
et al., 2011), clinical sample cohorts (Aberg et al., 2014), and post-mortem brain 
tissue (Mill et al., 2008, Jaffe et al., 2016, Pidsley et al., 2014). To date, such 
studies have primarily focused on DNA methylation at CpG dinucleotides, as 
this is the best characterised and most stable epigenetic modification. To date, 
studies characterizing schizophrenia-associated methylomic variation have 
been limited by small sample number or the assessment of a single brain region 
(Chen et al., 2014, Numata et al., 2014, Wockner et al., 2014, Pidsley et al., 
2014, Jaffe et al., 2016, Ruzicka et al., 2015).  
A previous study by our group investigated schizophrenia-associated 
methylomic variation in the adult brain and its relationship to changes in DNA 
methylation during human fetal brain development (Pidsley et al., 2014). The 
data presented in that initial study strongly support the hypothesis that 
schizophrenia has an important early neurodevelopmental component, and 
suggest that epigenetic mechanisms may mediate the relationship between 
neurodevelopmental disturbances and risk of disease. In this chapter I describe 
a follow-on study using additional post-mortem brain samples dissected from 






I obtained tissue from three human post-mortem brain banks to study 
methylomic variation associated with schizophrenia. Each cohort comprises of 
multiple brain regions from schizophrenia patients and non-psychiatric controls. 
The use of these samples in the research presented here was approved by the 
University of Exeter Medical School Research Ethics Committee (reference 
number 13/02/009). 
3.2.1.1. Medical Research Council London 
Neurodegenerative Diseases Brain Bank  
The MRC London Neurodegenerative Diseases Brain Bank (LNDBB) (MRC 
London Neurodegenerative Disease Brain Bank website, 2016) was established 
in 1989 in the Department of Neuropathology, Institute of Psychiatry, King’s 
College London and is part of the United Kingdom (UK) Brain Banks Network 
funded by the Medical Research Council (MRC). It primarily focuses on 
neurodegenerative diseases including Alzheimer’s disease, Frontotemporal 
dementias and Motor Neurone Disease but it also holds a number of other 
disease collections including various movement disorders, HIV, autism and 
schizophrenia. I obtained post-mortem prefrontal cortex (PFC; Broadmann Area 
(BA) 9), cerebellum (CER), striatum (STR; putamen) and hippocampus (HC) 
samples from a total of 23 schizophrenia patients and 29 non-psychiatric 
controls who donated their brains to the LNDBB. Subjects were approached in 
life for written consent for brain banking, and all tissue donations were collected 
and stored following legal and ethical guidelines (National Health Service 
reference number 08/MRE09/38; the Human Tissue Authority license number 
for the LNDBB brain bank is 12293). Samples were dissected by a trained 
neuropathologist, snap-frozen and stored at -80°C. Schizophrenia patients were 
diagnosed by trained psychiatrists according to Diagnostic and Statistical 
Manual of Mental Disorders (DSM) criteria (for the latest edition see American 
Psychiatric Association (2013)). In the beginning of this project I visited the 
LNDBB and personally collected relevant information from the medical records 




3.2.1.2. Douglas Bell-Canada Brain Bank  
The Douglas-Bell Canada Brain Bank (DBCBB) (Douglas-Bell Canada Brain 
Bank website, 2016) was established in 1980 and is based at the Douglas 
Mental Health University Institute (a McGill University affiliate), Montreal, 
Québec, Canada. The bank collects brains from people who suffered from 
different neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s 
disease, and other dementias, as well as diverse mental disorders, including 
schizophrenia, major depression, bipolar disorder, and substance use 
disorders. I obtained post-mortem PFC (BA9), CER and STR (putamen) 
samples from a total of 18 schizophrenia patients and 18 non-psychiatric 
controls who donated their brains to the DBCBB.  Samples were collected post-
mortem following consent obtained with next of kin, according to tissue banking 
practices regulated by the Quebec Health Research Fund, and based on the 
Organisation for Economic Co-operation and Development (OECD) Guidelines 
on Human Biobanks and Genetic Research Databases. Samples were 
dissected by neuropathology technicians, snap-frozen and stored at -80°C. 
Psychiatric diagnoses were based on best-estimate diagnostic procedures, 
following Structured Clinical Interviews for DSM Disorders I (SCID I) (for the 
latest edition see American Psychiatric Association (2013)) conducted with 
informants. 
3.2.1.3. Medical Research Council Edinburgh Brain and 
Tissue Banks 
The Edinburgh Brain and Tissue Banks (EBTB) (Edinburgh Brain and Tissue 
Banks website, 2016) were established in 1990 at the University of Edinburgh, 
UK. The banks are part of the UK Brain Banks Network funded by the MRC and 
include Creutzfeldt-Jakob disease, human immunodeficiency virus, stroke, 
motor neurone disease, dementia and sudden death banks. I obtained post-
mortem PFC (BA9), CER, basal ganglia (STR)1 and HC samples from a total of 
8 schizophrenia patients and 9 non-psychiatric controls who donated their 
brains to the EBTB. All individuals died suddenly and unexpectedly and the 
next-of-kin of all individuals authorised the use of the tissue for research 
                                                          
1
 As the EBTB could not clarify which part of the basal ganglia the samples were collected from I will 




purposes by completing and signed an Authorisation Form, confirming their 
wish of donating the brains (consistent with the requirements of the Human 
Tissue (Scotland) Act 2006). All samples were collected and stored in 
accordance with good clinical practice requirements, legal and ethical 
guidelines. The medical records of all schizophrenia cases were assessed by 
two Consultant Psychiatrists and diagnosis made according to DSM criteria (for 
the latest edition see American Psychiatric Association (2013)). The samples 
stored in the Edinburgh Banks are fully authorised for research by families and 
ethically approved for research use in accordance with the terms of current UK 
Human Tissue legislation. The Brain Bank has local Research Ethics 
Committee approval (LREC 2003/8/37) and works within the legal framework of 
the Human Tissue (Scotland) Act 2006. 
 
Figures 3.1 to 3.4 show the anatomical location of the PFC (A), basal ganglia 
(including the STR; putamen) (B), HC (C) and CER (D) in the human brain, 
respectively. An overview of the functions of each of these brain regions and 
their relevance to schizophrenia is given in Chapter 1 Section 1.1.2. 
Demographic data of all samples is presented in Appendix A - Supplementary 
Table 1. DNA was isolated from tissue samples as described in the Chapter 2 
section 2.2. Briefly, genomic DNA was isolated using a standard phenol-
chloroform extraction protocol and tested for degradation and purity using 
spectrophotometry. 500 ng DNA from each sample was treated with sodium 
bisulfite using the EZ-96 Gold DNA methylation kit (Zymo Research, Irvine, CA, 
USA). DNA methylation was quantified using the Illumina Infinium 
HumanMethylation450 BeadChip (Illumina, San Diego, CA, USA) run on an 
Illumina HiScan System (Illumina, San Diego, CA, USA) using the 
manufacturers’ standard protocol. Appendix A - Supplementary Table 2 





Figure 3.1. Figure showing the anatomical location of the prefrontal cortex 
in the human brain. Adapted from Genes to Cognition Online (Cold Spring 






Figure 3.2. Figure showing the anatomical location of the basal ganglia 
(including the putamen) in the human brain. Adapted from Genes to 





Figure 3.3. Figure showing the anatomical location of the hippocampus in 
the human brain. Adapted from Genes to Cognition Online (Cold Spring 





Figure 3.4. Figure showing the anatomical location of the cerebellum in 
the human brain. Adapted from Genes to Cognition Online (Cold Spring 




3.2.2. Samples and cohort quality control 
Quality control (QC) and normalisation steps were performed on the raw 
Illumina 450K array data generated from the three cohorts separately. Signal 
intensities for each probe were extracted using Illumina GenomeStudio software 
(Illumina, San Diego, CA, USA) and imported into R (R Core Team, 2015) using 
the methylumi and minfi packages (Aryee et al., 2014, Davis S, 2015). The 
standard deviation across all samples from all cohorts and brain regions was 
calculated for each probe. The thousand probes with highest standard deviation 
across all samples were plotted to visualise differences across brain regions 
and sample cohorts (Figure 3.5). 
 
Figure 3.5. Hierarchical clustering of the thousand most variably-
methylated probes across all samples. LNDBB, MRC London 
Neurodegenerative Diseases Brain Bank; DBCBB, Douglas-Bell Canada Brain 




As expected, all brain regions show distinct DNA methylation profiles that are 
consistent across cohorts, with the CER being a clear outlier, concurring with 
data from previous studies (Davies et al., 2012, Hannon et al., 2016, Ladd-
Acosta et al., 2007). Of note, ES12, ES13, ES14, ES15, ES16 and ES18 CER 
samples from the EBTB cohort appear considerably different from the CER 
samples from the other two cohorts, suggesting these samples might actually 
represent a different region of the brain. To further investigate this I used an 
algorithm within the online DNA methylation age calculator to predict the tissue 
of origin of each sample (Horvath, 2016) (see section 3.2.4 for specific details). 
The tissue prediction feature of this tool can be helpful in identifying mislabelled 
samples, however this feature has not been published and the author suggests 
caution in interpreting the predictions (see the online tool tutorial by Horvath 
(2013b)).  Appendix A - Supplementary Tables 3 to 5 show the tissue 
prediction results for all samples in this study and Table 3.1 shows the tissue 
prediction only for the CER samples. Whereas the majority CER samples are 
predicted as cerebellum (“Brain CRBLM”) and have a high cerebellum 
prediction value (0.48 ± 0.06), the EBTB samples highlighted in grey are not 
predicted as cerebellum and show a considerably lower cerebellum prediction 
value (0.03 ± 0.01). This is consistent with the multidimensional scaling (MDS) 
plot of the thousand most variable probes across all samples (Figure 3.6), 
showing the samples from the same brain regions clustering together with 
exception of the same EBTB CER samples. Furthermore, these samples 
present a higher prediction value for pons (< 0.10) than the remaining samples, 
suggesting that they might have been dissected from pons, a structure lying 
between the midbrain and the medulla oblongata and in front of the CER 
(Appendix A - Supplementary Table 3). In light of these observations I 







Table 3.1. Tissue prediction for the cerebellum samples in this study 
using the DNA methylation age calculator (Horvath, 2016). Brain CRBLM, 
cerebellum; LNDBB , MRC London Neurodegenerative Diseases Brain Bank; 
DBCBB, Douglas-Bell Canada Brain Bank; EBTB, Edinburgh Brain and Tissue 











MS01 DBCBB schizophrenia 9647450027_R06C01 Brain CRBLM 0.52 
MS03 DBCBB schizophrenia 9647455007_R02C02 Brain CRBLM 0.44 
MS04 DBCBB schizophrenia 9647450013_R02C02 Brain CRBLM 0.53 
MS05 DBCBB control 9647450019_R04C02 Brain CRBLM 0.47 
MS06 DBCBB schizophrenia 9647450013_R05C02 Brain CRBLM 0.48 
MS07 DBCBB schizophrenia 9647450019_R05C02 Brain CRBLM 0.48 
MS08 DBCBB control 9647450027_R02C01 Brain CRBLM 0.48 
MS09 DBCBB control 9647450013_R04C02 Brain CRBLM 0.49 
MS10 DBCBB control 9647450019_R06C01 Brain CRBLM 0.52 
MS11 DBCBB schizophrenia 9647450013_R01C01 Brain CRBLM 0.46 
MS12 DBCBB schizophrenia 9647450019_R05C01 Brain CRBLM 0.47 
MS13 DBCBB control 9647455007_R01C01 Brain CRBLM 0.47 
MS14 DBCBB control 9647450013_R06C02 Brain CRBLM 0.48 
MS15 DBCBB control 9647450013_R06C01 Brain CRBLM 0.47 
MS16 DBCBB control 9647450027_R03C01 Brain CRBLM 0.52 
MS17 DBCBB control 9647450013_R04C01 Brain CRBLM 0.43 
MS18 DBCBB schizophrenia 9647450019_R01C01 Brain CRBLM 0.48 
MS19 DBCBB control 9553932139_R04C02 Brain CRBLM 0.55 
MS20 DBCBB schizophrenia 9647455007_R03C02 Brain CRBLM 0.48 
MS21 DBCBB schizophrenia 9647450019_R01C02 Brain CRBLM 0.51 
MS22 DBCBB control 9553932139_R05C02 Brain CRBLM 0.54 
MS23 DBCBB schizophrenia 9647450019_R04C01 Brain CRBLM 0.45 
MS25 DBCBB schizophrenia 9647450027_R02C02 Brain CRBLM 0.45 
MS26 DBCBB control 9647455007_R04C01 Brain CRBLM 0.52 
MS27 DBCBB schizophrenia 9647450027_R01C02 Brain CRBLM 0.47 
MS28 DBCBB schizophrenia 9647450013_R02C01 Brain CRBLM 0.47 
MS30 DBCBB schizophrenia 9647450013_R01C02 Brain CRBLM 0.51 
MS31 DBCBB control 9647455007_R06C02 Brain CRBLM 0.48 
MS32 DBCBB schizophrenia 9647450027_R06C02 Brain CRBLM 0.47 
MS33 DBCBB control 9553932139_R06C02 Brain CRBLM 0.58 
MS34 DBCBB control 9647450027_R04C02 Brain CRBLM 0.45 
MS35 DBCBB control 9647450027_R04C01 Brain CRBLM 0.49 
MS36 DBCBB control 9647450013_R03C01 Brain CRBLM 0.48 
ES01 EBTB schizophrenia 9553932139_R03C02 Brain CRBLM 0.47 
ES02 EBTB control 9647455007_R03C01 Brain CRBLM 0.47 
ES03 EBTB control 9647455007_R05C02 Brain CRBLM 0.48 
ES04 EBTB control 9647450027_R05C02 Brain CRBLM 0.54 
ES05 EBTB schizophrenia 9647450019_R06C02 Brain CRBLM 0.5 
ES06 EBTB schizophrenia 9647455007_R04C02 Brain CRBLM 0.46 
ES07 EBTB schizophrenia 9647455007_R05C01 Brain CRBLM 0.17 
ES09 EBTB schizophrenia 9647455007_R06C01 Brain CRBLM 0.2 
ES10 EBTB control 9647450019_R03C02 Brain CRBLM 0.48 
ES11 EBTB schizophrenia 9647455007_R02C01 Brain CRBLM 0.5 
ES12 EBTB schizophrenia 9647450013_R05C01 GlialCell 0.02 
ES13 EBTB control 9647450027_R01C01 GlialCell 0.04 
ES14 EBTB control 9647450013_R03C02 GlialCell 0.02 




ES16 EBTB control 9647450019_R02C01 GlialCell 0.03 
ES17 EBTB control 9647450027_R05C01 Brain CRBLM 0.33 
ES18 EBTB schizophrenia 9647455007_R01C02 GlialCell 0.04 
1 LNDBB schizophrenia 6042316042_R03C01 Brain CRBLM 0.51 
2 LNDBB schizophrenia 6042316047_R02C01 Brain CRBLM 0.46 
3 LNDBB schizophrenia 6042316024_R06C02 Brain CRBLM 0.46 
4 LNDBB schizophrenia 6042316042_R05C01 Brain CRBLM 0.49 
5 LNDBB schizophrenia 6042316024_R03C01 Brain CRBLM 0.5 
6 LNDBB schizophrenia 6042316031_R03C02 Brain CRBLM 0.49 
7 LNDBB schizophrenia 6042316024_R04C01 Brain CRBLM 0.47 
8 LNDBB schizophrenia 6042316024_R04C02 Brain CRBLM 0.48 
9 LNDBB schizophrenia 6042316031_R05C02 Brain CRBLM 0.46 
10 LNDBB schizophrenia 6042316024_R02C02 Brain CRBLM 0.51 
11 LNDBB schizophrenia 6042316024_R02C01 Brain CRBLM 0.51 
12 LNDBB schizophrenia 6042316024_R01C01 Brain CRBLM 0.47 
13 LNDBB schizophrenia 6042316042_R05C02 Brain CRBLM 0.48 
14 LNDBB schizophrenia 6042316031_R01C01 Brain CRBLM 0.5 
15 LNDBB schizophrenia 6042316047_R03C02 Brain CRBLM 0.45 
16 LNDBB schizophrenia 6042316031_R06C01 Brain CRBLM 0.53 
17 LNDBB schizophrenia 6042316024_R05C02 Brain CRBLM 0.46 
18 LNDBB schizophrenia 6042316042_R04C02 Brain CRBLM 0.51 
19 LNDBB schizophrenia 6042316031_R02C01 Brain CRBLM 0.49 
20 LNDBB schizophrenia 6042316031_R04C02 Brain CRBLM 0.49 
23 LNDBB schizophrenia 6042316031_R02C02 Brain CRBLM 0.48 
25 LNDBB control 6042316042_R01C02 Brain CRBLM 0.45 
26 LNDBB control 6042316031_R03C01 Brain CRBLM 0.46 
28 LNDBB control 6042316047_R06C01 Brain CRBLM 0.48 
30 LNDBB control 6042316024_R06C01 Brain CRBLM 0.5 
31 LNDBB control 6042316042_R06C02 Brain CRBLM 0.49 
32 LNDBB control 6042316047_R05C01 Brain CRBLM 0.55 
33 LNDBB control 6042316042_R02C02 Brain CRBLM 0.48 
34 LNDBB control 6042316031_R06C02 Brain CRBLM 0.52 
35 LNDBB control 6042316047_R05C02 Brain CRBLM 0.52 
37 LNDBB control 6042316024_R05C01 Brain CRBLM 0.5 
38 LNDBB control 6042316047_R04C02 Brain CRBLM 0.51 
39 LNDBB control 6042316031_R01C02 Brain CRBLM 0.43 
40 LNDBB control 6042316047_R04C01 Brain CRBLM 0.48 
41 LNDBB control 6042316042_R04C01 Brain CRBLM 0.44 
42 LNDBB control 6042316031_R05C01 Brain CRBLM 0.42 
44 LNDBB control 6042316031_R04C01 Brain CRBLM 0.47 
45 LNDBB control 6042316042_R03C02 Brain CRBLM 0.47 
46 LNDBB control 6042316042_R01C01 Brain CRBLM 0.52 
47 LNDBB control 6042316042_R02C01 Brain CRBLM 0.5 
49 LNDBB control 6042316024_R01C02 Brain CRBLM 0.46 
51 LNDBB control 6042316042_R06C01 Brain CRBLM 0.51 
52 LNDBB control 6042316047_R01C01 Brain CRBLM 0.54 






Figure 3.6. Multidimensional scaling of the thousand most variable probes 
across all samples. Six cerebellum samples from the Edinburgh Brain and 
Tissue Banks (circled) do not cluster with the remaining cerebellum 
samples. PFC, prefrontal cortex (blue); CER, cerebellum (orange); STR, 
striatum (green) and HC, hippocampus (dark red). 
MDS plots of probes located on each of the autosomal chromosomes and for 
the thousand most variable probes across all samples were used to check for 
DNA extraction, bisulfite treatment and microarray batch effects. Figure 3.7 
shows an example of MDS plots coloured by microarray chip (A) and DNA 
extraction batch (B); the samples cluster by sex but not by colours, indicating 
that no obvious batch effects were identified. MDS plots of probes on each sex 
chromosome were used to check that the predicted sex corresponded with the 
reported sex for each individual.  One individual from each cohort was identified 
as having a 47,XXY karyotype (presence of 2 X-chromosomes and 1 Y-
chromosome consistently across all brain regions) and excluded from my 
schizophrenia analysis (a detailed analysis of genomic variation in one of these 
47,XXY (Klinefelter Syndrome) samples is presented in Chapter 7). Figure 3.8 




chromosomes of the 47,XXY sample from the DBCBB cohort. Another CER 
sample showed different predicted and reported sex and was excluded from 
analysis. The DNA Methylation age calculator (Horvath, 2016) also predicts sex 
from DNA methylation data (see section 3.2.4 for specific details on this tool). 
All the samples that survived QC had matching reported sex with the sex 
predicted by the age calculator (Appendix A - Supplementary Table 3).  
 
Figure 3.7. Example of multidimensional scaling plots for the thousand 
most variable probes across all the striatum MRC London 
Neurodegenerative Diseases Brain Bank samples. The samples are 
coloured by chip array (A) and DNA extraction batch (B) and in both cases 






Figure 3.8. Example of multidimensional scaling plots of the X-
chromosome (A) and Y-chromosome (B) probes across all the prefrontal 
cortex Douglas-Bell Canada Brain Bank samples. The sample circled in blue 
clusters with females for the X-chromosome probes (A) and with males for the 
Y-chromosome probes (B). 
The ten sodium bisulfite conversion control probes on the array were used to 
calculate the efficiency of the conversion reaction and samples showing a score 
less than 90% were excluded from analysis (PFC: 2; STR: 1; CER: 0; HC: 0). 
Figure 3.9 shows an example of the conversion plot for the LNDBB and 
DBCBB PFC samples. Correlation data from the 65 SNP probes on the array 
between brain region pairs confirmed that matched tissues were sourced from 
the same individual. Figure 3.10 shows an example of a correlation plot 
between DBCBB CER and PFC samples. Appendix A - Supplementary Table 
2 provides detailed information on exclusion criteria for each sample profiled in 






Figure 3.9. Example of bisulfite conversion plot. Shown are the bisulfite 
conversion values (y-axis) for the MRC London Neurodegenerative Diseases 
Brain Bank and Douglas-Bell Canada Brain Bank prefrontal cortex samples. 
The samples in red are below the 90% bisulfite conversion threshold (horizontal 





Figure 3.10. Example of a correlation plot for SNP probes for matched 
samples from two brain regions. The figure shows correlation of the 65 SNP 
probes on the 450K array between prefrontal cortex (PFC; vertical) and 
cerebellum (CER; horizontal) samples from the Douglas-Bell Canada Brain 
Bank. High positive correlation (red) indicates that matched tissues were 
sourced from the same individual, with lower correlations for all other 
comparisons. 
3.2.3. Data pre-processing and normalisation 
 The 65 SNP probes, probes on sex chromosomes, cross-hybridizing probes 
(Price et al., 2013, Chen et al., 2013) and probes containing a SNP with minor 
allele frequency >5% within 10 base pairs (bp) of the single base extension 
were excluded from analysis (Chapter 2 section 2.3.2.1). The pfilter function of 
the wateRmelon package (Pidsley et al., 2013) was used to filter data by 
beadcount and detection P-value. Samples with >1% probes with a detection P-




detection P-value > 0.05 in at least 1% of samples and/or a beadcount <3 in 5% 
of samples were also removed. Reasons for exclusion for each sample are 
presented in Appendix A - Supplementary Table 2. The dasen function in 
wateRmelon was used to normalise the data as previously described (Pidsley et 
al., 2013). Table 3.2 summarises the number of probes that survived QC in 
each cohort and brain region and were included in the differently methylated 
probe analyses and Table 3.3 and Appendix A - Supplementary Tables 1 and 
3 summarise the demographic and sentrix barcode ID for the samples included 
in the analyses, respectively. DNA methylation (β) values were calculated from 
unmethylated (U) and methylated (M) signal [M/(U + M + 100)] and ranged from 
0 to 1 (corresponding to 0 to 100% DNA methylation). Figure 3.11 shows the 
example of β values distribution before (A; raw data) and after normalisation (B) 
of the DBCBB STR samples. As is evident from the figure, one sample 
(MS07STR) failed and was excluded during QC. Figure 3.12 shows the density 
of β values distribution for all probes, type I probes and type II probes before (A) 
and after (B) normalisation. A sensitivity test was performed using the G*Power 
software (Faul et al., 2007) and revealed the ability to detected a DNA 
methylation difference of 9.12% at a P-value < 0.05 and 49.49% at the multiple 
testing threshold used in this study (see Section 3.2.8) (sample size of 88 
individuals, 80% statistical power). 
Table 3.2. Total number of probe included in the analyses after data 
normalisation and quality control. DBCBB, Douglas-Bell Canada Brain Bank; 
LNDBB, MRC London Neurodegenerative Diseases Brain Bank. 
 
Prefrontal cortex Striatum Hippocampus Cerebellum 
LNDBB 415,426 419,489 417,213 410,756 
DBCBB 417,033 417,470 - 417,039 



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.11. Boxplots showing the β values distribution for each striatum 
samples from the Douglas-Bell Canada Brain Bank. Shown are the β values 





Figure 3.12. Density plots showing the β values distribution for the 
striatum samples from the Douglas-Bell Canada Brain Bank. Shown are the 
β values distribution before (A) and after (B) quality control and normalisation 




3.2.4. DNA methylation age calculation 
The DNA methylation age online calculator (Horvath, 2013a, Horvath, 2015, 
Horvath, 2016) was used to estimate DNA methylation age for each sample. 
The DNA methylation age calculator was developed using 8,000 samples from 
a broad range of healthy tissues, cancer tissues and cell lines. The calculator 
allows the estimation of DNA methylation age from a complete 450K dataset, 
using weighted average data from 353 ‘clock CpGs’, which is then transformed 
to DNA methylation age using a calibration function. DNA methylation age for 
each sample in this study is presented in Appendix A - Supplementary Table 
1. I calculated the correlation coefficients between the chronological age and 
DNA methylation age for each brain region from each sample. To test whether 
there is DNA methylation age acceleration in schizophrenia, I performed a 
regression model with DNA methylation age values as the dependent variable, 
chronological age and diagnosis as fixed effects and an interaction term 
between chronological age and diagnosis. 
3.2.5. Cell composition estimates 
The epigenetic profile of a cell contributes to its unique gene expression pattern 
and DNA methylation is known to be a mark of cell and tissue type (Roadmap 
Epigenomics Consortium et al., 2015, Rivera and Ren, 2013). This has obvious 
implications in EWAS that use bulk tissue samples with a heterogeneous 
population of cells and in recent years different approaches have emerged that 
allow us to estimate cell type composition in different human tissues 
(Houseman et al., 2015, Guintivano et al., 2013). 
 I estimated neuronal composition for each sample using the Cell EpigenoType 
Specific (CETS) package in R (Guintivano et al., 2013). Neuronal composition 
estimates for each sample are presented in Appendix A - Supplementary 
Table 1 and Figure 3.13. The CER neuronal estimates derived from CETS 
correlated significantly with age (ρ = 0.48, P = 1.26E-05) in contrast to PFC (ρ= 
0.06, P = 0.58), STR (ρ= -0.24, P = 0.032) and HC (ρ=0.09, P = 0.65) estimates 
(Figure 3.14). This concurs with data reported by Guintivano et al. (2013) and is 
likely explained by age-related variation in the proportion of NeuN expressing 
and non-expressing neurons (e.g. Purkinje neurons) in the CER. Purkinje 




to decrease with age in mice (Sturrock, 1990, Sturrock, 1989b, Sturrock, 
1989a). These observations make CETS unsuitable for estimating cell 
composition in this brain region (Guintivano et al., 2013). For this reason, 
subsequent analyses on CER did not include neuronal proportion estimates as 
an independent variable.  
 
Figure 3.13. Neuronal proportion estimates calculated using the CETS 
package in R (Guintivano et al., 2013). Shown are neuronal proportion 
estimates (y-axis) for prefrontal cortex (PFC; blue), cerebellum (CER; yellow), 
striatum (STR; green) and hippocampus (HC; red) samples from both the MRC 
London Neurodegenerative Diseases Brain Bank (LNDBB) and Douglas-Bell 






Figure 3.14. Correlation between chronological age and neuronal 
proportion estimates. Shown is the correlation between chronological age (x-
axis) and neuronal proportion estimates (y-axis) in the prefrontal cortex (A), 
striatum (B), hippocampus (C) and cerebellum (D). Neuronal proportion 
estimates were calculated using the CETS package (Guintivano et al., 2013).  
3.2.6. Identification of differentially methylated positions and 
regions  
To identify schizophrenia-associated DNA methylation differences at the 
individual probe level in each brain region I performed a linear regression using 
the pre-processed and normalised DNA methylation (β) values of each cohort 
as the dependent variable and disease status, chronological age, sex and 




estimates were not included as a variable for CER samples as described above 
(section 3.2.2). Given the nature of these samples, medication, smoking status 
and other important phenotypical information was not available and therefore I 
could not include these as independent variables. 
The adjusted DNA methylation values for each probe and sample were 
calculated as follows: 
a) repeating the linear regression model for each brain region and cohort 
without including diagnosis as an independent variable; 
b) calculating the sum of the regression residuals and intercept for each 
probe and sample.  
The resulting P-values of the linear regression in the HC LNDBB data were 
used to identify differently methylated CpG sites in this brain region.  For tissues 
collected from both brain banks (PFC, STR and CER), a fixed effect meta-
analysis on the adjusted mean DNA methylation values computed with inverse 
variance weights was performed in each probe using the metacont function 
from the meta package in R (Schwarzer, 2015). Only the probes that survived 
QC and were common to both cohorts in each brain region were used in the 
meta-analysis (Table 3.2).  
To identify differentially methylated regions (DMRs), I identified spatially 
correlated P-values in our data using the Python module comb-p (Pedersen et 
al., 2012) to group spatially correlated DMPs (seed P-value < 1.00E-3, minimum 
of two probes) at a maximum distance of 300bp in each brain region. DMR P-
values were corrected for multiple testing using Šidák correction (Šidák, 1967), 
which corrects the combined P for na/nr tests, where na is the total number of 
probes tested in the initial EWAS and nr the number of probes in the given 
region. 
Permutation tests were performed for multiple purposes. The sample was 
randomly split into cases and controls 2,000 times (matching the numbers in 
each group in the real analysis), and for each permutation an EWAS was 
performed using a linear regression model for each cohort and brain region 
which were combined using a meta-analysis of both cohorts for PFC, STR and 




each permutation were calculated and used to compute the 95% confidence 
intervals presented in the quantile-quantile (QQ) plots for each analysis 
(Figures 3.20 to 3.23, section 3.3.3). 
3.2.7. Additional probe annotation and enrichment analysis for 
regulatory regions and schizophrenia GWAS regions 
I annotated the probes on the 450K array using the Genomic Regions 
Enrichment of Annotations Tool (GREAT) (McLean et al., 2010). GREAT 
associates genomic regions with genes by defining a cis-regulatory region for 
each gene in the genome. In the context of this study, annotating 450K probes 
of interest with GREAT (i.e. DMPs and DMRs) can provide information on 
whether these probes lie within putative regulatory regions mapped to genes of 
interest.  
Probes were also annotated to transcription factor binding sites (TFBSs) and 
DNase1 hypersensitivity sites (DHSs) using published 450K array probe 
annotation (Slieker et al., 2013) based on data made publically available as part 
of the ENCODE project (ENCODE Project Consortium, 2012, Maurano et al., 
2012).  The overlap between these regulatory features and different thresholds 
of DMPs (50 top ranked, DMPs P < 1.00E-03and DMPs P < 0.05) was tested 
for enrichment using a two sided Fisher’s 2x2 exact test (Fisher, 1922).  
A recent large-scale GWAS of schizophrenia identified 128 independent 
associations spanning 108 genomic regions in a meta-analysis of over 80,000 
samples (Schizophrenia Working Group of the Psychiatric Genomics, 2014). 
5006, 5058, 5066 and 4951 Illumina 450K array probes included in our PFC, 
STR, HC and CER analyses, respectively, were located within these broad 
genomic regions. The overlap between different thresholds of DMPs (50 top 
ranked, DMPs P < 1.00E-03and DMPs P < 0.05) and GWAS regions was tested 




3.2.8. Establishing multiple testing significance threshold for 
EWAS analysis 
To establish a stringent multiple-testing significance threshold to identify 
schizophrenia-associated DMPs, the data from a large schizophrenia Illumina 
450K dataset (n = 675 individuals) from another ongoing study in our lab 
(Hannon E et al., under review) was randomly split into cases and controls 
5,000 times, and for each permutation an EWAS was performed using a linear 
regression model controlling for age, sex, smoking and cell composition and the 
probe-level P-values were recorded. The minimum (or most significant) P-value 
was identified for each permutation and the 5th quantile across the 
permutations was used to estimate the nominal P-value for 5% family-wise error 
(P = 1.66E-07). 
3.2.9. Cross-region multilevel model 
As reported in previous studies (Davies et al., 2012, Hannon et al., 2016, Ladd-
Acosta et al., 2007), my data show that at a global level the CER is very distinct 
to the other three brain regions included in this study (Figures 3.5 and 3.6); for 
this reason I excluded the CER from the multi-region model and focused on 
identifying consistent signals across the PFC, STR and HC. To identify 
homogeneous DNA methylation effects across PFC, STR and HC data a null 
model of no heterogeneity was fitted using disease, sex, age and cohort as 
fixed effects. As the brain regions were dissected from the same set of 
individuals, each individual’s DNA methylation values are potentially non-
independent across brain regions. In addition, DNA methylation values within a 
brain region are also expected to be correlated across individuals, therefore 
both of these covariates were included as random effects. The comb-p tool 
(Pedersen et al., 2012) was then used to identify significant DMRs across the 
three brain regions, using the P-values of the cross-region model as described 




3.2.10. Validation with bisulfite-PCR-pyrosequencing 
Independent technical verification was performed using bisulfite-PCR-
pyrosequencing on region chr17:154420-154443 within the RPH3AL gene that 
was consistently associated with schizophrenia (see section 3.3.3.1). The 
validation was performed in the PFC and STR samples used for 450K array 
analysis. Pyrosequencing assays were designed using the PyroMark Assay 
design software (Qiagen, Hilden, Germany). PCR amplification was performed 
on sodium bisulfite treated DNA (see section 3.2.2) in duplicate. Fully 
methylated control samples and negative controls were included in all 
experiments. Primers and assay conditions are presented in Table 3.4. The 
assay covers five CpG sites, although the final two CpGs were excluded from 
analysis due to variable quality at the end of the sequencing assay. DNA 
methylation was quantified across amplicons using the Pyromark Q24 system 
(Qiagen) following the manufacturer's standard instructions. DNA methylation 
values were retrieved using the Pyromark Q24 CpG 2.0.6 software (Qiagen, 
Hilden, Germany). Figures 3.15 and 3.16 show examples of a successful and 
failed pyrosequencing run, respectively. Appendix A - Supplementary Table 2 
presents information on excluded samples from pyrosequencing analyses. For 
a full description of bisulfite-PCR-pyrosequencing methodology please see 
Chapter 2 section 2.3.3.  
Table 3.4. Primers and assay conditions for the bisulfite-polymerase chain 
reaction pyrosequencing assay targeting the chr17:154410-154672 
schizophrenia-associated differentially methylated region in the RPH3AL 
gene. 
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Figure 3.15. Example of a pyrogram of a successful pyrosequencing run 
assessing the DMR on the RPH3AL gene. Shown is the pyrogram for a 
striatum sample from the MRC London Neurodegenerative Diseases Brain 
Bank (ID = 16STR). The assay covers five CpG, although the final two CpGs 




Figure 3.16. Example of a pyrogram of a failed pyrosequencing run 
assessing the DMR on the RPH3AL gene. Shown is the pyrogram for a 
prefrontal cortex sample from the MRC London Neurodegenerative Diseases 
Brain Bank (ID = 16PFC). This sample was excluded from analysis (see 





3.3.1. Overview of experimental strategy 
In total, I quantified genome-wide patterns of DNA methylation in 341 samples 
derived from four brain regions dissected from 105 individuals (49 
schizophrenia and 56 non-psychiatric controls) obtained from 3 independent 
brain banks, using the Illumina Infinium HumanMethylation450 BeadChip (450K 
array) (Illumina Inc., San Diego, CA, USA) (see section 3.2.1). Based on my 
initial QC, I excluded the entire EBTB cohort due to uncertainty of brain region 
for some of the CER samples (see section 3.2.2). Additionally I excluded 2 
individuals that were identified with a 47,XXY karyotype (see Chapter 7), 3 
samples that failed bisulfite conversion, 1 sample with the wrong reported sex 
and 5 samples that failed based on the detection P-value (Appendix A - 
Supplementary Table 2). Overall, this represents very stringent filtering of the 
data used in my subsequent analyses. 
In total, data from 76 PFC (38 schizophrenia and 38 controls), 82 STR (37 
schizophrenia and 45 controls), 33 HC (16 schizophrenia and 17 controls) and 
77 CER (37 schizophrenia and 40 controls) samples from both the LNDBB and 
DBCBB passed stringent QC metrics and were used for analysis (demographics 
for these samples are presented in Table 3.3). A linear regression was 
performed in each brain region from each cohort separately and for tissues 
collected from both brain banks (PFC, STR and CER) a fixed-effect meta-
analysis approach was used to combine analyses results from both cohorts. 
The initial analyses focused on identifying DMPs and DMRs associated with 
disease status. Analyses were initially performed independently for each brain 
region, subsequently employed a multi-level model to identify consistent DNA 
methylation associations with schizophrenia present across the PFC, STR, and 
HC. An overview of the analysis approach in this chapter is given in Figure 3.7 
and a representation on how this analysis integrates with the remaining 









3.3.2. No global DNA methylation changes or DNA methylation 
age acceleration in schizophrenia 
As expected, no global differences in DNA methylation - estimated by averaging 
across all probes on the array included in our analysis - were identified between 
schizophrenia patients and controls in any of the four brain regions (PFC: 
schizophrenia (SZ) = 48.43%, controls (CTR) =  48.57%, P = 0.51; STR: SZ =  
49.20%, CTR =  49.16%, P =  0.12; HC: SZ =  48.44%, CTR =  48.38%, P = 
0.05; CER: SZ =  47.25%, CTR = 47.27%, P =  0.89). Furthermore, the 
estimated DNA methylation age for each sample calculated using an epigenetic 
clock based on DNA methylation values (Horvath, 2013a, Horvath, 2015) was 
strongly correlated with actual chronological age in each brain region (Figure 
3.18), with no evidence for accelerated “DNA methylation aging” in affected 
individuals (Figure 3.19). Taken together, these data indicate that 
schizophrenia is not associated with any systemic methylomic differences in the 






Figure 3.18. Correlation between chronological age and DNA methylation 
age. Shown is the correlation between chronological age (x-axis) and DNA 
methylation age (y-axis) for samples from both cohorts for A) prefrontal cortex, 
B) striatum, C) hippocampus, and D) cerebellum. DNA methylation age was 
calculated using the DNA methylation age online calculator (Horvath, 2016, 






Figure 3.19. Correlation between chronological age and DNA methylation 
age separated by schizophrenia cases (red) and controls (black). Shown is 
the correlation between chronological age (x-axis) and DNA methylation age (y-
axis) for samples from both cohorts for A) prefrontal cortex, B) striatum, C) 




3.3.3. Differently methylated positions associated with 
schizophrenia  
My first analyses focused on identifying DNA methylation differences between 
schizophrenia cases and non-psychiatric controls. There was widespread 
evidence for schizophrenia-associated variation at specific loci across the 
genome in each brain region. QQ plots for the analyses in each tissue are 
shown in Figures 3.20 to 3.23, highlighting little evidence of systematic P-value 
inflation (PFC λ = 1.18, STR λ = 1.02, HC λ = 1.13, CER λ = 1.23) in any of the 
four brain regions. Manhattan plots for the analyses in each brain region are 
shown in Figures 3.24 to 3.27. The fifty top ranked schizophrenia-associated 
DMPs in each brain region are listed in Tables 3.5 to 3.8 and Figures 3.28 to 
3.31, with those passing a highly stringent family-wise significance threshold (P 
< 1.66E-07, see section 3.1.3), shown in Table 3.9 and Figure 3.32.  
Although the specific list of top ranked DMPs identified in each tissue is distinct, 
many DMPs are characterised by consistent effects across brain regions 
(Figures 3.28 to 3.31), and for DMPs identified in each of the four individual 
brain regions, schizophrenia-associated DNA methylation differences are 
significantly positively correlated with those at the same probes in the other 
three brain regions (Figures 3.33 to 3.36 and Table 3.10). 
Of note, genes annotated to several of these top ranked probes have been 
previously implicated in the etiology and pathophysiology of schizophrenia. For 
example: 
 The top ranked DMP - cg08743050, which is significantly 
hypomethylated in PFC (P = 1.84E-08) - is located in the gene body of the 
neural cell adhesion molecule 1 (NCAM1) gene, which encodes a cell adhesion 
protein with a well-established role in neurodevelopment and synaptic plasticity 
(Ronn et al., 1998, Sunshine et al., 1987). 
 cg08103144 is significantly hypomethylated in STR (P = 3.64E-08) and 
located within the synaptopodin gene (SYNPO), a gene encoding an actin-
associated protein that plays a role in actin-based cell shape and motility that 
has been shown to be differentially expressed in schizophrenia brains (Focking 




 cg22221320 is significantly hypermethylated in STR (P = 7.88E-08) and 
located in the guanylate binding protein 4 (GBP4), a gene that has been found 
to be differentially expressed in schizophrenia patients (Sanders et al., 2013).  
 Also of interest is cg15607358, which is hypermethylated in STR (P = 
1.03E-05) and annotated to the solute carrier family 6-neurotransmitter 
transporter GABA-member 13 (SLC6A13) gene, also known as GABA 
transporter 2 (GAT2), which is a transporter of the key inhibitory 
neurotransmitter GABA. The GABAergic system has been extensively 
implicated in neurodevelopment and schizophrenia pathology (Schmidt and 
Mirnics, 2015).  
Other DMPs were also of potential interest in the context of schizophrenia such 
as: 
 cg20044211 is significantly hypermethylated in PFC (P = 7.54E-06) and 
annotated to the gene body of the NOTCH4 gene, which is a member of the 
NOTCH pathway with an important role in neurodevelopment (Lasky and Wu, 
2005). 
 cg19028706 is significantly hypomethylated in PFC (P = 6.71E-06) and 
annotated to the gene body of trafficking protein kinesin binding 1 (TRAK1). 
This gene encodes a protein that complexes with the protein encoded by the 
disrupted in schizophrenia 1 (DISC1) gene. A balanced translocation involving 
DISC1 that segregates with several major psychiatric disorders including 
schizophrenia has been intensively studied in a Scottish pedigree (St Clair et 
al., 1990), although the involvement of this locus in the etiology of the disorder 
remains controversial and common genetic variation in this region was not 
identified in recent GWAS analyses (Schizophrenia Working Group of the 
Psychiatric Genomics, 2014). The complex involving TRAK1 and DISC1 plays a 
role in mitochondrial transport in neuronal axons (Ogawa et al., 2014, Norkett et 
al., 2016) 
 cg10071493 is hypermethylated in PFC (P = 2.13E-06) and is annotated 
to the calcium channel voltage-dependent T type alpha 1H subunit (CACNA1H) 
gene in the GREAT annotation database (McLean et al., 2010) (the probes is 
located 23726bp upstream the transcription start site of the gene) (see section 




voltage-dependent calcium channel complex, previously implicated in epilepsy 
(Eckle et al., 2014).  
 cg10383028 probe is hypomethylated in HC (P = 5.30E-06) and 
annotated to the transcription start site of the calcium voltage-gated channel 
subunit alpha1 G (CACNA1G) gene.  
Notably, variation in other voltage-gated calcium channel genes has been 
implicated in schizophrenia, including common genetic variants in CACNA1C, 
CACNB2 and CACNA1I in the latest schizophrenia GWAS (Schizophrenia 
Working Group of the Psychiatric Genomics, 2014).  
 
 
Figure 3.20. Quantile-quantile plot for the prefrontal cortex (PFC) case-
control schizophrenia EWAS. Shown are the expected (x-axis) and observed 
(y-axis) quantiles observed in the meta-analysis of the PFC of both the MRC 
London Neurodegenerative Diseases Brain Bank and Douglas-Bell Canada 





Figure 3.21. Quantile-quantile plot for the striatum (STR) case-control 
schizophrenia EWAS. Shown are the expected (x-axis) and observed (y-axis) 
quantiles observed in the meta-analysis of the STR of both the MRC London 
Neurodegenerative Diseases Brain Bank and Douglas-Bell Canada Brain Bank. 
Blue shading indicates 95% confidence intervals. λ = 1.02.  
 
Figure 3.22. Quantile-quantile plot for the hippocampus (HC) case-control 
schizophrenia EWAS. Shown are the expected (x-axis) and observed (y-axis) 
quantiles observed in the linear regression analysis of the HC data from the 
MRC London Neurodegenerative Diseases Brain Bank. Blue shading indicated 





Figure 3.23. Quantile-quantile plot for the cerebellum (CER) case-control 
schizophrenia EWAS. Shown are the expected (x-axis) and observed (y-axis) 
quantiles observed in the meta-analysis of the CER of both the MRC London 
Neurodegenerative Diseases Brain Bank and Douglas-Bell Canada Brain Bank. 
Blue shading indicates 95% confidence intervals. λ = 1.23. 
 
Figure 3.24. Manhattan plot for the prefrontal cortex (PFC) case-control 
schizophrenia EWAS. Shown are the -log10(P-values) (y-axis) of the meta-
analysis of the PFC of both the MRC London Neurodegenerative Diseases 
Brain Bank and Douglas-Bell Canada Brain Bank by chromosomal position (x-
axis). The horizontal line indicates a stringent multiple-testing significance 






Figure 3.25. Manhattan plot for the striatum (STR) case-control 
schizophrenia EWAS. Shown are the -log10(P-values) (y-axis) of the meta-
analysis of the STR of both the MRC London Neurodegenerative Diseases 
Brain Bank and Douglas-Bell Canada Brain Bank by chromosomal position (x-
axis). The horizontal line indicates a stringent multiple-testing significance 
threshold (P = 1.66E-07) (see section 3.2.8). 
 
 
Figure 3.26. Manhattan plot for the hippocampus (HC) case-control 
schizophrenia EWAS. Shown are the log10(P-values) (y-axis) of the linear 
regression analysis of the HC data from the MRC London Neurodegenerative 
Diseases Brain Bank by chromosomal position (x-axis). The horizontal line 






Figure 3.27. Manhattan plot for the cerebellum (CER) case-control 
schizophrenia EWAS. Shown are the -log10(P-values) (y-axis) of the meta-
analysis of the CER of both the MRC London Neurodegenerative Diseases 
Brain Bank and Douglas-Bell Canada Brain Bank by chromosomal position (x-
axis). The horizontal line indicates a stringent multiple-testing significance 
























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.28. Heatmap showing the fifty top ranked schizophrenia-
associated differently methylated positions in the prefrontal cortex (PFC). 
Shown for each probe is the mean DNA methylation difference between cases 
and controls, with the corresponding difference at the same probe for the three 
other brain regions (striatum (STR), hippocampus (HC) and cerebellum (CER)) 
dissected from the same individuals. Probes are ordered by P-value for 






Figure 3.29. Heatmap showing the fifty top ranked schizophrenia-
associated differently methylated positions in the striatum (STR). Shown 
for each probe is the mean DNA methylation difference between cases and 
controls, with the corresponding difference at the same probe for the three other 
brain regions (prefrontal cortex (PFC), hippocampus (HC) and cerebellum 
(CER)) dissected from the same individuals. Probes are ordered by P-value for 






Figure 3.30. Heatmap showing the fifty top ranked schizophrenia-
associated differently methylated positions in the hippocampus (HC). 
Shown for each probe is the mean DNA methylation difference between cases 
and controls, with the corresponding difference at the same probe for the three 
other brain regions (prefrontal cortex (PFC), striatum (STR) and cerebellum 
(CER)) dissected from the same individuals. Probes are ordered by P-value for 







Figure 3.31. Heatmap showing the fifty top ranked schizophrenia-
associated differently methylated positions in the cerebellum (CER). 
Shown for each probe is the mean DNA methylation difference between cases 
and controls, with the corresponding difference at the same probe for the three 
other brain regions (prefrontal cortex (PFC), striatum (STR) and hippocampus 
(HC)) dissected from the same individuals. Probes are ordered by P-value for 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.33. Correlation between DNA methylation differences for the fifty 
top ranked schizophrenia-associated probes identified in identified in the 
prefrontal cortex and the DNA methylation differences in the same probes 
in the remaining brain regions (y-axis). Striatum = green; hippocampus = 





Figure 3.34. Correlation between DNA methylation differences for the fifty 
top ranked schizophrenia-associated probes identified in identified in the 
striatum and the DNA methylation differences in the same probes in the 
remaining brain regions (y-axis). Prefrontal cortex = blue; hippocampus = 





Figure 3.35. Correlation between DNA methylation differences for the fifty 
top ranked schizophrenia-associated probes identified in identified in the 
hippocampus and the DNA methylation differences in the same probes in 
the remaining brain regions (y-axis). Prefrontal cortex = blue; striatum = 





Figure 3.36. Correlation between DNA methylation differences for the fifty 
top ranked schizophrenia-associated probes identified in identified in the 
cerebellum and the DNA methylation differences in the same probes in the 
remaining brain regions (y-axis). Prefrontal cortex = blue; striatum = green; 


































































































































































































































































































































































































































































































3.3.4. Controlling for unknown confounding variables 
As mentioned previously (section 3.2.6), detailed data regarding medication, 
smoking status and other important phenotypical information was not available 
for the post-mortem samples used in this thesis and therefore I could not 
include these as independent variables in my analysis model. Because it is 
likely that these or other unmeasured factors beyond the variables included in 
my analysis model (i.e. age, sex, and neuronal proportion estimates) confound 
the analyses results, however, I investigated the impact of additional surrogate 
variables capturing variation in DNA methylation on the association statistics for 
schizophrenia-associated DMPs. 
To do this I repeated the EWAS linear regression iteratively including up to 10 
principal components (PCs) derived from the DNA methylation data as 
independent variables. I compared these to the DNA methylation differences 
from the initial analysis model. In all tissues, I observed a strong positive 
correlation for schizophrenia-associated DNA methylation differences between 
analyses (Figures 3.37 to 3.40). This sensitivity analysis implies that although 
additional confounders potentially exist in the dataset, the identified 
schizophrenia-associated DMPs are relatively robust to the major PCs 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.3.5. Enrichment of overlap between schizophrenia-associated 
differently methylated positions and regulatory features and 
GWAS regions 
The 450K array probes were annotated to TFBSs and DHSs using published 
data (Slieker et al., 2013, ENCODE Project Consortium, 2012, Maurano et al., 
2012) and the overlap between schizophrenia-associated DMPs identified in the 
different brain regions and these regulatory features tested for enrichment using 
a two sided Fisher’s 2x2 exact test (Fisher, 1922). Tables 3.11 to 3.14 present 
the results of these tests for all brain regions.  
The fifty top ranked probes from each brain region show no significant overlap 
with either of the regulatory features at the Bonferroni corrected threshold for 
the twenty-four tests (P = 2.08E-03). PFC schizophrenia-associated DMPs 
(Table 3.11) show a significant under-enrichment for TFBS at the significance 
threshold of P < 1.00E-03 (odds ratio (OR) = 0.78 and P = 4.61E-05) and P < 
0.05 (OR = 0.86 and P = 1.03E-39), and a significant under-enrichment for DHS 
at the significance threshold of P < 1.00E-03 (OR = 0.88 and P = 2.03E-26). In 
the STR (Table 3.12), DMPs associated with schizophrenia with a P < 0.05 
show an enrichment for both DHS (OR = 1.06 and P = 6.14E-05) and TFBS 
(OR = 1.11 and P = 4.38E-13). In the HC (Table 3.13), DMPs associated with 
schizophrenia with a P < 0.05 show an enrichment for TFBS (OR = 1.10 and P 
= 3.47E-11). ). In the CER (Table 3.14), DMPs associated with schizophrenia 






Table 3.11. Results of the Fisher’s 2x2 exact tests for significant overlap 
between schizophrenia-associated differently methylated positions 
(DMPs) in the prefrontal cortex and regulatory features. Shown are the 
results for overlap enrichment with the 50 top ranked probes, DMPs with an 
association P-value < 1.00E-03 and DMPs with an association P-value < 0.05. 




Odds ratio P Odds ratio P 
Top ranked 50 1.03 1 1.27 0.40 
P < 1.00E-03 0.83 3.03E-03 0.78 4.61E-05 
P <0.05 0.88 2.03E-26 0.86 1.03E-39 
Table 3.12. Results of the Fisher’s 2x2 exact tests for significant overlap 
between schizophrenia-associated differently methylated positions 
(DMPs) in the striatum and regulatory features. Shown are the results for 
overlap enrichment with the 50 top ranked probes, DMPs with an association P-
value < 1.00E-03 and DMPs with an association P-value < 0.05. DHS, DNA 




Odds ratio P Odds ratio P 
Top ranked 50 1.13 0.78 0.73 0.32 
P < 1.00E-03 1.11 0.21 1.05 0.58 
P <0.05 1.06 6.14E-05 1.11 4.38E-13 
Table 3.13. Results of the Fisher’s 2x2 exact tests for significant overlap 
between schizophrenia-associated differently methylated positions 
(DMPs) in the hippocampus and regulatory features. Shown are the results 
for overlap enrichment with the 50 top ranked probes, DMPs with an association 
P-value < 1.00E-03 and DMPs with an association P-value < 0.05. DHS, DNA 




Odds ratio P Odds ratio P 
Top ranked 50 2.00 0.02 1.94 0.02 
P < 1.00E-03 1.09 0.48 1.01 0.91 




Table 3.14. Results of the Fisher’s 2x2 exact tests for significant overlap 
between schizophrenia-associated differently methylated positions 
(DMPs) in the cerebellum and regulatory features. Shown are the results for 
overlap enrichment with the 50 top ranked probes, DMPs with an association P-
value < 1.00E-03 and DMPs with an association P-value < 0.05. DHS, DNA 
hypersensitivity sites; TFBS, transcription factor binding sites.  
 
I tested the same sets of DMPs (top ranked fifty, P < 1.00E-03 and P < 0.05) for 
significant overlap with probes within genomic regions associated with 
schizophrenia in the latest schizophrenia GWAS (Schizophrenia Working Group 
of the Psychiatric Genomics, 2014). A total of 5006, 5058, 5066 and 4951 
Illumina 450K array probes included in our PFC, STR, HC and CER analyses, 
respectively, were located within these broad genomic regions. None of the 
different sets of schizophrenia-associated DMPs from any of the brain regions 
show a significant overlap with GWAS regions (at Bonferroni corrected 










Odds ratio P Odds ratio P 
Top ranked 50 1.03 1.00 0.99 1.00 
P < 1.00E-03 1.06 0.26 1.08 0.11 




Table 3.15. Results of the Fisher’s 2x2 exact tests for significant overlap 
between schizophrenia-associated differently methylated positions 
(DMPs) in all the brain regions and GWAS regions. Shown are the results for 
the overlap between the 50 top ranked probes, DMPs with an association P-
value < 1.00E-03 and DMPs with an association P-value < 0.05. OR = odds 
ratio and probes within genomic regions associated with schizophrenia 
(Schizophrenia Working Group of the Psychiatric Genomics, 2014). 
  PFC   
OR 




HC  OR HC  P CER 
OR 
CER P 
Top ranked 50 1.66 0.46 1.66 0.46 0.00 1.00 0.00 1.00 
P < 1.00E-03 0.62 0.20 0.52 0.27 0.56 0.59 0.97 1.00 
P <0.05 0.94 0.28 1.08 0.24 1.01 0.92 0.98 0.73 
 
3.3.6. Differentially methylated regions associated with 
schizophrenia 
I next used comb-p (Pedersen et al., 2012) (section 3.2.6) to identify spatially 
correlated regions of differential DNA methylation significantly associated with 
schizophrenia (Šidák-corrected P < 0.05, number of consecutive probes ≥ 2) in 
each of the 4 brain regions (Figure 3.41 and Table 3.16). One region 
(PRSS30P; TMPRSS8) was identified in both PFC and CER and seven regions 
showed a nominally significant association with schizophrenia (median P-value 
across all probes) in at least one other brain region (GBP4, PRDM9, 
FAM24B/LOC399815, CAT, TFDP1/TMCO3, PRSS30P/TMPRSS8, 
DOC2B/RPH3AL). Although the remaining 18 regions were associated with 
disease in only one brain region, many of these DMRs are characterised by 
consistent schizophrenia-associated differences in DNA methylation across 





































































































































































































































































Of note, DMRs were identified in the vicinity of several genes previously 
implicated in the etiology of schizophrenia including PRDM9; this gene encodes 
a protein with histone H3K4 trimethyltransferase activity during meiosis (Berg et 
al., 2010) and has been previously hypothesised to play a role in schizophrenia 
(Crow, 2011). Two different sets of probes in the transcription start site of 
PRDM9 (chr5:23506738-23507031; chr5:23507450-23507657) show significant 
hypermethylation in the CER. The probe in between these two regions 
(cg25336267) was excluded during QC thus it is possible that the entire region 
chr5:23506738-23507657 within the PRDM9 gene is significantly associated 
with schizophrenia in the CER. The chr19:19639970-19640076 DMR within the 
YjeF N-terminal domain containing 3 (YJEFN3) gene identified in the PFC 
overlaps with the chr19:19374022-19658022 region identified in the latest 
schizophrenia GWAS (most significant association: rs2905426 – P = 3.63E-10) 
(Schizophrenia Working Group of the Psychiatric Genomics, 2014). Additionally, 
a region in chr6:30853948-30854234 is significantly associated with 
schizophrenia in PFC and located within the discoidin domain receptor tyrosine 
kinase 1 (DDR1) gene. This gene has been shown to be upregulated during 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.3.6.1. Differently methylated region in chromosome 17 
A DMR spanning four probes within an intron of the RPH3AL gene on 
chromosome 17, which encodes a protein that plays a direct regulatory role in 
calcium-ion-dependent exocytosis, is consistently hypomethylated in 
schizophrenia patients across all four brain regions (PFC: median DNA 
methylation difference = -8.03%, median P = 8.27E-04; STR: median DNA 
methylation difference = -5.32%, median P = 7.14E-03; HC: median DNA 
methylation difference = -7.84%, median P = 1.78E-02; CER: median DNA 
methylation difference = -10.24, median P = 3.86E-03) (Figures 3.42 A and B, 
Figures 3.43 A and B and Figures 3.44 to 3.46). A consecutive probe 
(cg15212418 - chr17:155046) also showed significant hypomethylation in PFC, 
STR and CER (PFC: DNA methylation difference = -7.39%, P = 1.24E-3; STR: 
DNA methylation difference = -9.74%, P = 2.86E-05; CER: DNA methylation 
difference = -9.30%, P = 2.12E-3). This probe was not contained in the DMR, 
probably due to the window size used in comb-p (300bp), but it is clearly part of 
a coordinated sequence of differently methylated CpGs (Figures 3.44 to 3.46). 
Interestingly, this probe shows a dramatic Bonferroni-significant increase in 
DNA methylation associated with brain development in a study by our group 
using fetal brain samples (regression coefficient= 0.29, P = 2.56E-10 in Spiers 
et al. (2015)) (Figure 3.47). This is particularly interesting since schizophrenia 
has been suggested to have neurodevelopmental origins (Owen et al., 2011, 
Weinberger, 1995). The probes within this DMR are also annotated to the 
double C2-like domains beta (DOC2B) gene in the GREAT annotation database 
(McLean et al., 2010). The DMR is located upstream the transcription start site 
of this gene (Figures 3.44 to 3.46), which encodes a protein that regulates 
calcium-dependent neurotransmitter release in synapses (Groffen et al., 2010).  
Synapses are the junctions between two neurons that allow the electrical or 
chemical signal to pass from one neuron to the other. Synaptic dysfunction has 








To validate the differences identified across this DMR using the Illumina 450K 
array we employed bisulfite-PCR-pyrosequencing to quantify DNA methylation 
across an amplicon spanning three CpG sites (cg11940040 and two adjacent 
CpG sites not on the 450K array) in the PFC (n = 35 schizophrenia and 36 
controls) and STR (n = 36 schizophrenia and 41 controls) samples (Appendix 
A - Supplementary Table 2 presents samples excluded in the 
pyrosequencing). All three sites were significantly hypomethylated in 
schizophrenic patients compared to controls in both brain regions (Table 3.17 
and Figures 3.42 C and 3.43 C), with DNA methylation differences reflecting 
those identified using the 450K array (PFC: average DNA methylation 
difference = -8.68%, P = 1.72E-03; STR: average DNA methylation difference = 






Figure 3.42. Validation of a schizophrenia-associated hypomethylated 
region within the RPH3AL gene in the prefrontal cortex (PFC). The 
chr17:154410-154672 schizophrenia-associated region identified using the 
Illumina 450K array (A and B) in the PFC samples. We used bisulfite-PCR-
pyrosequencing to validate schizophrenia-associated hypomethylation at 





Figure 3.43. Validation of a schizophrenia-associated hypomethylated 
region within the RPH3AL gene in the striatum (STR). The chr17:154410-
154672 schizophrenia-associated region identified using the Illumina 450K 
array (A and B) in the PFC samples. We used bisulfite-PCR-pyrosequencing to 
validate schizophrenia-associated hypomethylation at cg11940040 and two 





Figure 3.44. Manhattan plot showing the probes within 50 kilobases of the 
chr17:154410-154672 region in the prefrontal cortex. Shown are the -
log10(P-values) (y-axis) of the meta-analysis of the prefrontal cortex by 
chromosomal position (x-axis). The points in lighter blue show the probes 
identified in the differently methylated region and the triangle shape shows the 
cg11940040 probe. 
 
Figure 3.45. Manhattan plot showing the probes within 50 kilobases of the 
chr17:154410-154672 region in the striatum. Shown are the -log10(P-values) 
(y-axis) of the meta-analysis of the striatum by chromosomal position (x-axis). 
The points in lighter green show the probes identified in the differently 






Figure 3.46. Manhattan plot showing the probes within 50 kilobases of the 
chr17:154410-154672 region in the cerebellum. Shown are the -log10(P-
values) (y-axis) of the meta-analysis of the cerebellum by chromosomal position 
(x-axis). The points in lighter orange show the probes identified in the differently 
methylated region and the triangle shape shows the cg11940040 probe. 
 
Figure 3.47. Probe cg15212418 shows dramatic DNA methylation (y-axis) 
changes associated with developmental age (x-axis) in fetal brain samples 
(Spiers et al., 2015). This probe shows significant DNA hypomethylation in 
schizophrenia brains and is adjacent to the schizophrenia-associated DMR in 























































































































































































































































































































































































































































































3.3.7. Consistent methylomic markers of schizophrenia across 
brain regions 
I next employed a multi-level model to further explore consistent schizophrenia-
associated differences across multiple brain regions (see section 3.2.9). As 
reported in previous analyses of epigenetic variation in the human brain (Davies 
et al., 2012, Hannon et al., 2016, Ladd-Acosta et al., 2007), my data indicate 
that the CER is very distinct at a global level to the other three brain regions 
included in this study (Figures 3.5  and 3.6); for this reason I excluded the CER 
from the cross-region model and focused on identifying consistent signals 
across the PFC, STR and HC. Figures 3.48 and 3.49 present the QQ and 
Manhattan plot for this analysis, respectively. Of note, there is some inflation in 
the distribution of P-values in the multi-region case-control analysis (λ = 1.43); 
although the multilevel model used is designed to control for the non-
independence of brain regions from the same individual, it is possible that 
combining datasets has resulted in some residual inflation. Compared to other 
published EWAS analyses, however, this inflation is relatively modest and I did 
not identify an excessively large number of DMPs passing our stringent family-
wise significance threshold. Table 3.18 and Figure 3.50 lists the fifty top ranked 
cross-region DMPs.  
Although no DMP reached the highly stringent multiple testing significance 
threshold (P < 1.66E-07, see section 3.2.8), some cross-region DMPs are of 
interest. For example, the cg07500432 shows consistent schizophrenia-
associated hypermethylation in all three brain regions. This probe is within an 
intron of the par-6 family cell polarity regulator gamma (PARD6G) gene, which 
encodes a protein involved in asymmetrical cell division and cell polarization 
processes. Of more interest is the fact that this probe is also annotated to the 
activity-dependent neuroprotective protein homeobox 2 (ADNP2) gene in the 
GREAT annotation (McLean et al., 2010) (the probe is located 51,674kb 
upstream the ADNP2 gene). This gene is highly expressed in the brain 
compared to other tissues and has been suggested to play a role in 
neurodevelopment (Kushnir et al., 2008) and has been previously implicated in 
schizophrenia (Merenlender-Wagner et al., 2015). The DMP analysis also 
provides further support for several loci identified in our previous study of 




05), RASA3 (cg24803255: P = 1.51E-04), PPFIA1 (cg08171022: P = 1.19E-02) 
and MYT1L (cg00236305: P = 4.62E-04) (Table 3.19), suggesting that DNA 
methylation differences at these loci consistent effects across the three regions.  
Significant schizophrenia-associated cross-region DMRs are presented in Table 
3.20 and Figure 3.51. Of note, the top ranked cross-region DMRs include a 
highly-significant signal spanning 11 CpG sites (Šidák-corrected P = 8.90E-11) 
annotated to WNT5A, an important neurodevelopmental locus (Horigane et al., 
2016), in addition to regions annotated several loci discussed above such as 
GBP4 (Šidák-corrected P = 0.01), PRDM9 (Šidák-corrected P = 0.04) and 






Figure 3.48. Quantile-quantile plot for case-control schizophrenia EWAS. 
Shown are the expected (x-axis) and observed (y-axis) quantiles observed in 
the multi-level model including data from the PFC, STR and HC.  
 
Figure 3.49. Manhattan plot for case-control schizophrenia EWAS. Shown 
are the log10(P-values) (y-axis) of the multi-level model including data from the 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3.50. Heatmap showing the fifty top ranked schizophrenia-
associated differently methylated positions identified using a multi-region 
model incorporating prefrontal cortex (PFC), striatum (STR) and 
hippocampus (HC). Shown for each probe is the DNA methylation difference 
between cases and controls, with the corresponding difference at the same 
probe for the three individual brain regions. Probes are ordered by P-value for 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































 Discussion  3.4.
3.4.1. Overview of results 
In this study I quantified genome-wide patterns of DNA methylation in post-
mortem brain samples isolated from PFC, STR, HC and CER obtained from 
three independent cohorts of schizophrenia patients and controls. One of the 
cohorts was removed from analyses during stringent QC steps due to the 
detection of the incorrect tissue type for one brain region, and the two remaining 
cohorts were used in all subsequent analyses. I identified numerous DMPs and 
DMRs associated with disease in each individual brain region. Although the 
specific list of top ranked DMPs identified in each brain region is distinct, many 
of these were characterised by consistent effects across brain regions. The 
multilevel model across PFC, STR and HC data identified differential 
methylation in DMPs and DMRs across all three brain regions.  
Genes annotated to several of the schizophrenia-associated DMPs and DMRs 
identified have been previously implicated in the pathophysiology of 
schizophrenia or have relevant roles in brain function; such as NCAM1 (which 
encodes a neural cell adhesion molecule with a well-established role in 
neurodevelopment and synaptic plasticity) (Sunshine et al., 1987, Ronn et al., 
1998), SYNPO (which encodes a actin-associated protein that is associated 
with postsynaptic densities and dendritic spines and differentially expressed in 
schizophrenia brain) (Focking et al., 2015), GBP4 (which encodes a gene that 
has been found to be differentially expressed in schizophrenia patients) 
(Sanders et al., 2013) and PRDM9 (which encodes a protein with histone H3K4 
trimethyltransferase activity during meiosis that has been previously 
hypothesized to play a role in schizophrenia) (Berg et al., 2010, Crow, 2011), 
among others. 
There is no evidence for enrichment of probes within TFBS and DHS regions in 
the fifty top ranked DMPs for each brain region. At more relaxed thresholds of 
significance, however, the PFC DMPs show a significant under-enrichment for 
TFBS and DHS, the STR and CER DMPs show a significant enrichment for 





Despite this being, to my knowledge, the first study to quantify DNA methylation 
across four different brain regions from schizophrenia patients and controls, 
using samples from independent brain banks, this study has a number of 
important limitations.  
First, the number of samples assessed in this study is relatively low, especially 
for analyses involving the HC, which was only available from one of the two 
cohorts used in the analyses. The small number of samples limits the power to 
detect significant associations with schizophrenia (Dempster et al., 2013). 
Future efforts by the community should focus on extending participation in 
brain-banking efforts to maximise the number of samples available for 
molecular epidemiology. Second, these data arise from measuring DNA 
methylation at a single, post-mortem time point. Given the dynamic nature of 
epigenetic processes, it would be important to measure DNA methylation in the 
living brain at different time points, which is currently impossible. 
Third, because epigenetic processes play an important role in defining cell type-
specific patterns of gene expression (Roadmap Epigenomics Consortium et al., 
2015, Talens et al., 2010, Varley et al., 2013), the use of bulk tissue from each 
brain region is a potential confounder in DNA methylation studies (Guintivano et 
al., 2013, Heijmans and Mill, 2012). Despite my efforts to control for the effect of 
cell type diversity in DNA methylation quantification in the analyses using in 
silico approaches to estimate neuronal proportions, this approach is not suitable 
to estimate the neuronal proportion in the CER and cannot inform about disease 
relevant DNA methylation changes specific to individual brain cell types.  
Forth, there is increasing awareness of the importance of 5-hydroxymethyl 
cytosine (5-hmC) in the human brain (Branco et al., 2012, Kriaucionis and 
Heintz, 2009), although this modification cannot be distinguished from DNA 
methylation using standard bisulfite-based approaches (Lunnon et al., 2016b, 
Booth et al., 2012). It is therefore plausible that many of the differences 
identified in this study are confounded by modifications other than DNA 
methylation. To date and to my knowledge, no study has evaluated the role of 




profiling methods should make this feasible in the near future (Lunnon et al., 
2016b). Future work by our group and others is focussing on using novel single-
cell approaches to examine cellular heterogeneity in complex tissues such as 
the brain and facilitate the identification of pathological changes in specific cells 
(and cell types). 
Finally, although I controlled for age, sex and neuronal composition estimates 
(where possible) in the analyses, it is plausible that other factors may be 
confounding the case-control analyses of schizophrenia. For example, 
epidemiological data highlights a much higher rate of smoking in schizophrenia 
patients compared to unaffected controls (Dalack et al., 1998, de Leon and 
Diaz, 2005). Although smoking has been shown to have striking effects on DNA 
methylation in blood (Elliott et al., 2014), none of the robust smoking-associated 
DMPs identified in blood are amongst the schizophrenia DMPs identified in any 
of the four brain regions assessed in this chapter. Furthermore, I investigated 
the impact of including additional PC as independent variables capturing 
variation in DNA methylation on the association statistics for schizophrenia-
associated DMPs, finding that the identified schizophrenia-associated DMPs 
are relatively robust to the major PCs associated with methylomic variance. 
3.4.3. Implications, strengths and future directions 
Despite the relatively small sample size, I was able to identify a number of 
DMPs and DMRs passing the stringent significance threshold in both the 
analyses of diagnosed schizophrenia. Furthermore, although the magnitude of 
DNA methylation change at the differentially methylated loci was relatively small 
(i.e. involving a relative small proportion of cells in a given brain region), we 
were able to technically validate the Illumina 450K array data using bisulfite-
pyrosequencing. Definitively distinguishing cause from effect in epigenetic 
epidemiology is difficult, especially for disorders like schizophrenia that manifest 
in inaccessible tissues such as the brain and are therefore particularly refractory 
to longitudinal study (Heijmans and Mill, 2012). However, the observation of 
consistent changes across multiple brain regions in two independent cohorts for 
many DMPs and DMRs suggests that the identified loci are potentially directly 





Finally, although this study presents novel evidence for associations between 
schizophrenia diagnosis and variable DNA methylation across different brain 
regions, replication using larger sample sizes is required to further support 
these results. Future studies should focus on understanding the transcriptional 
consequences of the observed associations, and testing whether these 
associations are causal or a consequence of disease and/or medication.   
In summary, these data provide evidence for extensive differences in DNA 
methylation across multiple brain regions in schizophrenia. To my knowledge, 
this study represents the first analysis of epigenetic variation associated with 




Chapter 4 - Methylomic profiling of schizophrenia 
polygenic risk burden in the brain 
 Introduction 4.1.
Twin and family studies have highlighted a notable heritable component to 
schizophrenia (Craddock et al., 2005), however the role of genetic variation in 
the etiology of the disorder is complex. Rare, highly penetrant inherited and de 
novo mutations have been implicated in some cases of schizophrenia (Xu et al., 
2011, St Clair et al., 1990, Stefansson et al., 2014, Purcell et al., 2014), 
although susceptibility is predominantly attributed to the action of common 
genetic variants of low penetrance. Recently, a large-scale genome-wide 
association study (GWAS) identified 108 independent genomic loci exhibiting 
genome-wide significant association with schizophrenia (Schizophrenia Working 
Group of the Psychiatric Genomics, 2014).  
Genetic variation has been shown to influence DNA methylation in the human 
brain (Gibbs et al., 2010, Gamazon et al., 2013). Genetic variants associated 
with variation in DNA methylation levels are denoted methylation quantitative 
trait loci (mQTLs) and evidence suggest that genetic mediation of the 
methylome provides a link between genetic variation and the establishment of 
complex phenotypes (Wagner et al., 2014, Gutierrez-Arcelus et al., 2013). 
Recent publications from our group and others have studied the implication of 
mQTLs (Hannon et al., 2016, Jaffe et al., 2016) in schizophrenia, providing 
support for the hypothesis that common variants associated with schizophrenia 
may function through directly influencing the methylome to affect the disease 
phenotype. 
Polygenic risk scores (PRS) are defined as the sum of trait-associated alleles 
across many genetic loci, weighted by effect sizes estimated by GWAS 
analyses. There has been recent interest in using PRS as disease biomarkers, 
although their utility for exploring the molecular genomic mechanisms involved 
in disease pathogenesis is largely unexplored. For example, PRS-associated 
epigenetic variation is potentially less affected by factors associated with the 
disease itself (e.g. medication exposure, stress, and smoking), which can 




The most recent schizophrenia GWAS (Schizophrenia Working Group of the 
Psychiatric Genomics, 2014) calculated that a schizophrenia PRS derived from 
all independent nominally significant associated alleles (association P-
value < 0.05) captures about 7% of total liability for the disorder in an European 
population. Although this is not currently useful for clinical risk predication, it 
could be predictive of chronicity, treatment resistance or useful in the 
stratification of patients (O'Donovan, 2015). So far schizophrenia PRS have 
been used to investigate several schizophrenia-linked traits such as creativity 
(Power et al., 2015), cognitive decline (Liebers et al., 2016) and antipsychotic 
drug response (Frank et al., 2015). A recent study suggests that schizophrenia 
PRS correlates with negative symptoms and anxiety disorder but not with 
psychotic experiences or depression in adolescents from a population-based 
birth cohort (Jones et al., 2016). 
Despite the recent advances in understanding the genetic epidemiology of 
schizophrenia, little is known about the mechanisms by which schizophrenia 
risk variants mediate disease susceptibility in the brain (Fullard et al., 2016, 
Psych et al., 2015). In this chapter I investigate whether schizophrenia PRS 
impacts on DNA methylation, and whether this impact is independent from 
direct genetic effects on DNA methylation (i.e. mQTLs). I identified several 
differently methylated positions (DMP) and regions (DMR) in all four brain 
regions investigated and across brain regions. I show that these associations, 
showing that PRS-associated loci are independent from disease-associated 
methylomic variation and are not the consequence of cis-acting brain mQTLs. 
These data highlight the utility of PRS for identifying molecular pathways 





4.2.1. Samples genotyping and quality control 
The 88 individuals (n = 41 schizophrenia patients and n = 47 non-psychiatric 
controls) from the LNDBB and DBCBB used in the final DNA methylation 
dataset (see Chapter 3) were selected for genotyping. Detailed information 
about the sample cohorts is given in Chapter 3 Section 3.2.1 and 
Supplementary Table 1 and detailed DNA extraction information is described 
in Chapter 2 section 2.2. Genomic DNA (~200 ng) from each individual was 
used for genotyping on the Illumina Infinium HTS HumanOmniExpress-24 
BeadChip v1-0 using an iScan Microarray Scanner (Illumina, San Diego, CA, 
USA), and I processed each sample according to manufacturer’ standard 
instructions. The brain region of origin of each genotyped sample is given in 
Table 4.1. Illumina GenomeStudio software was used for genotype calling and 
the data were exported as .ped and .map files. PLINK (Purcell et al., 2007) was 
used to remove samples with > 5% missing data and SNPs with > 1% missing 
values, Hardy-Weinberg equilibrium P < 1.00E-03 or minor allele frequency of < 
5%.  
Table 4.1. Table showing the brain region of origin of the DNA samples 
genotyped in the present chapter. Detailed information of all samples of all 
samples is presented in Appendix A - Supplementary Table 1. 
Individual Brain Bank Group 
Brain region used 
for genotyping 
Genotyping array barcode 
1 LNDBB schizophrenia prefrontal cortex 7942519024_R03C01 
2 LNDBB schizophrenia prefrontal cortex 7942519024_R02C02 
3 LNDBB schizophrenia prefrontal cortex 7942519009_R02C01 
4 LNDBB schizophrenia prefrontal cortex 7942519009_R05C02 
5 LNDBB schizophrenia prefrontal cortex 7930649111_R01C01 
6 LNDBB schizophrenia prefrontal cortex 7942519009_R03C01 
7 LNDBB schizophrenia prefrontal cortex 7930649111_R04C02 
8 LNDBB schizophrenia prefrontal cortex 7942519009_R04C02 
9 LNDBB schizophrenia prefrontal cortex 7942519009_R01C01 
10 LNDBB schizophrenia prefrontal cortex 7942519009_R04C01 
11 LNDBB schizophrenia prefrontal cortex 7930649095_R06C01 
12 LNDBB schizophrenia striatum 9933568129_R04C02 
13 LNDBB schizophrenia prefrontal cortex 7930649111_R03C02 
14 LNDBB schizophrenia prefrontal cortex 7930649111_R03C01 
15 LNDBB schizophrenia prefrontal cortex 7930649095_R03C02 
16 LNDBB schizophrenia prefrontal cortex 7942519009_R06C02 
17 LNDBB schizophrenia prefrontal cortex 7942519024_R06C02 
18 LNDBB schizophrenia prefrontal cortex 7942519024_R04C02 
19 LNDBB schizophrenia prefrontal cortex 7942519024_R05C01 
20 LNDBB schizophrenia prefrontal cortex 7930649095_R05C02 
21 LNDBB schizophrenia prefrontal cortex 7930649095_R01C01 
23 LNDBB schizophrenia prefrontal cortex 7942519009_R01C02 
24 LNDBB schizophrenia prefrontal cortex 7942519024_R01C01 




26 LNDBB control prefrontal cortex 7930649095_R03C01 
27 LNDBB control striatum 9933568081_R07C01 
28 LNDBB control prefrontal cortex 7930649095_R04C02 
30 LNDBB control prefrontal cortex 7942519009_R02C02 
31 LNDBB control prefrontal cortex 7942519009_R06C01 
32 LNDBB control prefrontal cortex 7930649111_R05C02 
33 LNDBB control prefrontal cortex 7930649095_R02C01 
34 LNDBB control striatum 9933568081_R04C01 
35 LNDBB control prefrontal cortex 7942519024_R01C02 
36 LNDBB control striatum 9933568129_R06C02 
37 LNDBB control prefrontal cortex 7930649111_R02C01 
38 LNDBB control prefrontal cortex 7942519024_R06C01 
39 LNDBB control striatum 9933568129_R11C02 
40 LNDBB control prefrontal cortex 7930649095_R02C02 
41 LNDBB control prefrontal cortex 7942519024_R05C02 
42 LNDBB control prefrontal cortex 7930649095_R04C01 
43 LNDBB control striatum 9933568081_R08C01 
44 LNDBB control prefrontal cortex 7930649111_R06C02 
45 LNDBB control prefrontal cortex 7930649111_R01C02 
46 LNDBB control prefrontal cortex 7930649111_R05C01 
47 LNDBB control prefrontal cortex 7942519009_R03C02 
49 LNDBB control prefrontal cortex 7930649095_R01C02 
50 LNDBB control striatum 9933568081_R11C01 
51 LNDBB control prefrontal cortex 7930649111_R04C01 
52 LNDBB control prefrontal cortex 7942519024_R02C01 
53 LNDBB control prefrontal cortex 7942519024_R04C01 
54 LNDBB control prefrontal cortex 7930649111_R02C02 
MS01 DBCBB schizophrenia cerebellum 9933568081_R02C01 
MS02 DBCBB schizophrenia prefrontal cortex 9933568129_R11C01 
MS03 DBCBB schizophrenia cerebellum 9933568157_R06C02 
MS04 DBCBB schizophrenia cerebellum 9933568129_R03C01 
MS05 DBCBB control cerebellum 9933568129_R09C01 
MS06 DBCBB schizophrenia striatum 9933568129_R08C01 
MS07 DBCBB schizophrenia cerebellum 9933568129_R12C02 
MS08 DBCBB control cerebellum 9933568129_R07C01 
MS09 DBCBB control striatum 9933568129_R08C02 
MS10 DBCBB control striatum 9933568129_R09C02 
MS11 DBCBB schizophrenia prefrontal cortex 9933568129_R03C02 
MS12 DBCBB schizophrenia striatum 9933568129_R06C01 
MS13 DBCBB control cerebellum 9933568129_R04C01 
MS14 DBCBB control striatum 9933568129_R10C01 
MS15 DBCBB control striatum 9933568081_R05C01 
MS16 DBCBB control striatum 9933568129_R02C02 
MS17 DBCBB control striatum 9933568129_R02C01 
MS18 DBCBB schizophrenia striatum 9933568157_R12C02 
MS19 DBCBB control cerebellum 9933568081_R06C01 
MS20 DBCBB schizophrenia striatum 9933568129_R01C01 
MS21 DBCBB schizophrenia striatum 9933568081_R10C01 
MS22 DBCBB control striatum 9933568129_R07C02 
MS23 DBCBB schizophrenia striatum 9933568129_R10C02 
MS24 DBCBB control striatum 9933568081_R09C01 
MS25 DBCBB schizophrenia striatum 9933568157_R05C02 
MS26 DBCBB control striatum 9933568157_R08C02 
MS27 DBCBB schizophrenia striatum 9933568157_R07C02 
MS28 DBCBB schizophrenia striatum 9933568081_R03C01 
MS29 DBCBB schizophrenia cerebellum 9933568157_R09C02 
MS30 DBCBB schizophrenia striatum 9933568157_R10C02 
MS31 DBCBB control striatum 9933568129_R01C02 
MS32 DBCBB schizophrenia striatum 9933568129_R05C01 
MS33 DBCBB control striatum 9933568081_R01C01 
MS34 DBCBB control prefrontal cortex 9933568157_R11C02 
MS35 DBCBB control striatum 9933568129_R12C01 




4.2.2. Ethnicity prediction 
Sample ethnicity was determined by merging the genotypes with data from 
HapMap Phase 3 (Wellcome Trust Sanger Institute, 2016) and linkage 
disequilibrium (LD) pruning the overlapping SNPs such that no pair of SNPs 
within 1500 bp had r2 > 0.20. GCTA software (Yang et al., 2011) was then used 
to calculate principal components (PC) of the genetic data, which were visually 
inspected to predict ethnicity for each sample (Figure 4.1) by comparison with 
the known ethnicities of the HapMap sample. The schizophrenia GWAS used to 
calculate schizophrenia PRS in this chapter was carried out mainly in patients of 
European ancestry. Therefore I decided to exclude samples predicted as 
ancestry outliers (non-Caucasians; PC 2 < 0.03; n = 10) from further analyses 
of PRS, to avoid population stratification. In general these samples show higher 
schizophrenia PRS than Caucasian samples regardless of disease status 
(Figure 4.2) (see section 4.2.3 for PRS calculation), hence their inclusion could 
confound results. Sentrix barcodes and sample exclusion criteria are presented 
in Appendix A - Supplementary Table 2. 
 
Figure 4.1. Principal components (PC) 1 and 2 of genetic data for both the 
MRC London Neurodegenerative Diseases Brain Bank (LNDBB) and the 
Douglas-Bell Canada Brain Bank (DBCBB) cohorts. The samples with a PC 
2 < 0.03 (red line) were determined as ancestry outliners and removed from all 





Figure 4.2. Principal component 2 of genetic data for both the MRC 
London Neurodegenerative Diseases Brain Bank (circle) and the Douglas-
Bell Canada Brain Bank (triangle) vs respective polygenic risk scores 
(PRS). The samples with a principal component 2 < 0.03 (green line) were 
determined as ancestry outliners and removed from all the polygenic risk score 
analyses. In general, non-Caucasian samples show higher PRS than 
Caucasian samples regardless of whether they are schizophrenia cases (green) 




4.2.3. Polygenic risk score calculation 
To impute variation at SNPs not present on the array used in this study (see 
Section 4.2.1), genotypes were recoded into .vcf files using PLINK1.9 (Chang 
et al., 2015) and VCFtools (Danecek et al., 2011) before uploading to the 
Michigan Imputation Server (Cloudgene, 2016), which uses SHAPEIT 
(Delaneau et al., 2012) to phase haplotypes, and Minimac3 (Howie et al., 2012) 
with the most recent 1000 Genomes reference panel (phase 3, version 5) 
(EMBL-EBI, 2016).  
PRS were calculated in PLINK (Purcell et al., 2007) using the imputation 
dosages and the score file downloaded from the Psychiatric Genomics 
Consortium (PGC) website (Psychiatric Genomics Consortium, 2015) where 
schizophrenia GWAS results have been clumped, retaining the best association 
(identified by P-value) in each LD block. Data from all the schizophrenia-
associated genetic variants at a P-value < 0.05 (a total of 99,940 genetic 
variants) were included because this was the association threshold at which  
SNPs explained the most variance (Psychiatric Genomics Consortium, 2015). 
PRS for each sample are presented in Appendix A - Supplementary Table 1. 
4.2.4. DNA methylation data 
The DNA methylation data from the PFC (33 schizophrenia and 34 controls), 
STR (32 schizophrenia and 39 controls), HC (11 schizophrenia and 12 controls) 
and CER (33 schizophrenia and 35 controls) samples used in this chapter were 
pre-processed and normalised as described in Chapter 3 section 3.2.3 and the 
probes included in all the analyses are the same (Table 3.2). Detailed 
demographic data of all samples are presented in Appendix A - 
Supplementary Table 1. Table 4.2 presents summary demographic 
information on the samples included in this chapter and Appendix A - 
Supplementary Table 2 presents reasons for exclusion for both DNA 
methylation and genotyping data and barcode array information. Neuronal 
proportion estimates for each sample were calculated using the CETS package 
in R (Guintivano et al., 2013) for each brain region, as described in Chapter 3, 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.2.5. Identification of differentially methylated positions and 
regions  
To identify PRS-associated DNA methylation differences at the single probe 
level in each brain region I performed a linear regression of the pre-processed 
and normalised DNA methylation (β) values in each cohort using the imputed 
PRS, age, sex and neuronal proportion estimates as independent variables.  
Neuronal proportion estimates were not included as independent variables in 
the CER analysis for reasons described in Chapter 3 section 3.2.5. Given the 
nature of the samples used in this study, information about medication, smoking 
status and other phenotypic information was not available and could not be 
included as covariates in analyses. The adjusted DNA methylation values for 
each probe and sample were calculated as described in Chapter 3 section 
3.2.6. 
The resulting P-values of the linear regression in the HC LNDBB data were 
used to identify differently methylated positions (DMPs) in this brain region. For 
tissues collected from both brain banks (i.e. PFC, STR and CER), a fixed-effect 
meta-analysis based on the linear regression estimates and their standard 
errors was computed with inverse variance weights using the metagen function 
from the meta package in R (Schwarzer, 2015). Only probes that passed the 
stringent QC metrics and were common to both cohorts in each brain region 
were used in the meta-analysis (Table 3.2 in Chapter 3). 
To identify differentially methylated regions (DMRs), I identified spatially 
correlated P-values in the data using the Python module comb-p (Pedersen et 
al., 2012) to group spatially correlated DMPs (seed P-value < 1.00E-3, minimum 
of two probes) at a maximum distance of 300bp in each brain region. DMR P-
values were corrected for multiple testing using Šidák correction (Šidák, 1967), 
which corrects the combined P for na/nr tests, where na is the total number of 





4.2.6. Additional probe annotation and enrichment analysis for 
regulatory regions 
I annotated the probes on the Illumina 450K array using the GREAT annotation 
tool (McLean et al., 2010). Probes were also annotated to transcription factor 
binding sites (TFBSs) and DNase1 hypersensitivity sites (DHSs) (Slieker et al., 
2013, ENCODE Project Consortium, 2012, Maurano et al., 2012). Details on 
these annotations are provided in Chapter 3 section 3.2.7.  The overlap 
between these regulatory features and different thresholds of DMPs (50 top 
ranked, DMPs P < 1.00E-03 and DMPs P < 0.05) were tested for enrichment 
using a two sided Fisher’s 2x2 exact test (Fisher, 1922). 
The overlap between the 450K probes within genomic regions identified in the 
latest GWAS (Schizophrenia Working Group of the Psychiatric Genomics, 
2014) (see Chapter 3 section 3.2.7) and  the same thresholds of DMPs for 
each brain region was also tested for enrichment using a two sided Fisher’s 2x2 
exact test (Fisher, 1922). 
4.2.7. Establishing multiple testing significance threshold for 
EWAS analysis 
To establish a stringent multiple-testing significance threshold to identify 
schizophrenia-associated DMPs, the data from another large schizophrenia 
Illumina 450K dataset (n = 675 individuals) from an ongoing study in our lab 
(Hannon E et al., under review) were randomly split into cases and controls 
5,000 times, and for each permutation an EWAS was performed using a linear 
regression model controlling for age, sex, smoking and cell composition and the 
probe-level P-values were recorded. The minimum (or most significant) P-value 
was identified for each permutation and the 5th quantile across the permutations 
was used to estimate the nominal P-value for 5% family-wise error (P = 1.66E-
07). 
4.2.8. Cross-tissue mixed model 
To identify homogeneous DNA methylation effects across PFC, STR and HC 
data a null model of no heterogeneity was fitted using disease, sex, age and 
cohort as fixed effects. I excluded the CER from the multi-region model for 




dissected from the same set of individuals, each individual’s DNA methylation 
values are potentially non-independent across brain regions. In addition, DNA 
methylation values within a brain region are also expected to be correlated 
across individuals, therefore both of these covariates were included as random 
effects. The comb-p algorithm (Pedersen et al., 2012) was then used to identify 
significant DMRs across the three brain regions, using the P-values of the 
cross-region model as described in section 4.2.5.  
4.2.9. Methylation quantitative trait loci 
To test whether the PRS associations identified reflect a direct cis-genetic effect 
on DNA methylatyion, we next characterized brain mQTLs associated with the 
99,904 variants included in the PRS calculation, using a genome-wide mQTL 
significance threshold of P = 3.69E-13, as described in a recent paper from our 
group (Hannon et al., 2016). In summary, an additive linear model was fitted to 
test if the number of alleles (coded 0, 1 and 2) predicted DNA methylation at 
each site, including covariates for age, sex, brain bank and the first two principal 
components from the genotype data to control for ethnicity differences. Given 
the low number of samples from the HC, mQTL analyses were not performed 
for this brain region. 
 Results 4.3.
4.3.1. Overview of experimental strategy 
In Chapter 3, I identify schizophrenia-associated DNA methylation differences 
in the PFC, STR, HC and CER samples from the LNDBB and DBCBB cohorts 
using the Illumina Infinium HumanMethylation450 BeadChip (Illumina Inc., San 
Diego, CA, USA) (see Chapter 3). In the present chapter I aimed to identify 
DNA methylation differences associated with schizophrenia polygenic risk 
burden and compare these to schizophrenia-associated differences and direct 
cis-genetic effects on DNA methylation. 
I genotyped the schizophrenia patients and non-psychiatric controls using the 
Illumina Infinium HTS HumanOmniExpress-24 BeadChip v1-0 (Illumina Inc., 
San Diego, CA, USA). One sample was excluded based on stringent QC of the 




determined using data from HapMap Phase 3 (see section 4.2.2) and non-
Caucasian ancestry outliers (n = 10) were excluded from subsequent analyses. 
In total, the genotyping and DNA methylation data from 67 PFC (33 
schizophrenia and 34 controls), 71 STR (32 schizophrenia and 39 controls), 23 
HC (11 schizophrenia and 12 controls) and 68 CER (33 schizophrenia and 35 
controls) samples from both the LNDBB and DBCBB passed stringent QC 
metrics and were used for analysis (demographic summaries for these samples 
are presented in Table 4.2). SNP data were imputed using the latest data 
release from the 1,000 Genomes project, and a PRS for each sample was 
generated using data from the recent schizophrenia GWAS (Schizophrenia 
Working Group of the Psychiatric Genomics, 2014).  
A linear regression was performed in each brain region from each cohort 
separately and for tissues collected from both brain banks (PFC, STR and CER) 
a fixed-effect meta-analysis approach was used to combine analyses results 
from both cohorts. The initial analyses focused on identifying DMPs and DMRs 
associated with schizophrenia PRS. Analyses were first performed 
independently for each brain region, and I subsequently employed a multi-level 
model to identify consistent DNA methylation associations with PRS present 
across the PFC, STR, and HC. An overview of the analysis approach in this 
chapter is given in Figure 3.3 and a representation on how this analysis 









4.3.2. Differently methylated positions associated with 
schizophrenia  polygenic risk score 
In this chapter, I wanted to explore whether an increased burden of polygenic 
variants associated with schizophrenia was itself associated with variation in 
DNA methylation in the brain. Despite the relatively small sample size, it was 
striking that schizophrenia patients (n = 34) were characterized by a 
significantly higher PRS than controls (n = 40) (P = 4.43E-03) (Figure 4.4), 
highlighting the robust nature of the schizophrenia PRS and the power of this 
approach for classifying genetic risk.  
 
Figure 4.4. Polygenic risk score in both schizophrenia cases and non-
psychiatric controls included in the analyses of this chapter. 
I employed a linear model controlling for age, sex, and neuronal estimates 
(except in the CER, as described in section 4.2.5), followed by a fixed-effect 
meta-analysis to identify DNA methylation variation associated with the 
schizophrenia PRS. Quantile-quantile (QQ) plots for the analyses in each tissue 




value inflation (PFC λ = 0.96, STR λ = 1.10, HC λ = 1.17, CER λ = 1.26) in any 
of the four brain regions. Manhattan plots for the analyses in each brain region 
are shown in Figures 4.9 to 4.12.  
The PRS-associated DMPs passing the stringent family-wise significance 
threshold (P < 1.66E-07, see section 4.2.7), are listed in Table 4.3 and 
presented in Figures 4.13 to 4.15. The fifty top ranked PRS-associated DMPs 
in each brain region presented in Tables 4.4 to 4.7 and Figures 4.16 to 4.19. 
Although the specific top ranked PRS-associated loci in each brain region are 
distinct, effect sizes at PRS-associated DMPs are significantly correlated across 
brain regions (Figures 4.20 to 4.23 and Table 4.8), with the exception of the 
HC where the low number of samples (n = 23) means my analysis is probably 
underpowered to detect robust effects.  
Several PRS-associated DMPs are of relevance in the context of schizophrenia 
and associated neurobiological functions. These include: 
 cg12595281, which is characterised by a significant increase of DNA 
methylation with increased PRS in the STR (P = 6.85E-08) (Table 4.5 and 
Figure 4.14) and is annotated to the transcription start site of the repulsive 
guidance molecule family member a (RGMA) gene. This gene encodes an axon 
guidance protein thought to be important in interneuron migration and 
differentiation during neurogenesis (O'Leary et al., 2013, Matsunaga et al., 
2004).  
 cg19852211, which is characterised by increased DNA methylation with 
increased PRS in the PFC (P = 3.25E-05) (Table 4.4) and is annotated to the 
cluster of protocadherin alpha genes 1 to 4 (PCDHA1, PCDHA2, PCDHA3 and 
PCDHA4). These genes are organised in a cluster and encode integral plasma 
membrane, cell adhesion proteins localised at synaptic junctions in neurons 
(Hamada and Yagi, 2001, Kohmura et al., 1998).  
 cg04293307, which is characterised by increased DNA methylation with 
increased PRS in the PFC (P = 6.07E-06) (Table 4.4) and is annotated to the 
gene body of AXIN2, a gene that encodes a protein known component of the 
Wnt signalling pathway (Kikuchi, 1999). This pathway plays a crucial role in n 
controlling self-renewal and differentiation during neurodevelopment (Kalani et 




 cg15022015, which is characterised by increased DNA methylation with 
increased PRS in the STR (P = 3.82E-06) (Table 4.5) and is annotated to the 
gene body of the regulatory associated protein of MTOR, complex 1 (RPTOR) 
gene. Ablation of the protein encoded by this gene in oligodendrocytes has 
revealed a potential role of this protein in the central nervous system 
myelination during mouse development (Bercury et al., 2014).  
 cg07984684, which is characterised by increased DNA methylation with 
increased PRS in the CER (P = 3.12E-07) (Table 4.7) and is annotated to the 
transcription start site of the charged multivesicular body protein 1A (CHMP1A) 
gene. Mochida et al. linked loss-of function mutations in this gene reduced 
cerebellar and cerebral cortical size (Mochida et al., 2012). In the same study, 
knockout of the CHMP1A orthologue in zebrafish (chmp1a) resulted in reduced 
cerebellum and forebrain volume in these animals.  
Other DMPs associated with PRS are annotated to genes that have been 
implicated in other neurological and neurodevelopmental disorders related to 
schizophrenia including autism-spectrum disorder (ASD), attention-
deficit/hyperactivity disorder (ADHD) and language deficits: 
 cg01682070 shows increased DNA methylation with increased PRS in 
the CER (P = 4.20E-08) (Table 4.7 and Figure 4.15). This probe is within the 
gene body of the thousand-and-one-amino acid 2 kinase (TAOK2) gene, which 
encodes a protein that is thought to play an essential role in dendrite 
morphogenesis (de Anda et al., 2012). Microdeletions and duplications in 
chromosome 16 affecting this gene have been implicated in ASD (Weiss et al., 
2008), another neurodevelopmental disease.  
 cg0486234 shows increase DNA methylation associated with increased 
PRS in the PFC (P = 8.04E-06) (Table 4.4). The probe is annotated to the RNA 
binding protein, fox-1 homolog (C. elegans) 1 gene (RBFOX1). This gene 
encodes a protein thought to regulate a network of genes involved in synaptic 
function and calcium signalling (Lee et al., 2016). Chromosomal translocations 
and copy number variations in this gene have been associated with ASD 
(Martin et al., 2007, Sebat et al., 2007).  
 cg19376461 shows increased DNA methylation associated with 




to the gene body of the inner mitochondrial membrane peptidase subunit 2 
(IMMP2L) gene. This gene encodes a protein involved in processing the signal 
peptide sequences used to direct mitochondrial proteins to the mitochondria. 
Deletions in this gene have been implicated in several neuropsychiatric 
disorders ADHD (Elia et al., 2010), ASD (Maestrini et al., 2010) and Tourette 
syndrome (Patel et al., 2011). 
 cg01331540 shows increased DNA methylation associated with 
increased PRS in the STR (P = 5.39E-06) (Table 4.5). The probe is annotated 
to the gene body of the forkhead box P (FOXP1) gene. Deletions, mutations 
and chromosomal aberrations affecting this gene have been associated with 
several neurodevelopmental conditions, such as ASD, speech and language 
deficits and motor development delay (Talkowski et al., 2012, Hamdan et al., 
2010, O'Roak et al., 2011). This gene also seems to be important in striatal 
development in mice (Bacon et al., 2015).  
Epidemiological studies have long suggested a role of the immune system 
dysregulation in schizophrenia (Benros et al., 2011, Nielsen et al., 2013) and 
infection (Sorensen et al., 2009), a hypothesis that was supported by 
schizophrenia transcriptomic (Mistry et al., 2013, Roussos et al., 2012) and 
GWAS analyses (International Schizophrenia et al., 2009, Schizophrenia 
Working Group of the Psychiatric Genomics, 2014). Interestingly, two of the 
PRS-associated DMPs in the PFC are annotated to genes that play an 
important role in the immune system. First, cg14595786 (P = 2.45E-07) (Table 
4.4) is annotated to the transcription start site of the sialic acid binding Ig like 
lectin 9 (SIGLEC9) gene. The siglecs are a family of lectins thought to promote 
cell–cell interactions and regulate cell function in the innate and adaptive 
immune systems (Crocker et al., 2007). The SIGLEC9 membrane protein is 
expressed in monocytes, neutrophils and natural killer cells (Zhang et al., 2000, 
Angata and Varki, 2000). Second, cg01948217 (P = 7.02E-07) (Table 4.4) is 
annotated to the transcription start site of the bactericidal/permeability-
increasing protein (BPI) gene, which encodes a neutrophil-expressed protein 
that plays a role in inflammatory response to Gram-negative bacteria (Marra et 





Figure 4.5. Quantile-quantile plot for the prefrontal cortex (PFC) 
schizophrenia polygenic risk score EWAS. Shown are the expected (x-axis) 
and observed (y-axis) quantiles observed in the meta-analysis of the (PFC) of 
both cohorts. λ = 0.96. 
 
Figure 4.6. Quantile-quantile plot for the striatum (STR) schizophrenia 
polygenic risk score EWAS. Shown are the expected (x-axis) and observed 






Figure 4.7. Quantile-quantile plot for the hippocampus (HC) schizophrenia 
polygenic risk score EWAS. Shown are the expected (x-axis) and observed 
(y-axis) quantiles observed in the meta-analysis of the HC of the MRC London 
Neurodegenerative Diseases Brain Bank samples. λ = 1.17. 
 
Figure 4.8. Quantile-quantile plot for the cerebellum (CER) schizophrenia 
polygenic risk score EWAS. Shown are the expected (x-axis) and observed 






Figure 4.9. Manhattan plot for the prefrontal cortex schizophrenia 
polygenic risk score EWAS. Shown are the -log10(P-values) (y-axis) of the 
meta-analysis of the prefrontal cortex of both cohorts by chromosomal position 
(x-axis). The horizontal line indicates a stringent multiple-testing significance 
threshold (P = 1.66E-07) (see section 4.2.7). 
 
 
Figure 4.10. Manhattan plot for the striatum schizophrenia polygenic risk 
score EWAS. Shown are the -log10(P-values) (y-axis) of the meta-analysis of 
the striatum of both cohorts by chromosomal position (x-axis). The horizontal 
line indicates a stringent multiple-testing significance threshold (P = 1.66E-07) 







Figure 4.11. Manhattan plot for the hippocampus schizophrenia polygenic 
risk score EWAS. Shown are the -log10(P-values) (y-axis) of the linear 
regression analysis of the hippocampus data from the MRC London 
Neurodegenerative Diseases Brain Bank by chromosomal position (x-axis). The 
horizontal line indicates a stringent multiple-testing significance threshold (P = 
1.66E-07) (see section 4.2.7). 
 
 
Figure 4.12. Manhattan plot for the cerebellum schizophrenia polygenic 
risk score EWAS. Shown are the -log10(P-values) (y-axis) of the meta-analysis 
of the cerebellum of both cohorts by chromosomal position (x-axis). The 
horizontal line indicates a stringent multiple-testing significance threshold (P = 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.13. Top ranked schizophrenia polygenic risk score (PRS)-
associated differentially methylated position (DMP) in the prefrontal 
cortex. Shown are adjusted DNA methylation values (y-axis) for the DMP 
associated with PRS (x-axis)) in the prefrontal cortex at a highly stringent 
significance threshold (P < 1.66E-07) (see section 4.2.7). Additional 
information on these DMPs is given in Table 4.3.  
 
 
Figure 4.14. Top ranked schizophrenia polygenic risk score (PRS)-
associated differentially methylated positions (DMPs) in the striatum. 
Shown are adjusted DNA methylation values (y-axis) for the DMPs associated 
with PRS (x-axis) in the striatum at a highly stringent significance threshold (P < 
1.66E-07) (see section 4.2.7). Additional information on these DMPs is given in 






Figure 4.15. Top ranked schizophrenia polygenic risk score (PRS)-
associated differentially methylated positions (DMPs) in the cerebellum. 
Shown are adjusted DNA methylation values (y-axis) for the DMPs associated 
with PRS (x-axis) in the cerebellum at a highly stringent significance threshold 
(P < 1.66E-07) (see section 4.2.7). Additional information on these DMPs is 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.17. Heatmap showing the fifty top ranked differently methylated 
positions associated with schizophrenia polygenic risk score (PRS) in the 
striatum (STR). Shown for each probe is the DNA methylation effect size 
associated with PRS, with the corresponding effect at the same probe for the 
three other brain regions (prefrontal cortex (PFC), hippocampus (HC) and 
cerebellum (HC)) dissected from the same individuals. Probes are ordered by 
P-value for PRS-associated hypomethylation (blue, top) and hypermethylation 







Figure 4.18. Heatmap showing the fifty top ranked differently methylated 
positions associated with schizophrenia polygenic risk score (PRS) in the 
striatum (STR). Shown for each probe is the DNA methylation effect size 
associated with PRS, with the corresponding effect at the same probe for the 
three other brain regions (prefrontal cortex (PFC), hippocampus (HC) and 
cerebellum (HC)) dissected from the same individuals. Probes are ordered by 
P-value for PRS-associated hypomethylation (blue, top) and hypermethylation 







Figure 4.19. Heatmap showing the fifty top ranked differently methylated 
positions associated with schizophrenia polygenic risk score (PRS) in the 
hippocampus (HC). Shown for each probe is the DNA methylation effect size 
associated with PRS, with the corresponding effect at the same probe for the 
three other brain regions (prefrontal cortex (PFC), striatum (STR) and 
cerebellum (CER)) dissected from the same individuals. Probes are ordered by 
P-value for PRS-associated hypomethylation (blue, top) and hypermethylation 






Figure 4.20. Correlation between DNA methylation differences for the fifty 
top ranked polygenic risk score (PRS)-associated probes identified in the 
prefrontal cortex and the DNA methylation differences in the same probes 
in the remaining brain regions (y-axis). Striatum = green; hippocampus = 
red; cerebellum = orange.  ρ = Pearson’s correlation coefficient. The DNA 





Figure 4.21. Correlation between DNA methylation differences for the fifty 
top ranked polygenic risk score (PRS)-associated probes identified in the 
striatum and the DNA methylation differences in the same probes in the 
remaining brain regions (y-axis). Prefrontal cortex = blue; hippocampus = 
red; cerebellum = orange.  ρ = Pearson’s correlation coefficient. The DNA 





Figure 4.22. Correlation between DNA methylation differences for the fifty 
top ranked polygenic risk score (PRS)-associated probes identified in the 
hippocampus and the DNA methylation differences in the same probes in 
the remaining brain regions (y-axis). Prefrontal cortex = blue; striatum = 
green; cerebellum = orange.  ρ = Pearson’s correlation coefficient. The DNA 





Figure 4.23. Correlation between DNA methylation differences for the fifty 
top ranked polygenic risk score (PRS) associated probes identified in the 
cerebellum and the DNA methylation differences in the same probes in the 
remaining brain regions (y-axis). Prefrontal cortex = blue; striatum = green; 
hippocampus = red.  ρ = Pearson’s correlation coefficient. The DNA methylation 


















































































































































































































































































































































































































































































































4.3.2.1. Enrichment of overlap between polygenic risk score-
associated differently methylated positions and 
regulatory features  
The Illumina 450K array probes were annotated to TFBSs and DHSs using 
published data (Slieker et al., 2013, ENCODE Project Consortium, 2012, 
Maurano et al., 2012) and the overlap between PRS-associated DMPs 
identified in the different brain regions and these regulatory features tested for 
enrichment using a two sided Fisher’s 2x2 exact test (Fisher, 1922). Tables 4.9 
to 4.12 present the results of these tests for all brain regions.  
The fifty top ranked and DMPs with a P-value < 1.00E-03 show no significant 
enrichment for probes overlapping DHS or TFBS in any of the brain regions at 
the Bonferroni corrected threshold for the twenty-four tests (P = 2.08E-03). 
DMPs with a P-value < 0.05 show a significant under-enrichment for probes 
overlapping TFBS in the PFC (Table 4.9), STR (Table 4.10) and CER (Table 
4.12), but not the HC (Table 4.11). The same set of probes show a significant 
under-enrichment for probes overlapping DHS in the PFC (Table 4.9) but not 
the other brain regions.  
Table 4.9. Results of the Fisher’s 2x2 exact tests for significant overlap 
between polygenic risk score-associated differently methylated positions 
(DMPs) in the prefrontal cortex and regulatory features. Shown are the 
results for overlap enrichment with the 50 top ranked probes, DMPs with an 
association P-value < 1.00E-03 and DMPs with an association P-value < 0.05. 




Odds ratio P Odds ratio P 
Top ranked 50 1.31 0.40 1.00 1.00 
P < 1.00E-03 0.84 0.04 0.90 0.22 







Table 4.10. Results of the Fisher’s 2x2 exact tests for significant overlap 
between polygenic risk score-associated differently methylated positions 
(DMPs) in the striatum and regulatory features. Shown are the results for 
overlap enrichment with the 50 top ranked probes, DMPs with an association P-
value < 1.00E-03 and DMPs with an association P-value < 0.05. DHS, DNA 




Odds ratio P Odds ratio P 
Top ranked 50 1.13 0.78 0.67 0.20 
P < 1.00E-03 1.06 0.31 0.89 0.04 
P <0.05 0.99 0.43 0.88 1.26E-22 
Table 4.11. Results of the Fisher’s 2x2 exact tests for significant overlap 
between polygenic risk score-associated differently methylated positions 
(DMPs) in the hippocampus and regulatory features. Shown are the results 
for overlap enrichment with the 50 top ranked probes, DMPs with an association 
P-value < 1.00E-03 and DMPs with an association P-value < 0.05. DHS, DNA 




Odds ratio P Odds ratio P 
Top ranked 50 1.04 0.89 1.18 0.57 
P < 1.00E-03 0.94 0.57 1.00 1.00 
P <0.05 1.00 0.97 1.04 5.29E-03 
Table 4.12. Results of the Fisher’s 2x2 exact tests for significant overlap 
between polygenic risk score-associated differently methylated positions 
(DMPs) in the cerebellum and regulatory features. Shown are the results for 
overlap enrichment with the 50 top ranked probes, DMPs with an association P-
value < 1.00E-03and DMPs with an association P-value < 0.05. DHS, DNA 




Odds ratio P Odds ratio P 
Top ranked 50 0.74 0.32 0.56 0.05 
P < 1.00E-03 0.94 0.37 0.89 0.11 





4.3.3. Differently methylated regions associated with 
schizophrenia  polygenic risk score 
I used comb-p (Pedersen et al., 2012) to identify spatially correlated regions of 
differential DNA methylation associated with schizophrenia PRS (Šidák-
corrected P < 0.05, number of consecutive probes ≥ 2). PRS-associated DMRs 
in each of the four brain regions are listed in Table 4.13 and Figure 4.24.  
Although all PRS-associated DMRs were identified in just one brain region 
(Table 4.13), the majority are characterised by consistent effects across all 
brain regions (Figure 4.24). Interestingly, most DMRs show decreased DNA 
methylation with PRS (blue). 
Two DMRs identified in the PFC spanning RNF39 and HLA-DPB2 reside within 
the major histocompatibility complex (MHC) on chromosome 6.  The MHC locus 
spans several megabases on chromosome 16 and contains 18 highly 
polymorphic human leukocyte antigen (HLA) genes that encode proteins with 
antigen-presenting roles in the immune system (Benacerraf, 1981). Of note, 
genetic variants in the MHC locus have been strongly linked to schizophrenia 
GWAS studies (International Schizophrenia et al., 2009, Schizophrenia Working 
Group of the Psychiatric Genomics, 2014), highlighting the potential importance 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.3.4. Consistent methylomic markers of schizophrenia polygenic 
risk burden across brain regions 
I next employed a multi-level model including data from the PFC, STR and HC 
(see section 4.2.8) to identify consistent PRS-associated DMPs across these 
brain regions. The QQ and Manhattan plots for this analysis are presented in 
Figures 4.25 and 4.26. There is some inflation in the distribution of P-values in 
the multi-region case-control analysis (λ = 1.33), although less than the inflation 
observed in the disease-controls multilevel analysis presented on Chapter 3 
(section 3.3.7). 
 Of interest, several DMPs were relevant in the context of schizophrenia: 
 The top ranked PRS-associated DMP (cg04910228), at which PRS is 
negatively correlated with DNA methylation (estimate = -0.38%, P = 6.50E-07), 
is located within the TSNAX-DISC1 locus on chromosome 1 (Figure 4.27 A). A 
balanced translocation involving this gene that segregates with several major 
psychiatric disorders including schizophrenia has been intensively studied in a 
Scottish pedigree (St Clair et al., 1990), although the involvement of this locus 
in the etiology of the disorder remains controversial and common genetic 
variation in this region was not identified in recent GWAS analyses (Sullivan, 
2013, Porteous et al., 2014). These data suggest that an increased polygenic 
burden for schizophrenia may impact upon regulatory variation of the DISC1 
locus in the brain; 
 cg08619378 is annotated to the gene body of the adenylate cyclase 1 
(ADCY1) gene and shows decreased DNA methylation with increased PRS 
across brain regions (P = 1.73E-05) (Figure 4. 27 B). The protein encoded by 
this gene is primarly expressed in the brain and its role is to couple Ca(2+) to 
cyclic AMP (cAMP), which is involved is synaptic functions such as long-term 
potentiation, long-term depression, and depotentiation, processes important for 
memory formation (Wang and Zhang, 2012, Wang et al., 2004) 
 A probe annotated the 5’UTR of the microtubule associated protein tau 
(MAPT) gene decreases DNA methylation with PRS (cg26019600, P = 2.99E-
05) (Figure 4.27 C). This gene encodes several different isoforms of the tau 
protein, which have a crucial role in keeping the function of microtubules and 




multiple neurodegenerative disorders including Alzheimer’s disease, 
Parkinson’s disease, frontotemporal dementia, amongst others (for a review see 
Zhang et al. (2015)). 
Next I identified PRS-associated DMRs consistent across PFC, STR and HC 
using comb-p (Pedersen et al., 2012) in the P-values from the cross-region 
multilevel model. Top ranked cross-region DMPs associated with schizophrenia 
PRS are presented in Table 4.14 and Figure 4.28 and DMRs are presented in 
Table 4.15 and Figure 4.29.  
Of interest: 
 A PRS-associated DMR of 6 probes spanning WNT5A is within the 
schizophrenia-associated DMR spanning 11 probes in the same gene 
described in Chapter 3 section 3.3.7. This is an important cross-brain region 
association with both schizophrenia polygenic risk burden and schizophrenia 
diagnosis given the previously discussed neurodevelopmental relevance of this 
locus (Chapter 3 section 3.3.6.1). 
 In addition to the 17 probe-wide DMR spanning RNF39 that was 
identified again (see above section 4.3.3), another PRS-associated DMR within 
the MHC region in chromosome 6 was identified in the cross-brain region model 
(HLA-J), reinforcing the association of DNA methylation variation at loci within 
this region with schizophrenia polygenic risk burden.  
 Another DMR is annotated to the lymphocyte-specific protein 1 (LSP1) 
gene which encodes an intracellular F-actin binding protein expressed in 
immune cells such as lymphocytes, neutrophils and macrophages (Pulford et 
al., 1999).  
 A DMR in chromosome 16 is annotated to the interferon regulatory factor 
8 (IRF8) gene, which encodes a protein that plays an important role in immune 
cells differentiation and cell fate (Yanez and Goodridge, 2016). 
 A DMR spanning 7 probes in the glial cell derived neurotrophic factor 
(GDNF) gene shows significant association with schizophrenia PRS. This gene 
encodes a neurotrophic factor that promotes the differentiation and survival to 
different types of neurons and has been implicated in Parkinson’s disease 




catecholaminergic neuron survival (these include dopaminergic, epinephrine 
and norepinephrine neurons) both in vivo (Pascual et al., 2008) and in vitro (Lin 
et al., 1993), although this has recently been disputed (Kopra et al., 2015).  
 
Figure 4.25. Quantile-quantile plot for the schizophrenia polygenic risk 
score EWAS. Shown are the expected (x-axis) and observed (y-axis) quantiles 
observed in the multi-level model including data from the PFC, STR and HC. 
 
Figure 4.26. Manhattan plot for the schizophrenia polygenic risk score 
EWAS. Shown are the -log10(P-values) (y-axis) of the multi-level model 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.28. Heatmap showing the fifty top ranked differently methylated 
positions associated with schizophrenia polygenic risk score identified 
using a multi-region model incorporating prefrontal cortex (PFC), striatum 
(STR) and hippocampus (HC). Shown for each probe is the DNA methylation 
effect size, with the corresponding difference at the same probe for the three 
individual brain regions. Probes are ordered by P-value for PRS-associated 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 4.29. Heatmap showing differently methylated regions (DMRs) 
associated with schizophrenia polygenic risk score (PRS) identified using 
a multi-region model incorporating prefrontal cortex (PFC), striatum (STR) 
and hippocampus (HC). Shown in chromosomal order are PRS DNA 
methylation differences in each of the significant DMRs, with disease-
associated differences in the corresponding probes shown for the three 




4.3.5. Comparison between methylomic analysis of schizophrenia 
PRS and diagnosed schizophrenia  
In this section I compare the PRS EWAS results presented in this chapter with 
the schizophrenia EWAS results presented in Chapter 3. Of note, in this section 
I refer to both the ‘DNA methylation difference’ from the schizophrenia EWAS 
and the ‘DNA methylation change per PRS unit’ from the PRS EWAS as ‘effect 
size’ for simplicity. Although there is no direct overlap between the top ranked 
schizophrenia-associated DMPs (Chapter 3 section 3.3.3 Tables 3.5 to 3.8) 
and PRS-associated DMPs (Tables 4.4 to 4.7), as expected the effect sizes at 
the top ranked PRS-associated probes are significantly correlated with those at 
the same sites in the schizophrenia EWAS, and vice versa, across all brain 
regions (Figures 4.30 to 4.33). 
Next, I investigated whether including PRS as an independent co-variate in the 
schizophrenia EWAS had any effects on the schizophrenia EWAS associations. 
Because the PRS analyses only included Caucasian samples, I repeated the 
schizophrenia EWAS (as described in Chapter 3 section 3.2.6) using only the 
samples included in the PRS analysis (n = 88), with and without the inclusion of 
PRS as a covariate and compared the results. For the top ranked 
schizophrenia-associated DMPs, there was a high correlation of effect size and 
P-value detected in the schizophrenia EWAS with those identified in the PRS 
EWAS across all four brain regions (Effect size: ρ > 0.99 in all brain regions; P-
value: ρ >0.99 in the PFC and CER, ρ = 0.84 in the STR and ρ =0.56 in the 
HC), indicating that polygenic risk burden is not impacting greatly on 






Figure 4.30. Correlation between schizophrenia case-control EWAS and 
schizophrenia polygenic risk score EWAS for the prefrontal cortex. A) 
Correlation between and effect sizes in the PRS EWAS (y-axis) for the DMPs 
identified in the case-control EWAS. B) Correlation between effect sizes in the 
PRS EWAS (x-axis) and DNA methylation differences in the case-control EWAS 
(y-axis) in the PRS EWAS.  
 
Figure 4.31. Correlation between schizophrenia case-control EWAS and 
schizophrenia polygenic risk score EWAS for the striatum. A) Correlation 
between and effect sizes in the PRS EWAS (y-axis) for the DMPs identified in 
the case-control EWAS. B) Correlation between effect sizes in the PRS EWAS 
(x-axis) and DNA methylation differences in the case-control EWAS (y-axis) in 





Figure 4.32. Correlation between schizophrenia case-control EWAS and 
schizophrenia polygenic risk score EWAS for the hippocampus. A) 
Correlation between and effect sizes in the PRS EWAS (y-axis) for the DMPs 
identified in the case-control EWAS. B) Correlation between effect sizes in the 
PRS EWAS (x-axis) and DNA methylation differences in the case-control EWAS 
(y-axis) in the PRS EWAS.  
 
Figure 4.33. Correlation between schizophrenia case-control EWAS and 
schizophrenia polygenic risk score EWAS for the cerebellum. A) 
Correlation between and effect sizes in the PRS EWAS (y-axis) for the DMPs 
identified in the case-control EWAS. B) Correlation between effect sizes in the 
PRS EWAS (x-axis) and DNA methylation differences in the case-control EWAS 




4.3.6. Polygenic risk score-associated methylomic variation does 
not reflect direct genetic effects on DNA methylation 
A total of 5,006, 5,058, 5,066 and 4,951 Illumina 450K array probes included in 
the PFC, STR, HC and CER analyses, respectively, were located within 
genomic regions associated with schizophrenia in the latest schizophrenia 
GWAS (Schizophrenia Working Group of the Psychiatric Genomics, 2014). 
Interestingly, one of the top ranked PRS-associated DMPs was located within a 
GWAS-nominated genomic region - cg01682070 (annotated to TAOK2), at 
which DNA methylation was positively correlated with PRS in the CER (P = 
4.30E-08) (this locus was discussed in section 4.3.2). Additionally, a number of 
nominally-significant PRS-associated DMPs (P < 1.00E-03) co-localize to 
GWAS regions (Table 4.16). However, despite this, none of the different sets of 
PRS-associated DMPs from any of the brain regions show a significant overlap 
with GWAS regions (Table 3.17) (Bonferroni corrected P = 4.17E-03). 
To assess whether PRS associations were direct effects of genetic variation, 
mQTLs associated with the 99,904 variants used to derive the PRS were 
calculated, using linkage disequilibrium (LD)-pruned independent SNPs and a 
genome-wide mQTL significance threshold of P = 3.69E-13 (Hannon et al., 
2016). Given the low number of samples from the HC, mQTL analyses were not 
performed for this brain region. In total we identified 255 associations between 
genetic variants and DNA methylation sites in the PFC, representing 198 unique 
SNPs (Appendix A - Supplementary Table 6), with 247 mQTL pairs 
(representing 201 independent SNPs) identified in the STR (Appendix A - 
Supplementary Table 7) and 282 mQTL pairs (representing 219 independent 
SNPs) identified in the CER (Appendix A - Supplementary Table 8). None of 
the top ranked PRS-associated DMPs in any of the three brain regions, in 
addition to those identified in the multi-region model, were significantly 
associated with any of the genetic variants included in the PRS calculation. 
Because it is possible that weaker-effect mQTLs may still underlie some of the 
PRS-associated epigenetic variation, I subsequently relaxed our mQTL 
significance threshold to P < 1.00E-10, again finding no overlap with PRS-
associated DMPs (Figure 4.34). These data indicate that PRS-associated 
epigenetic variation does not directly result from genetic influences on DNA 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4.17. Results of the Fisher’s 2x2 exact tests for significant overlap 
between polygenic risk score-associated differently methylated positions 
(DMPs) in all the brain regions and GWAS regions  Shown are the results for 
the overlap between the 50 top ranked probes, DMPs with an association P-
value < 1.00E-03 and DMPs with an association P-value < 0.05. OR = odds 
ratio and probes within genomic regions associated with schizophrenia 
(Schizophrenia Working Group of the Psychiatric Genomics, 2014). 
  PFC   
OR 




HC OR HC P CER 
OR 
CER P 
Top ranked 50 1.66 0.46 0.00 1.00 0.00 1.00 1.67 0.46 
P < 1.00E-03 1.09 0.83 1.17 0.53 1.52 0.24 0.85 0.53 



































































































































































































































































































































4.4.1. Overview of results 
In this chapter I examined the association between DNA methylation and 
schizophrenia polygenic risk score in post-mortem brain samples isolated from 
PFC, STR, HC and CER. I identified numerous DMPs and DMRs associated 
polygenic risk burden in individual brain regions as well as across brain regions. 
Many of the PRS-associated loci have been previously implicated in the etiology 
of schizophrenia, most notably several regions in the MHC region, which has 
been implicated in schizophrenia in genetic studies (International Schizophrenia 
et al., 2009, Schizophrenia Working Group of the Psychiatric Genomics, 2014) 
and GADD45B which plays a role in neurogenesis and previously found to be 
differentially methylated in psychosis (Gavin et al., 2012). Strikingly, the top 
ranked probe associated with PRS in the multi-region model (i.e. across PFC, 
STR and HC) is located in the gene body of DISC1, a gene previously strongly 
linked to schizophrenia in a Scottish pedigree with a balanced translocation 
spanning the locus (St Clair et al., 1990). The data suggest that an increased 
PRS for schizophrenia may impact upon regulatory variation of the DISC1 locus 
in the brain, implicating a potentially common functional pathway between 
polygenic and highly penetrant single locus etiologies that warrants further 
investigation.  
Other PRS-associated loci, such as SIGLEC9 and BPI, encode proteins that 
play crucial roles in the immune system (Crocker et al., 2007, Zhang et al., 
2000, Angata and Varki, 2000). This is an important observation given the 
hypothesised involvement of the immune system and inflammation response in 
schizophrenia (see Chapter 1 section 1.1.6). Furthermore, several PRS-
associated loci are of relevance in the context of neuronal function and 
neurodevelopment, such as RGMA (which encodes an axon guidance protein 
thought to be important in interneuron migration and differentiation during 
neurogenesis (O'Leary et al., 2013, Matsunaga et al., 2004)), the cluster of 
genes PCDHA 1 to 4 (which encode integral plasma membrane, cell adhesion 




Kohmura et al., 1998)), AXIN2 (which encodes a known component of the Wnt 
signalling pathway (Kikuchi, 1999), a pathway that plays a crucial role in n 
controlling self-renewal and differentiation during neurodevelopment (Kalani et 
al., 2008, Nusse, 2008)) and GDNF (which encodes a neurotrophic factor that 
promotes the differentiation and survival to different types of neurons and has 
been implicated in Parkinson’s disease (Ibanez, 2008)). Finally, some of the 
PRS-associated loci have been previously implicated in other 
neurodevelopmental disorders, in particular ASD, including TAOK2, RBFOX1, 
IMMP2L and FOXP1. 
Many of the DMPs and DMRs associated with increased genetic burden for 
schizophrenia are independent of the changes observed associated with a 
diagnosis of schizophrenia itself, identified in the case-control analyses 
presented in Chapter 3. However, although there was no direct overlap 
between the top ranked schizophrenia-associated and PRS-associated DMPs, 
as expected, the effect sizes at the top ranked PRS-associated probes were 
significantly correlated with those at the same sites in the case-control analysis, 
indicating that schizophrenia PRS is not completely independent from disease 
diagnosis. Furthermore, there was no evidence for direct genetic effects on 
DNA methylation for variants included in the PRS (i.e. via mQTLs and 
enrichment of DMPs in GWAS regions), indicating that the PRS-associated 
epigenetic variation observed does not directly result from cis-genetic influences 





The study presented in this chapter has a number of important limitations. First, 
the limitations discussed in Chapter 3 (section 3.4.2) are also relevant in the 
context of this chapter. In summary, the number of samples assessed in this 
study is relatively low, which limits the power to detect significant associations 
(Dempster et al., 2013); the use of bulk tissue from each brain region is a 
potential confounder in DNA methylation studies (Guintivano et al., 2013, 
Heijmans and Mill, 2012); it is possible that many of the differences identified in 
this study are confounded by modifications other than DNA methylation and it is 
also possible that factors not accounted as covariates in the analyses (i.e. 
smoking, medication)  may be confounding the PRS EWAS results. 
In addition to these, there are other limitations that should be considered. First, 
PRS were calculated using the data from the latest and largest schizophrenia 
GWAS to date, incorporating all independent nominally significant associated 
alleles (P < 0.05). The authors predicted that the PRS explained only about 7% 
of total liability for the disorder (Schizophrenia Working Group of the Psychiatric 
Genomics, 2014). Although this is the schizophrenia GWAS capturing the most 
genetic variance to date, a large proportion of the variance remains 
unexplained. However it is worth noting that the PRS score was found to be 
significantly higher in schizophrenia cases compared to controls in the relatively 
small number of samples, highlighting the robust nature of the schizophrenia 
PRS. Second, the GWAS was carried out mainly in patients of European 
ancestry to avoid population stratification, therefore for the same reason I only 
used Caucasian samples on the analysis presented here. To date no high-
powered schizophrenia GWAS has been performed in non-Caucasian samples, 
in particular from African ancestry, which have fundamentally different LD 
structures from Caucasian populations (International HapMap, 2005). Finally, 
schizophrenia PRS is not completely independent from diagnosis and the 
underlying correlation might confound the results, although the overlap of 
between schizophrenia-associated DNA methylation changes and PRS-
associated changes was minimal suggesting that PRS is having independent 




4.4.3. Implications, strengths and future directions 
To my knowledge, this is the first study investigating DNA methylation changes 
associated with schizophrenia polygenic risk burden, or any other complex 
disease phenotype. It highlights the utility of PRS for identifying molecular 
pathways associated with etiological variation, which complement the 
associations identified with schizophrenia diagnosis. Although schizophrenia 
PRS is not useful for clinical risk predication, it is possible that it may be 
predictive of chronicity, treatment resistance or in the stratification of patients 
(O'Donovan, 2015). Furthermore, the identification of PRS-associated variation 
in DNA methylation is potentially less confounded by medication intake and 
other disease-associated exposures that can influence case-control analyses. 
Future studies should focus on understanding by which mechanisms an 
increased schizophrenia polygenic burden influences epigenetic regulation if not 
by a direct, cis-genetic influence on DNA methylation as my data suggest. 
Finally, although the resulting combined data from Chapter 3 and the present 
chapter present novel evidence for associations between schizophrenia 
diagnosis, schizophrenia polygenic burden and variable DNA methylation 
across different brain regions, further replication using larger sample sizes is 
required to further validate these results. Future studies should also focus on 




Chapter 5 - Systems-level analysis of DNA methylation 
in the schizophrenia brain 
 Chapter aims and structure 5.1.
In this chapter I was interested in studying the co-methylation structure of the 
DNA methylation across the genome in each of the four brain regions assessed, 
and exploring differences in that structure between schizophrenia patients and 
non-psychiatric controls. This chapter describes my exploration of network 
analysis methodology and its application to my DNA methylation data; it is 
structured in comprehensive sections that explain the rationale and the results 
of each approach in a stepwise manner. 
 Background 5.2.
One of the main aims of my thesis was to identify variable DNA methylation 
associated with schizophrenia using tissue from four different brain regions 
(prefrontal cortex (PFC), striatum (STR), hippocampus (HC) and cerebellum 
(CER)). In Chapters 3 and 4 I investigated DNA methylation changes 
associated with schizophrenia and schizophrenia polygenic risk burden at 
individual CpG sites and extended these analyses to explore regions of 
consecutive differentially methylated CpG sites across the genome. In the 
present chapter I aim to take a systems-level approach by exploring networks of 
highly correlated CpG sites. My aim was to explore the co-methylation structure 
of DNA methylation in each of the brain regions, independently of genomic 
position, and investigate which modules of co-methylated loci are altered in 
schizophrenia (for a definition of module see Table 5.1). 
5.2.1. Network analysis 
Biological systems, such as the genome, a cell or an organism, are made up of 
individual parts (e.g. molecules or organs) which interact dynamically to make 
the system function.  Although it is important to investigate changes in individual 
components of a biological system, it is crucial to understand how the different 
parts of the system interact; in other words, to understand both the underlying 
structure and dynamics of the system. Because a system is not just a list of its 




components separately. Furthermore, a small change in an individual 
component of a regulatory system will potentially have major effects on the 
entire system. This is analogous to a transport network system – although it is 
important to draw and study the static roadmaps, it is crucial to understand 
traffic patterns, why they emerge and how to control them (Kitano, 2002). 
Figure 5.1 shows the example of the roadmaps in Boston, USA (A) and an 
analysis of traffic patterns in the same city (B) (taken from Wang (2012)). Just 
by analysing the roadmaps is not possible to conclude which areas of Boston 
are more affluent and might be more affected by a traffic disruption.  
Network analysis provides a way of representing the complex interactions 
between the interconnected components of a given system (Zhang and 
Horvath, 2005). It has been widely used in a broad range of disciplines, from 
social and economic studies (Jackson, 2010) to molecular biology (Barabasi 
and Oltvai, 2004). Examples of the latter are gene co-expression networks 
(Parikshak et al., 2013, Zhang and Horvath, 2005, Voineagu et al., 2011), 
protein-protein interaction networks (Schwikowski et al., 2000), and cell-cell 
interaction networks (Hartwell et al., 1999). The rapid progress in genomic, 
transcriptomic and epigenomic profiling techniques enables us to collect a large 
amount of data and gives us a unique opportunity to understand the dynamics 
and structure of entire biological systems. Additionally, the individual 
interrogation of thousands or millions of genomic positions or genes across the 
genome generates a multiple comparison problem that such data reduction 
techniques can mitigate.  
Figure 5.2 shows an example of a correlation network where the main 
components of the network are described as ‘nodes’ and the interactions 
between them as ‘edges’. On a gene co-expression network, for example, the 
genes would be the nodes and the pair-wise correlation of their expression 
profiles determines which edges are included. In a network of co-methylated 
CpG sites, the nodes would be the individual CpG sites and the edges would be 





Figure 5.1. Roadmap (A) and traffic patterns (B) of Boston, USA. Figure B 











5.2.2. Weighted gene co-methylation network analysis 
In this chapter I applied the weighted gene co-methylation network analysis 
(WGCNA) approach (Zhang and Horvath, 2005) to the DNA methylation data, 
using the WGCNA  package (Langfelder and Horvath, 2008) in R (R Core 
Team, 2015). The package was developed to construct networks from gene 
expression data, but it can be used with any matrix of correlation coefficients. 
Figure 5.3 taken from Langfelder and Horvath (2008) describes the general 
WGCNA methodology applied to gene expression data. Briefly, the first step is 
to construct a network of genes that are co-regulated (i.e. vary together) in the 
dataset. This network represents one system that is broken up into several 
modules of co-regulated genes, which will represent the main subcomponents 
of the network. In gene co-expression networks, for example, the defined 
modules represent functionally district groups of co-expressed genes with 
similar functions (Carlson et al., 2006). These modules are interesting entities 
and can then be explored in several ways; for example, the modules can be 
correlated with traits of interest (e.g. diagnosis, sex, age), pathway or gene 
ontology analysis can be used to identify biological functions associated with 
each module, or the central genes of each module can identified and further 
investigated.  
I applied this methodology to the DNA methylation datasets generated for each 
brain region separately (described in Chapter 3 section 3.2). Table 5.1 has 
been adapted from Langfelder and Horvath (2008) to be applicable to DNA 








Figure 5.3. Overview of Weighted Gene Co-expression Network Analysis 
(WGCNA) methodology. This flowchart presents a brief overview of the main 




Table 5.1. Glossary of weighted gene co-methylation analysis terminology 







Co-methylation networks are defined as undirected, weighted networks 
of DNA methylation sites (i.e. Illumina 450K array probes). The nodes of 
the network correspond to DNA methylation probes, and the edges 
between probes represent the pair-wise correlations between these 
probes. During the network construction,    the absolute value of the 
correlation coefficients are raised the to a power (soft-thresholding), to 
emphasizes high or strong correlations at the expense of low or weak 
correlations, to allow modules of highly correlated probes to be 
identified. 
Module 
Modules are clusters within the global network of highly interconnected 
probes. In a signed network, modules correspond to positively 
correlated probes, whereas in an unsigned network, modules 




The module eigengene (ME) is defined as the first principal component 
calculated from the DNA methylation values of all members (of that 
modules. It can be considered representative of the overall DNA 
methylation profile in a given module. 
Module 
membership (MM) 
For each probe, module membership (MM) is defined as the correlation 
between its DNA methylation values and the ME of a given module. The 
MM measure can be defined for all probes irrespective of which module 
they were allocated to. 
Hub probe 
The term is used to describe ‘highly connected’ probes within a 
particular module. In this project I consider 'hub probes' as those 
belonging to a given module with a high module membership to that 




5.2.3. Overview of experimental strategy 
I applied WGCNA to DNA methylation data from 76 PFC (38 schizophrenia and 
38 controls), 82 STR (37 schizophrenia and 45 controls), 33 HC (16 
schizophrenia and 17 controls) and 77 CER (37 schizophrenia and 40 controls) 
samples to i) identify discrete modules of co-methylated CpG sites and ii) test 
the association of their first principal component (ME, see Table 5.1) with 
schizophrenia and other traits. For details on the samples and demographic 
information relating to the samples used in this analysis, please see Chapter 3 
section 3.2.  
The initial approach focused on creating networks of Illumina 450K array probes 
for schizophrenia patients and non-psychiatric controls separately within each 
brain region and identifying both overlapping and unique modules of co-
methylated probes between cases and controls networks. This approach is 
based on my observation that within a given brain region schizophrenia cases 
and controls are not characterised by systemic methylomic differences (see 
Chapter 3 section 3.3.2). Therefore I expected to see broadly similar structures 
between both cases and controls networks within the same brain region with a 
few dissimilarities related to disease. After using this approach (see below) I 
concluded it was not the optimal method to use. I subsequently created 
networks for all samples from each brain region (i.e. including both 
schizophrenia cases and controls) and tested for a significant association of 
each module with schizophrenia status, schizophrenia polygenic risk score 
(PRS) and other traits of interest. I performed gene ontology (GO) enrichment 
analysis on the genes belonging to the schizophrenia-associated modules. 
Finally, I imposed the structure of modules of co-methylated probes identified in 
a fetal brain dataset generated by our lab (Spiers et al., 2015) to my adult brain 
data (schizophrenia cases + controls) and tested these for association with 
schizophrenia. This approach was used to explore the hypothesis that 
schizophrenia has neurodevelopmental origins, and may result from genomic 
dysregulation during periods of brain development (see Chapter 1 section 
1.1.5). In the following sections I will describe each of these steps and 




presented in Figure 5.4 and a representation on how this analysis integrates 








 Data pre-processing and normalisation 5.3.
I performed WGCNA on Illumina 450K array data generated on samples from 
the PFC, STR, HC and CER from the MRC London Neurodegenerative 
Diseases Bran Bank (LNDBB) and the Douglas-Bell Canada Brain Bank 
(DBCBB) cohorts that were used for analyses in Chapter 3. Laboratory and 
data quality control (QC) procedures are described in Chapter 2 sections 2.2 
to 2.4 and Chapter 3 section 3.2.3. Detailed demographic information on all 
samples is presented in Appendix A - Supplementary Table 1 and sample 
exclusion criteria are described in Appendix A - Supplementary Table 2. 
Table 3.3 gives an overview of available demographic data available for the 
samples included in the analyses in this chapter.  
Briefly, data were pre-processed and normalised using the pfilter and dasen 
functions of the wateRmelon package (Pidsley et al., 2013) in R (R Core Team, 
2015) as described in Chapter 3 section 3.2.3. For tissues collected from both 
brain banks (PFC, STR and CER) array data obtained from both cohorts were 
pre-processed and normalised together. In total, 413,563, 417,447, 409,762 
and 417,213 probes survived QC, respectively and were included in the network 
analyses of PFC, STR, HC and CER presented here. Adjusted DNA 
methylation values were calculated for each probe by fitting a linear regression 
model separately for each brain region including sex, age, brain bank and 
neuronal proportion estimates (except in the CER - for reasons described in 





 Network construction and module detection 5.4.
The WGCNA package (Langfelder and Horvath, 2008), implemented in R (R 
Core Team, 2015), was used to generate networks of co-methylated probes. 
The functions described here are part of this package unless otherwise stated. 
WGCNA uses a soft-thresholding approach for the construction of biological 
networks since this preserves the continuous nature of the underlying 
correlation information (Zhang and Horvath, 2005). Networks were created for 
1) schizophrenia cases only, 2) non-psychiatric controls only and 3) both cases 
and controls together for each brain region, totalling 12 networks. The rationale 
for this approach is presented in section 5.2.3 and throughout the next sections 
of this chapter. 
I used the pickSoftThreshold function, which assesses scale free topology for 
multiple soft-thresholding powers, to inform my decision about which soft-
thresholding power would be the most appropriate for the network construction. 
Of note, a network is said to follow a scale free topology if it follows a power law 
distribution.  I based the calculation on a maximum block size of 5,000, which is 
the maximum number of probes that the function included in each block for 
calculation so that it can be handled by available computing infrastructure. This 
number was kept consistent for all networks. The proposed methodology of the 
WGCNA package, based on work from Zhang and Horvath (2005), is to choose 
the optimum soft-thresholding power to satisfy the criterion of scale-free 
topology. To do this I inspected plots showing the scale free topology, fitting 
index R2 versus the different soft-thresholding powers.  Figure 5.5 shows an 
example of such plot for the DBCBB cerebellum (cases + controls) network. 
Both Zhang and Horvath (2005) and Langfelder and Horvath (2008) suggest 
that it is optimal to choose the lowest soft-thresholding power (x-axis) for which 
the curve flattens out upon reaching a high R2 value (>0.80) (y-axis). To be 
consistent across all networks I chose the power 6, which was the lowest power 
that satisfied the R2 criterion in all the datasets. This also the default value used 





Figure 5.5. Example of the analysis of network topology for increasing 
soft-thresholding powers. Shown is the scale free topology fitting index R2 (y-
axis) versus soft-thresholding power (x-axis) for the cerebellum Douglas-Bell 
Canada Brain Bank (cases + controls) network. 
Unsigned networks were created using the blockwiseModules function with a 
soft-threshold parameter of 6 with a block size of 5,000. An unsigned network 
will consider the absolute correlation between two probes irrespective of 
whether they are positively or negatively correlated (see term ‘Module’ on Table 
5.1). Each module was labelled with a unique arbitrary colour name. For each 
module within each network, the first principal component from the matrix of 
DNA methylation values of was calculated using the moduleEigengenes 
function to give a module eigengene (ME) for each module (see term ‘Module 
eigengene’ on Table 5.1). A module membership (MM) measure for each 
module was calculated for each probe by calculating Pearson’s correlation 
coefficient between the DNA methylation values and the ME (see term ‘Module 




 Similarities between separate networks for schizophrenia 5.5.
cases and non-psychiatric controls 
My first approach was to generate DNA methylation networks for schizophrenia 
cases and controls separately for each brain region (see section 5.4). This 
approach is based on my observation that within each brain region 
schizophrenia cases and controls are not characterised by systemic methylomic 
differences (see Chapter 3 section 3.3.2). Therefore I expected to see 
considerable similarity between modules of co-methylated probes in both case 
and control networks within the same brain region with small differences in 
modules associated with disease. To test this hypothesis, I started by exploring 
the PFC networks generated separately for schizophrenia cases and controls. 
Tables 5.2 and 5.3 present the number, colour and size of modules in the 
controls and schizophrenia cases network, respectively. Every network has a 
‘grey’, module that is comprised of all probes that were not assigned to any 





Table 5.2. Modules identified in the network using prefrontal cortex data 
from the non-psychiatric controls of the MRC London Neurodegenerative 
Diseases Brain Bank and Douglas-Bell Canada Brain Bank. 
Module Module colour N Probes 
0 grey 144546 
1 turquoise 57824 
2 Blue 10014 
3 brown 9801 
4 yellow 9072 
5 green 8542 
6 Red 8126 
7 black 8064 
8 Pink 7369 
9 magenta 7036 
10 purple 6836 
11 greenyellow 6642 
12 Tan 6533 
13 salmon 6514 
14 cyan 6386 
15 midnightblue 6283 
16 lightcyan 5997 
17 grey60 5945 
18 lightgreen 5744 
19 lightyellow 5386 
20 royalblue 4969 
21 darkred 4461 
22 darkgreen 3968 
23 darkturquoise 3960 
24 darkgrey 3902 
25 orange 3585 
26 darkorange 3451 
27 white 3431 
28 skyblue 3361 
29 saddlebrown 3230 
30 steelblue 2950 
31 paleturquoise 2926 
32 violet 2839 
33 darkolivegreen 2779 
34 darkmagenta 2708 
35 sienna3 2428 
36 yellowgreen 2388 
37 skyblue3 2192 
38 plum1 2099 
39 orangered4 1966 
40 mediumpurple3 1732 
41 lightsteelblue1 1646 
42 lightcyan1 1503 
43 ivory 1411 
44 floralwhite 1341 
45 darkorange2 1021 
46 brown4 906 
47 bisque4 787 
48 darkslateblue 724 
49 plum2 592 
50 thistle2 544 
51 thistle1 524 
52 salmon4 483 
53 palevioletred3 472 
54 navajowhite2 469 
55 maroon 440 
56 lightpink4 379 
57 lavenderblush3 336 
58 honeydew1 334 
59 darkseagreen4 291 
60 coral1 170 
61 antiquewhite4 160 
62 coral2 160 
63 mediumorchid 159 
64 skyblue2 144 
65 yellow4 125 
66 skyblue1 124 
67 plum 117 
68 orangered3 108 




Table 5.3. Modules identified in the network using prefrontal cortex data 
from the schizophrenia cases of the MRC London Neurodegenerative 
Diseases Brain Bank and Douglas-Bell Canada Brain Bank. 
Module Module colour N Probes 
0 grey 126049 
1 turquoise 113624 
2 blue 29578 
3 brown 25900 
4 yellow 10804 
5 green 10670 
6 red 8832 
7 black 6859 
8 pink 6621 
9 magenta 6435 
10 purple 4840 
11 greenyellow 4181 
12 tan 4097 
13 salmon 4059 
14 cyan 3736 
15 midnightblue 3458 
16 lightcyan 3178 
17 grey60 3094 
18 lightgreen 2824 
19 lightyellow 2664 
20 royalblue 2353 
21 darkred 1951 
22 darkgreen 1850 
23 darkturquoise 1597 
24 darkgrey 1582 
25 orange 1577 
26 darkorange 1487 
27 white 1445 
28 skyblue 1358 
29 saddlebrown 1337 
30 steelblue 1247 
31 paleturquoise 1088 
32 violet 1053 
33 darkolivegreen 1019 
34 darkmagenta 997 
35 sienna3 890 
36 yellowgreen 878 
37 skyblue3 805 
38 plum1 800 
39 orangered4 755 
40 mediumpurple3 747 
41 lightsteelblue1 684 
42 lightcyan1 682 
43 ivory 614 
44 floralwhite 594 
45 darkorange2 467 
46 brown4 426 
47 bisque4 325 
48 darkslateblue 320 
49 plum2 243 
50 thistle2 232 
51 thistle1 189 
52 salmon4 168 
53 palevioletred3 159 




5.5.1. Approaches to match networks for schizophrenia cases 
and non-psychiatric controls 
I attempted to match each module derived from the control network with at least 
one corresponding module from the case network using the following 
approaches: i) counting the overlap of probes between each control and case 
modules and ii) testing for significant overlap of common probes between each 
pair of modules. The next sections present the results of each of those 
methodologies. 
5.5.1.1. Count the overlap of probes between each pair of 
modules from the controls and cases networks 
The first approach to match the cases and control networks to find overlapping 
and unique modules within each brain region involved counting the overlapping 
probes between each pair of modules from the cases and controls networks. 
Appendix A - Supplementary Table 9 presents the overlap of probes 
assigned to each pair of cases and controls modules. Figure 5.6 shows a 
graphical representation of these overlaps, with each bar representing one 
module from the controls network and the colours representing the 
schizophrenia modules. The area of a given colour within each bar is 
proportional to the overlap of probes between the control module (bar) and that 
respective schizophrenia module (colour).  
Appendix A - Supplementary Tables 10 and 11 (schizophrenia modules 1-27 
and 28-54, respectively) show the percentage overlap of each control module 
with each schizophrenia module (expressed as a percentage of the size of the 
respective control module). It is clear from these tables and figure that each of 
the control modules, in particular for the larger modules, have some degree of 
overlap with all the schizophrenia modules, and vice-versa. Using this method it 
was not possible to establish a clear matching between the modules in the 
cases and the controls networks. Similarly, I counted the overlap of ‘hub probes’ 
between each pair of modules, defining ‘hub probes’ as probes assigned to a 
module and that have a MM > 0.80 (see Table 5.1). Figure 5.7 shows a 
graphical representation of that overlap. Again, it was not possible to 
conclusively establish which module of the controls network corresponded to 























































































































































































































































































































































































































































































































































































































































































































































5.5.1.2. Test for significant overlap of common probes 
between cases and controls modules 
I next applied a hypergeometric test using the phyper function in R (R Core 
Team, 2015), which determines the probability of the overlap between two lists 
of genes to be a chance event (Fury et al., 2006). Appendix A - 
Supplementary Tables 12 and 13 (schizophrenia modules 1-27 and 28-54, 
respectively) present the P-values of the hypergeometric test between all pairs 
of schizophrenia and control modules. Again, all control modules show 
significant overlap with at least one schizophrenia module, making it unfeasible 
to definitively establish a correspondent schizophrenia module for each control 
module.  
Finally, I used the matchLabels function from the WGCNA package (Langfelder 
and Horvath, 2008). This function calculates the significant overlap between 
modules of two networks using a Fisher’s exact test (Fisher, 1922) and relabels 
the ‘reference network’ modules (here the schizophrenia network) based on a 
‘source network’ (here controls network). Appendix A - Supplementary Tables 
14 and 15 (schizophrenia modules 1-27 and 28-54, respectively) present the P-
values of the Fisher’s exact test from the matchLabels function. The function 
redistributed the 54 modules of the schizophrenia network into 88 new modules, 
a considerably higher number, which indicates that the two networks could not 
be matched effectively. The Fisher’s exact test P-values support this 
conclusion, with most modules overlapping significantly with more than one 
module of the other network. This is not surprising given that the 
hypergeometric test and the Fisher’s exact test use similar approaches.  
As mentioned above, I used these approaches on the PFC schizophrenia cases 
and controls networks, which proved unsuccessful. This could be due to the 
small sample size in both schizophrenia patients and controls groups of 
samples or the high number of probes used to create the networks (see section 
5.4 for further discussion on this topic). As the attempt to establish an overlap 
between modules was unsuccessful in the PFC, I proceeded to explore the 





 Networks including schizophrenia cases and non-5.6.
psychiatric controls 
After an initial exploration of the PFC networks derived from schizophrenia 
patients and controls separately (section 5.5) I concluded that identifying 
overlapping and dissimilar modules between the two was not the optimal 
approach to use. Therefore I next created networks of co-methylated probes 
including schizophrenia cases and non-psychiatric controls for each brain 
region. 34 modules were identified in the PFC network, 29 in the STR, 97 in the 
HC and 32 in the CER.  The high number of modules identified in the HC data 
compared to the other brain tissues results from the small number of samples 
available for this tissue, and suggests that it might be inappropriate to perform 
network analysis on these data due to the amount of noise. Therefore the HC 
network was not considered for further analysis. Tables 5.4 to 5.6 present the 
number of probes and arbitrary colour label for each module for the PFC, STR 
and CER networks.   
5.6.1. Modules associated with several traits 
To identify modules associated with specific traits, a Pearson’s correlation 
coefficient was calculated for each module between the ME and disease status, 
brain bank, sex, age, neuronal proportion estimates (except for the CER), PRS 
and ethnicity (for details on these two traits please see Chapter 4). Tables 5.4 
to 5.6 show the correlation coefficients (ρ) and P-values for these correlations.  
Since I included DNA methylation values with age, sex, brain bank and 
neuronal estimates (except in the CER) regressed out, these would not be 
expected to correlate with any of the modules in the networks. In cases where 
such co-variates have not been regressed out is common to see modules of co-
methylated probes strongly associated with them (Pidsley et al., 2014, Spiers et 
al., 2015). Figures 5.8 to 5.10 show the heatmaps of the correlation coefficients 







Interestingly, in the three networks there are modules which are significantly 
correlated (P < 0.05) with schizophrenia PRS  (PFC: ‘pink’, ‘darkorange’, ‘white’, 
‘violet’ and ‘darkmagenta’, STR: ‘lightcyan’ and ‘orange’, CER: ‘green’, 
‘darkgreen’, ‘darkturquoise’, ‘darkgrey’ and ‘saddlebrown’). The majority of 
these modules however also correlate significantly with ethnicity. To investigate 
whether these correlations resulted from variation in schizophrenia polygenic 
risk burden or the presence of (ethnic) outliers I later repeated the construction 
of the networks including only Caucasian samples (these results are presented 
in section 5.6.4). 
As schizophrenia diagnosis is a dichotomous trait, I performed an independent 
t-test between the ME and disease status for each module to identify modules 
associated with schizophrenia within each network. The t-test P-values are 
presented in Tables 5.8 to 5.10. Five PFC modules were nominally associated 
with schizophrenia (Table 5.4 and Figure 5.8) (P-values – ‘brown’: 0.05, ‘black’: 
0.05, ‘tan’: 0.04, ‘salmon’: 0.04 and ‘darkgrey’: 0.04), although none of these 
survived Bonferroni correction for the 95 modules tested; P = 5.26E-04. The 
STR and CER networks, in contrast, had no modules even nominally 
associated with schizophrenia. The five schizophrenia-associated modules in 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 5.8. Heatmap showing the correlation coefficient between each 
prefrontal cortex module eigengene and different phenotypical traits. 
Shown are the modules identified in the network using prefrontal cortex data 
from both non-psychiatric cases and schizophrenia controls from the MRC 
London Neurodegenerative Diseases Brain Bank and Douglas-Bell Canada 





Figure 5.9. Heatmap showing the correlation coefficient between each 
striatum module eigengene and different phenotypical traits. Shown are 
the modules identified in the network using striatum data from both non-
psychiatric cases and schizophrenia controls from the MRC London 




Figure 5.10. Heatmap showing the correlation coefficient between each 
cerebellum module eigengene and different phenotypical traits. Shown are 
the modules identified in the network using cerebellum data from both non-
psychiatric cases and schizophrenia controls from the MRC London 




5.6.2. Prefrontal cortex modules associated with schizophrenia 
Figures 5.11 and 5.12 were created using Cytoscape v3.2.1 (Lopes et al., 
2010) and show the stronger correlations (ρ > 0.80) between the ‘hub probes’ 
(MM > 0.80) in the ‘brown’ and ‘black’ PFC module. Shown are the genes 
annotated to the respective ‘hub probes’, unless the probe is not annotated to a 
gene, in which case the probe name is shown. The remaining three modules do 
not have enough ‘hub probes’ to create a meaningful graphic representation.  
Table 5.7 presents the ‘hub probes’ (MM > 0.80) and their annotated genes for 
all five modules associated with schizophrenia in the PFC. Of relevance, three 
of these genes are particularly interesting in the context of schizophrenia: 
 The lysine demethylase 3B (KDM3B)  gene (cg03315484, ‘black’ 
module) is one of the genes implicated in the largest schizophrenia GWAS to 
date (Schizophrenia Working Group of the Psychiatric Genomics, 2014)) 
 The ankyrin 3 (ANK3) gene (cg22150335, ‘brown’ module) encodes a 
protein found on the axons and nodes of Ranvier of neurons in the central and 
peripheral nervous systems and has been previously implicated in 
schizophrenia and bipolar disorder (Ferreira et al., 2008, Wirgenes et al., 2014).  
 The MTOR, complex 1 (RPTOR) gene is annotated to a probe 
significantly associated with PRS (cg15022015, associated with PRS in the 
STR: P = 3.82E-06 and multi-region model: P = 3.44E-05. See Chapter 4 
section 4.3.4 for details). Of note, this is a distinct probe from o the ‘brown’ 







Figure 5.11. ‘Brown’ module of the prefrontal cortex (PFC) network 
(schizophrenia cases and non-psychiatric controls). The figure shows the 
strongest correlations (ρ > 0.80) between the ‘hub probes’ (MM > 0.80) in the 
‘brown’ PFC module. Shown are the genes annotated to the respective ‘hub 
probes’. If the probe is not annotated to a gene the probe name is presented. 
The size of the circles indicates the degree of the node, or in other words the 
number of strong correlations (ρ > 0.80) between the probes annotated to that 
gene and other probes (larger meaning higher number of connections). The 






Figure 5.12. ‘Black’ module of the prefrontal cortex (PFC) network 
(schizophrenia cases and non-psychiatric controls). The figure shows the 
stronger correlations (ρ > 0.80) between the ‘hub probes’ (MM > 0.80) in the 
‘black’ PFC module. Shown are the genes annotated to the respective ‘hub 
probes’. If the probe is not annotated to a gene the probe name is presented. 
The size of the circles indicates the degree of the node, or in other words the 
number of strong correlations (ρ > 0.80) between the probes annotated to that 
gene and other probes (larger meaning higher number of connections). The 





Table 5.7. List of ‘hub probes’ (module membership > 0.80) from the 
prefrontal cortex modules ‘brown’, ‘black’, ‘tan’, ‘salmon’ and ‘darkgrey’  












cg01411652 chr1:14113172 0.81 3 brown PRDM2 
Body; 
3'UTR 
cg11413570 chr1:109260678 0.80 3 brown FNDC7 Body 
cg03391019 chr1:161927947 0.81 3 brown ATF6 Body 
cg06492521 chr10:532357 0.81 3 brown DIP2C Body 
cg18503829 chr10:729956 0.83 3 brown DIP2C Body 
cg10610648 chr10:5969457 0.80 3 brown FBXO18 Body 
cg22150335 chr10:62148959 0.83 3 brown ANK3 Body 
cg02712553 chr10:64136038 0.81 3 brown ZNF365 Body 
cg06017143 chr11:82403271 0.80 3 brown - - 




cg17174980 chr12:14109514 0.80 3 brown GRIN2B 5'UTR 
cg23251170 chr12:50496350 0.81 3 brown GPD1 TSS1500 
cg09814354 chr12:132278430 0.82 3 brown SFRS8 Body 
cg01614703 chr12:132278510 0.81 3 brown SFRS8 Body 
cg16522412 chr13:33926811 0.81 3 brown - - 





cg12964420 chr13:50975679 0.81 3 brown - - 
cg25253705 chr13:78314465 0.82 3 brown SLAIN1 
Body; 
TSS1500 
cg08504583 chr13:78315584 0.81 3 brown SLAIN1 
Body; 
5'UTR 
cg02676602 chr13:113698408 0.81 3 brown MCF2L Body 
cg02810375 chr13:113698416 0.82 3 brown MCF2L Body 
cg07443074 chr13:113698946 0.80 3 brown MCF2L Body 
cg22495636 chr13:113698951 0.83 3 brown MCF2L Body 
cg12314335 chr13:113699016 0.86 3 brown MCF2L Body 
cg14190534 chr14:90848416 0.86 3 brown - - 
cg18335991 chr15:74724562 0.84 3 brown SEMA7A 
Body; 
5'UTR 
cg17017272 chr15:91447374 0.84 3 brown MAN2A2 TSS200 
cg27573017 chr17:48258708 0.82 3 brown - - 
cg10281768 chr17:78720226 0.81 3 brown RPTOR Body 
cg14211837 chr18:53695649 0.84 3 brown - - 
cg01312167 chr2:54292798 0.84 3 brown - - 
cg17736821 chr2:64844761 0.82 3 brown - - 
cg06264659 chr2:64998062 0.80 3 brown - - 
cg06909228 chr2:74602278 0.81 3 brown DCTN1 
Body; 
TSS1500 
cg02882004 chr2:201334663 0.81 3 brown SPATS2L Body 




cg26648185 chr21:32927013 0.83 3 brown TIAM1 5'UTR 
cg27243685 chr21:43642366 0.81 3 brown ABCG1 
Body; 
5'UTR 
cg06044751 chr4:169789830 0.80 3 brown PALLD 
5'UTR; 
Body 
cg16153168 chr5:68114337 0.82 3 brown - - 
cg02073775 chr5:71478626 0.81 3 brown MAP1B Body 
cg22485921 chr5:131557716 0.81 3 brown P4HA2 5'UTR 
cg11548059 chr6:42225756 0.83 3 brown TRERF1 Body 




cg10296548 chr6:158797675 0.81 3 brown TULP4 Body 
cg00035268 chr6:168225394 0.81 3 brown C6orf124 Body 
cg00733493 chr7:45126655 0.80 3 brown NACAD Body 
cg27156041 chr7:98199360 0.81 3 brown - - 
cg15742515 chr8:1402185 0.82 3 brown - - 
cg03080147 chr8:17270347 0.82 3 brown MTMR7 Body 
cg02130905 chr8:27116213 0.80 3 brown STMN4 TSS1500 





cg24868421 chr10:64577216 0.81 7 black EGR2 
5'UTR; 
TSS1500 






cg04375578 chr11:18655531 0.82 7 black SPTY2D1 Body 











cg00748938 chr14:94641781 0.84 7 black PPP4R4 Body 
cg18495307 chr17:42385942 0.83 7 black RUNDC3A 
1stExon; 
5'UTR 






cg10661629 chr19:2900748 0.82 7 black ZNF57 TSS200 
cg02279127 chr19:55574702 0.81 7 black RDH13 
TSS200; 
5'UTR 
cg23348161 chr2:240964931 0.86 7 black NDUFA10 TSS200 




cg00001245 chr3:15106710 0.80 7 black MRPS25 
1stExon; 
5'UTR 











cg03315484 chr5:137688433 0.88 7 black KDM3B 
1stExon; 
5'UTR 
cg27658416 chr6:28603033 0.85 7 black - - 
cg22142122 chr6:28979338 0.82 7 black - - 




cg10189605 chr6:58287430 0.86 7 black GUSBL2 Body 
cg23493127 chr6:144164392 0.82 7 black LTV1 TSS200 
cg25214914 chr1:155910523 0.83 12 tan RXFP4 TSS1500 
cg04130507 chr1:182030753 0.80 12 tan ZNF648 
5'UTR; 
1stExon 
cg27454102 chr10:32428473 0.84 12 tan - - 
cg09519218 chr10:126390317 0.81 12 tan FAM53B Body 
cg27274382 chr11:76376064 0.80 12 tan LRRC32 Body 
cg02054358 chr17:70335431 0.81 12 tan - - 
cg23787321 chr2:43385844 0.80 12 tan - - 
cg05082708 chr4:4765299 0.81 12 tan - - 
cg04859102 chr6:31527893 0.81 12 tan - - 
cg11869828 chr11:116700447 0.80 13 salmon APOC3 TSS200 
cg12332902 chr2:98330020 0.84 13 salmon ZAP70 TSS200 
cg12003230 chr21:44899139 0.83 13 salmon C21orf84 TSS1500 
cg16562486 chr1:2925740 0.89 24 darkgrey - - 
cg27518860 chr1:35250839 0.91 24 darkgrey GJB3 Body 
cg10702366 chr1:60070383 0.96 24 darkgrey FGGY Body 
cg13444583 chr10:132600162 0.88 24 darkgrey - - 





cg15774028 chr17:78183443 0.94 24 darkgrey SGSH 3'UTR 
cg00141153 chr17:78183500 0.89 24 darkgrey SGSH 3'UTR 
cg15458322 chr19:10070965 0.89 24 darkgrey COL5A3 3'UTR 
cg16889990 chr19:57631478 0.84 24 darkgrey USP29 TSS200 




cg18033443 chr3:14584240 0.83 24 darkgrey GRIP2 TSS1500 
cg25785495 chr3:134910848 0.82 24 darkgrey EPHB1 Body 
cg00699947 chr4:4592560 0.85 24 darkgrey - - 






Recently, a study reported over 500 novel interactions with genes previously 
implicated in schizophrenia using a new protein-protein interactions (PPI) 
approach (Ganapathiraju et al., 2016). PPI maps can aid understanding 
complex regulatory networks underlying disease etiology by identifying groups 
of genes that interact with liability genes for a particular disease. The authors of 
this study identified 365 new interactions with genes from the latest 
schizophrenia GWAS (Schizophrenia Working Group of the Psychiatric 
Genomics, 2014) and 147 new interactions with genes that were implicated in 
schizophrenia pior to the GWAS era (i.e. as candidate genes).  
I next investigated whether the genes annotated to the ‘hub probes’ of the 
schizophrenia-associated modules are present in the interactions identified by 
Ganapathiraju et al. (2016). To do this I used the list of interacting genes in the 
Supplementary File 2 from their paper (Ganapathiraju et al., 2016) and the 
online tool the authors made available to investigate the PPI identified in all of 
their studies (Ganapathiraju, 2012-2016). Table 5.8 shows the genes annotated 
to ‘hub probes’ of schizophrenia-associated modules that have an interaction 
with at least one schizophrenia-linked gene in Ganapathiraju et al. (2016).  
Interestingly, two genes of the ‘brown’ module interact with disrupted in 
schizophrenia 1 (DISC1) gene. A balanced translocation involving this gene that 
segregates with several major psychiatric disorders including schizophrenia has 
been intensively studied in a Scottish pedigree (St Clair et al., 1990). 
Furthermore, I identified PRS-associated differential DNA methylation at a 
probe annotated to this gene in a cross-region model including data from PFC, 
STR and HC (see Chapter 4 section 4.3.4). Furthermore, 7 genes from the 
‘brown’, ‘black, ‘salmon’ and ‘darkgrey’ modules have interactions with genes 
associated with schizophrenia in the latest GWAS (Schizophrenia Working 

























































































































































































































































































































































































































































































































































































































































































To test if the same modules were associated with schizophrenia in the other 
brain tissues I imposed the PFC network structure on the data from the other 
brain regions. To do this I calculated the ME of the PFC modules using the 
STR, HC and CER data and performed an independent t-test between the MEs 
of schizophrenia cases and controls as described above. None of the five 
modules were associated with schizophrenia in the other brain regions (Table 
5.9) suggesting the effects were specific to the PFC.  
Table 5.9. Association between modules identified in the prefrontal cortex 
and schizophrenia in the striatum (STR), hippocampus (HC) and 
cerebellum (CER). Shown are the P-values for the t-tests between disease 
status and eigengenes for each prefrontal cortex module. None are significantly 
associated with schizophrenia in any of the three other brain regions. 
Highlighted in grey are the modules that were nominally associated with 
schizophrenia in the PFC network. 
PFC module No. PFC module colour P PFC P STR P HC P CER 
3 brown 0.05 0.30 0.64 0.54 
7 black 0.05 0.31 0.11 0.24 
12 tan 0.04 0.32 0.93 0.40 
13 salmon 0,04 0.37 0.40 0.58 




5.6.3. Gene ontology analysis on schizophrenia-associated 
modules 
I next performed an enrichment analysis on GO terms associated with genes 
belonging to each PFC schizophrenia-associated module to test for a significant 
enrichment of particular GO terms (Ashburner et al., 2000). I used an approach 
developed by our group, as described in Lunnon et al. (2016b). In summary, all 
probes within each module were annotated to genes using the standard Illumina 
annotation file (GRCh37/hg19). A logistic regression model was used to test if 
genes in each module predicted pathway membership, while controlling for the 
number of probes in each network annotated to each gene. Pathways were 
downloaded from the GO website (Gene Ontology Consortium, 2015) and 
mapped to genes including all parent ontology terms. All genes with at least one 
450k probe annotated and mapped to at least one GO pathway were 
considered. Pathways were filtered to those containing between 10 and 2000 
genes. After applying this method to all pathways, the list of significant 
pathways (P < 0.05) was refined by grouping related pathways to control for the 
effect of overlapping genes. This was achieved by taking the most significant 
pathway, and retesting all remaining significant pathways while controlling 
additionally for this best term. If the test genes no longer predicted the pathway, 
the term was said to be explained by the more significant pathway, and hence 
these pathways were grouped together. This algorithm was repeated, taking the 
next most significant term, until all pathways were considered as the most 
significant or found to be explained by a more significant term. 
Tables 5.10 to 5.14 present pathways with a P-value < 1.00E-03 ranked by 
significance for the 5 PFC modules. Notably, the eleven most significantly 
enriched pathways on the largest (‘brown’) module are neuronal function- and 
neurodevelopment-relevant pathways, such as GO:0007399 - nervous system 
development, GO:0097458 – neuron part and GO:0010975 - regulation of 




Table 5.10. Pathway analysis in the prefrontal cortex ‘brown’ module 
using data from schizophrenia cases and controls. Analysis testing for a 
significant enrichment of genes belonging to the prefrontal cortex ‘brown’ 
module overlapping gene ontology (GO) terms. 








GO:0097458 neuron part 830 365 2.07E-15 
GO:0007399 nervous system development 1804 721 2.31E-15 
GO:0030054 cell junction 778 332 3.47E-13 
GO:0045202 Synapse 514 240 1.00E-12 
GO:0042995 cell projection 1334 522 1.25E-12 
GO:0010975 regulation of neuron projection development 248 126 3.87E-11 
GO:0006928 cellular component movement 1199 460 1.54E-10 
GO:0050793 regulation of developmental process 1612 594 1.76E-10 
GO:0019226 transmission of nerve impulse 629 264 4.57E-10 
GO:0030424 Axon 278 142 6.04E-10 
GO:0051960 regulation of nervous system development 517 228 7.45E-10 
GO:0008092 cytoskeletal protein binding 696 284 1.53E-09 
GO:0035556 intracellular signal transduction 1423 522 1.69E-09 
GO:0000904 cell morphogenesis involved in differentiation 586 261 5.84E-09 
GO:0051056 
regulation of small GTPase mediated signal 
transduction 
380 175 1.01E-08 
GO:0016301 kinase activity 766 297 1.72E-08 
GO:0007268 synaptic transmission 608 249 2.10E-08 
GO:0048167 regulation of synaptic plasticity 104 61 2.12E-08 
GO:0019220 regulation of phosphate metabolic process 1502 548 2.24E-08 
GO:0051270 regulation of cellular component movement 538 218 2.76E-08 
GO:0007155 cell adhesion 798 324 9.83E-08 
GO:0007169 
transmembrane receptor protein tyrosine 
kinase signaling pathway 
554 228 1.55E-07 
GO:1902531 regulation of intracellular signal transduction 1240 450 1.65E-07 
GO:0035023 regulation of Rho protein signal transduction 135 66 3.51E-07 
GO:0006897 Endocytosis 362 146 3.52E-07 
GO:0030695 GTPase regulator activity 273 125 4.13E-07 
GO:0043547 positive regulation of GTPase activity 161 80 9.81E-07 
GO:0031252 cell leading edge 289 131 1.01E-06 
GO:0051128 regulation of cellular component organization 1411 503 1.06E-06 
GO:0010648 negative regulation of cell communication 839 318 1.17E-06 
GO:0030426 growth cone 110 58 1.17E-06 
GO:0009605 response to external stimulus 1154 413 1.21E-06 
GO:0031226 intrinsic component of plasma membrane 1249 434 2.18E-06 
GO:0034330 cell junction organization 178 82 2.94E-06 
GO:0005085 guanyl-nucleotide exchange factor activity 175 87 2.97E-06 
GO:0070848 response to growth factor 549 219 3.16E-06 
GO:0071526 semaphorin-plexin signaling pathway 16 13 4.84E-06 
GO:0009611 response to wounding 998 342 5.62E-06 
GO:0030111 regulation of Wnt signaling pathway 195 90 6.54E-06 
GO:0045121 membrane raft 203 89 6.74E-06 
GO:0048471 perinuclear region of cytoplasm 506 191 7.80E-06 
GO:0018212 peptidyl-tyrosine modification 122 60 1.04E-05 
GO:0005231 
excitatory extracellular ligand-gated ion 
channel activity 
48 26 1.34E-05 
GO:0007612 Learning 99 51 1.42E-05 
GO:0008289 lipid binding 535 195 1.66E-05 
GO:0015020 glucuronosyltransferase activity 27 17 1.84E-05 





regulation of phosphatidylinositol 3-kinase 
activity 
30 19 2.23E-05 
GO:0005794 Golgi apparatus 1183 399 2.31E-05 
GO:0070307 lens fiber cell development 12 10 2.59E-05 
GO:0044089 
positive regulation of cellular component 
biogenesis 
24 18 3.78E-05 
GO:0030168 platelet activation 210 85 4.87E-05 
GO:0032940 secretion by cell 404 153 4.89E-05 
GO:0006029 proteoglycan metabolic process 84 41 5.93E-05 
GO:0019899 enzyme binding 1183 416 6.65E-05 
GO:0015081 sodium ion transmembrane transporter activity 125 53 6.75E-05 
GO:0031338 regulation of vesicle fusion 14 10 7.20E-05 
GO:0005328 neurotransmitter:sodium symporter activity 21 14 8.80E-05 
GO:0045913 
positive regulation of carbohydrate metabolic 
process 
47 25 9.13E-05 
GO:0030198 extracellular matrix organization 310 129 9.24E-05 
GO:0035591 signaling adaptor activity 61 31 9.68E-05 
GO:0048745 smooth muscle tissue development 19 13 1.03E-04 
GO:0031012 extracellular matrix 422 162 1.25E-04 
GO:0019902 phosphatase binding 131 59 1.26E-04 
GO:0045161 neuronal ion channel clustering 12 10 1.41E-04 
GO:0061097 regulation of protein tyrosine kinase activity 50 26 1.45E-04 
GO:0006811 ion transport 983 329 1.49E-04 
GO:0048306 calcium-dependent protein binding 47 24 1.50E-04 
GO:0000979 
RNA polymerase II core promoter sequence-
specific DNA binding 
29 18 1.67E-04 
GO:0001568 blood vessel development 425 162 1.87E-04 
GO:0005057 receptor signaling protein activity 131 56 1.89E-04 
GO:0048013 ephrin receptor signaling pathway 28 17 2.27E-04 
GO:0019897 extrinsic component of plasma membrane 87 41 2.53E-04 
GO:0005509 calcium ion binding 661 249 2.80E-04 
GO:0009986 cell surface 500 171 3.23E-04 
GO:0016358 dendrite development 64 35 3.80E-04 
GO:0030010 establishment of cell polarity 63 35 4.04E-04 
GO:0007158 neuron cell-cell adhesion 10 8 4.10E-04 
GO:0032863 activation of Rac GTPase activity 10 8 4.31E-04 
GO:0043235 receptor complex 256 109 4.36E-04 
GO:0005544 calcium-dependent phospholipid binding 28 15 4.68E-04 
GO:0045833 negative regulation of lipid metabolic process 61 29 4.92E-04 
GO:0045620 
negative regulation of lymphocyte 
differentiation 
30 16 5.02E-04 
GO:0090004 
positive regulation of establishment of protein 
localization to plasma membrane 
21 13 5.65E-04 
GO:0018210 peptidyl-threonine modification 42 22 5.81E-04 
GO:0072006 nephron development 86 41 5.90E-04 
GO:0001106 
RNA polymerase II transcription corepressor 
activity 
18 12 6.64E-04 
GO:0010893 
positive regulation of steroid biosynthetic 
process 
12 9 6.86E-04 
GO:0030276 clathrin binding 23 13 6.91E-04 
GO:0050853 B cell receptor signaling pathway 30 16 7.20E-04 
GO:0072661 protein targeting to plasma membrane 18 13 8.75E-04 
GO:0005942 phosphatidylinositol 3-kinase complex 14 9 8.78E-04 




Table 5.11. Pathway analysis in the prefrontal cortex ‘black’ module using 
data from schizophrenia cases and controls. Analysis testing for a significant 
enrichment of genes belonging to the prefrontal cortex 7.black module 
overlapping gene ontology (GO) terms. 









regulation of proteasomal ubiquitin-dependent 
protein catabolic process 
67 23 1.02E-07 
GO:0034593 
phosphatidylinositol bisphosphate phosphatase 
activity 
13 8 1.27E-07 
GO:0044265 cellular macromolecule catabolic process 669 123 2.15E-07 
GO:0007049 cell cycle 1210 208 4.35E-06 
GO:0042809 vitamin D receptor binding 14 7 4.93E-06 
GO:0009894 regulation of catabolic process 670 138 7.07E-06 
GO:0003723 RNA binding 869 148 7.49E-06 
GO:0044772 mitotic cell cycle phase transition 275 58 2.06E-05 
GO:0005654 nucleoplasm 1398 234 2.40E-05 
GO:0009263 deoxyribonucleotide biosynthetic process 12 6 2.96E-05 
GO:0031625 ubiquitin protein ligase binding 158 38 4.14E-05 
GO:0044389 small conjugating protein ligase binding 158 38 4.14E-05 
GO:0005811 lipid particle 50 15 4.54E-05 
GO:0006661 phosphatidylinositol biosynthetic process 87 23 4.66E-05 
GO:0016126 sterol biosynthetic process 36 12 5.17E-05 
GO:0016780 phosphotransferase activity 15 7 5.72E-05 
GO:0015630 microtubule cytoskeleton 898 158 5.72E-05 
GO:0034708 methyltransferase complex 75 20 6.05E-05 
GO:0051641 cellular localization 1713 276 6.99E-05 
GO:0043981 histone H4-K5 acetylation 13 6 7.28E-05 
GO:0043982 histone H4-K8 acetylation 13 6 7.28E-05 
GO:0045717 
negative regulation of fatty acid biosynthetic 
process 
10 5 7.62E-05 
GO:0009132 nucleoside diphosphate metabolic process 25 9 8.49E-05 
GO:0000050 urea cycle 10 5 8.99E-05 
GO:0032042 mitochondrial DNA metabolic process 13 6 1.03E-04 
GO:0016241 regulation of macroautophagy 23 9 1.05E-04 
GO:0031312 extrinsic component of organelle membrane 10 5 1.06E-04 
GO:2001251 negative regulation of chromosome organization 40 13 1.16E-04 
GO:0001953 negative regulation of cell-matrix adhesion 20 8 1.23E-04 
GO:0043249 erythrocyte maturation 10 5 1.29E-04 
GO:0048505 regulation of timing of cell differentiation 11 6 1.42E-04 
GO:0061028 establishment of endothelial barrier 13 6 1.76E-04 
GO:0050768 negative regulation of neurogenesis 96 27 1.83E-04 
GO:0090344 negative regulation of cell aging 13 6 1.88E-04 
GO:1902337 
regulation of apoptotic process involved in 
morphogenesis 




GO:0010884 positive regulation of lipid storage 18 7 2.05E-04 
GO:0010762 regulation of fibroblast migration 16 7 2.09E-04 
GO:1902494 catalytic complex 726 123 2.19E-04 
GO:0048008 
platelet-derived growth factor receptor signaling 
pathway 
32 11 2.71E-04 
GO:0045879 
negative regulation of smoothened signaling 
pathway 
24 9 2.86E-04 
GO:0043555 regulation of translation in response to stress 11 5 3.18E-04 
GO:2000058 
regulation of protein ubiquitination involved in 
ubiquitin-dependent protein catabolic process 
17 7 3.62E-04 
GO:0006464 cellular protein modification process 1892 296 4.05E-04 
GO:0036211 protein modification process 1892 296 4.05E-04 
GO:0019012 Virion 15 6 4.24E-04 
GO:0019028 viral capsid 15 6 4.24E-04 
GO:0044423 virion part 15 6 4.24E-04 
GO:0008409 5'-3' exonuclease activity 11 5 4.32E-04 
GO:0006260 DNA replication 207 41 4.46E-04 
GO:0006974 cellular response to DNA damage stimulus 626 106 4.46E-04 
GO:0010833 telomere maintenance via telomere lengthening 36 11 4.68E-04 
GO:0034061 DNA polymerase activity 32 10 4.77E-04 
GO:0005524 ATP binding 1430 231 4.93E-04 
GO:0090317 negative regulation of intracellular protein transport 65 17 5.20E-04 
GO:0030522 intracellular receptor signaling pathway 167 35 5.30E-04 
GO:0043009 chordate embryonic development 589 112 5.45E-04 
GO:0005730 Nucleolus 636 105 6.42E-04 
GO:0016197 endosomal transport 142 30 6.56E-04 
GO:0001501 skeletal system development 412 83 6.89E-04 
GO:0005669 transcription factor TFIID complex 20 7 7.25E-04 
GO:0048488 synaptic vesicle endocytosis 18 7 7.60E-04 
GO:0032269 
negative regulation of cellular protein metabolic 
process 
472 88 7.86E-04 
GO:0060079 
regulation of excitatory postsynaptic membrane 
potential 
41 14 8.31E-04 
GO:0031648 protein destabilization 20 7 8.58E-04 
GO:2000178 
negative regulation of neural precursor cell 
proliferation 
17 7 8.79E-04 
GO:0033057 multicellular organismal reproductive behavior 20 7 9.05E-04 










Table 5.12. Pathway analysis in the prefrontal cortex ‘tan’ module using 
data from schizophrenia cases and controls. Analysis testing for a significant 
enrichment of genes belonging to the prefrontal cortex 12.tan module 
overlapping gene ontology (GO) terms. 









regulation of potassium ion transmembrane 
transport 
20 7 1.51E-10 
GO:0043268 positive regulation of potassium ion transport 16 6 7.03E-10 
GO:0017166 vinculin binding 10 4 4.85E-09 
GO:0034767 positive regulation of ion transmembrane transport 22 6 2.48E-07 
GO:0043034 costamere 17 5 4.39E-07 
GO:0032012 regulation of ARF protein signal transduction 42 9 6.08E-07 
GO:0044304 main axon 50 10 6.43E-07 
GO:0035591 signaling adaptor activity 61 10 1.56E-06 
GO:1902531 regulation of intracellular signal transduction 1240 91 1.59E-06 
GO:0032794 GTPase activating protein binding 14 4 1.99E-06 
GO:0072677 eosinophil migration 10 3 2.11E-06 
GO:0044295 axonal growth cone 12 4 2.53E-06 
GO:0019226 transmission of nerve impulse 629 55 3.18E-06 
GO:0042993 
positive regulation of transcription factor import into 
nucleus 
34 6 3.85E-06 
GO:0042753 positive regulation of circadian rhythm 10 3 4.41E-06 
GO:0033268 node of Ranvier 14 4 6.18E-06 
GO:1901016 
regulation of potassium ion transmembrane 
transporter activity 
15 4 6.29E-06 
GO:0030054 cell junction 778 65 6.34E-06 
GO:0043270 positive regulation of ion transport 139 16 8.18E-06 
GO:0070098 chemokine-mediated signaling pathway 27 5 8.67E-06 
GO:0006897 endocytosis 362 32 9.74E-06 
GO:0046689 response to mercury ion 11 3 1.08E-05 
GO:0005085 guanyl-nucleotide exchange factor activity 175 22 1.13E-05 
GO:0048584 positive regulation of response to stimulus 1344 88 1.20E-05 
GO:0004673 protein histidine kinase activity 10 3 1.31E-05 
GO:0036041 long-chain fatty acid binding 11 3 1.48E-05 
GO:0005083 small GTPase regulator activity 166 20 2.71E-05 
GO:0015695 organic cation transport 19 4 4.54E-05 
GO:0030506 ankyrin binding 20 5 6.65E-05 
GO:0017124 SH3 domain binding 115 14 6.95E-05 
GO:0009312 oligosaccharide biosynthetic process 13 3 7.23E-05 
GO:0016023 cytoplasmic membrane-bounded vesicle 927 62 8.53E-05 
GO:0005249 voltage-gated potassium channel activity 83 11 8.68E-05 
GO:0008092 cytoskeletal protein binding 696 55 9.75E-05 
GO:0051707 response to other organism 558 35 9.87E-05 




GO:0005925 focal adhesion 126 15 1.47E-04 
GO:0097481 neuronal postsynaptic density 11 3 1.69E-04 
GO:0050954 sensory perception of mechanical stimulus 135 16 2.01E-04 
GO:0019894 kinesin binding 25 5 2.09E-04 
GO:0048525 negative regulation of viral process 47 6 2.12E-04 
GO:0030676 Rac guanyl-nucleotide exchange factor activity 11 3 2.73E-04 
GO:0003013 circulatory system process 272 23 2.75E-04 
GO:0001945 lymph vessel development 20 4 3.22E-04 
GO:0005680 anaphase-promoting complex 23 4 3.32E-04 
GO:0050775 positive regulation of dendrite morphogenesis 13 3 3.83E-04 
GO:0090344 negative regulation of cell aging 13 3 3.91E-04 
GO:0006972 hyperosmotic response 24 4 4.00E-04 
GO:0016235 aggresome 22 4 4.16E-04 
GO:0010453 regulation of cell fate commitment 28 5 4.19E-04 
GO:1902603 carnitine transmembrane transport 12 3 4.26E-04 
GO:0005887 integral component of plasma membrane 1202 76 4.32E-04 
GO:0072283 metanephric renal vesicle morphogenesis 11 3 4.53E-04 
GO:0001775 cell activation 582 40 4.61E-04 
GO:0031998 regulation of fatty acid beta-oxidation 13 3 4.75E-04 
GO:0042088 T-helper 1 type immune response 17 3 5.68E-04 
GO:0050848 regulation of calcium-mediated signaling 35 5 6.11E-04 
GO:0051225 spindle assembly 42 6 6.48E-04 
GO:0051270 regulation of cellular component movement 538 41 6.85E-04 
GO:0008015 blood circulation 270 22 7.45E-04 
GO:0010939 regulation of necrotic cell death 16 3 7.73E-04 
GO:0043368 positive T cell selection 20 4 8.18E-04 
GO:0004672 protein kinase activity 579 44 8.61E-04 












Table 5.13. Pathway analysis in the prefrontal cortex ‘salmon’ module 
using data from schizophrenia cases and controls. Analysis testing for a 
significant enrichment of genes belonging to the prefrontal cortex 13.salmon 
module overlapping gene ontology (GO) terms. 









regulation of blood vessel endothelial cell 
migration 
43 10 2.81E-12 
GO:0007155 cell adhesion 798 73 1.03E-11 
GO:0051270 regulation of cellular component movement 538 50 2.50E-11 
GO:0043537 
negative regulation of blood vessel endothelial 
cell migration 
20 6 4.70E-11 
GO:0090049 
regulation of cell migration involved in 
sprouting angiogenesis 
15 5 1.27E-10 
GO:0007156 homophilic cell adhesion 135 25 3.57E-10 
GO:0003951 NAD+ kinase activity 16 5 1.46E-09 
GO:0015271 outward rectifier potassium channel activity 10 4 1.33E-08 
GO:0040013 negative regulation of locomotion 169 20 1.64E-08 
GO:0071435 potassium ion export 10 4 2.85E-08 
GO:0001570 vasculogenesis 69 11 5.94E-08 
GO:0048747 muscle fiber development 34 7 7.30E-08 
GO:0019048 
modulation by virus of host morphology or 
physiology 
25 6 7.63E-08 
GO:0001944 vasculature development 452 39 9.75E-08 
GO:0001945 lymph vessel development 20 5 1.40E-07 
GO:0050951 sensory perception of temperature stimulus 14 4 2.33E-07 
GO:0002042 
cell migration involved in sprouting 
angiogenesis 
15 4 3.46E-07 
GO:0031362 
anchored component of external side of 
plasma membrane 
16 4 3.64E-07 
GO:0060840 artery development 55 9 6.39E-07 
GO:0010631 epithelial cell migration 60 9 6.90E-07 
GO:0090132 epithelium migration 60 9 6.90E-07 
GO:0060841 venous blood vessel development 15 4 8.76E-07 
GO:0043551 
regulation of phosphatidylinositol 3-kinase 
activity 
30 6 9.91E-07 
GO:0031664 
regulation of lipopolysaccharide-mediated 
signaling pathway 
16 4 1.02E-06 
GO:1901888 regulation of cell junction assembly 40 7 1.12E-06 
GO:0043547 positive regulation of GTPase activity 161 19 1.53E-06 
GO:0045909 positive regulation of vasodilation 25 5 2.19E-06 
GO:0005509 calcium ion binding 661 52 2.42E-06 
GO:0045834 positive regulation of lipid metabolic process 98 12 2.54E-06 
GO:0006012 galactose metabolic process 11 3 2.68E-06 
GO:0046503 glycerolipid catabolic process 28 5 2.98E-06 
GO:0034763 
negative regulation of transmembrane 
transport 
16 4 3.54E-06 




GO:0004089 carbonate dehydratase activity 12 3 4.35E-06 
GO:0002281 
macrophage activation involved in immune 
response 
11 3 5.89E-06 
GO:0002832 
negative regulation of response to biotic 
stimulus 
19 4 6.68E-06 
GO:0071467 cellular response to pH 12 3 8.27E-06 
GO:0009611 response to wounding 998 60 9.62E-06 
GO:0038084 
vascular endothelial growth factor signaling 
pathway 
11 3 1.04E-05 
GO:0009628 response to abiotic stimulus 902 55 1.26E-05 
GO:0032101 regulation of response to external stimulus 463 31 1.51E-05 
GO:0072044 collecting duct development 11 3 1.70E-05 
GO:0009415 response to water 11 3 1.70E-05 
GO:0046885 regulation of hormone biosynthetic process 18 4 2.20E-05 
GO:0032720 
negative regulation of tumor necrosis factor 
production 
29 5 2.57E-05 
GO:0030214 hyaluronan catabolic process 13 3 2.67E-05 
GO:0001701 in utero embryonic development 360 29 3.39E-05 
GO:0043271 negative regulation of ion transport 62 8 3.51E-05 
GO:0006066 alcohol metabolic process 310 23 3.81E-05 
GO:0060039 pericardium development 17 4 4.01E-05 
GO:0005901 Caveola 63 9 4.36E-05 
GO:0017158 
regulation of calcium ion-dependent 
exocytosis 
27 5 5.09E-05 
GO:0032332 
positive regulation of chondrocyte 
differentiation 
18 4 5.43E-05 
GO:0016575 histone deacetylation 25 5 6.58E-05 
GO:0060976 coronary vasculature development 12 3 7.66E-05 
GO:0043406 positive regulation of MAP kinase activity 185 16 9.17E-05 
GO:0034358 plasma lipoprotein particle 38 5 1.16E-04 
GO:0032317 regulation of Rap GTPase activity 14 3 1.23E-04 
GO:0042219 cellular modified amino acid catabolic process 15 3 1.24E-04 
GO:0003158 endothelium development 59 8 1.26E-04 
GO:0043500 muscle adaptation 27 5 1.29E-04 
GO:0070412 R-SMAD binding 21 4 1.43E-04 
GO:0019838 growth factor binding 110 12 1.46E-04 
GO:0018108 peptidyl-tyrosine phosphorylation 120 13 1.56E-04 
GO:0002920 regulation of humoral immune response 42 5 1.65E-04 
GO:0045920 negative regulation of exocytosis 13 3 1.69E-04 
GO:0050900 leukocyte migration 216 16 1.87E-04 
GO:0032153 cell division site 44 6 1.88E-04 
GO:0032155 cell division site part 44 6 1.88E-04 
GO:0070887 cellular response to chemical stimulus 1868 96 1.99E-04 
GO:0061061 muscle structure development 417 32 2.19E-04 
GO:0035810 positive regulation of urine volume 15 3 2.20E-04 
GO:0061298 
retina vasculature development in camera-
type eye 
14 3 2.21E-04 
GO:0014910 regulation of smooth muscle cell migration 33 5 2.24E-04 
GO:0048008 
platelet-derived growth factor receptor 
signaling pathway 




GO:0010243 response to organonitrogen compound 671 44 2.50E-04 
GO:0097061 dendritic spine organization 13 3 2.54E-04 
GO:0048569 post-embryonic organ development 15 3 2.55E-04 
GO:0042588 zymogen granule 13 3 2.57E-04 
GO:0018146 keratan sulfate biosynthetic process 29 4 2.92E-04 
GO:0048841 
regulation of axon extension involved in axon 
guidance 
13 3 3.03E-04 
GO:0001941 postsynaptic membrane organization 13 3 3.23E-04 
GO:0006656 phosphatidylcholine biosynthetic process 25 4 3.41E-04 
GO:0051904 pigment granule transport 17 3 3.49E-04 
GO:0051905 establishment of pigment granule localization 17 3 3.49E-04 
GO:0071813 lipoprotein particle binding 26 4 3.60E-04 
GO:0071814 protein-lipid complex binding 26 4 3.60E-04 
GO:0048638 regulation of developmental growth 127 13 3.89E-04 
GO:0034405 response to fluid shear stress 25 4 3.95E-04 
GO:0071695 anatomical structure maturation 46 6 3.98E-04 
GO:0030510 regulation of BMP signaling pathway 63 8 5.13E-04 
GO:0042886 amide transport 73 8 5.62E-04 
GO:0030029 actin filament-based process 381 30 5.63E-04 
GO:0001754 eye photoreceptor cell differentiation 40 5 6.14E-04 
GO:0035850 
epithelial cell differentiation involved in kidney 
development 
23 4 6.59E-04 
GO:0043198 dendritic shaft 32 5 7.44E-04 
GO:0001848 complement binding 10 2 7.76E-04 
GO:0035428 hexose transmembrane transport 10 2 8.04E-04 
GO:0042056 chemoattractant activity 20 3 8.56E-04 
GO:0043548 phosphatidylinositol 3-kinase binding 23 4 8.77E-04 










Table 5.14. Pathway analysis in the prefrontal cortex ‘darkgrey’ module 
using data from schizophrenia cases and controls. Analysis testing for a 
significant enrichment of genes belonging to the prefrontal cortex 24.darkgrey 
module overlapping gene ontology (GO) terms. 









carboxy-terminal domain protein kinase 
complex 




10 2 4.28E-11 
GO:0019098 reproductive behavior 30 3 1.74E-08 
GO:0005527 macrolide binding 15 2 8.80E-08 
GO:0005528 FK506 binding 15 2 8.80E-08 
GO:0006029 proteoglycan metabolic process 84 5 3.00E-07 
GO:0033363 secretory granule organization 18 2 7.64E-07 
GO:0045822 negative regulation of heart contraction 18 2 9.01E-07 
GO:0050885 
neuromuscular process controlling 
balance 
58 4 1.56E-06 
GO:0031290 retinal ganglion cell axon guidance 18 2 1.66E-06 
GO:0060384 Innervation 18 2 1.82E-06 
GO:0005201 extracellular matrix structural constituent 62 4 1.93E-06 
GO:0072676 lymphocyte migration 20 2 3.42E-06 
GO:0034110 regulation of homotypic cell-cell adhesion 19 2 3.52E-06 
GO:0009100 glycoprotein metabolic process 340 10 1.24E-05 
GO:0050877 neurological system process 1168 24 1.29E-05 
GO:0031683 
G-protein beta/gamma-subunit complex 
binding 
21 2 1.61E-05 
GO:0008146 sulfotransferase activity 50 3 2.39E-05 
GO:0010880 
regulation of release of sequestered 
calcium ion into cytosol by sarcoplasmic 
reticulum 
23 2 3.19E-05 
GO:0060119 inner ear receptor cell development 25 2 4.91E-05 
GO:0016266 O-glycan processing 52 3 7.66E-05 
GO:0060326 cell chemotaxis 137 5 8.51E-05 
GO:0004435 
phosphatidylinositol phospholipase C 
activity 
28 2 1.03E-04 
GO:0044705 multi-organism reproductive behavior 28 2 1.26E-04 
GO:0031589 cell-substrate adhesion 131 5 1.81E-04 
GO:0034704 calcium channel complex 54 3 1.87E-04 
GO:0046942 carboxylic acid transport 190 6 2.36E-04 
GO:0061515 myeloid cell development 29 2 3.35E-04 





transmembrane receptor protein tyrosine 
phosphatase activity 
20 2 4.89E-04 
GO:0019198 
transmembrane receptor protein 
phosphatase activity 
20 2 4.89E-04 
GO:0021955 
central nervous system neuron 
axonogenesis 
29 2 4.93E-04 
GO:0007040 lysosome organization 34 2 5.04E-04 
GO:0019855 calcium channel inhibitor activity 10 1 5.31E-04 
GO:0032515 
negative regulation of phosphoprotein 
phosphatase activity 
10 1 5.56E-04 
GO:0045717 
negative regulation of fatty acid 
biosynthetic process 
10 1 5.88E-04 
GO:0051775 response to redox state 10 1 5.99E-04 
GO:0015651 
quaternary ammonium group 
transmembrane transporter activity 
10 1 6.02E-04 
GO:0071295 cellular response to vitamin 10 1 6.75E-04 
GO:0004887 thyroid hormone receptor activity 10 1 6.78E-04 
GO:0090280 positive regulation of calcium ion import 10 1 6.97E-04 
GO:0097435 fibril organization 10 1 7.13E-04 
GO:0071498 cellular response to fluid shear stress 10 1 7.36E-04 
GO:0090140 regulation of mitochondrial fission 10 1 7.36E-04 
GO:0031045 dense core granule 10 1 8.01E-04 
GO:0048711 
positive regulation of astrocyte 
differentiation 
10 1 8.38E-04 
GO:0090184 
positive regulation of kidney 
development 
10 1 8.53E-04 





5.6.4. Exclusion of non-Caucasian samples 
The PFC, STR and CER networks all contain modules that are significantly 
correlated with PRS (see section 5.6.1). Most of these modules, however, are 
also correlated with ethnicity (identified from genotype data). To investigate 
whether the associations with PRS were a result of the inclusion of non-
Caucasian samples in the networks I repeated the generation of the networks 
excluding these samples (for details on sample ethnicity derived from genetic 
data see Chapter 4 section 4.2.2).  
Tables 5.15 to 5.17 present the number of modules for each brain region 
network, probes in each module and results of Pearson’s correlation between 
each module’s ME and PRS and ethnicity. Figures 5.13 to 5.15 show the 
heatmaps for these correlations. The PFC and STR networks have no modules 
associated with PRS after the exclusion of non-Caucasian samples, indicating 
that the initial observations were potentially driven by ancestry outliers. In 
contrast, the CER network contained three modules associated with PRS. 
Given the differences already observed in the CER DNA methylation data 
compared to the other brain regions present in this study (see Chapter 3 




Table 5.15. Modules identified in the network using prefrontal cortex data 
from Caucasian non-psychiatric cases and schizophrenia controls from 
the MRC London Neurodegenerative Diseases Brain Bank and Douglas-
Bell Canada Brain Bank. Shown are the coefficients (ρ) and P-values of 
Pearson’s correlations between each module eigengene and polygenic risk 
score and ethnicity. 
Module Module colour N 
Probes 





0 grey 254126 - - - - 
1 turquoise 78101 -8.04E-02 0.52 0.02 0.84 
2 blue 19802 0.08 0.52 -1.06E-02 0.93 
3 brown 10058 -0.13 0.28 -9.10E-02 0.46 
4 yellow 8356 -1.76E-02 0.89 -1.12E-01 0.37 
5 green 7933 0.03 0.80 0.10 0.44 
6 red 7657 -0.16 0.19 -6.80E-02 0.58 
7 black 5394 -0.01 0.91 -7.32E-02 0.56 
8 pink 3279 -0.11 0.39 -1.79E-02 0.89 
9 magenta 2950 -0.12 0.35 -0.10 0.42 
10 purple 2015 0.12 0.35 -0.14 0.26 
11 greenyellow 2012 0.15 0.23 -5.70E-02 0.65 
12 tan 1677 0.15 0.23 0.09 0.47 
13 salmon 898 -8.99E-02 0.47 0.12 0.33 
14 cyan 848 1.55E-03 0.99 -1.12E-02 0.93 
15 midnightblue 792 -7.64E-03 0.95 0.24 0.05 
16 lightcyan 777 0.07 0.60 -1.57E-01 0.21 
17 grey60 754 -0.12 0.34 0.05 0.72 
18 lightgreen 587 0.19 0.13 -5.71E-02 0.65 
19 lightyellow 513 -0.12 0.35 0.05 0.66 
20 royalblue 459 -0.12 0.35 -8.21E-02 0.51 
21 darkred 440 0.04 0.77 0.07 0.58 
22 darkgreen 429 -5.14E-03 0.97 0.03 0.81 
23 darkturquoise 420 0.06 0.62 0.08 0.55 
24 darkgrey 419 0.11 0.37 0.04 0.75 
25 orange 324 0.02 0.86 0.02 0.89 
26 darkorange 317 -0.15 0.24 0.09 0.47 
27 white 264 -0.19 0.12 0.08 0.52 
28 skyblue 241 -1.38E-02 0.91 0.03 0.83 
29 saddlebrown 232 -8.90E-02 0.47 -8.39E-02 0.50 
30 steelblue 204 -8.76E-02 0.48 0.17 0.18 
31 paleturquoise 203 -9.60E-02 0.44 0.04 0.73 
32 violet 197 -0.14 0.25 0.21 0.09 
33 darkolivegreen 186 0.14 0.26 0.09 0.48 
34 darkmagenta 176 0.03 0.80 -1.55E-01 0.21 
35 sienna3 151 -1.31E-02 0.92 -1.92E-01 0.12 
36 yellowgreen 137 6.81E-03 0.96 -2.08E-02 0.87 
37 skyblue3 134 0.02 0.88 0.14 0.26 






Table 5.16. Modules identified in the network using striatum data from 
Caucasian non-psychiatric cases and schizophrenia controls from the 
MRC London Neurodegenerative Diseases Brain Bank and Douglas-Bell 
Canada Brain Bank. Shown are the coefficients (ρ) and P-values of Pearson’s 
correlations between each module eigengene and polygenic risk score and 
ethnicity. 
Module Module colour N Probes 
Polygenic risk score Ethnicity 
ρ correlation P ρ correlation P 
0 grey 191031 - - - - 
1 turquoise 68834 1.84E-03 0.28 -8.56E-02 0.79 
2 blue 23456 -1.19E-02 0.99 -1.64E-02 0.48 
3 brown 22049 0.09 0.92 0.02 0.89 
4 yellow 17218 0.04 0.45 0.04 0.86 
5 green 14078 0.13 0.77 8.34E-03 0.73 
6 red 13654 -0.02 0.27 0.10 0.94 
7 black 11055 0.12 0.85 0.09 0.43 
8 pink 8284 0.07 0.33 0.11 0.48 
9 magenta 6852 0.09 0.58 0.04 0.38 
10 purple 6032 -3.82E-02 0.46 -0.11 0.72 
11 greenyellow 5786 -0.12 0.75 -1.24E-02 0.34 
12 tan 5232 -0.15 0.33 0.07 0.92 
13 salmon 5164 -6.90E-02 0.20 -5.22E-02 0.57 
14 cyan 4920 -7.30E-02 0.57 -3.06E-02 0.67 
15 midnightblue 3992 0.17 0.55 -7.27E-02 0.80 
16 lightcyan 2890 0.18 0.16 -3.50E-03 0.55 
17 grey60 1742 0.05 0.14 -2.09E-02 0.98 
18 lightgreen 888 -6.60E-04 0.67 -4.22E-02 0.86 
19 lightyellow 742 -0.04 1.00 -0.13 0.73 
20 royalblue 474 0.11 0.73 0.02 0.30 
21 darkred 423 -0.18 0.35 0.16 0.85 
22 darkgreen 379 -0.17 0.14 -1.43E-02 0.19 
23 darkturquoise 360 -1.34E-02 0.17 -8.34E-02 0.91 
24 darkgrey 281 -0.12 0.91 0.07 0.49 
25 orange 274 0.17 0.33 -0.11 0.56 
26 darkorange 237 -0.22 0.17 -8.43E-02 0.35 
27 white 189 -0.18 0.07 -2.81E-02 0.48 
28 skyblue 176 -0.14 0.12 -7.01E-02 0.82 
29 saddlebrown 143 0.11 0.24 0.55 0.56 
30 steelblue 141 -0.15 0.37 0.08 0.00 
31 paleturquoise 136 -0.17 0.21 0.05 0.51 
32 violet 112 -0.17 0.15 -9.96E-02 0.68 
33 darkolivegreen 112 -5.18E-02 0.16 0.14 0.41 





Table 5.17. Modules identified in the network using cerebellum data from 
Caucasian non-psychiatric cases and schizophrenia controls from the 
MRC London Neurodegenerative Diseases Brain Bank and Douglas-Bell 
Canada Brain Bank. Shown are the coefficients (ρ) and P-values of Pearson’s 
correlations between each module eigengene and polygenic risk score and 













0 grey 153386 - - - - 
1 turquoise 62966 0.02 0.84 -0.14 0.24 
2 blue 29356 -3.65E-03 0.98 -2.48E-02 0.84 
3 brown 26545 -0.18 0.14 -4.06E-02 0.74 
4 yellow 23161 5.20E-03 0.97 0.14 0.25 
5 green 18048 -0.25 0.04 -0.15 0.23 
6 red 11976 0.04 0.76 0.26 0.03 
7 black 10625 -5.92E-02 0.63 0.43 2.93E-04 
8 pink 9220 -0.23 0.06 -5.80E-02 0.64 
9 magenta 6576 7.79E-03 0.95 0.19 0.12 
10 purple 6520 0.05 0.67 0.02 0.87 
11 greenyellow 5775 -0.17 0.16 -0.17 0.15 
12 tan 5277 0.13 0.27 0.14 0.24 
13 salmon 4998 0.63 7.32E-09 -0.11 0.39 
14 cyan 4588 0.02 0.88 0.29 0.02 
15 midnightblue 4030 0.06 0.60 -0.15 0.22 
16 lightcyan 3849 9.12E-03 0.94 0.10 0.40 
17 grey60 3512 0.47 5.79E-05 -5.68E-02 0.65 
18 lightgreen 3273 -8.67E-02 0.48 -3.26E-02 0.79 
19 lightyellow 3183 -2.10E-02 0.86 0.16 0.19 
20 royalblue 3061 0.57 4.98E-07 0.21 0.08 
21 darkred 2062 -7.33E-02 0.55 -6.38E-02 0.61 
22 darkgreen 1830 -0.10 0.40 -9.21E-04 0.99 
23 darkturquoise 1793 0.24 0.05 0.11 0.37 
24 darkgrey 1571 0.04 0.74 0.21 0.08 
25 orange 972 -4.90E-02 0.69 -0.20 0.11 
26 darkorange 481 -0.18 0.13 0.01 0.91 
27 white 346 -0.11 0.39 0.12 0.32 
28 skyblue 324 2.65E-03 0.98 -8.98E-02 0.47 
29 saddlebrown 174 -0.29 0.02 -0.17 0.16 
30 steelblue 173 8.55E-04 0.99 0.02 0.89 





Figure 5.13. Heatmap showing the correlation coefficient between each 
prefrontal cortex module eigengene and polygenic risk score and 
ethnicity. Shown are the modules identified in the network using prefrontal 
cortex data from the Caucasians non-psychiatric cases and schizophrenia 
controls from the MRC London Neurodegenerative Diseases Brain Bank and 





Figure 5.14. Heatmap showing the correlation coefficient between each 
striatum module eigengene and polygenic risk score and ethnicity. Shown 
are the modules identified in the network using striatum data from the 
Caucasians non-psychiatric cases and schizophrenia controls from the MRC 
London Neurodegenerative Diseases Brain Bank and Douglas-Bell Canada 





Figure 5.15. Heatmap showing the correlation coefficient between each 
cerebellum module eigengene and polygenic risk score and ethnicity. 
Shown are the modules identified in the network using cerebellum data from the 
Caucasians non-psychiatric cases and schizophrenia controls from the MRC 
London Neurodegenerative Diseases Brain Bank and Douglas-Bell Canada 




 Fetal brain correlation network 5.7.
Given previous evidence for a neurodevelopmental basis to schizophrenia 
(Spiers et al., 2015) I next investigated whether co-methylated modules 
identified in human fetal brain were also associated with schizophrenia. 
Previously our group generated an Illumina 450K array dataset from fetal brain 
samples (n = 179), ranging from 23 to 184 days post-conception (Spiers et al., 
2015) and showed that there were several co-methylated modules strongly 
associated with brain development. For each brain region network I imposed 
the module structure of the fetal brain network by calculating the MEs of the 
modules identified in the fetal brain dataset for each of the adult brain samples 
and testing for association between the ME and schizophrenia within each adult 
brain region using an independent sample t–test as described above (section 
5.6.2). 
Table 5.18 presents the P-values of these tests for all the fetal brain modules. 
Although none of the modules was significantly associated with schizophrenia 
at a Bonferroni corrected threshold (corrected for the 92 tests; P = 5.43E-04), 
seven PFC, 1 HC and 1 CER modules were nominally associated with 
schizophrenia. Strikingly, five of the PFC schizophrenia-associated modules (P-
values:  ‘brown’: 0.04, ‘darkgreen’: 0.02, ‘grey60’: 0.02, ‘red’: 0.02 and ‘yellow’: 
0.02) were also significantly correlated with fetal age in Spiers et al. (2015). The 
largest of these modules (fetal ‘brown’ module) was highly enrichment for 
probes annotated to genes in pathways relevant to neurodevelopment (Spiers 
et al., 2015). These observations have particular relevance since schizophrenia 
has been suggested to have neurodevelopmental origins (Owen et al., 2011, 




Table 5.18. Association of the fetal brain modules with schizophrenia in 
the adult brain data. Shown are the t-test P-values for schizophrenia cases 
and controls in the adult prefrontal cortex, striatum, hippocampus and 
cerebellum datasets using the fetal brain module structure and the correlation 












with fetal age 
(Spiers et al., 
2015) 
black 0.52 0.42 0.43 0.97 0.01 (8.75E-01) 
blue 0.20 0.26 0.14 0.62 -0.14 (6.44E-02) 
brown 0.04 0.99 0.37 0.57 0.54 (5.63E-15) 
cyan 0.44 0.66 0.40 0.42 -0.22 (3.42E-03) 
darkgreen 0.02 0.64 0.42 0.24 -0.45 (1.61E-10) 
darkred 0.15 0.71 0.57 0.93 0.31 (2.30E-05) 
green 0.12 0.40 0.21 0.58 -0.12 (9.72E-02) 
greenyellow 0.16 0.37 0.19 0.61 -0.32 (9.86E-06) 
grey60 0.02 1.00 0.39 0.28 -0.52 (1.59E-13) 
lightcyan 8.28E-03 0.62 0.04 0.23 -0.01 (9.40E-01) 
lightgreen 0.05 0.81 0.36 0.91 -0.05 (5.23E-01) 
lightyellow 0.12 0.58 0.22 0.73 -0.22 (3.31E-03) 
magenta 0.18 0.47 0.11 0.14 -0.21 (5.64E-03) 
midnightblue 0.04 0.88 0.72 0.22 0.12 (9.63E-02) 
pink 0.10 0.91 0.27 0.49 0.47 (3.84E-11) 
purple 0.67 0.33 0.64 0.03 0.06 (3.99E-01) 
red 0.02 0.85 0.36 0.38 -0.23 (1.68E-03) 
royalblue 0.30 0.28 0.18 0.10 0.05 (4.91E-01) 
salmon 0.08 0.75 0.25 0.57 0.22 (2.56E-03) 
tan 0.09 0.99 0.27 0.72 0.33 (4.81E-06) 
turquoise 0.09 0.46 0.20 0.47 0.19 (9.87E-03) 







5.8.1. Overview of the results 
In this chapter I used WGCNA to study the co-methylation structure of DNA 
methylation in each of the four brain regions, exploring differences in network 
structures between schizophrenia patients and controls. The initial approach 
focused on creating separate networks for schizophrenia patients and non-
psychiatric controls within each brain region and identifying overlapping and 
unique modules of co-methylated probes between cases and controls networks. 
I attempted to match each module of the control network with at least one 
corresponding module from the schizophrenia network and concluded that this 
was not possible and therefore this was not the optimal method to use.  
I subsequently created networks for each brain region using the entire set of 
samples (i.e. including both schizophrenia cases and controls) and tested for a 
significant association of these with schizophrenia status, schizophrenia PRS 
and other traits of interest. Several modules in each brain region are correlated 
with PRS, although these are also associated with ethnicity, except in the 
cerebellum. I repeated the networks including only Caucasian samples and 
retested for correlation with PRS. None of the new modules are correlated with 
PRS in the PFC and STR after excluding non-Caucasian samples. In the CER, 
three modules are correlated with PRS after excluding the non-Caucasian 
samples, although, given the differences already observed in the CER DNA 
methylation data compared to the other brain regions present in this study (see 
Chapter 3 sections 3.2.2 and 3.2.5),  these associations need to be explored 
further.  
Five modules are nominally associated with schizophrenia in the PFC network 
and none in the STR and CER networks. Three of the genes annotated to the 
‘hub probes’ of the PFC schizophrenia-associated modules are particularly 
interesting in the context of schizophrenia: KDM3B (‘black’ module) 
(Schizophrenia Working Group of the Psychiatric Genomics, 2014),  ANK3 
(‘brown’ module) (Ferreira et al., 2008, Wirgenes et al., 2014) and RPTOR  
(‘brown’ module, associated with PRS in Chapter 4 section 4.3.4). 
Furthermore, two genes of the ‘brown’ module showed interactions with the 




schizophrenia-linked genes (Ganapathiraju et al., 2016). Seven other genes 
belonging to the PFC schizophrenia-associated modules also had interactions 
with genes associated with schizophrenia in the latest GWAS (Schizophrenia 
Working Group of the Psychiatric Genomics, 2014). GO enrichment analysis 
revealed that the eleven most significantly enriched pathways on the largest 
(PFC ‘brown’) schizophrenia-associated module are neuronal function- and 
neurodevelopment-relevant pathways.  
Finally, I imposed the structure of modules of co-methylated probes identified in 
a fetal brain dataset (Spiers et al., 2015) to my adult brain data and tested these 
for association with schizophrenia. Strikingly, five schizophrenia-associated 
‘fetal network’ modules  in the PFC were also significantly correlated with fetal 
age in Spiers et al. (2015) and the largest of these modules (fetal ‘brown’ 
module) was highly enriched for probes annotated to genes in pathways 
relevant to neurodevelopment (Spiers et al., 2015). These observations have 
particular relevance since schizophrenia has been suggested to have 
neurodevelopmental origins (Owen et al., 2011, Weinberger, 1995). 
5.8.2. Strengths, limitations and future directions 
This chapter represents a first step in exploring the network structure of the 
DNA methylation data generated in this thesis and how this structure is affected 
in different brain regions of schizophrenia patients. I identified modules of co-
methylated sites nominally associated with schizophrenia in the PFC and genes 
central to those modules that have been previously linked to schizophrenia or 
have shown to interact with schizophrenia linked-genes. Five modules of co-
methylated probes that were correlated with fetal age in Spiers et al. (2015) are 
also found to be associated with schizophrenia in the PFC. Furthermore, both 
the largest schizophrenia-associated module identified in the PFC dataset and 
the largest fetal module associated with schizophrenia in the PFC are enriched 
for probes in pathways relevant to neurodevelopment. These observations 
support a neurodevelopmental origin of schizophrenia.  
In future studies, it would be important to explore the networks of both 
schizophrenia patients and non-psychiatric controls separately. This would 
potentially allow studying modules of co-methylated probes that are unique or 




disrupted between the two networks. It was not possible to use this approach in 
this chapter (see section 5.5), which could be due to the small sample size for 
schizophrenia patients and controls from each brain region. Another likely 
reason is the number of probes used to create the networks. Networks of co-
expression genes are usually constructed using thousands to dozens of 
thousands of genes (Parikshak et al., 2013, Zhang and Horvath, 2005, 
Voineagu et al., 2011). The inclusion of ~480,000 probes will potentially 
increase the noise in the network. In the future, ways of reducing the amount of 
probes in the network should be explored. For example: 
 Exclude non-variable probes across all samples; 
 Combine adjacent probes into regions of correlated probes and create a 
common metric to represent these probes; 
 Combine probes annotated to a single gene or gene feature and create a 
common metric to represent these probes. 
All these suggestions have potential limitations and should be explored 
carefully. The use of systems-level approaches to explore the epigenome has 
not been widely applied, and new analytical approaches are required. After 
refining the WGCNA approach for use in DNA methylation data, it will be 
important to study more carefully which co-methylated modules are associated 
with schizophrenia and schizophrenia polygenic burden in the different brain 
regions. 
In summary, this chapter presents a first step in exploring network analysis in 
DNA methylation data. I identified several modules of co-methylated probes 
associated with schizophrenia in the PFC and report additional evidence that 
supports a neurodevelopmental origin of schizophrenia. However, this 




Chapter 6 - Transcriptomic profiling of schizophrenia 
prefrontal cortex 
 Introduction 6.1.
The ‘transcriptome’ refers to the complete population of transcripts expressed in 
a cell and their quantity, at a given developmental stage or physiological 
condition (e.g. disorder). Cataloguing and quantifying the transcriptome is a 
crucial step in interpreting the functional elements of the genome and for 
understanding the role of gene regulation in development and disease.  
To date only a few studies have attempted to profile transcriptomic differences 
in schizophrenia brain compared to healthy individuals. A comprehensive 
overview of recent gene expression studies in schizophrenia is given in 
Chapter 1 section 1.1.3. Initial studies focused on characterising gene 
expression levels of individual candidate genes linked to schizophrenia based 
on their function utilising quantitative polymerase chain reaction (qPCR). 
Recently, several studies have taken a transcriptome-wide, hypothesis free 
approach. Although this represents a significant advance in the field of 
schizophrenia genomics research, such studies have primarily focussed on 
peripheral tissues (which may have limited utility for understanding gene 
expression differences in the brain) or used small sample sizes of post-mortem 
brain tissue. 
The RNA sequencing (RNA-seq) method was developed in 2008 (Nagalakshmi 
et al., 2008) and has since then revolutionised the study of transcriptomic 
variation.  Previously, the most popular choice for transcriptomic profiling 
was microarray based methods. RNA-seq represents an improvement 
compared to gene expression arrays since it allows for the full coverage of the 
transcriptome and the identification of new transcripts and isoforms (Wilhelm 
and Landry, 2009, Haas and Zody, 2010, Wang et al., 2009). There are also 
less problems with cross-hybridization artifacts and the poor quantification of 
low and highly expressed genes. The wide uptake of RNA-seq has meant that 
several pre-processing, aligning and analysis pipelines have been developed 
(Conesa et al., 2016), including analysis pipelines appropriate for case-control 
studies (Robinson et al., 2010). 
324 
 
In this Chapter I undertook a case-control RNA-seq gene expression study 
using post-mortem brain samples from schizophrenia patients and controls. I 
identified several disease-relevant genes showing expression changes in 
schizophrenia, with several of these annotated to CpG sites showing 
schizophrenia-associated DNA methylation variation in Chapter 3. 
 Methods 6.2.
6.2.1. Total RNA isolation from prefrontal cortex samples 
In this chapter I profiled transcriptomic variation in the prefrontal cortex (PFC) 
using RNA isolated from schizophrenia patients and non-psychiatric controls 
from the Medical Research Council (MRC) London Neurodegenerative 
Diseases Brain Bank (LNDBB) and Douglas-Bell Canada Brain Bank (DBCBB). 
Details on these sample cohorts are given in Chapter 3 section 3.2.1. Total 
RNA was isolated from the PFC of 39 schizophrenia patients and 45 controls. 
Appendix A - Supplementary Table 1 presents demographic information on 
all the samples included in this Chapter. Total RNA was isolated using the 
miRNeasy Mini Kit (Qiagen, Venlo, Holland) followed by a clean-up to remove 
fragmented RNA using the RNeasy MinElute Cleanup Kit (Qiagen, Venlo, 
Holland). The purity and integrity of RNA samples was assessed before and 
after clean-up using a Nanodrop ND-8000 (Thermo Fisher Scientific, MA, USA) 
and the Agilent RNA 6000 Nano Kit ran on an Agilent 2100 Bioanalyzer 
Instrument (Agilent Technologies, Santa Clara, CA, USA). Details on total RNA 
isolation, cleaning and quality check are described in Chapter 2 section 2.2. 
Table 6.2 gives an overview of the RNA concentration and RNA integrity 
number (RIN) results from the Bioanalyzer Instrument and 260/280 and 260/230 
ratios from the Nanodrop for all samples extracted, before and after the clean-





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.2.2. Complementary DNA libraries preparation and RNA 
sequencing 
Based on these quality measures I selected the 23 optimal schizophrenia 
samples and the 23 optimal non-psychiatric control samples for inclusion in the 
subsequent RNA-seq experiment. Table 6.2 provides details about the samples 
selected for sequencing (highlighted in grey). 
Complementary DNA (cDNA) libraries were generated from 500ng of the 
selected RNA samples using the TruSeq Stranded Total RNA with Ribo-Zero 
Gold Library Preparation LT kit (Illumina, San Diego, CA, USA). Details on 
cDNA library preparation are presented in Chapter 2 section 2.5.1. External 
RNA Controls Consortium (ERCC) spike-in control mixes (Ambion, Thermo 
Fisher Scientific, Waltham, MA, USA) were added to each RNA sample during 
the preparation of the libraries, according to the manufacturer’s instructions. 
The fragment size range, molarity and the quality of the libraries was assessed 
using D1000 ScreenTapes (Agilent Technologies, Santa Clara, CA, USA) 
processed on a 2200 TapeStation Instrument (Agilent Technologies, Santa 
Clara, CA, USA) as described in Chapter 2 section 2.5.2. For an example of 
the quantification of the resulting cDNA libraries see Figure 2.15 in Chapter 2. 
The samples were multiplexed, with 8 samples run per sequencing lane, with 
each pool containing an equal amount of each individual library to make a final 
concentration of 10mM. To accomplish this, individual "barcode" sequences 
were added to each sample so they could be de-multiplexed and distinguished 
during data analysis. Table 6.3 presents details on each sample library, 
including the Illumina TruSeq adapter barcode used for each sample and 
whether spike-in mix 1 or 2 was added. After I had prepared the libraries, the 
sequencing of the libraries was performed by the University of Exeter 
Sequencing Service on an Illumina HiSeq 2500 Sequencing System to generate 
paired-end reads, according to manufacturer’s instructions (see Chapter 2 
section 2.5.3 for more details on pair-ended sequencing). Samples were 
randomised for sex and diagnosis throughout the total RNA isolation, cDNA 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.2.3. Data pre-processing  
Raw data were de-multiplexed using the index barcode information provided in 
Table 6.3 and the raw data for each sample were stored as .fastq files. The 
numbers of raw reads from Read 1 (R1), Read 2 (R2) and Paired Reads 
(R1+R2) for each sample is presented in Table 6.4. Each Illumina HiSeq 2500 
lane provides ~200 million paired-end reads (Exeter Sequencing Service, 
2015). I multiplexed 8 samples per lane; therefore I expected to obtain ~25 
million paired-end reads per sample. As Table 6.4 shows, all samples show 
considerably good sequencing coverage and therefore none of the samples 
was excluded based on low read coverage.  
As part of the initial quality control (QC) steps performed by the Exeter 
Sequencing Service, Dr Konrad Paszkiewicz assessed the dynamic range for 
each of the samples using the ERCC spike-in controls (Jiang et al., 2011). The 
ERCC controls (Ambion, Thermo Fisher Scientific, Waltham, MA, USA) are a 
set of 92 unlabelled, poly-adenylated transcripts designed to be added to an 
RNA analysis experiment after sample isolation. The data generated for these 
transcripts during sequencing can then be compared with expected fold-
changes provided by the manufacturer (Thermo Fisher Scientific, 2012). In this 
experiment sample 15 from the LBDBB failed to show a good correlation 
between observed and expected expression levels of the ERCC transcripts. 
Figure 6.1 shows the examples of sample MS06 from the DBCBB (A) and 
sample 15 from the LBDBB (B). On a successful sample (A), the expected 
expression levels (log2(FPKM); y-axis) should appear proportional to the 
observed expression (x-axis) levels throughout most of the range. For details on 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6.1. Correlation between log2 of the observed and expected 
expression levels of the ERCC spike-in control transcripts. Shown are the 
examples of sample MS06 from the Douglas-Bell Canada Brain Bank (A) and 
sample 15 from the MRC London Neurodegenerative Diseases Brain Bank (B). 
FPKM, fragments per kilobase of exon per million fragments mapped. 
The samples were inspected for contamination by investigating what 
percentage of reads mapped uniquely to the human genome, to other species 
genomes or to human ribosomal RNA (rRNA). In order to do this the FastQ 
Screen software was used (Babraham Bioinformatics Group, 2015), which 
allows to screen a library of sequences against a set of sequence databases. 
Six samples (18 and 44 from the LNDBB and MS34PFC, MS04PFC, MS09PFC 
and MS03PFC from the DBCBB) showed some contamination with 
Adabidopsis, yeast and rRNA. Figure 6.2 presents the example of sample 
MS02 from the DBCBB, which shows high percentage of unique mapping (light 
blue) and negligible levels of contamination. Figure 6.3 shows the example of 
sample MS34 from the DBCBB, which presents some level of contamination. 
The contamination of RNA from other species should not be problematic, given 
that the reads were subsequently mapped to the human genome/transcriptome, 
however the contamination with human rRNA indicates sub-optimal rRNA 
removal during prior library preparation (see Chapter 2 section 2.5.1) and 
might be problematic during data analysis. I decided to keep these samples in 
the dataset and evaluate the consequence of this contamination in downstream 









































































































































































































































































































































6.2.4. Inspection of raw data with FastQC 
I next inspected the raw reads (.fastq files of both read 1 and read 2 from each 
sample) using the FastQC software version 0.10.1 (Andrews, 2010). The 
software provides a modular set of analyses for high throughput sequencing 
raw data. In this section I present examples of some of the important metrics 
given by FastQC that were used to inspect the RNA-seq data included in this 
chapter.  
6.2.4.1. Phred quality scores 
One of the important metrics to consider is the ‘per base sequence quality’. 
Figure 6.4 shows an example of a FastQC ‘per base sequence quality’ plot for 
read 1 of sample 18 from the LDNBB. The plot shows an overview of the range 
of quality values across all bases at each position in the .fastq file. To provide 
an estimate of confidence in a given base call, the Illumina sequencing pipeline 
assigns a quality score (Q, Phred scale) to each base called, which estimates 
the chance that the call is incorrect: 
 Q10 = 1 in 10 chance of incorrect base call 
 Q20 = 1 in 100 chance of incorrect base call 
 Q30 = 1 in 1000 chance of incorrect base call 
 Q40 = 1 in 10,000 chance of incorrect base call 
A score above 30 is considered good and above 20 is considered acceptable 
(Andrews, 2010). The quality of calls on the Illumina platform will degrade as 
the run progresses (towards the end of a read). Figure 6.5 shows an example 
of the distribution of Phred scores for all read 1 reads of sample 18 from the 
LNDBB. The plot shows a smooth peak around Q=37, indicating that the 





Figure 6.4. Example of a ‘per base sequence quality’ plot given by the 
FastQC software. Shown is the plot for read 1 of sample 18 from the LNDBB. 
The y-axis shows the Phred score along the read (x-axis). The central red line is 
the median value; the yellow box represents the inter-quartile range (25-75%), 
the upper and lower whiskers represent the 10% and 90% points, respectively, 




Figure 6.5. Example of a ‘per sequence quality’ plot given by the FastQC 
software. Shown is the plot for read 1 of sample 18 from the LNDBB. The x-
axis illustrates the mean Phred score per read (y-axis). 
6.2.4.2. Per base sequence and GC content 
Figures 6.6 and 6.7 show the base (A, C, G and T) and CG content (y-axis) by 
position in the reads (x-axis), respectively. Ideally, there should be no variation 
among base calls along the length of the read, and the CG content should be 
constant along the read. In RNA-seq data generated using Illumina technology 
there is usually variation of base call and CG content at the beginning of reads. 
This happens because the random priming that occurs at the beginning of the 
sequences is not truly random; the first twelve bases (2 hexamer primers) 
anneal preferentially to sequences that prime more efficiently ((Hansen et al., 
2010). This also explains why the Phred score is lower in the beginning of the 
read (Figure 6.4). This effect is removed after trimming the sequences (see 




Figure 6.6. Example of a ‘per base sequence content’ plot given by the 
FastQC software. Shown is the plot for read 1 of sample 18 from the LNDBB. 





Figure 6.7. Example of a ‘per base CG content’ plot given by the FastQC 
software. Shown is the plot for read 1 of sample 18 from the LNDBB. The y-
axis shows the mean CG content along the read (x-axis). 
The ‘per sequence GC content’ density plot (Figure 6.8) shows the distribution 
of GC content (x-axis) per reads (y-axis), where the data (red curve) are 
expected to approximately follow the theoretical distribution (blue curve). If the 
curve presents a shoulder in a region of high GC content (right of the graphic), it 
is usually an indication of ribosomal RNA (rRNA) or other species’ RNA 
contamination. The majority of my samples showed a good approximation to the 
theoretical distribution. However, contamination by rRNA and other species’ 




Figure 6.8. Example of a ‘per sequence GC content’ plot given by the 
FastQC software. Shown is the density plot for read 1 of sample 18 from the 
LNDBB. The x-axis shows the mean CG content (%) per read (y-axis). 
6.2.4.3. Sequence duplication levels 
Figure 6.9 shows an example of the ‘sequence duplication levels’ plot. This plot 
presents the level of duplicated sequences in the library. FastQC assumes a 
uniform coverage since it was developed for genomic DNA sequencing. In a 
library that covers the whole genome uniformly (such as one resulting from 
genomic DNA sequencing), a high level of duplication is likely to indicate some 
kind of enrichment bias (e.g. PCR over-amplification). However, in an RNA-seq 
experiment, genes that are highly expressed will have a very high level of 




Figure 6.9. Example of a ‘sequence duplication levels’ plot given by the 
FastQC software. Plot for read 1 of sample 18 from the LNDBB. The y-axis 
shows the percentage of reads considered as duplicates and the x-axis shows 
the number of reads with that level of duplication.  
6.2.5. Trimming of raw reads using Trimmomatic 
I used Trimmomatic version 0.36 (Bolger et al., 2014) to pre-process the raw 
reads and remove adapter sequences and low quality sequences. Trimmomatic 
is a command line tool that runs within the Linux operating system and uses a 
set of algorithms to crop and trim the data based on quality measures, as well 
as remove adapter sequences.  
The following list describes the commands used in the raw RNA-seq data used 
in this Chapter: 
ILLUMINACLIP – Exclude adapter and other Illumina-specific sequences from 
each read. 
LEADING - Exclude bases off the start of a read if below a threshold quality 
number .  
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TRAILING - Exclude bases off the end of a read if below a threshold quality 
number.  
SLIDINGWINDOW - Performs a sliding window trimming approach. It starts 
scanning at the 5’ end and clips the read once the average quality within the 
window falls below a threshold. 
HEADCROP - Exclude the specified number of bases from the start of the read. 
These are the ‘random’ primers that need to be excluded (see section 6.2.4.2). 
MINLEN - Exclude the entire read if it is below a specified length. 
For paired-end data, Trimmomatic outputs a ‘paired’ output file for read 1 and 
read 2 from each sample, where both reads survived the QC and an ‘unpaired’ 
output, where only one or none of the reads survived the processing. The 
‘paired’ output was used for further analysis. Table 6.4 in section 6.2.3 shows 
the number of trimmed reads (read 1, read 2 and paired) for each sample, as 
well as the percentage of trimmed paired reads in relation to the raw reads for 
each sample. The paired output for both read 1 and read 2 from each sample 
was inspected in FastQC and compared with the FastQC report of the raw 
reads (see section 6.2.4.1). Figures 6.10 to 6.12 show an example of the 
comparison between the raw reads and the trimmed reads for the ‘per base 
quality’, ‘sequence content ‘and ‘CG content’ plots. As Figure 6.10 shows, the 
low quality end of the reads was successfully trimmed. All three figures indicate 
that the lower quality at the beginning of the read, due to non-random priming 





Figure 6.10. Example of a ‘per base sequence quality’ plot given by the 
FastQC software before (A) and after (B) using Trimmomatic. Shown are 
the plots for read 1 of sample 18 from the LNDBB. The y-axis shows the Phred 




Figure 6.11. Example of a ‘per base sequence content’ plot given by the 
FastQC software before (A) and after (B) using Trimmomatic. Plot for read 
1 of sample 18 from the MRC London Neurodegenerative Diseases Brain Bank. 




Figure 6.12. Example of a ‘per base CG content’ plot given by the FastQC 
software before (A) and after (B) using Trimmomatic. Shown are the plots 
for read 1 of sample 18 from the MRC London Neurodegenerative Diseases 
Brain Bank. The y-axis shows the mean CG content along the read (x-axis). 
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6.2.6. Aligning reads to the human reference transcriptome and 
quantifying gene expression 
In order to quantify gene expression levels I next aligned (or mapped) the pre-
processed reads to the human reference transcriptome. Mapping to a reference 
transcriptome rather than the genome is generally faster and more specific but 
does not enable de novo transcript discovery or splicing analysis (Conesa et al., 
2016). For the purpose of the analyses presented here I was interested in 
identifying differently expressed (DE) genes between schizophrenia patients 
and controls and therefore I mapped the reads to the reference transcriptome.  
I first downloaded the reference cDNA sequences from the Genome Reference 
Consortium Human Build 38 (GRCh38.p5) (genome assembly 
GCA_000001405.20) from the Ensembl website (for the ftp address see 
Genome Reference Consortium (2013)). I also downloaded the ERRC spike-in 
sequences from the Thermo Fisher Scientific website (Thermo Fisher Scientific, 
2016) and appended these sequences to the human reference transcriptome so 
I could align the corresponding reads to the control transcripts and remove them 
from downstream analyses. Next I used bowtie (Langmead et al., 2009) within 
RSEM version 1.2.29 (Li and Dewey, 2011) to prepare the reference library. 
Bowtie is a fast and memory-efficient tool designed for the alignment of large 
sets of short DNA sequences (i.e. reads) to large genomes (or transcriptomes). 
RSEM is a software package run under Linux operating system for estimating 
gene expression levels from RNA-seq data (Li and Dewey, 2011). RSEM has 
built-in support for bowtie so the preparation of the reference library, alignment 
and gene expression calculation can be done within RSEM. To achieve this I 
used the following RSEM functions and parameters: 
 Preparing the reference library: 
rsem-prepare-reference --transcript-to-gene-map --bowtie - 
This command uses bowtie to prepare the reference library for alignment using 
the reference human cDNA sequences extracted from Ensembl (Genome 
Reference Consortium, 2013). The ‘--transcript-to-gene-map’ parameter 
uses the information on the reference transcriptome files to map the transcripts 
to specific gene IDs.  
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 Aligning to the reference transcriptome and calculating gene 
expression 
rsem-calculate-expression --paired-end - This command aligns the 
input (trimmed) reads against the reference library using bowtie and estimates 
expression values for each gene using the alignment output.  
An important note is that after mapping reads to a reference library, these may 
map uniquely (be assigned to only one position in the reference library) or map 
to multiple locations (i.e. ‘multireads’). When mapping to a reference genome, 
‘multireads’ are primarily a result of repetitive sequences or paralogous genes 
(Conesa et al., 2016). When aligning to a reference transcriptome, ‘multireads’ 
are more frequent because reads that would have mapped uniquely to a gene 
DNA sequence can map to all gene isoforms (several transcripts for the same 
gene) (Conesa et al., 2016).  
Table 6.4 (section 6.2.3) presents the number of mapped reads for each 
sample as well as the number (and percentage relative to the number of original 
raw reads) of unique mapped reads (unique gene IDs). All samples contained 
‘multireads’, which is expected from reads aligned to the transcriptome as 
explained above. To address this RSEM uses an expectation-maximization 
algorithm to estimate maximum likelihood expression values for each individual 
gene (Li and Dewey, 2011). The output is a .bam file for each sample with the 
aligned reads and a matrix of “expected counts” per individual gene, which are 
used for differential expression analysis (see section 6.2.7). To merge the 
“expected counts” files from each sample into a single matrix with expected 
counts for all samples I used the abundance_estimates_to_matrix.pl pipeline 
within the Trinity platform developed by the Broad Institute (Haas et al., 2013). 




6.2.7. Differential expression analysis 
To identify the expressed genes across all samples and differentially expressed 
genes between schizophrenia patients and controls I used the edgeR 
Bioconductor package (Robinson et al., 2010) in R (R Core Team, 2015). I 
chose this package from a large range of available software for differential 
expression analysis since it allows the incorporation of co-variates such as age 
and sex within the analysis pipeline (McCarthy et al., 2012).  
The “expected counts” matrix with gene counts for all samples (see section 
6.2.6) was imported into R and a DGEList object was created using the DGEList 
function in edgeR. This object allows the storage of counts and sample 
information, as all the downstream normalisation and analysis steps in edgeR. 
The object also contains the library size (i.e. total gene counts) for each sample. 
The Bioconductor biomaRt package in R (Durinck et al., 2009) was used to 
annotate the Ensembl gene IDs in the dataset (Flicek et al., 2014) with gene 
symbols obtained from the HUGO Gene Nomenclature Committee (HGNC) 
(European Bioinformatics Institute, 2016). 
6.2.8. Gene and sample exclusion  
First, the ERCC spike-in transcripts and genes on the sex chromosomes were 
excluded from all libraries. Next, I excluded low expressed genes; genes were 
kept for further analysis if they had more than 1 counts per million (CPM) in at 
least 10 samples, as recommended (Robinson et al., 2010). Incorrect assembly 
sequences and allelic (haplotype) sequences were also excluded (see the 
Ensembl blog for details (Bronwen (Genebuild) - Ensembl blog, 2011)). In total, 
16,920 genes remained after excluding ERCC transcripts (92), genes on the 
sex chromosomes (1,699 on the X-chromosome and 430 on the Y-
chromosome), incorrect and allelic sequences (3,957) and low expressed genes 
(15,688). Figure 6.16 in section 6.2.8.1 presents the distribution of raw counts. 
I next calculated principal components (PC) for the data and plotted the first PC 
against the second PC to look for outliers and batch effects (Figure 6.13). The 
six samples labelled show a greater variance in PC1 then the remaining 
samples. Of note, these are the samples that showed some degree of 
contamination with human rRNA and RNA from other species (section 6.2.3) 
and were excluded from further analysis. I next inspected multidimensional 
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scaling (MDS) plots to check for sex, RNA isolation, library preparation and lane 
allocation batch effects. Figures 6.14 and 6.15 show examples of these plots 
for sex and cohort, respectively. No batch effects were found after exclusion of 
the six contaminated samples and no further samples were removed from 
analyses. Criteria for sample exclusion from the analyses are illustrated in 
Table 6.5 and Table 6.6 summarises demographic information of the samples 
used for analyses in this chapter. 
 
 
Figure 6.13. Principal component 1 (x-axis) versus principal component 2 




Figure 6.14. Example of multidimensional scaling plots for all samples included 
in the analyses of this chapter. The samples are coloured by sex. 
 
Figure 6.15. Example of multidimensional scaling plots for all samples 
included in the analyses of this chapter. The samples are coloured by 
cohort. LNDBB, MRC London Neurodegenerative Diseases Brain Bank; 
DBCBB, Douglas-Bell Canada Brain Bank.  
354 
 
Table 6.5. Criteria for sample exclusion or inclusion in the analyses 
performed in this chapter.  
Sample Brain Bank Group Sample inclusion/ exclusion 
1 LNDBB schizophrenia included 
2 LNDBB schizophrenia included 
8 LNDBB schizophrenia included 
9 LNDBB schizophrenia included 
11 LNDBB schizophrenia included 
13 LNDBB schizophrenia included 
14 LNDBB schizophrenia included 
15 LNDBB schizophrenia failed based on ERCC control QC 
16 LNDBB schizophrenia included 
18 LNDBB schizophrenia failed due to rRNA contamination 
19 LNDBB schizophrenia included 
20 LNDBB schizophrenia included 
22 LNDBB schizophrenia included 
24 LNDBB schizophrenia included 
25 LNDBB control included 
26 LNDBB control included 
27 LNDBB control included 
29 LNDBB control included 
31 LNDBB control included 
32 LNDBB control included 
33 LNDBB control included 
34 LNDBB control included 
40 LNDBB control included 
43 LNDBB control included 
44 LNDBB control failed due to rRNA contamination 
45 LNDBB control included 
46 LNDBB control included 
47 LNDBB control included 
49 LNDBB control included 
51 LNDBB control included 
MS01 DBCBB schizophrenia included 
MS02 DBCBB schizophrenia included 
MS03 DBCBB schizophrenia failed due to rRNA contamination 
MS04 DBCBB schizophrenia failed due to rRNA contamination 
MS05 DBCBB control included 
MS06 DBCBB schizophrenia included 
MS08 DBCBB control included 
MS09 DBCBB control failed due to rRNA contamination 
MS11 DBCBB schizophrenia included 
MS17 DBCBB control included 
MS20 DBCBB schizophrenia included 
MS21 DBCBB schizophrenia included 
MS30 DBCBB schizophrenia included 
MS33 DBCBB control included 
MS34 DBCBB control failed due to rRNA contamination 























































































































































































































































































































































































































































































































































































































































































































































































































6.2.8.1. Data normalisation  
The calcNormFactors function was used to normalise the RNA-seq data for 
differences in library size between samples using the trimmed mean of M-
values method (Robinson and Oshlack, 2010). The method finds a set of 
scaling factors for the library sizes that minimise the log fold-changes between 
the samples for most genes. These scaling factors are then multiplied by the 
original library sizes to calculate ‘effective library sizes’ that will be incorporated 
in the downstream analyses.  
edgeR models the data using a negative binomial distribution. The Poisson 
distribution is the classical approach to model counts data; however, it does not 
take into account a gene-wise dispersion parameter, which is a characteristic of 
RNA-seq data. The negative binomial distribution is an extension to the Poisson 
distribution, which does take into account this over-dispersion (Hoffman, 2003). 
Correctly estimating the dispersion and incorporating this information in the 
differential expression testing model is crucial; underestimating the gene-wise 
dispersion will give rise to false positives whereas over-estimating it may lead to 
false negatives (Landau and Liu, 2013).  
To estimate the dispersion on multifactorial models, the developers of edgeR 
suggest the use of the Cox-Reid profile-adjusted likelihood method (Cox and 
Reid, 1987). To implement this I used the estimateDisp function to estimate the 
gene-wise dispersion using sex, age, cohort and neuronal proportion estimates 
as co-variates. The neuronal proportion estimates were calculated using the 
CETS package (Guintivano et al., 2013) in R from the DNA methylation data 
from the same samples (details on neuronal proportion estimates calculation 
can be found in Chapter 3 section 3.2.5). For the four samples that did not 
have neuronal proportion estimates available I used the mean of the other 
samples estimates. Figures 6.16, 6.17 and 6.18 show the log2 distributions of 
the raw counts, the counts after exclusion of genes (see section 6.2.8) and 




Figure 6.16. Log2 distribution of the raw gene counts (counts per million) 
estimated by RSEM (Li and Dewey, 2011). 
 
Figure 6.17. Log2 distribution of the raw gene counts (counts per million) 
estimated by RSEM (Li and Dewey, 2011) after excluding ERCC 
transcripts, genes on the sex chromosomes, incorrect assembly 




Figure 6.18. Log2 distribution of the gene counts (counts per million) 
estimated by RSEM  (Li and Dewey, 2011) after normalisation with edgeR 
(Robinson et al., 2010). 
 
6.2.8.2. Differential expression analysis 
To identify differentially expressed genes on a multifactorial dataset edgeR uses 
a generalised linear model (GLM) quasi-likelihood test (Robinson et al., 2010). 
To do this I used the glmQLFit function to fit a quasi-likelihood negative binomial 
generalized log-linear model and the glmQLFTest function to perform the quasi-
likelihood F-test on the 16,920 genes that survived stringent QC steps (see 





6.3.1. Overview of the experimental strategy 
In this Chapter I quantified PFC transcript levels in schizophrenia patients and 
non-psychiatric controls obtained from two brain banks. Details on the samples 
cohorts are presented on Chapter 3 section 3.2.1. In total, I extracted total 
RNA from the PFC of 39 schizophrenia patients and 45 controls. I chose 23 
schizophrenia cases and 23 controls for RNA-seq analysis based on optimal 
RNA quality metrics (see Table 6.2 and section 6.2.1). The cDNA libraries for 
each sample were prepared using the TruSeq Stranded Total RNA with Ribo-
Zero Gold Library Preparation LT kit (Illumina, San Diego, CA, USA) and RNA-
sequencing was carried out on an Illumina HiSeq 2500 Sequencing System. 
After stringent QC filtering of the RNA-seq data, one sample was excluded 
based on spike-in QC measures and 6 other samples were excluded due to 
rRNA contamination (for sample exclusion criteria see Table 6.2). In total, RNA-
seq data from 19 schizophrenia cases and 20 non-psychiatric controls were 
used for analyses. Table 6.6 summarises the demographic information on the 
samples used in the analyses. I used a GLM quasi-likelihood F-test to identify 
DE genes between schizophrenia cases and controls and then I examined the 
overlap between significantly DE genes and DNA methylation results presented 
in Chapter 3. An overview of the analysis approach in this chapter is given in 
Figure 6.19 and a representation on how this analysis integrates with the 








6.3.2. Differentially expressed genes between schizophrenia 
patients and non-psychiatric controls 
The primary aim of this chapter was to identify DE genes in the PFC of 
schizophrenia patients compared with controls. To do this I used a GLM quasi-
likelihood F-test on the 16,920 out of 38,786 genes that survived stringent QC 
steps and were expressed (see section 6.2.8) using sex, age, cohort and 
neuronal proportion estimates as covariates. Figure 6.20 shows the quantile-
quantile (QQ) plot for the analysis, which shows evidence of under-inflation (λ = 
0.69 and suggests the analysis was moderately under-powered. Table 6.7 
shows the results for the fifty top ranked schizophrenia associated DE genes. 
Figure 6.21 presents the log2 fold-change in expression (x-axis) versus the –
log10 of the P-values for all expressed genes, with the fifty top ranked genes 
coloured in red.  
. 
Figure 6.20. Quantile-quantile plot for the differential expression analysis. 
Shown are the expected (x-axis) and observed (y-axis) quantiles observed in 
the differential expression analysis of the prefrontal cortex of both the MRC 
London Neurodegenerative Diseases Brain Bank and Douglas-Bell Canada 
Brain Bank. λ = 0.69. 
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Table 6.7. Top ranked schizophrenia-associated differently expressed 
genes identified in the prefrontal cortex. Listed are the Ensembl gene IDs 
(Flicek et al., 2014), the corresponding gene symbols from the HUGO Gene 
Nomenclature Committee (HGNC) (European Bioinformatics Institute, 2016), 
the genomic coordinates, the log2 fold-change (FC), the log2 counts per million 
(CPM) across all samples and the P-value of the analysis. 
Ensembl gene ID HGNC gene symbol Genomic position (GRCh38) log2 FC log2 CPM P-value 
ENSG00000064886 CHI3L2 chr1:111200771-111243440 -3.03 1.25 2.38E-05 
ENSG00000255769 GOLGA2P10 chr15:82472993-82513950 1.97 0.68 2.57E-05 
ENSG00000129951 PLPPR3 chr19:812488-821977 0.44 3.90 2.81E-04 
ENSG00000141505 ASGR1 chr17:7173431-7179564 0.52 2.44 3.91E-04 
ENSG00000273259  chr14:94592058-94624646 -3.32 4.80 4.93E-04 
ENSG00000026508 CD44 chr11:35138870-35232402 -1.77 4.16 5.16E-04 
ENSG00000249337 SNX18P25 chr4:49588772-49589529 0.86 0.94 5.84E-04 
ENSG00000163638 ADAMTS9 chr3:64515654-64688000 -1.17 4.66 9.17E-04 
ENSG00000230528 NOS2P3 chr17:20436337-20447249 1.13 0.56 9.25E-04 
ENSG00000165507 C10orf10 chr10:44970981-44978810 -1.01 5.01 1.09E-03 
ENSG00000221937 TAS2R40 chr7:143222037-143223079 -1.26 0.45 1.29E-03 
ENSG00000141526 SLC16A3 chr17:82228397-82261129 -0.54 3.03 1.35E-03 
ENSG00000197993 KEL chr7:142941114-142962681 -1.15 0.84 1.38E-03 
ENSG00000182240 BACE2 chr21:41167801-41282518 -0.49 3.62 1.40E-03 
ENSG00000100225 FBXO7 chr22:32474676-32498829 -0.36 6.21 1.55E-03 
ENSG00000205129 C4orf47 chr4:185426249-185449826 0.75 0.21 1.68E-03 
ENSG00000204655 MOG chr6:29656981-29672372 -1.89 3.94 1.77E-03 
ENSG00000128918 ALDH1A2 chr15:57953424-58497866 -0.51 1.96 2.16E-03 
ENSG00000013364 MVP chr16:29820394-29848039 -0.59 4.59 2.29E-03 
ENSG00000179588 ZFPM1 chr16:88453317-88537016 0.46 2.49 2.49E-03 
ENSG00000141510 TP53 chr17:7661779-7687550 -0.53 2.60 2.59E-03 
ENSG00000167553 TUBA1C chr12:49188736-49274603 -0.74 2.23 2.84E-03 
ENSG00000230549 USP17L1 chr8:7332387-7333979 -0.84 1.17 2.85E-03 
ENSG00000196136 SERPINA3 chr14:94612384-94624055 -2.21 3.82 2.86E-03 
ENSG00000186326 RGS9BP chr19:32675407-32678300 0.76 0.70 2.89E-03 
ENSG00000136098 NEK3 chr13:52132639-52159861 -0.68 3.50 2.94E-03 
ENSG00000170667 RASA4B chr7:102482445-102517781 0.44 4.40 3.06E-03 
ENSG00000139926 FRMD6 chr14:51489100-51730727 0.36 4.53 3.11E-03 
ENSG00000106689 LHX2 chr9:124001670-124033301 0.37 4.87 3.49E-03 
ENSG00000173110 HSPA6 chr1:161524540-161526910 2.94 3.07 3.66E-03 
ENSG00000105808 RASA4 chr7:102573807-102616757 0.33 5.84 3.75E-03 
ENSG00000114737 CISH chr3:50606490-50611831 -0.90 0.17 3.77E-03 
ENSG00000013588 GPRC5A chr12:12890782-12917937 -0.81 0.81 3.92E-03 
ENSG00000156253 RWDD2B chr21:29004384-29019378 -0.38 3.68 4.08E-03 
ENSG00000138621 PPCDC chr15:75023555-75117462 -0.42 1.99 4.13E-03 
ENSG00000118785 SPP1 chr4:87975650-87983426 -1.13 6.61 4.13E-03 
ENSG00000259271 ANKRD62P1 chr22:16671090-16679493 0.82 0.44 4.18E-03 
ENSG00000087510 TFAP2C chr20:56629302-56639283 1.03 -0.11 4.28E-03 
ENSG00000135245 HILPDA chr7:128455849-128458418 -0.98 3.81 4.49E-03 
363 
 
ENSG00000266714 MYO15B chr17:75588058-75626501 -0.45 4.99 4.51E-03 
ENSG00000198959 TGM2 chr20:38127387-38166578 -0.80 4.84 4.52E-03 
ENSG00000164687 FABP5 chr8:81280363-81284777 -0.47 3.74 4.54E-03 
ENSG00000130943 PKDREJ chr22:46255663-46263355 -0.78 1.19 4.62E-03 
ENSG00000227057 WDR46 chr6:33279108-33289527 1.85 1.28 4.67E-03 
ENSG00000224831  chr3:149982181-149983308 1.07 0.11 4.72E-03 
ENSG00000134817 APLNR chr11:57233577-57237314 -0.99 4.30 4.74E-03 
ENSG00000198944 SOWAHA chr5:132813587-132816797 0.38 6.25 4.76E-03 
ENSG00000148926 ADM chr11:10304680-10307397 -0.99 2.07 4.81E-03 
ENSG00000270670  chr10:89837612-89839334 -0.62 1.23 4.88E-03 




Figure 6.21. Volcano plot for the differential expression analysis. Shown 
are the log2 fold-change (FC; x-axis) versus the -log10 P-values (y-axis) from the 
differential expression analysis on all expressed genes in the PFC of both the 
MRC London Neurodegenerative Diseases Brain Bank and Douglas-Bell 
Canada Brain Bank. The fifty top ranked differently expressed genes are 




Figure 6.22 presents the log2 FC for the fifty top ranked DE genes presented in 
Table 6.7 and Figures 6.23 and 6.24 show the CPM for schizophrenia cases 
and controls for the same genes. Since the level of expression varies 
considerably across all genes I separated the genes with less than 25 CPM 
across all samples (Figure 6.23) and more than 25 CPM across all samples 
(Figure 6.24).  
The top schizophrenia-associated DE gene is chitinase 3-like-2 (CHI3L2) which 
encodes a protein involved in cartilage biogenesis. Although none of the DE 
genes reached a Bonferroni corrected threshold for the 16,920 genes used in 
the analysis (P = 2.96E-06), two of the top ranked DE genes have been 
previously found to be differently expressed in schizophrenia patients: 
 The myelin oligodendrocyte glycoprotein (MOG) gene was down-
regulated in the PFC of schizophrenia patients (log2 FC = -1.89, P = 1.77E-03). 
This gene encodes a protein expressed on the oligodendrocyte cell membrane 
and the surface of myelin sheaths. Tkachev and colleagues have also found 
this gene to be down-regulated in the PFC of schizophrenia patients using gene 
expression microarrays (FC = −2·91; P = 7.00E-03) and quantitative PCR (FC = 
−2·58; P = 3.90E-03) (Tkachev et al., 2003). This gene is located within the 
major histocompatibility complex (MHC) on chromosome 6. Genetic variants in 
the MHC locus have been strongly linked to schizophrenia GWAS studies 
(International Schizophrenia et al., 2009, Schizophrenia Working Group of the 
Psychiatric Genomics, 2014), as discussed in Chapter 4 section 4.3.3. 
 The serpin family A member 3 (SERPINA3) gene was down-regulated in 
schizophrenia patients (log2 FC = -2.21, P = 2.86E-03). This gene encodes a 
plasma protease inhibitor. Its physiological function is unclear although is 
considered to be an acute-phase inflammatory protein (Horvath and Mirnics, 
2014). This gene has been found to be up-regulated in the PFC (Brodmann 
area (BA) 9) (Arion et al., 2007), dorsolateral PFC (BA 46) (Fillman et al., 2013) 
and in the middle frontal gyrus (Fillman et al., 2014) of schizophrenia patients. 
Dysregulation in this protein has also been widely implicated in Alzheimer’s 
disease (Baker et al., 2007). 
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Additional novel schizophrenia-associated DE genes identified in this study are 
of potential interest in the context of schizophrenia etiology given their known 
role in neurobiological function: 
 Phospholipid phosphatase related 3 (PLPPR3) was up-regulated in the 
PFC of schizophrenia patients compared to controls (log2 FC = 0.44, P = 2.81E-
04). This gene encodes a membrane protein belonging to the lipid phosphate 
phosphatase (LPP) family of proteins, which play a role in cell migration and 
axonal growth in the developing neurons (Brauer et al., 2003).  
 CD44 was down-regulated in schizophrenia patients (log2 FC = -1.77, P 
= 5.16E-04). The protein encoded by the CD44 gene is a cell-surface 
glycoprotein involved in cell-cell interactions. This gene encodes 38 splice 
variants (Flicek et al., 2014). Some of the CD44 isoforms have been implicated 
in the activation of T lymphocytes (Goodison et al., 1999), which play central 
role in cell-mediated immunity.  This is interesting given the potential 
importance of the immune system in schizophrenia etiology already discussed 
in Chapter 1 section 1.1.6. 
 The F-box protein 7 (FBXO7) also known as Parkinson disease 15 
(PARK15) was also down-regulated in schizophrenia patients (log2 FC = -0.36, 
P = 1.55E-03). Mutations in this gene have been implicated in early-onset 
Parkinson’s disease (Deng et al., 2013), a degenerative disorder of the central 
nervous system.  
 Two genes encoding for members of the GAP1 family of GTPase-
activating proteins (RASA4 and RASA4B) were up-regulated in the 
schizophrenia patients (log2 FC = 0.33, P = 3.75E-03 and log2 FC = 0.44, P = 
3.06E-03, respectively). This is interesting because a 450K probe (cg24803255) 
within another gene from this family (RASA3) was hypomethylated in the PFC in 
our DNA methylation analysis (see Chapter 3 section 3.3.7). Together these 





































































































































































































































































































































































































































































































6.3.3. Comparison with DNA methylation results 
In Chapter 3 I identified DNA methylation changes associated with 
schizophrenia using post-mortem tissue from schizophrenia patients and non-
psychiatric controls. In this section I explore the overlap between the results 
from the DNA methylation analyses and the results from the gene expression 
analyses. Of note, the human genome version used to annotate the 450K array 
methylation probes was hg19/GRCh37, whereas in the RNA-seq analysis I 
used the GRCh38 human genome version for annotation. For this reason I 
compare the RNA-seq and the DNA methylation results based on gene symbols 
and not genomic location to avoid confusion. 
6.3.3.1. DNA methylation probes overlapping DE genes 
First I investigated 450K array probes annotated to schizophrenia-associated 
DE genes identified in section 6.3.2. Figure 6.25 shows a diagram of the 
approach utilised. I initially investigated 450K probes that were annotated to 
schizophrenia-associated DE genes using the Illumina annotation (Figure 6.25 
A). Table 6.8 presents the selection of these probes that are nominally 
associated with schizophrenia (P < 0.05) in the PFC.  
Next, I investigated the probes in the vicinity to the TSS of the schizophrenia-
associated DE genes (Figure 6.25 B). Table 6.9 shows probes which are 
nominally associated with schizophrenia (P < 0.05) and whose closest TSS is a 
DE gene. Fourteen of the DE genes show evidence of nominal schizophrenia-
associated DMPs in their vicinity.  
Finally, I identified probes nominally associated with schizophrenia that are 
annotated to a DE gene using the Genomic Regions Enrichment of Annotations 
Tool (GREAT) (McLean et al., 2010) (Figure 6.25 C), instead of the Illumina 
annotation GREAT associates genomic regions with genes by defining a cis-
regulatory region for each gene in the genome. Identifying 450K probes of 
interest using GREAT annotation can provide additional information on whether 
these probes lie within putative regulatory regions mapped to DE genes. Table 
6.19 shows schizophrenia nominally-associated DMPs that are annotated to DE 




Several of the schizophrenia-associated DE genes have several nominally-
associated DMPs annotated to them. For example, the ZFPM1 gene is 
annotated to 14 DMPs (12 Illumina annotation and 2 GREAT annotation), the 
WDR46 gene is associated with 8 DMPs (Illumina annotation) and the 
SLC16A3 gene is annotated to 10 DMPs (7 Illumina annotation and 3 GREAT 
annotation) and has 2 other DMPs annotated to its TSS. Furthermore, the CD44 
gene is annotated to 9 DMPs (7 Illumina annotation and 2 GREAT annotation) 
and has 2 other DMPs annotated to its TSS. This gene plays central role in cell-
mediated immunity (Goodison et al., 1999) and its potential relevance in the 
context of schizophrenia has already been discussed in Section 6.3.2. 
Interestingly, these multiple DMPs per DE gene are not clustered in known 
regions of regulation (e.g. promoters) but rather are located throughout the 
gene (e.g. gene body, first exon, etc.). A possible explanation is that the 
observed methylomic variation in intergenic regions might have a function on 
regulating the expression of the gene. A potential mechanism is that these 
events are modulating alternative splicing of these transcripts (see section 






Figure 6.25. Methodological approach to investigate DNA methylation 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.3.3.2. Expressed genes overlapping differently methylated 
probes and regions 
I was also interested in investigating whether those genes annotated to the top 
ranked DMPs identified in the PFC and differently methylated regions (DMRs) 
were also differently expressed. Because the DMRs identified in any of the four 
brain regions were generally characterised by consistent DNA methylation 
effects across the other brain regions (see Chapter 3 Figure 3.41) I decided to 
investigate all the DMRs identified in any of the brain regions. Figure 6.26 
presents a diagram of the approach utilised. 
First I identified expressed genes annotated to DMRs identified in any of the 
four brain regions (using both Illumina and GREAT annotation). Chapter 3 
section 3.3.6 presents the DMRs identified. Table 6.11 shows the log2 fold-
change and P-values of the schizophrenia differential expression analysis for 
the expressed genes annotated to the DMRs (Table 3.16).  
Next I identified expressed genes annotated to the fifty top ranked 
schizophrenia-associated DMPs identified in the PFC (using both Illumina and 
GREAT annotation). Chapter 3 section 3.3.3 presents the DMPs identified.  
Table 6.12 shows the log2 fold-change and P-values of the schizophrenia 
differential expression analysis for the genes annotated to the DMPs (Table 
3.5). Surprisingly, none of the genes annotated to DMRs or DMPs were 
differentially expressed in the PFC of schizophrenia patients, suggesting that 
the DNA methylation changes observed do not appear to have a direct, cis-











































































































































































































































Table 6.11. Results of the schizophrenia differential expression analysis 
for the expressed genes annotated to the differentially methylated regions 
(DMRs) identified in Chapter 3. Shown are the genes annotated to all DMRs 
identified in any of the fours brain regions (both Illumina and GREAT (McLean 
et al., 2010) annotation). 







ENSG00000162654 GBP4 -0.22 4.05 0.16 
ENSG00000171786 NHLH1 0.14 0.02 0.66 
ENSG00000235750 KIAA0040 -0.41 2.14 0.15 
ENSG00000116147 TNR 0.03 8.78 0.80 
ENSG00000162804 SNED1 0.03 5.39 0.80 
ENSG00000159674 SPON2 -0.05 2.92 0.78 
ENSG00000159692 CTBP1 0.06 7.01 0.58 
ENSG00000063978 RNF4 0.02 5.69 0.89 
ENSG00000125386 FAM193A -0.01 5.59 0.94 
ENSG00000168884 TNIP2 -0.07 2.48 0.60 
ENSG00000204580 DDR1 -0.21 4.60 0.62 
ENSG00000182095 TNRC18 0.05 6.81 0.64 
ENSG00000155034 FBXL18 0.12 5.42 0.30 
ENSG00000155034 FBXL18 0.12 5.42 0.30 
ENSG00000167701 GPT 0.20 2.20 0.24 
ENSG00000213185 FAM24B -0.41 0.57 0.06 
ENSG00000170430 MGMT -0.15 3.01 0.24 
ENSG00000177947 ODF3 0.21 0.34 0.45 
ENSG00000121691 CAT -0.07 4.64 0.59 
ENSG00000196498 NCOR2 -0.04 7.15 0.72 
ENSG00000073060 SCARB1 -0.12 5.35 0.31 
ENSG00000061936 SFSWAP 0.00 6.05 0.97 
ENSG00000150403 TMCO3 -0.04 5.39 0.73 
ENSG00000198176 TFDP1 -0.02 4.78 0.85 
ENSG00000272636 DOC2B 0.08 5.88 0.61 
ENSG00000181031 RPH3AL -0.25 0.97 0.28 
ENSG00000250067 YJEFN3 0.17 4.88 0.13 
ENSG00000182871 COL18A1 -0.20 4.54 0.21 










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.4.1. Overview of the results 
In this Chapter I profiled transcriptomic variation in PFC tissue from 
schizophrenia patients and non-psychiatric controls obtained from two brain 
banks. After stringent pre-processing and QC steps, I identified several 
nominally significant DE genes associated with schizophrenia. Two of the top 
ranked schizophrenia-associated DE genes have been previously reported to 
be differentially expressed in schizophrenia brains. First the MOG gene, which 
is down-regulated in the PFC of schizophrenia patients in my data, has been 
previously reported to be down-regulated in the PFC in schizophrenia patients 
(Tkachev et al., 2003). Furthermore, this gene is located within the MHC region 
on chromosome 6. Genetic variants in the MHC locus have been strongly linked 
to schizophrenia in recent large collaborative GWAS studies (International 
Schizophrenia et al., 2009, Schizophrenia Working Group of the Psychiatric 
Genomics, 2014). Second, the SERPINA3 gene, which is down-regulated in 
schizophrenia patients, has been found to be up-regulated in the PFC 
(Brodmann area (BA) 9) (Arion et al., 2007), dorsolateral PFC (BA 46) (Fillman 
et al., 2013) and in the middle frontal gyrus (Fillman et al., 2014) of 
schizophrenia patients in several other studies. Other schizophrenia-associated 
DE genes are of potential interest in the context of schizophrenia etiology, such 
as PLPPR3 (which may play a role in cell migration and axonal growth in the 
developing neurons (Brauer et al., 2003)) and CD44 (isoforms of this gene have 
been implicated in the activation of T lymphocytes (Goodison et al., 1999), 
which play central role in cell-mediated immunity). 
Furthermore I investigated 450K array probes annotated to schizophrenia-
associated DE genes. Several of the schizophrenia-associated DE genes have 
a number of nominally-associated DMPs annotated to them, such as ZFPM1, 
WDR46, CD44 and SLC16A3. Interestingly, these DMPs were not consecutive 
but were rather located in diverse parts of the genes (e.g. gene body, 
transcription start site, first exon, etc.). A potential explanation is that these are 
modulating alternative splicing events. Recent studies provide evidence that 
DNA methylation within gene bodies correlated positively with gene expression 
(Ball et al., 2009), and it thought to play a role in alternative splicing (Maunakea 
et al., 2013). I also identified schizophrenia-associated DMPs in the vicinity to 
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the transcription start sites of several DE genes. Finally, I investigated whether 
those genes annotated to the differently methylated probes (DMPs) and regions 
(DMRs) identified Chapter 3 were also differently expressed. Surprisingly, none 
of the genes annotated to DMRs or DMPs are differentially expressed in the 
PFC of schizophrenia patients, suggesting that the DNA methylation changes 
observed may not have a direct, cis-effect on gene expression. 
6.4.2. Limitations, strengths and future directions 
This study has a number of limitations and strengths that should be considered. 
First, although none of the schizophrenia-associated DE genes reaches 
Bonferroni corrected threshold, I identified several associated DE genes that 
have been previously found to be aberrantly expressed in schizophrenia brains 
and are of interest in the context of its etiology. Post-mortem brain samples are 
difficult to obtain and isolating high quality RNA from these is challenging (see 
Chapter 2 section 2.2.4). Therefore, although underpowered, this is a relatively 
large RNA-seq study using post-mortem brain tissue from schizophrenia cases 
and controls. This observation provides encouragement for RNA-seq case-
control studies using post-mortem brain tissue in complex disorders such as 
schizophrenia. Future studies should focus on replication in larger cohorts of 
samples. Furthermore, these findings should be validated using a gold-standard 
gene expressing technique, such as qPCR. 
Although the role of DNA methylation in genomic regulation is well-established 
(see Chapter 1 section 1.2.2.4), we are far from fully understanding how DNA 
methylation dynamically regulates the expression of genes. Until recently, the 
majority of the studies on DNA methylation focused on CpG islands at the TSS 
of genes, which has influenced general perceptions about the function of DNA 
methylation on gene expression regulation. Although there is abundant 
evidence that DNA methylation at the TSS is associated with silencing of some 
genes, recent studies using epigenome-wide survey techniques have 
emphasised that the relationship between DNA methylation and gene 
expression depend on the position of this DNA mark on the gene (Jones, 2012).  
Furthermore, there is increasing awareness of the importance of 5-
hydroxymethyl cytosine (5-hmC) in the human brain (Branco et al., 2012, 
Kriaucionis and Heintz, 2009), although this modification cannot be 
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distinguished from DNA methylation using standard bisulfite-based approaches 
(Lunnon et al., 2016b, Booth et al., 2012). The study of this modification adds 
another layer of complexity to the intricate role of epigenetic mechanisms in 
gene expression regulation. It is plausible that many of the differences identified 
in Chapter 3 and explored in this chapter are confounded by modifications 
other than DNA methylation. 
In this Chapter I present evidence of schizophrenia-associated DNA methylation 
variation proximal to schizophrenia-associated DE genes. However, the reverse 
relationship is not observed; the genes annotated to the top ranked 
schizophrenia-associated DMPs are not differentially expressed in 
schizophrenia. Given that the DNA methylation analysis using PFC presented in 
Chapter 3 used a larger sample size than the used in the gene expression 
analysis, it is possible that the transcriptomic analysis is underpowered to detect 
subtle gene expression changes associated with methylomic variation. Another 
plausible explanation is that the schizophrenia-associated DNA methylation 
variation observed is having an indirect, trans-impact of gene expression 
regulation (i.e. through insulators and enhancers). Given the limitations 
discussed above is not possible to draw definite conclusions from these 
observations. The work from consortiums such as the NIH Roadmap 
Epigenomics Mapping Consortium as well as studies using a systems-level 
approach (such as the one described in Chapter 5) will be crucial to understand 
the intricate relationships between epigenetic mechanisms and transcriptional 
regulation in the near future (Bernstein et al., 2010).  
In summary, this Chapter presents the first case-control gene expression study 
of schizophrenia in samples also profiled for DNA methylation identifying 
several gene expression changes in the PFC of individuals with the disease. 
Furthermore, I provide evidence of the overlap between nominally 
schizophrenia-associated DNA methylation variation and schizophrenia-
associated DE genes. Future studies should focus on refining the analytical 
approach used, replicating the results in a larger sample size and 
understanding the intricate relationship between DNA methylation variation and 
gene expression regulation and its implications in complex disease. 
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Chapter 8 - General Discussion 
The primary aim of this thesis was to expand the existing knowledge about the 
extent of methylomic and transcriptomic variation in the brain in schizophrenia; I 
explored these topics in Chapters 3 to 6. Furthermore, in Chapter 7 I present a 
methylomic and transcriptomic analysis of two brain regions from an individual 
with Klinefelter syndrome (KS), identified during my analysis of schizophrenia 
brain data. In this final chapter I give an overview of the results of my research, 
placing these in the context of the existing literature on genomic variation in 
schizophrenia, before concluding with a discussion of the limitations and 
strengths of my work and a discussion of what I believe to be the future 
directions for the field. 
 Key findings from my research 8.1.
8.1.1. Methylomic profiling of schizophrenia in the brain 
In Chapter 3 I quantified genome-wide patterns of DNA methylation in post-
mortem brain tissue isolated from four different brain region; prefrontal cortex 
(PFC), striatum (STR), hippocampus (HC) and cerebellum (CER). I identified 
numerous differentially methylated positions (DMPs) and regions (DMRs) 
associated with disease in each individual brain region. In addition, I used a 
multilevel model to identify consistent DNA methylation variation across the 
PFC, STR and HC - I did not include the CER in this analysis given the distinct 
DNA methylation profile seen in this brain region (Chapter 3 section 3.2.2) 
(Davies et al., 2012, Hannon et al., 2016, Ladd-Acosta et al., 2007). The 
multilevel model identified several DMPs and DMRs across all three brain 
regions. Genes annotated to many of the schizophrenia-associated DMPs and 
DMRs included loci relevant in the context of what we know about the 
pathophysiology of schizophrenia – for example NCAM1 (Sunshine et al., 1987, 




8.1.2. Methylomic profiling of schizophrenia polygenic risk 
burden in the brain 
In Chapter 4 I studied the association between DNA methylation and 
schizophrenia polygenic risk score (PRS) in post-mortem brain samples isolated 
from PFC, STR, HC and CER. I identified numerous DMPs and DMRs 
associated with PRS in individual brain regions as well as across brain regions. 
Many of the PRS-associated loci are relevant to schizophrenia, including 
several regions in the major histocompatibility complex (MHC) (International 
Schizophrenia et al., 2009, Schizophrenia Working Group of the Psychiatric 
Genomics, 2014), GADD45B (Gavin et al., 2012), RGMA (O'Leary et al., 2013, 
Matsunaga et al., 2004), the cluster of genes PCDHA 1 to 4 (Hamada and Yagi, 
2001, Kohmura et al., 1998)), AXIN2 (Kikuchi, 1999) (Kalani et al., 2008, Nusse, 
2008)), GDNF (Ibanez, 2008)) and DISC1 (St Clair et al., 1990). Other PRS-
associated loci, such as SIGLEC9 and BPI, encode proteins that play crucial 
roles in the immune system (Crocker et al., 2007, Zhang et al., 2000, Angata 
and Varki, 2000). Many of the DMPs and DMRs associated with increased 
genetic burden for schizophrenia are independent of the changes observed 
associated with a diagnosis of schizophrenia itself, identified in the case-control 
analyses presented in Chapter 3. Furthermore, there was no evidence for direct 
genetic effects on DNA methylation for variants included in the PRS, indicating 
that the PRS-associated epigenetic variation observed does not directly result 
from cis-genetic influences on DNA methylation. 
8.1.3. Systems-level analysis of DNA methylation in the 
schizophrenia brain 
I was interested in studying the co-methylation structure of DNA methylation 
across the genome in the PFC, STR and CER, and exploring differences in that 
structure between schizophrenia patients and non-psychiatric controls. In 
Chapter 5 I used weighted gene co-methylation analysis (WGCNA) to do this. 
Five modules of co-methylated loci were nominally associated with 
schizophrenia in the PFC network. Several genes annotated to the ‘hub probes’ 
of these modules are particularly interesting in the context of schizophrenia: 
KDM3B (Schizophrenia Working Group of the Psychiatric Genomics, 2014),  
ANK3 (Ferreira et al., 2008, Wirgenes et al., 2014) and RPTOR. Seven genes 
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belonging to the schizophrenia-associated modules also showed interactions 
with genes linked to schizophrenia in a recent study reporting novel interaction 
networks with schizophrenia-linked genes (Ganapathiraju et al., 2016). Gene 
ontology enrichment analysis revealed a significant enrichment for neuronal 
function- and neurodevelopment-relevant pathways in the largest 
schizophrenia-associated module. Furthermore, five schizophrenia-associated 
‘fetal network’ modules  in the PFC were also significantly correlated with brain 
development in a recent study by Spiers et al. (2015); the largest of these 
modules was highly enriched for probes annotated to genes in pathways 
relevant to neurodevelopment (Spiers et al., 2015).  
8.1.4. Transcriptomic profiling of schizophrenia prefrontal cortex 
In Chapter 6 I characterised the transcriptome of PFC tissue from 
schizophrenia patients and non-psychiatric controls. I identified several 
differentially expressed (DE) genes associated with schizophrenia, several of 
them relevant in the context of schizophrenia, including MOG (Tkachev et al., 
2003), SERPINA3 (Arion et al., 2007, Fillman et al., 2013, Fillman et al., 2014), 
PLPPR3 (Brauer et al., 2003)) and CD44 (Goodison et al., 1999). Several of the 
schizophrenia-associated DE genes have a number of nominally-associated 
DMPs annotated to them, such as ZFPM1, WDR46, CD44 and SLC16A3, 
located in diverse parts of the genes and potentially modulating alternative 
splicing events (Maunakea et al., 2013). Conversely, none of the genes 
annotated to DMRs or DMPs are DE genes in the PFC of schizophrenia 
patients, suggesting that the DNA methylation changes observed may not have 
a direct, cis-effect on gene expression. 
8.1.5. Epigenomic and transcriptomic signatures of a Klinefelter 
syndrome (47,XXY) karyotype in the brain 
As part of an integrated ‘-omics’ study of schizophrenia (Pidsley et al., 2014),  
we identified an individual with KS (a 47,XXY karyotype). Detailed post-mortem 
records show that although the 47,XXY patient had a similar total brain mass to 
other patients they had a markedly lower CER mass. The reduced cerebellum 
mass is consistent with the patient’s autopsy report of movement disorders; 
previous studies demonstrate an association between cerebellar ataxia and 
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reduced cerebellar size (Richter et al., 2005). Reductions in cerebral volume 
have been previously reported in KS (Skakkebaek et al., 2016, Skakkebaek et 
al., 2014, Giedd et al., 2007). Relative to other samples, the 47,XXY patient 
showed evidence for global DNA hypomethylation in the PFC and 
hypermethylation in the CER. Furthermore, we identified numerous autosomal 
regions showing consistent differential DNA methylation in the 47,XXY patient 
compared with other samples. Of note, several of these loci are relevant in the 
context of this syndrome, including SPAG1 (Lin et al., 2001), PIWIL1 (Reuter et 
al., 2011) and LHX4 (Machinis et al., 2001). Given the comorbid diagnosis of 
schizophrenia in this patient, it is interesting that several of the loci identified are 
located in close proximity to other neurobiologically-relevant genes, including 
NOTCH4, EPHB3 and KCNN1 (Ho et al., 2009, Liebl et al., 2003, Dolga and 
Culmsee, 2012). Numerous genes were found to be differentially expressed 
(DE) in the 47,XXY PFC and CER compared to the remaining samples. There 
was no evidence for skewed X-chromosome inactivation (XCI) in either of the 
brain regions from the 47,XXY patient. 
KS is often comorbid with psychiatric and neurodevelopmental phenotypes 
including language-based learning disabilities, decreased verbal intelligence 
and difficulties with task planning and inhibitory control (Boada et al., 2009). 
Given that such cognitive symptoms are often present in individuals with KS, 
future studies should focus on investigating methylomic and gene regulation 
variation in different brain regions of KS patients. However, post-mortem brain 
samples from these individuals are difficult to obtain. During the course of my 
PhD and after the study presented in Chapter 7 was published (Viana et al., 
2014), I identified another individual with a 47,XXY karyotype (see Chapter 3 
section 3.2.2). Furthermore, I obtained STR and HC tissue from the same 
individual presented in Chapter 7. Currently I am completing a study including 
DNA methylation, genotyping and transcriptomics (RNA-seq) data from the 




The analyses presented in this thesis have several important limitations that 
should be considered. Specific limitations to each analysis have already been 
discussed in each Chapter; here my focus is on the general limitations of using 
post-mortem brain tissue in molecular epidemiology and what aspects future 
research should focus on. First, although this represents one of the largest 
analyses of schizophrenia brain tissues yet undertaken, the number of samples 
assessed in my work is relatively low. The small number of samples limits the 
power to detect significant associations, especially given the small effect sizes 
expected in a complex disease such as schizophrenia (Dempster et al., 2013). 
Future efforts by the community should focus on extending participation in 
brain-banking efforts to maximise the number of samples available for 
molecular epidemiology. In this regard, recent efforts such as the UK Brain 
Bank Network (Medical Research Council, 2016) and the US CommonMind 
Consortium (The CommonMind Consortium, 2016) will facilitate advances in 
understanding the molecular pathology of neuropsychiatric disorders. 
Second, because epigenetic processes play an important role in defining cell 
type-specific patterns of gene expression (Roadmap Epigenomics Consortium 
et al., 2015, Talens et al., 2010, Varley et al., 2013), the use of ‘bulk’ tissue from 
each brain region is a potential confounder in DNA methylation (Guintivano et 
al., 2013, Heijmans and Mill, 2012) and gene expression studies (Gentles et al., 
2015). Despite my efforts to control for the effect of cell type diversity in DNA 
methylation and gene expression quantification in the analyses using in silico 
approaches to estimate neuronal proportions, this approach is not perfect, not 
appropriate to estimate the neuronal proportion in the CER, and cannot inform 
about disease relevant DNA methylation changes specific to individual neuronal 
cell types. Future efforts should focus on advances in purifying neural cell-types 
for genomic profiling (Jeffries and Mill, In Press), and developing methods for 
single cell genomic profiling.  
Third, there is increasing awareness of the importance of 5-hydroxymethyl 
cytosine (5-hmC) in the human brain (Branco et al., 2012, Kriaucionis and 
Heintz, 2009), although this modification cannot be distinguished from DNA 
methylation using standard bisulfite-based approaches (Lunnon et al., 2016b, 
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Booth et al., 2012). It is therefore plausible that many of the differences 
identified in this study are confounded by modifications other than DNA 
methylation. To date, no study has evaluated the role of 5-hmC in schizophrenia 
or any other psychiatric disorder, although novel profiling methods should make 
this feasible in the near future (Lunnon et al., 2016b).  
Fourth, although I controlled for age, sex and derived neuronal composition 
(where possible) in the analyses presented in this thesis, it is plausible that 
other factors such as smoking or medication still influenced my results. Post-
mortem samples are a precious resource and, when available, are often poorly 
characterised in terms of medication intake or life style habits such as smoking. 
Furthermore, even when information on medication is available, it is often 
impossible to distinguish between medication intake and disease status as all 
schizophrenia patients are usually prescribed some type of antipsychotic 
medication during their lifetime. Future efforts should be made to recruit 
samples for biobanking as early as possible before death so that detailed pre-
mortem exposure and phenotypic data can be collected.  
 Integration of schizophrenia findings – strengths, 8.3.
implications and future directions 
Chapters 3 to 6 represent a comprehensive study of schizophrenia-associated 
methylomic, transcriptomic and regulatory variation across four brain regions. 
This section aims to discuss and integrate the findings of the separate 
Chapters, within the context of the existing literature. In Table 8.1 I summarise 
the genes implicated across the different analyses. 
Overall, the results presented in this thesis do not support a global change in 
DNA methylation or gene expression in the brain of schizophrenia patients 
compared to non-psychiatric controls, which concurs with previous DNA 
methylation and gene expression studies of schizophrenia (see Chapter 1 
section 1.4). Instead, I identified changes at specific loci/genes implicated in 
schizophrenia. To my knowledge, the data presented here represent the most 
comprehensive combined study of methylomic, genomic and transcriptomic 
variation across different regions of the brain in schizophrenia to date. The use 
of PRS derived using data from a large schizophrenia GWAS (Schizophrenia 
406 
 
Working Group of the Psychiatric Genomics, 2014) to investigate methylomic 
variation associated with schizophrenia polygenic burden that is independent 
from direct cis-genetic effects represents an important step forward in the study 
of polygenic mediation of the epigenome in disease. Furthermore, the 
significant difference in PRS between schizophrenia patients and non-
psychiatric controls observed in this study (Chapter 4 Figure 4.4) highlights the 
relevance of using PRS as a tool to investigate molecular aetiology of 
schizophrenia, even in relatively small samples. 
In Chapter 5 I used a systems-level approach to identify modules of co-
methylated loci that might be dysregulated in schizophrenia. Despite the need 
to refine the application of WGCNA to DNA methylation data I was able to make 
several important observations. First, this analysis seems to highlight the 
importance of the PFC methylome in schizophrenia, with five modules of co-
methylated probes associated with disease in this brain region. Second, it 
allowed identifying evidence of co-methylation at several genes that have been 
previously shown to interact (Ganapathiraju et al, 2016) with DISC1 or genes 
implicated in the latest GWAS (Schizophrenia Working Group of the Psychiatric 
Genomics, 2014). This provides further support for an interaction between 
genetic variants associated with schizophrenia and DNA methylation at distinct 
loci, and highlights the importance of undertaking systems-level analyses in 
complex disorders such as schizophrenia. Finally, the work presented in 
Chapter 6 identifies several differentially expressed genes in the PFC in 
schizophrenia patients, and also provides evidence for an overlap between 
several of these genes and schizophrenia-associated methylomic variation. 
For decades researchers have struggled to understand the biological 
mechanisms mediating the onset of psychiatric conditions such as 
schizophrenia, mainly due to their pleiotropic and polymorphic nature. Based on 
its symptomatology and early epidemiological studies, schizophrenia has been 
hypothesised to be a disease with neurodevelopmental origin and 
immunological implications. The work comprised in this thesis represents an 




Several aspects of my data provide further evidence to support a 
neurodevelopmental origin for schizophrenia: i) several of the genes associated 
with both schizophrenia diagnosis and schizophrenia polygenic risk burden are 
genes involved in neurodevelopmental processes, including ADNP2 (Kushnir et 
al, 2008), AXIN2 (Kushnir et al, 2008), GAT2 (Schmidt and Mirnics, 2015), 
PLPPR3 (Brauer et al., 2003), RPTOR (Bercury et al, 2014) and DOC2B 
(Groffen et al, 2010); ii) a large schizophrenia-associated module of co-
methylated probes in the PFC shows significant enrichment for GO pathways 
involved in neurodevelopment; and iii) five fetal age–associated modules of co-
methylated probes identified in the fetal brain (Spiers et al., 2015) were also 
associated with schizophrenia in the PFC. Furthermore, several loci associated 
with the schizophrenia PRS have been previously implicated in other 
neurodevelopmental disorders such as autism-spectrum disorder (ASD) and 
attention deficit hyperactivity disorder (ADHD), supporting the notion that these 
different neurodevelopmental disorders might share common biological 
pathways (Carroll and Owen, 2009). 
Additionally, several of the loci associated with schizophrenia polygenic risk 
burden provide further support for the involvement of the immune system in 
schizophrenia etiology; these loci include BPI (Marra et al, 1992), IRF8 (Yanez 
and Goodridge, 2016), LSP1 (Pulford et al, 1999) and SIGLEC9 (Zhang et al, 
2000, Angata and Varki, 2000). This evidence is reinforced by the observed 
association between PRS and DNA methylation at loci within the MHC region: 
e.g. HLA-DPB2, HLA-J and RNF39. Genetic variants in the MHC region have 
been robustly associated with schizophrenia in recent GWAS studies 
(International Schizophrenia et al., 2009, Schizophrenia Working Group of the 
Psychiatric Genomics, 2014). This region spans several megabases on 
chromosome 6 and contains 18 highly polymorphic human leukocyte antigen 
(HLA) genes that encode proteins with antigen-presenting roles in the immune 
system (Benacerraf, 1981).  Interestingly, whereas DNA methylation changes at 
the several neurodevelopmental-relevant loci seem to be associated with both 
schizophrenia diagnosis and schizophrenia polygenic risk burden, changes in 
DNA methylation at immune-related genes seem to be more often associated 
with changes in polygenic risk score. A hypothesis arising from this observation 
would be that the increased burden of schizophrenia genetic risk variants is 
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associated with DNA methylation variation at immune-related genes. During the 
course of the disease, DNA methylation status at these loci is potentially 
changed through the action of antipsychotic medication, explaining why they are 
not detectable in the diagnosis analysis, where controlling for medication was 
impossible. My future work is focussed on understanding the genomic changes 
associated with exposure to antipsychotic medications, enabling me to further 
explore this hypothesis. 
The associations presented in this thesis need to be replicated and validated in 
larger sample cohorts. Furthermore, it will be important to establish whether the 
differences reported are causal and have a direct impact on disease etiology or 
if they are consequences of the disease course and medication intake. 
Additionally, we need to understand the individual contribution of single variants 
as well as the impact in molecular mechanism and disease risk of the higher 
polygenic burden. The development of animal models of schizophrenia should 
be a focus of future studies. The advance of genome editing technologies, such 
as the CRISPR/Cas9 system (Capecchi, 2005), will enable to target and modify 
specific genetic variants and epigenetic modifications. The behavioural and 
phenotypical analysis of such models should give us large insight on the 
mechanisms of schizophrenia. These models could be developed in rodents but 
also in other vertebrate organisms such as zebrafish. Future efforts should also 
be made to study the effect of antipsychotic medication on epigenetic 
mechanisms and gene expression using alternative approaches, such as 
exposure of iPS-derived neurons of schizophrenia patients and animal 
exposure studies. I am currently assessing the transcriptome and methylome of 
the brain of zebrafish exposed to antipsychotic medication, which will hopefully 
provide insight about the molecular implications of antipsychotic exposure on 
the vertebrate brain. 
Another important development in schizophrenia research will be the analysis of 
the epigenome and transcriptome of individual brain cell types. Ultimately, the 
integrated profile of DNA methylation, histone modifications, gene expression, 
open chromatin regions and binding of transcription factors in single cells would 
be optimal, although at the moment it is not clear how single cell sequencing 
approaches will be applied to large cohorts of samples. Future work by our 
group and others is focussing on using novel single-cell approaches to examine 
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cellular heterogeneity in complex tissues such as the brain and facilitate the 
identification of pathological changes in specific cells (and cell types).    
 Conclusion 8.4.
In conclusion, the work presented in this thesis represents a comprehensive 
integrative study of methylomics, genomics and transcriptomics across different 
regions of the schizophrenia brain and makes an important contribution to the 
field of psychiatric genomics. I present further evidence to support the 
neurodevelopmental origin of schizophrenia, as well as a role of the immune 
system on schizophrenia etiology. My analyses into associations between 
schizophrenia polygenic burden and DNA methylation suggests that the indirect 
polygenic mediation of the methylome plays a role in schizophrenia. Future 
studies will be needed to replicate these results and elucidate the regulatory 
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453 
 
Supplementary Table 6.  Methylation QTLs (mQTL) identified in the 
prefrontal cortex for SNPs included in the schizophrenia polygenic risk 
score (PRS). Shown are associations between DNA methylation at specific 
Illumina 450K probes and genetic variants used to derive PRS in Chapter 4, in 
addition to the corresponding P-values for PRS-associated DNA methylation 








rs9726753 chr1:153591652 5.88E-49 cg08477332 chr1:153590243 0.36 
rs117194038 chr17:43927290 1.65E-47 cg17117718 chr17:43663208 0.97 
rs12635522 chr3:125708174 4.79E-46 cg15145296 chr3:125709740 0.09 
rs35059736 chr7:158224692 1.83E-44 cg01191920 chr7:158217561 0.54 
rs76344840 chr9:33120204 2.97E-43 cg20290983 chr6:43655470 0.34 
rs12635522 chr3:125708174 9.23E-38 cg04553112 chr3:125709451 0.06 
rs12635522 chr3:125708174 1.68E-37 cg02807482 chr3:125708958 0.07 
rs4792919 chr17:41873309 1.98E-37 cg26893861 chr17:41843967 0.71 
rs12635522 chr3:125708174 2.29E-34 cg06494592 chr3:125709126 0.1 
rs10857676 chr10:134970598 1.74E-33 cg00753039 chr10:134969141 0.29 
rs6680259 chr1:7122308 2.50E-33 cg20409752 chr1:7122726 0.01 
rs10920265 chr1:201822955 9.59E-33 cg11586189 chr1:201857591 0.25 
rs117194038 chr17:43927290 5.30E-32 cg22968622 chr17:43663579 0.43 
rs907033 chr16:83987856 1.14E-30 cg27171569 chr16:83987465 0.14 
rs11734838 chr4:7980737 1.43E-30 cg22688802 chr4:7980661 0.51 
rs9933817 chr16:83972660 3.25E-30 cg16457916 chr16:83968360 0.56 
rs4880509 chr10:1511150 7.38E-29 cg13684379 chr10:1511173 0.66 
rs4880509 chr10:1511150 1.71E-28 cg09316607 chr10:1511024 0.93 
rs2800973 chr22:19168616 2.02E-27 cg02655711 chr22:19163373 0.41 
rs60668498 chr19:44642672 9.76E-26 cg23489630 chr19:44645078 0.92 
rs4880509 chr10:1511150 1.48E-25 cg04012681 chr10:1511277 0.52 
rs13282161 chr8:1705041 7.43E-25 cg17694851 chr8:1707553 0.07 
rs13065 chr14:100996312 1.04E-23 cg18516195 chr14:101012996 0.86 
rs10271372 chr7:157793023 1.56E-23 cg12440927 chr7:157791721 0.04 
rs4807546 chr19:4182060 2.24E-23 cg23999422 chr19:4173466 0.64 
rs9348260 chr6:170516123 3.49E-23 cg22739554 chr6:170500876 0.1 
rs7833924 chr8:144996029 5.06E-23 cg10276948 chr8:144986694 0.06 
rs7833924 chr8:144996029 7.35E-23 cg09374673 chr8:144986488 0.06 
rs9933817 chr16:83972660 1.30E-22 cg16528738 chr16:83968260 0.94 
rs907033 chr16:83987856 2.05E-22 cg07978099 chr16:83986941 0.24 
rs2412322 chr17:48578726 3.11E-22 cg00901687 chr17:48585270 0.06 
rs4689604 chr4:7129556 1.06E-21 cg16307866 chr4:7129517 0.19 
rs7496866 chr15:27102200 1.31E-21 cg10318222 chr15:27111940 0.2 
rs6435711 chr2:213410065 1.54E-21 cg16329650 chr2:213403929 0.78 
rs13147452 chr4:1078124 3.25E-21 cg27284194 chr4:1044797 0.6 
rs1156782 chr6:115995564 6.21E-21 cg04193905 chr6:115989126 0.76 
rs2568198 chr2:85403546 8.25E-21 cg22128724 chr2:85402928 0.78 
rs4928043 chr3:54085900 9.48E-21 cg15798837 chr3:54122146 0.48 
rs10058772 chr5:180033292 1.31E-20 cg06967124 chr5:180045597 0.52 
rs5412 chr17:7184046 1.37E-20 cg01757206 chr17:7183913 0.18 
rs30927 chr16:55317598 1.54E-20 cg01064265 chr16:55363058 0.11 
rs13065 chr14:100996312 1.67E-20 cg19590140 chr14:101012492 0.81 
rs7833924 chr8:144996029 2.76E-20 cg06045337 chr8:145013910 0.01 
rs2412322 chr17:48578726 3.49E-20 cg11440486 chr17:48585216 0.08 
rs212781 chr6:133771248 4.13E-20 cg25075347 chr6:133731801 0.53 
rs1735173 chr8:146071261 4.84E-20 cg20672363 chr8:146075022 0.9 
rs10079713 chr5:28692468 6.95E-20 cg07881623 chr6:80731107 0.39 
rs13147452 chr4:1078124 9.41E-20 cg04106633 chr4:1044584 0.52 
454 
 
rs16961809 chr19:29226299 9.75E-20 cg12756686 chr19:29218302 0.26 
rs7516453 chr1:15972558 1.52E-19 cg17385448 chr1:15911702 0.9 
rs1350543 chr4:56014389 2.10E-19 cg01777861 chr4:56023843 0.79 
rs454759 chr12:125799159 2.43E-19 cg03923277 chr12:104359732 0.18 
rs11650633 chr17:80083807 2.92E-19 cg16920238 chr17:80076378 0.56 
rs57550038 chr17:14078445 3.24E-19 cg00902417 chr17:15492168 0.25 
rs4807546 chr19:4182060 3.25E-19 cg01287132 chr19:4173254 0.97 
rs2978902 chr8:6690173 6.20E-19 cg11878365 chr8:6692387 0.24 
rs7201047 chr16:86335556 6.38E-19 cg04352168 chr16:86334058 0.47 
rs1341741 chr10:888073 6.63E-19 cg26597838 chr10:835615 0.45 
rs1341741 chr10:888073 8.95E-19 cg20503657 chr10:835505 0.76 
rs16961809 chr19:29226299 9.06E-19 cg14983838 chr19:29218262 0.11 
rs11636395 chr15:45535684 1.04E-18 cg25801113 chr15:45476975 0.58 
rs9876131 chr3:136726790 1.34E-18 cg21827317 chr3:136751795 0.27 
rs16961809 chr19:29226299 1.90E-18 cg03161606 chr19:29218774 0.19 
rs11984421 chr7:100266633 2.09E-18 cg02938413 chr7:100330587 0.24 
rs1350543 chr4:56014389 2.39E-18 cg09978860 chr4:56023921 0.76 
rs12924275 chr16:9191790 2.77E-18 cg08831531 chr16:9218945 0.08 
rs9936140 chr16:10193417 2.88E-18 cg08242859 chr7:128032651 0.63 
rs56340588 chr7:127799341 3.00E-18 cg02301128 chr7:127792165 0.74 
rs2062480 chr1:197905400 3.12E-18 cg00114966 chr1:197893920 0.49 
rs74002504 chr2:241828338 3.34E-18 cg04034577 chr2:241836375 0.1 
rs9643305 chr8:134610055 4.90E-18 cg22582999 chr8:134594669 0.54 
rs8082590 chr17:17958402 5.31E-18 cg04398451 chr17:18023971 0.86 
rs12097673 chr1:2843180 5.61E-18 cg21402748 chr1:2838849 0.03 
rs72732566 chr5:36744234 7.70E-18 cg03995615 chr5:36744219 0.54 
rs7803698 chr7:64427895 8.13E-18 cg12143784 chr7:64541923 0.29 
rs9769809 chr7:64956889 1.06E-17 cg12143784 chr7:64541923 0.29 
rs3128778 chr4:2402474 1.07E-17 cg01601518 chr4:2404284 0.86 
rs7512217 chr1:15586878 1.13E-17 cg08815479 chr1:15573596 0.93 
rs79175383 chr12:96336533 1.49E-17 cg25229172 chr12:96336121 0.31 
rs7206985 chr17:9159202 1.57E-17 cg12361772 chr17:9160821 0.88 
rs2800973 chr22:19168616 1.61E-17 cg24911827 chr22:19170109 0.96 
rs2342082 chr12:123090380 1.85E-17 cg23029597 chr12:123009494 0.39 
rs6565516 chr17:78965146 1.89E-17 cg10070101 chr17:78963290 0.6 
rs6685767 chr1:46823929 2.25E-17 cg15580309 chr1:46814106 0.45 
rs7257916 chr19:45482884 2.38E-17 cg13119609 chr19:45449297 0.72 
rs2505949 chr6:80804414 2.48E-17 cg08355045 chr6:80787529 0.87 
rs11675057 chr2:26399481 2.89E-17 cg22920501 chr2:26401640 0.78 
rs11688491 chr2:98167020 3.06E-17 cg26665480 chr2:98280029 0.58 
rs4555948 chr6:160094492 3.17E-17 cg13221458 chr6:160112632 0.64 
rs7257916 chr19:45482884 3.24E-17 cg09555818 chr19:45449301 0.81 
rs7470675 chr9:132588337 3.47E-17 cg13529314 chr9:132598258 0.88 
rs74002504 chr2:241828338 3.63E-17 cg07537917 chr2:241836409 0.49 
rs6676743 chr1:110296338 4.07E-17 cg10807101 chr1:110282274 0.16 
rs56378923 chr10:72316604 4.21E-17 cg22643110 chr10:72319345 0.74 
rs908951 chr16:89697625 4.97E-17 cg08949735 chr16:89699720 0.74 
rs2246207 chr17:61987576 5.00E-17 cg06873352 chr17:61820015 0.61 
rs72635991 chr10:788658 5.00E-17 cg24280607 chr15:41709584 0.4 
rs62014776 chr16:1339750 5.51E-17 cg03705235 chr16:1371463 0.63 
rs7496866 chr15:27102200 5.62E-17 cg03325535 chr15:27111949 0.37 
rs13147452 chr4:1078124 7.37E-17 cg21130718 chr4:1044621 0.34 
rs930526 chr17:6473353 7.39E-17 cg23551722 chr17:6546898 0.66 
rs60061503 chr1:185364328 7.89E-17 cg11066601 chr1:185373486 0.58 
rs113935737 chr15:65123276 8.14E-17 cg25489524 chr15:65127973 0.84 
rs9812936 chr3:50043654 9.76E-17 cg12257692 chr3:49977190 0.96 
rs59462516 chr12:1165012 1.32E-16 cg07813377 chr12:1192425 0.68 
rs12467950 chr2:220275736 1.38E-16 cg15015639 chr2:220282977 0.8 
rs9348260 chr6:170516123 1.85E-16 cg21597487 chr6:170500638 0.19 
rs1350543 chr4:56014389 1.93E-16 cg16572876 chr4:56024045 0.93 
rs4929922 chr11:8975776 2.09E-16 cg21881798 chr11:8931708 0 
rs12595938 chr16:8958081 2.14E-16 cg08308162 chr16:8889244 0.8 
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rs28839814 chr4:13555899 2.63E-16 cg20477448 chr4:13656704 0.38 
rs1730794 chr4:3451960 3.04E-16 cg25120210 chr4:3464653 0.54 
rs9726753 chr1:153591652 3.13E-16 cg05659314 chr1:153590020 0.1 
rs3021270 chr22:40396409 3.35E-16 cg21771250 chr22:40406049 0.93 
rs6968990 chr7:32552159 3.51E-16 cg06627557 chr7:32535165 0.31 
rs62185165 chr2:241251453 3.62E-16 cg21947394 chr2:241260110 0.35 
rs1375813 chr3:142809577 4.50E-16 cg01520402 chr3:142790398 0.31 
rs9812936 chr3:50043654 4.87E-16 cg05623727 chr3:50126028 0.56 
rs12653391 chr5:439796 4.91E-16 cg00049323 chr5:472564 0.34 
rs58635565 chr8:41561181 5.08E-16 cg07533533 chr8:41559593 0.92 
rs12691433 chr7:154989404 5.13E-16 cg07944445 chr7:155006275 0.85 
rs13283037 chr9:97018520 5.44E-16 cg13980266 chr9:97022269 0.78 
rs117194038 chr17:43927290 5.52E-16 cg01934064 chr17:44064242 0.73 
rs10793287 chr11:77846706 6.02E-16 cg09721595 chr11:77773924 0.88 
rs1812214 chr8:105344070 7.22E-16 cg04554929 chr8:105342491 0.73 
rs9769809 chr7:64956889 7.61E-16 cg01136167 chr7:65037704 0.55 
rs2370234 chr1:25304464 7.89E-16 cg23273869 chr1:25296894 0.47 
rs7662812 chr4:24983413 8.17E-16 cg19676182 chr4:24981695 0.14 
rs7402982 chr15:99193269 8.24E-16 cg03437748 chr15:99193247 0.03 
rs12022839 chr1:58089133 8.59E-16 cg00026909 chr1:58089001 0.63 
rs11149799 chr16:75174049 8.71E-16 cg00897404 chr16:75182368 0.77 
rs7514450 chr1:220991171 8.91E-16 cg08655206 chr1:221058198 0.34 
rs4782336 chr16:89151518 1.01E-15 cg00697672 chr16:89151343 0.63 
rs45537633 chr6:41117824 1.18E-15 cg03644281 chr6:41068752 0.23 
rs11060115 chr12:129554644 1.19E-15 cg01290755 chr12:129554587 0.17 
rs4789846 chr17:80225545 1.29E-15 cg22805688 chr17:80197841 0.84 
rs7574691 chr2:240044687 1.30E-15 cg15934368 chr2:240044021 0.07 
rs11712066 chr3:151830309 1.48E-15 cg27098685 chr3:151867537 0.85 
rs30927 chr16:55317598 1.65E-15 cg07592723 chr16:55365146 0.32 
rs6597862 chr10:126649723 1.69E-15 cg06432487 chr10:126623651 0.54 
rs9817966 chr3:46650540 1.78E-15 cg24524379 chr3:46600244 0.16 
rs12674529 chr8:127885599 1.82E-15 cg21238284 chr8:127889295 0.78 
rs455104 chr17:10618227 1.89E-15 cg00549475 chr17:10632715 0.44 
rs30927 chr16:55317598 2.12E-15 cg06722193 chr16:55359355 0.17 
rs2276968 chr4:7070118 2.26E-15 cg06697600 chr4:7070879 0.55 
rs4571937 chr1:20897033 2.30E-15 cg00750606 chr1:20899121 0.85 
rs4770476 chr13:24269820 2.35E-15 cg07031408 chr13:24269867 0.51 
rs57094537 chr4:40261798 2.39E-15 cg25243082 chr4:40267141 0.83 
rs7016869 chr8:2474928 2.58E-15 cg02472801 chr8:2480483 0.18 
rs2637657 chr10:133993806 2.60E-15 cg18037376 chr10:134004552 0.52 
rs11675057 chr2:26399481 2.70E-15 cg25036284 chr2:26402008 0.81 
rs1919784 chr7:33105268 2.89E-15 cg22798885 chr7:33102694 0.74 
rs7663448 chr4:10054787 2.91E-15 cg26043149 chr18:55253948 0.29 
rs10987908 chr9:130936530 3.07E-15 cg10071929 chr9:130955135 0.72 
rs392124 chr17:9669921 3.17E-15 cg13468767 chr17:9672024 0.26 
rs13147452 chr4:1078124 3.59E-15 cg04016957 chr4:1044486 0.42 
rs3793202 chr7:6207142 4.84E-15 cg22849526 chr7:6199437 0.82 
rs6711715 chr2:130330516 5.25E-15 cg05903289 chr2:130345205 0.06 
rs11179581 chr12:37892432 5.32E-15 cg10856724 chr12:34555212 0.18 
rs117194038 chr17:43927290 5.58E-15 cg01341218 chr17:43662625 0.46 
rs7104785 chr11:804212 5.81E-15 cg01741372 chr11:783889 0.93 
rs9284725 chr2:102744854 5.95E-15 cg22835712 chr2:102737379 0.71 
rs7833924 chr8:144996029 5.96E-15 cg27082292 chr8:145001361 0.26 
rs11675057 chr2:26399481 6.22E-15 cg27170947 chr2:26402098 0.5 
rs4314559 chr7:2365892 6.93E-15 cg16553052 chr7:2349605 0.67 
rs12028536 chr1:228743706 7.56E-15 cg06261630 chr1:228741351 0.74 
rs4910458 chr11:9379402 8.41E-15 cg19695805 chr11:9385645 0.96 
rs7496866 chr15:27102200 8.56E-15 cg01378667 chr15:27111911 0.44 
rs257701 chr5:123737922 8.80E-15 cg01806427 chr5:123737813 0.76 
rs13044479 chr20:62245686 8.94E-15 cg09650180 chr20:62225654 0.74 
rs7833924 chr8:144996029 9.08E-15 cg05696706 chr8:145013932 0.01 
rs10987908 chr9:130936530 9.61E-15 cg09976142 chr9:130955436 0.58 
456 
 
rs4770476 chr13:24269820 9.62E-15 cg10885151 chr13:24270087 0.57 
rs12129745 chr1:28572317 1.07E-14 cg04993605 chr1:28573052 0.23 
rs34228916 chr12:115942842 1.14E-14 cg18639984 chr12:115943877 0.11 
rs8016689 chr14:103319981 1.21E-14 cg23020514 chr14:103360112 0.09 
rs8008761 chr14:90739754 1.29E-14 cg10090757 chr14:90744615 0.91 
rs4782336 chr16:89151518 1.30E-14 cg07845093 chr16:89151447 0.88 
rs2269906 chr17:42294337 1.34E-14 cg13607699 chr17:42295918 0.43 
rs10175462 chr2:113988492 1.41E-14 cg21550016 chr2:113992930 0.51 
rs72781258 chr2:20274213 1.73E-14 cg24657347 chr2:20261756 0.94 
rs8057544 chr16:537650 1.96E-14 cg27494100 chr16:537705 0.82 
rs72755098 chr15:64427587 2.09E-14 cg02848875 chr15:64387786 0.28 
rs9998888 chr4:824575 2.10E-14 cg24793722 chr4:824416 0.7 
rs193930 chr2:8107520 2.21E-14 cg03155496 chr2:8117019 0.46 
rs8053397 chr16:87573468 2.32E-14 cg08031982 chr16:87577539 0.18 
rs4984688 chr16:785717 2.32E-14 cg18653534 chr16:772142 0.37 
rs117194038 chr17:43927290 2.36E-14 cg22433210 chr17:43662623 0.82 
rs7143780 chr14:96154609 2.44E-14 cg03043804 chr14:96152706 0.49 
rs9782 chr12:103351826 2.56E-14 cg27569040 chr12:103351855 0.86 
rs9915323 chr17:37770481 2.59E-14 cg00129232 chr17:37814104 0.92 
rs17333520 chr11:31058834 2.60E-14 cg26647111 chr11:31128758 0.09 
rs111543213 chr19:37642385 2.61E-14 cg08835041 chr19:37461278 0.16 
rs9912302 chr17:44916982 2.75E-14 cg25836567 chr17:44929689 0.16 
rs10920265 chr1:201822955 2.87E-14 cg06775570 chr1:201857621 0.25 
rs2376584 chr17:76402116 3.21E-14 cg05887092 chr17:76393375 0.46 
rs16961809 chr19:29226299 3.22E-14 cg25267487 chr19:29217858 0.12 
rs3128778 chr4:2402474 3.27E-14 cg13053151 chr4:2403559 0.59 
rs3808524 chr8:23161983 3.42E-14 cg24531534 chr8:23162162 0.53 
rs10773762 chr12:130765366 3.60E-14 cg14604444 chr12:130766091 0.48 
rs12977777 chr19:35323365 3.64E-14 cg15695738 chr19:35329860 0.13 
rs11230570 chr11:60782634 3.68E-14 cg27098804 chr11:60776124 0.45 
rs4866663 chr5:2727471 4.15E-14 cg27345924 chr5:2727758 0.91 
rs6560691 chr10:134140245 4.24E-14 cg23771949 chr10:134165390 0.05 
rs7015233 chr8:144381511 5.46E-14 cg12888521 chr8:144346762 0.42 
rs10151225 chr14:52589352 5.59E-14 cg12071775 chr14:52591786 0.25 
rs28520336 chr6:17555977 5.81E-14 cg09879382 chr6:17581248 0.93 
rs10492997 chr1:19769371 6.19E-14 cg17081867 chr1:19768096 0.25 
rs7016869 chr8:2474928 6.30E-14 cg01414268 chr8:2480911 0.2 
rs10987908 chr9:130936530 6.90E-14 cg13642260 chr9:130955380 0.63 
rs10773762 chr12:130765366 7.12E-14 cg27633287 chr12:130766243 0.44 
rs2205661 chr22:45731759 7.17E-14 cg00733150 chr22:45705707 0.12 
rs12698058 chr7:157225536 7.24E-14 cg03453431 chr7:157225567 0.44 
rs10175462 chr2:113988492 7.76E-14 cg11763394 chr2:113992921 0.47 
rs4143866 chr16:85716366 7.96E-14 cg26571870 chr16:85723150 0.54 
rs7455225 chr7:73241386 9.64E-14 cg02874145 chr7:73246406 0.32 
rs10888514 chr1:152707929 9.78E-14 cg07796016 chr1:152779584 0.98 
rs4475020 chr3:14599121 1.10E-13 cg21529591 chr3:14596904 0.32 
rs6421977 chr11:407708 1.12E-13 cg18351999 chr11:406901 0.52 
rs4965672 chr15:101089241 1.20E-13 cg02597199 chr15:101098829 0.77 
rs6711715 chr2:130330516 1.21E-13 cg05962382 chr2:130345044 0.71 
rs2021560 chr19:22373470 1.23E-13 cg22620746 chr19:22234992 0.44 
rs4789885 chr17:77310495 1.30E-13 cg08223357 chr17:77302162 0.79 
rs16965349 chr17:36614524 1.32E-13 cg12050358 chr17:36612909 0.78 
rs12208321 chr6:56132243 1.35E-13 cg07143470 chr6:56111812 0.1 
rs12097673 chr1:2843180 1.35E-13 cg00996827 chr1:2838805 0.14 
rs3793969 chr11:1318884 1.36E-13 cg14329644 chr11:1253904 0.73 
rs4900242 chr14:95151985 1.45E-13 cg16462006 chr14:95155784 0.42 
rs58069944 chr8:2294105 1.46E-13 cg11900328 chr8:2263331 0.99 
rs2297475 chr10:90984623 1.55E-13 cg17741809 chr10:90985055 0.44 
rs29655 chr5:180267436 1.61E-13 cg19091830 chr5:180286094 0.21 
rs6946060 chr7:157644761 1.67E-13 cg22216157 chr7:157643037 0.82 
rs6946060 chr7:157644761 1.74E-13 cg25449441 chr7:157644471 0.94 
rs4928043 chr3:54085900 1.84E-13 cg01296889 chr3:54122032 0.22 
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rs45537633 chr6:41117824 1.87E-13 cg04346459 chr6:41068666 0.74 
rs28400431 chr8:143698404 1.87E-13 cg10104451 chr8:143696006 0.68 
rs72704639 chr1:150798335 1.91E-13 cg04414720 chr1:150670196 0.07 
rs2453606 chr17:19387091 1.92E-13 cg19949948 chr17:19361230 0.68 
rs28452050 chr16:29317318 1.94E-13 cg05645661 chr16:29329490 0.77 
rs668338 chr11:60713358 1.97E-13 cg06257669 chr11:60702218 0.43 
rs2870479 chr19:57449293 2.03E-13 cg12414181 chr15:75287860 0.86 
rs7794450 chr7:6625847 2.05E-13 cg19149522 chr7:6616423 0.13 
rs143349430 chr10:32183019 2.18E-13 cg04359828 chr10:32216031 0.24 
rs12653230 chr5:159735611 2.21E-13 cg17267804 chr5:159735392 0.07 
rs1055150 chr19:18499784 2.34E-13 cg21088460 chr19:18499786 0.87 
rs9525735 chr13:43661306 2.36E-13 cg14729962 chr13:43597565 0 
rs2145848 chr6:3035894 2.56E-13 cg05728019 chr6:3024023 0.86 
rs890393 chr18:74102435 2.60E-13 cg24786174 chr18:74118243 0.18 
rs11650633 chr17:80083807 2.65E-13 cg00755572 chr17:80077754 0.36 
rs7018316 chr8:144630169 2.85E-13 cg20458811 chr8:144631810 0.11 
rs11675057 chr2:26399481 3.21E-13 cg04944784 chr2:26401820 0.76 
rs10058772 chr5:180033292 3.26E-13 cg00744924 chr5:180042471 0.72 
rs75934331 chr1:183182029 3.30E-13 cg01417625 chr1:183187433 0.48 
rs5023799 chr13:47095293 3.55E-13 cg11342437 chr13:47126328 0.03 
rs12761857 chr10:7105868 3.56E-13 cg00998146 chr19:18284560 0.79 
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Supplementary Table 7.  Methylation QTLs (mQTL) identified in the 
striatum for SNPs included in the schizophrenia polygenic risk score 
(PRS). Shown are associations between DNA methylation at specific Illumina 
450K probes and genetic variants used to derive PRS in Chapter 4, in addition 
to the corresponding P-values for PRS-associated DNA methylation variation at 








rs6680259 chr1:7122308 1.55E-52 cg20409752 chr1:7122726 0.07 
rs9726753 chr1:153591652 3.54E-50 cg08477332 chr1:153590243 0.29 
rs12635522 chr3:125708174 5.95E-46 cg15145296 chr3:125709740 0.61 
rs117194038 chr17:43927290 2.87E-45 cg17117718 chr17:43663208 0.5 
rs76344840 chr9:33120204 4.29E-43 cg20290983 chr6:43655470 0.38 
rs4792919 chr17:41873309 1.00E-39 cg26893861 chr17:41843967 0.99 
rs35059736 chr7:158224692 2.93E-34 cg01191920 chr7:158217561 0.58 
rs12635522 chr3:125708174 3.18E-34 cg02807482 chr3:125708958 0.59 
rs12635522 chr3:125708174 5.04E-34 cg06494592 chr3:125709126 0.95 
rs9348260 chr6:170516123 1.16E-31 cg22739554 chr6:170500876 0.03 
rs12635522 chr3:125708174 1.92E-31 cg04553112 chr3:125709451 0.43 
rs117194038 chr17:43927290 3.19E-31 cg22968622 chr17:43663579 0.31 
rs7833924 chr8:144996029 5.67E-31 cg10276948 chr8:144986694 0.02 
rs907033 chr16:83987856 9.19E-31 cg27171569 chr16:83987465 0.29 
rs4880509 chr10:1511150 1.74E-30 cg09316607 chr10:1511024 0.71 
rs72732566 chr5:36744234 1.80E-30 cg03995615 chr5:36744219 0.95 
rs4880509 chr10:1511150 4.08E-30 cg13684379 chr10:1511173 0.49 
rs4807546 chr19:4182060 2.74E-28 cg23999422 chr19:4173466 0.76 
rs12653230 chr5:159735611 1.13E-27 cg17267804 chr5:159735392 0.02 
rs10857676 chr10:134970598 1.43E-27 cg00753039 chr10:134969141 0.54 
rs9933817 chr16:83972660 1.46E-27 cg16528738 chr16:83968260 0.36 
rs11650633 chr17:80083807 2.21E-26 cg16920238 chr17:80076378 0.63 
rs6597862 chr10:126649723 3.79E-26 cg06432487 chr10:126623651 0.92 
rs4880509 chr10:1511150 3.79E-26 cg04012681 chr10:1511277 0.71 
rs7833924 chr8:144996029 6.96E-26 cg09374673 chr8:144986488 0.05 
rs199503 chr17:44862162 2.97E-25 cg22968622 chr17:43663579 0.31 
rs11636395 chr15:45535684 4.47E-25 cg25801113 chr15:45476975 0.04 
rs117194038 chr17:43927290 5.23E-25 cg01934064 chr17:44064242 0.84 
rs4807546 chr19:4182060 7.48E-25 cg01287132 chr19:4173254 0.62 
rs9348260 chr6:170516123 1.05E-24 cg21597487 chr6:170500638 0.05 
rs9348260 chr6:170516123 1.14E-24 cg21235075 chr6:170500610 0.2 
rs11060115 chr12:129554644 6.89E-24 cg01290755 chr12:129554587 0.3 
rs199503 chr17:44862162 8.32E-24 cg17117718 chr17:43663208 0.5 
rs2412322 chr17:48578726 8.83E-24 cg00901687 chr17:48585270 0.09 
rs2505949 chr6:80804414 1.55E-23 cg08355045 chr6:80787529 0.47 
rs13065 chr14:100996312 1.68E-23 cg18516195 chr14:101012996 0.12 
rs2800973 chr22:19168616 4.34E-23 cg02655711 chr22:19163373 0.56 
rs4555948 chr6:160094492 5.15E-23 cg13221458 chr6:160112632 0.26 
rs5412 chr17:7184046 5.65E-23 cg01757206 chr17:7183913 0.53 
rs6455887 chr6:163674175 6.75E-23 cg07343445 chr6:163673130 0.11 
rs73752005 chr6:88092421 9.34E-23 cg06087457 chr6:88040249 0.41 
rs56340588 chr7:127799341 2.61E-22 cg02301128 chr7:127792165 0.54 
rs9933817 chr16:83972660 2.70E-22 cg16457916 chr16:83968360 0.8 
rs13147452 chr4:1078124 7.13E-22 cg27284194 chr4:1044797 0.59 
rs72755098 chr15:64427587 1.99E-21 cg02848875 chr15:64387786 0.32 
rs74002504 chr2:241828338 2.82E-21 cg04034577 chr2:241836375 0.33 
rs1350543 chr4:56014389 4.64E-21 cg09978860 chr4:56023921 0.97 
rs60061503 chr1:185364328 7.87E-21 cg11066601 chr1:185373486 0.85 
rs454759 chr12:125799159 9.47E-21 cg03923277 chr12:104359732 0.4 
459 
 
rs1350543 chr4:56014389 1.43E-20 cg01777861 chr4:56023843 0.81 
rs257701 chr5:123737922 1.59E-20 cg01806427 chr5:123737813 0.26 
rs7131362 chr11:1689325 3.18E-20 cg04938738 chr11:1689429 0.62 
rs60668498 chr19:44642672 3.93E-20 cg23489630 chr19:44645078 0.87 
rs12595938 chr16:8958081 6.21E-20 cg08308162 chr16:8889244 0.39 
rs28839814 chr4:13555899 8.95E-20 cg20477448 chr4:13656704 0.82 
rs28452050 chr16:29317318 1.09E-19 cg05645661 chr16:29329490 0.32 
rs35037013 chr10:54656418 1.12E-19 cg05984115 chr10:54631212 0.92 
rs2291393 chr17:80585094 1.13E-19 cg27136344 chr17:80606911 0.54 
rs16961809 chr19:29226299 1.20E-19 cg14983838 chr19:29218262 0.18 
rs11230233 chr11:55349858 1.27E-19 cg20623702 chr11:55431584 0.73 
rs650241 chr11:75277757 1.71E-19 cg26104986 chr11:75275303 0.08 
rs4143866 chr16:85716366 1.92E-19 cg26571870 chr16:85723150 0.68 
rs6685767 chr1:46823929 2.97E-19 cg15580309 chr1:46814106 0.12 
rs8082590 chr17:17958402 3.07E-19 cg04398451 chr17:18023971 0.56 
rs1341741 chr10:888073 4.50E-19 cg26597838 chr10:835615 0.94 
rs2412322 chr17:48578726 4.74E-19 cg11440486 chr17:48585216 0.11 
rs13147452 chr4:1078124 5.33E-19 cg21130718 chr4:1044621 0.74 
rs12097673 chr1:2843180 5.33E-19 cg21402748 chr1:2838849 0.84 
rs10793287 chr11:77846706 5.40E-19 cg09721595 chr11:77773924 0.73 
rs1294417 chr6:6741932 5.59E-19 cg06612196 chr6:6737390 0.81 
rs7803698 chr7:64427895 7.87E-19 cg12143784 chr7:64541923 0.13 
rs212781 chr6:133771248 1.12E-18 cg25075347 chr6:133731801 0.69 
rs62014776 chr16:1339750 1.21E-18 cg03705235 chr16:1371463 0.6 
rs9726753 chr1:153591652 1.23E-18 cg05659314 chr1:153590020 0.69 
rs6565516 chr17:78965146 1.41E-18 cg10070101 chr17:78963290 0.63 
rs2066700 chr13:50887725 1.58E-18 cg17976839 chr13:50923823 0.06 
rs11675057 chr2:26399481 1.61E-18 cg22920501 chr2:26401640 0.74 
rs4689604 chr4:7129556 1.69E-18 cg16307866 chr4:7129517 0.88 
rs16961809 chr19:29226299 1.88E-18 cg03161606 chr19:29218774 0.14 
rs2342082 chr12:123090380 2.10E-18 cg23029597 chr12:123009494 0.09 
rs13282161 chr8:1705041 2.29E-18 cg17694851 chr8:1707553 0.05 
rs684337 chr17:727349 2.30E-18 cg05176970 chr17:724273 0.72 
rs199503 chr17:44862162 2.40E-18 cg01934064 chr17:44064242 0.84 
rs62185165 chr2:241251453 2.58E-18 cg21947394 chr2:241260110 0.64 
rs3793202 chr7:6207142 3.00E-18 cg22849526 chr7:6199437 0.24 
rs3891052 chr14:105672895 3.86E-18 cg27037305 chr14:105689766 0.54 
rs16961809 chr19:29226299 4.54E-18 cg12756686 chr19:29218302 0.21 
rs45537633 chr6:41117824 4.90E-18 cg03644281 chr6:41068752 0.68 
rs4475020 chr3:14599121 5.36E-18 cg21529591 chr3:14596904 0.61 
rs10058772 chr5:180033292 5.48E-18 cg06967124 chr5:180045597 0.47 
rs13065 chr14:100996312 5.57E-18 cg19590140 chr14:101012492 0.47 
rs9390343 chr6:146010527 6.69E-18 cg01476807 chr6:146125657 0.94 
rs57550038 chr17:14078445 7.18E-18 cg00902417 chr17:15492168 0.33 
rs7257916 chr19:45482884 7.23E-18 cg09555818 chr19:45449301 0.65 
rs6801145 chr3:167312146 8.54E-18 cg18801567 chr3:167450363 0.02 
rs7662812 chr4:24983413 8.97E-18 cg19676182 chr4:24981695 1 
rs57094537 chr4:40261798 9.01E-18 cg25243082 chr4:40267141 0.58 
rs392124 chr17:9669921 1.16E-17 cg13468767 chr17:9672024 0.36 
rs4928043 chr3:54085900 1.34E-17 cg15798837 chr3:54122146 0.37 
rs6435711 chr2:213410065 2.36E-17 cg16329650 chr2:213403929 0.38 
rs2978902 chr8:6690173 2.70E-17 cg11878365 chr8:6692387 0.77 
rs10897269 chr11:62162088 2.70E-17 cg23876832 chr11:62092739 0.13 
rs9876131 chr3:136726790 3.09E-17 cg21827317 chr3:136751795 0.82 
rs7015233 chr8:144381511 3.83E-17 cg20232550 chr8:144344793 0.95 
rs890393 chr18:74102435 4.51E-17 cg24786174 chr18:74118243 0.14 
rs66712530 chr12:132664285 4.93E-17 cg26320244 chr12:132663455 0.44 
rs2568198 chr2:85403546 5.14E-17 cg22128724 chr2:85402928 0.72 
rs144716806 chr4:38854783 5.17E-17 cg26681822 chr4:38858561 0.38 
rs72704639 chr1:150798335 5.97E-17 cg09365446 chr1:150670422 0.15 
rs2014453 chr7:44142792 6.41E-17 cg12399411 chr7:44134432 0.59 
rs12214357 chr6:77577369 7.43E-17 cg17141972 chr6:77547510 0.53 
460 
 
rs13147452 chr4:1078124 8.06E-17 cg04106633 chr4:1044584 0.58 
rs12698058 chr7:157225536 9.93E-17 cg03453431 chr7:157225567 0.49 
rs9769809 chr7:64956889 1.03E-16 cg12143784 chr7:64541923 0.13 
rs13283037 chr9:97018520 1.09E-16 cg13980266 chr9:97022269 0.81 
rs10175462 chr2:113988492 1.12E-16 cg21550016 chr2:113992930 0.99 
rs4910458 chr11:9379402 1.16E-16 cg19695805 chr11:9385645 0.63 
rs9917823 chr3:183673780 1.39E-16 cg01324343 chr3:183735012 0.06 
rs12129745 chr1:28572317 1.48E-16 cg04993605 chr1:28573052 0.85 
rs4802745 chr19:51320111 1.71E-16 cg02725269 chr19:51327177 0.35 
rs3128778 chr4:2402474 1.78E-16 cg13053151 chr4:2403559 0.77 
rs2475509 chr6:39890217 1.79E-16 cg10871120 chr6:39891273 0.07 
rs2062480 chr1:197905400 1.85E-16 cg00114966 chr1:197893920 0.34 
rs12450494 chr17:7207887 2.22E-16 cg04514024 chr17:7222668 0.31 
rs7833924 chr8:144996029 2.22E-16 cg06045337 chr8:145013910 0.16 
rs10175462 chr2:113988492 2.53E-16 cg11763394 chr2:113992921 0.88 
rs28400431 chr8:143698404 2.54E-16 cg10104451 chr8:143696006 0.25 
rs4984688 chr16:785717 2.65E-16 cg18653534 chr16:772142 0.46 
rs4571937 chr1:20897033 2.83E-16 cg00750606 chr1:20899121 0.91 
rs9936140 chr16:10193417 2.84E-16 cg08242859 chr7:128032651 0.41 
rs13147452 chr4:1078124 3.33E-16 cg04016957 chr4:1044486 0.5 
rs4789846 chr17:80225545 3.71E-16 cg22805688 chr17:80197841 0.96 
rs1058167 chr22:42538029 3.83E-16 cg09322432 chr22:42527611 0 
rs2553022 chr7:100401862 3.90E-16 cg12616177 chr7:100434510 0.09 
rs12028536 chr1:228743706 4.04E-16 cg06261630 chr1:228741351 0.51 
rs4965672 chr15:101089241 4.41E-16 cg02597199 chr15:101098829 0.54 
rs72704639 chr1:150798335 5.04E-16 cg04414720 chr1:150670196 0.44 
rs11650633 chr17:80083807 5.82E-16 cg00755572 chr17:80077754 0.78 
rs10987908 chr9:130936530 6.99E-16 cg10071929 chr9:130955135 0.67 
rs62120467 chr2:3382624 7.07E-16 cg12447832 chr2:3383257 0.19 
rs9549822 chr13:112691814 7.07E-16 cg16875032 chr8:121823916 0.01 
rs7104785 chr11:804212 7.10E-16 cg01741372 chr11:783889 0.76 
rs274692 chr5:6734625 7.52E-16 cg10857441 chr5:6722123 0.43 
rs9817966 chr3:46650540 7.80E-16 cg24524379 chr3:46600244 0.38 
rs1341741 chr10:888073 1.02E-15 cg20503657 chr10:835505 0.59 
rs111543213 chr19:37642385 1.05E-15 cg08835041 chr19:37461278 0.45 
rs34228916 chr12:115942842 1.16E-15 cg18639984 chr12:115943877 0.93 
rs4782336 chr16:89151518 1.28E-15 cg07845093 chr16:89151447 0.6 
rs72781258 chr2:20274213 1.33E-15 cg24657347 chr2:20261756 0.86 
rs7018316 chr8:144630169 1.35E-15 cg20458811 chr8:144631810 0.95 
rs883138 chr7:150042793 1.54E-15 cg12556325 chr7:150026731 0.54 
rs193572 chr7:116835734 1.67E-15 cg16444922 chr7:116842338 0.42 
rs7514450 chr1:220991171 1.68E-15 cg15450098 chr1:221057561 0.05 
rs10753541 chr1:23061992 1.92E-15 cg05266663 chr1:23061564 0.54 
rs28701975 chr1:38272307 2.06E-15 cg00095214 chr1:38272200 0.44 
rs907033 chr16:83987856 2.70E-15 cg07978099 chr16:83986941 0.39 
rs7854075 chr9:96571211 2.70E-15 cg14396892 chr9:96623032 0.11 
rs10175462 chr2:113988492 3.31E-15 cg07772999 chr2:113993052 0.96 
rs2370234 chr1:25304464 3.33E-15 cg23273869 chr1:25296894 0.05 
rs6517397 chr21:38352125 3.52E-15 cg21871091 chr21:38349937 0.66 
rs2205661 chr22:45731759 3.64E-15 cg00733150 chr22:45705707 0.07 
rs12022839 chr1:58089133 4.85E-15 cg00026909 chr1:58089001 0.5 
rs11675057 chr2:26399481 4.93E-15 cg04944784 chr2:26401820 0.54 
rs10079713 chr5:28692468 5.93E-15 cg07881623 chr6:80731107 0.58 
rs1350543 chr4:56014389 6.00E-15 cg16572876 chr4:56024045 0.94 
rs1571624 chr13:112164791 6.50E-15 cg25943066 chr13:112164965 0.93 
rs1183079 chr7:2904672 6.75E-15 cg14668632 chr7:2872130 0.97 
rs930526 chr17:6473353 6.79E-15 cg23551722 chr17:6546898 0.87 
rs4648729 chr1:1808769 6.96E-15 cg03396347 chr1:1875803 0.8 
rs8044982 chr16:58521090 7.09E-15 cg02036364 chr16:58521443 0.75 
rs10987908 chr9:130936530 7.42E-15 cg13642260 chr9:130955380 0.47 
rs4793213 chr17:41307101 8.37E-15 cg23758822 chr17:41437982 0.16 
rs7663448 chr4:10054787 8.99E-15 cg15882809 chr6:26285828 0.91 
461 
 
rs11251278 chr10:2544043 9.11E-15 cg18171855 chr10:2543474 0.47 
rs12097673 chr1:2843180 9.33E-15 cg00996827 chr1:2838805 0.55 
rs62120467 chr2:3382624 9.82E-15 cg01472464 chr2:3383078 0.05 
rs7663448 chr4:10054787 9.89E-15 cg26043149 chr18:55253948 0.28 
rs8140485 chr22:50529146 1.05E-14 cg24864161 chr22:50528282 0.43 
rs9812936 chr3:50043654 1.11E-14 cg12257692 chr3:49977190 0.97 
rs1055150 chr19:18499784 1.15E-14 cg21088460 chr19:18499786 0.17 
rs1316524 chr1:31972540 1.25E-14 cg07096763 chr1:31971752 0.48 
rs4708675 chr6:168555071 1.34E-14 cg04463397 chr6:168556793 0.01 
rs4808736 chr19:18117488 1.39E-14 cg21649277 chr19:18117794 0.75 
rs7606595 chr2:15900274 1.43E-14 cg26669897 chr2:15909070 0.02 
rs7574691 chr2:240044687 1.48E-14 cg15635302 chr2:240043224 0.72 
rs16961809 chr19:29226299 1.51E-14 cg25267487 chr19:29217858 0.15 
rs28647894 chr17:80340483 1.55E-14 cg07797397 chr2:177052527 0.13 
rs2665971 chr17:74010038 1.58E-14 cg10138630 chr17:74024966 0.15 
rs6711715 chr2:130330516 1.62E-14 cg05962382 chr2:130345044 0.72 
rs2003181 chr14:105642016 1.63E-14 cg15868425 chr14:105643522 0.32 
rs12445614 chr16:89166832 1.70E-14 cg09427016 chr16:89167018 0.91 
rs4145082 chr6:86352016 1.75E-14 cg03285617 chr6:86179345 1 
rs12924275 chr16:9191790 2.20E-14 cg08831531 chr16:9218945 0.12 
rs2872542 chr20:61664872 2.81E-14 cg08045932 chr20:61659980 0.71 
rs7734278 chr5:178761358 2.82E-14 cg26694831 chr5:178763419 0.11 
rs12517252 chr5:149910986 2.83E-14 cg02633363 chr5:149906179 0.3 
rs7206985 chr17:9159202 2.94E-14 cg12361772 chr17:9160821 0.21 
rs7545884 chr1:67665785 3.00E-14 cg23726106 chr1:67600229 0.53 
rs1557026 chr1:228383367 3.10E-14 cg01200585 chr1:228362443 0.45 
rs30927 chr16:55317598 3.32E-14 cg02198701 chr16:55364614 0.06 
rs6711715 chr2:130330516 3.50E-14 cg05903289 chr2:130345205 0.35 
rs7305397 chr12:42850058 3.95E-14 cg19980929 chr12:42632907 0.7 
rs7710436 chr5:54056541 3.99E-14 cg06536806 chr5:54081633 0.5 
rs58069944 chr8:2294105 4.37E-14 cg11900328 chr8:2263331 0.91 
rs13224850 chr7:40168950 4.41E-14 cg13264672 chr7:39993440 0.74 
rs7016869 chr8:2474928 4.45E-14 cg02472801 chr8:2480483 0.49 
rs732215 chr7:50544063 4.58E-14 cg00647317 chr7:50633725 0.04 
rs6500602 chr16:4497451 4.86E-14 cg01793945 chr16:4420291 0.06 
rs12904722 chr15:42304003 4.90E-14 cg03080639 chr15:42302379 0.8 
rs17333520 chr11:31058834 4.92E-14 cg06552810 chr11:31128660 0.52 
rs2246207 chr17:61987576 5.22E-14 cg06873352 chr17:61820015 0.33 
rs7470605 chr9:136890107 5.38E-14 cg13789015 chr9:136890014 0.93 
rs9630726 chr17:43068628 5.49E-14 cg20215112 chr17:43065055 0.45 
rs2295232 chr6:153365384 6.81E-14 cg17707550 chr6:153380415 0.37 
rs10987908 chr9:130936530 8.00E-14 cg09976142 chr9:130955436 0.85 
rs45537633 chr6:41117824 8.16E-14 cg09580153 chr6:41068724 0.93 
rs6421977 chr11:407708 8.33E-14 cg18351999 chr11:406901 0.69 
rs9782 chr12:103351826 8.83E-14 cg27569040 chr12:103351855 0.44 
rs13269498 chr8:54578332 9.49E-14 cg10225865 chr8:54605566 0.96 
rs6946060 chr7:157644761 9.51E-14 cg24524099 chr7:157643007 0.74 
rs6702840 chr1:246626857 9.63E-14 cg04798314 chr1:246668601 0.61 
rs7560311 chr2:1803605 9.89E-14 cg21862353 chr2:1801628 0.35 
rs113935737 chr15:65123276 1.09E-13 cg07915896 chr15:65129816 0.43 
rs9525735 chr13:43661306 1.11E-13 cg05035143 chr13:43597297 0.03 
rs6946060 chr7:157644761 1.14E-13 cg22216157 chr7:157643037 0.96 
rs6968990 chr7:32552159 1.19E-13 cg06627557 chr7:32535165 0.21 
rs2872542 chr20:61664872 1.25E-13 cg23505145 chr19:12996616 0.15 
rs74002504 chr2:241828338 1.27E-13 cg07537917 chr2:241836409 0.41 
rs909832 chr1:25754025 1.33E-13 cg24991732 chr1:25594486 0.27 
rs2637647 chr10:133954267 1.35E-13 cg02162534 chr10:133956875 0.71 
rs10271372 chr7:157793023 1.35E-13 cg12440927 chr7:157791721 0.27 
rs7765960 chr6:13958385 1.43E-13 cg24233211 chr6:14002749 0.23 
rs143349430 chr10:32183019 1.58E-13 cg04359828 chr10:32216031 0.1 
rs6946377 chr7:64324352 1.62E-13 cg16681239 chr7:64349915 0.16 
rs13084718 chr3:13610039 1.81E-13 cg02146340 chr3:13610059 0.18 
462 
 
rs2376584 chr17:76402116 2.10E-13 cg02836325 chr17:76403955 0.12 
rs4557742 chr8:145508113 2.15E-13 cg15151778 chr8:145502134 0.21 
rs571780 chr9:136001763 2.60E-13 cg13753488 chr9:136001623 0.83 
rs699664 chr2:85780536 2.61E-13 cg02493740 chr2:85810744 0.36 
rs9998888 chr4:824575 2.70E-13 cg24793722 chr4:824416 0.86 
rs4807546 chr19:4182060 2.74E-13 cg18542377 chr19:4172961 0.27 
rs4334037 chr11:69256482 2.91E-13 cg23478547 chr11:69259265 0.09 
rs2800973 chr22:19168616 3.10E-13 cg24911827 chr22:19170109 0.51 
rs9861843 chr3:54159358 3.11E-13 cg12173409 chr3:54154746 0.55 
rs6027929 chr20:59535741 3.48E-13 cg19181528 chr20:59542589 0.16 
rs11251278 chr10:2544043 3.58E-13 cg05625103 chr10:2543513 0.28 
rs2993317 chr13:113687143 3.64E-13 cg07204236 chr13:113705910 0.66 
 
Supplementary Table 8.  Methylation QTLs (mQTL) identified in the 
cerebellum for SNPs included in the schizophrenia polygenic risk score 
(PRS). Shown are associations between DNA methylation at specific Illumina 
450K probes and genetic variants used to derive PRS in Chapter 4, in addition 
to the corresponding P-values for PRS-associated DNA methylation variation at 








rs12635522 chr3:125708174 2.67E-45 cg02807482 chr3:125708958 0.53 
rs12635522 chr3:125708174 1.67E-42 cg15145296 chr3:125709740 0.61 
rs2141182 chr12:131401591 1.06E-41 cg07816006 chr12:131401305 0.99 
rs9726753 chr1:153591652 2.20E-41 cg08477332 chr1:153590243 0.08 
rs12635522 chr3:125708174 9.50E-41 cg06494592 chr3:125709126 0.59 
rs10205909 chr2:3526603 2.28E-36 cg21240684 chr2:3526841 0.48 
rs557873 chr9:135336912 2.36E-36 cg21190742 chr9:135336993 0.34 
rs2141182 chr12:131401591 4.21E-35 cg10021924 chr12:131401275 0.92 
rs7803698 chr7:64427895 4.72E-35 cg24247132 chr7:64458642 0.23 
rs12635522 chr3:125708174 1.80E-34 cg04553112 chr3:125709451 0.28 
rs4789846 chr17:80225545 8.17E-34 cg02744699 chr17:80197898 0.37 
rs117194038 chr17:43927290 1.67E-33 cg22968622 chr17:43663579 0.52 
rs6680259 chr1:7122308 3.31E-33 cg20409752 chr1:7122726 0.03 
rs4807546 chr19:4182060 2.72E-31 cg01287132 chr19:4173254 0.74 
rs35059736 chr7:158224692 6.83E-31 cg01191920 chr7:158217561 0.76 
rs1726866 chr7:141672705 3.11E-30 cg19476643 chr7:141672455 0.8 
rs11712066 chr3:151830309 8.01E-30 cg27098685 chr3:151867537 0.31 
rs10857676 chr10:134970598 1.21E-29 cg00753039 chr10:134969141 0.55 
rs4792919 chr17:41873309 4.15E-29 cg26893861 chr17:41843967 0.99 
rs3214023 chr12:53682986 5.41E-29 cg04065151 chr12:53682969 0.88 
rs2800973 chr22:19168616 8.83E-29 cg02655711 chr22:19163373 0.51 
rs2412322 chr17:48578726 9.29E-29 cg00901687 chr17:48585270 0.01 
rs117194038 chr17:43927290 5.51E-28 cg10094238 chr17:43483251 0.78 
rs4807546 chr19:4182060 9.43E-28 cg23999422 chr19:4173466 0.48 
rs76344840 chr9:33120204 1.29E-27 cg20290983 chr6:43655470 0.08 
rs10793287 chr11:77846706 9.62E-27 cg09721595 chr11:77773924 0.67 
rs13065 chr14:100996312 1.23E-26 cg18516195 chr14:101012996 0.15 
rs6968990 chr7:32552159 3.17E-26 cg06133097 chr7:32552212 0.12 
rs4807546 chr19:4182060 5.63E-26 cg07492962 chr19:4173315 0.96 
rs117194038 chr17:43927290 5.91E-26 cg27244773 chr17:43483116 0.68 
rs4789846 chr17:80225545 4.83E-25 cg22805688 chr17:80197841 0.19 
rs12507178 chr4:86920281 5.94E-25 cg13324779 chr4:86923558 0.89 
rs650241 chr11:75277757 1.13E-24 cg26104986 chr11:75275303 0.16 
rs62185165 chr2:241251453 1.81E-24 cg21947394 chr2:241260110 0.19 
463 
 
rs13226756 chr7:149015681 2.87E-24 cg07762347 chr7:149016554 0.42 
rs2553022 chr7:100401862 3.03E-24 cg12616177 chr7:100434510 0.91 
rs1341741 chr10:888073 3.40E-24 cg26597838 chr10:835615 0.4 
rs16961809 chr19:29226299 3.48E-24 cg14983838 chr19:29218262 0.04 
rs2468300 chr12:84901620 3.71E-24 cg09278098 chr12:84902512 0.46 
rs4984688 chr16:785717 5.25E-24 cg18653534 chr16:772142 0.28 
rs2800973 chr22:19168616 5.97E-24 cg24911827 chr22:19170109 0.23 
rs12099513 chr12:5267322 1.98E-23 cg01414572 chr12:5248588 0.67 
rs16961809 chr19:29226299 6.17E-23 cg12756686 chr19:29218302 0.11 
rs2568198 chr2:85403546 8.69E-23 cg22128724 chr2:85402928 0.2 
rs2342082 chr12:123090380 1.11E-22 cg23029597 chr12:123009494 0.66 
rs164080 chr5:141391532 1.24E-22 cg25940447 chr5:141391533 0.04 
rs28452050 chr16:29317318 1.31E-22 cg05645661 chr16:29329490 0.38 
rs400132 chr1:2141866 2.46E-22 cg24578937 chr1:2090814 0.95 
rs9812936 chr3:50043654 2.71E-22 cg05623727 chr3:50126028 0.54 
rs2412322 chr17:48578726 3.26E-22 cg11440486 chr17:48585216 0.03 
rs930526 chr17:6473353 3.49E-22 cg23551722 chr17:6546898 0.7 
rs60668498 chr19:44642672 3.60E-22 cg23489630 chr19:44645078 0.38 
rs62154034 chr2:101953138 4.28E-22 cg23685994 chr2:101959022 0.75 
rs9921300 chr16:5641315 7.95E-22 cg03979510 chr16:5641033 0.59 
rs8053397 chr16:87573468 9.76E-22 cg08031982 chr16:87577539 0.79 
rs1345145 chr8:102144280 2.66E-21 cg13263591 chr8:102142199 0.02 
rs16965349 chr17:36614524 2.88E-21 cg12050358 chr17:36612909 0.8 
rs7496866 chr15:27102200 3.36E-21 cg10318222 chr15:27111940 0.04 
rs1285820 chr14:91840017 4.02E-21 cg10511902 chr14:91842949 0.19 
rs3760312 chr17:13970282 1.02E-20 cg27005118 chr17:13972210 0.82 
rs2620032 chr17:71745091 1.25E-20 cg24457076 chr17:71744550 0.52 
rs4807546 chr19:4182060 1.89E-20 cg09617135 chr19:4173482 0.53 
rs8053397 chr16:87573468 2.18E-20 cg03020503 chr16:87577655 0.38 
rs12672284 chr7:32825576 2.92E-20 cg11105292 chr7:32802564 0.26 
rs2269481 chr4:2386139 2.94E-20 cg11208915 chr4:2401758 0.47 
rs4729915 chr7:103081125 3.42E-20 cg21537297 chr8:144298583 0.03 
rs7833924 chr8:144996029 3.44E-20 cg06045337 chr8:145013910 0.47 
rs11738251 chr5:177819313 3.72E-20 cg00986130 chr5:177821799 0.79 
rs4789846 chr17:80225545 4.40E-20 cg21034531 chr17:80197757 0.89 
rs1780033 chr1:118339119 5.46E-20 cg01778345 chr1:118427435 0.99 
rs4264326 chr14:105411700 6.84E-20 cg21017887 chr14:105400489 0 
rs11146990 chr12:133027749 7.52E-20 cg15402627 chr12:133021489 0.58 
rs75934331 chr1:183182029 9.41E-20 cg01417625 chr1:183187433 0.75 
rs9769809 chr7:64956889 1.20E-19 cg24247132 chr7:64458642 0.23 
rs4737 chr16:75238103 1.23E-19 cg06389950 chr16:75240536 0.37 
rs1888502 chr21:41545747 1.41E-19 cg10828127 chr21:41550814 0.67 
rs74002504 chr2:241828338 1.85E-19 cg07537917 chr2:241836409 0.35 
rs1881191 chr2:236607924 2.76E-19 cg24888581 chr2:236616026 0.47 
rs117194038 chr17:43927290 3.41E-19 cg17117718 chr17:43663208 0.76 
rs6676743 chr1:110296338 3.47E-19 cg10807101 chr1:110282274 0.33 
rs16961809 chr19:29226299 4.01E-19 cg03161606 chr19:29218774 0.02 
rs6982268 chr8:12994642 4.62E-19 cg03231596 chr8:12987546 0.45 
rs2447027 chr10:14003363 4.69E-19 cg27572370 chr10:14002394 0.45 
rs2645673 chr4:77816229 4.95E-19 cg21917090 chr4:77816250 0.22 
rs9933817 chr16:83972660 5.08E-19 cg16528738 chr16:83968260 0.85 
rs17385407 chr1:160473286 5.46E-19 cg22696814 chr1:160398070 0.05 
rs117194038 chr17:43927290 5.58E-19 cg14260695 chr17:43506184 0.54 
rs7496866 chr15:27102200 9.61E-19 cg01378667 chr15:27111911 0.07 
rs77841981 chr7:5231658 9.82E-19 cg07508942 chr7:5267994 0.96 
rs3861297 chr18:75380032 1.05E-18 cg11874321 chr18:75380364 0.45 
rs11248093 chr4:2276047 1.20E-18 cg19771469 chr4:2275994 0.07 
rs144716806 chr4:38854783 1.31E-18 cg26681822 chr4:38858561 0.98 
rs4314559 chr7:2365892 1.32E-18 cg16553052 chr7:2349605 0.19 
rs7470605 chr9:136890107 1.51E-18 cg13789015 chr9:136890014 0.09 
rs11146990 chr12:133027749 1.92E-18 cg11090202 chr12:133021713 0.96 
rs4689604 chr4:7129556 2.21E-18 cg16307866 chr4:7129517 0.94 
464 
 
rs881347 chr10:134000130 2.66E-18 cg10144198 chr10:134001728 0.43 
rs12595938 chr16:8958081 3.12E-18 cg08308162 chr16:8889244 0.45 
rs1341741 chr10:888073 3.31E-18 cg20503657 chr10:835505 0.49 
rs274692 chr5:6734625 3.32E-18 cg10857441 chr5:6722123 0.16 
rs75231006 chr14:102987539 3.89E-18 cg23712530 chr14:102964522 0.07 
rs7807840 chr7:35834025 4.20E-18 cg11531232 chr7:35808197 0.16 
rs77841981 chr7:5231658 4.76E-18 cg12631105 chr7:5267896 0.96 
rs77617940 chr20:61814968 5.27E-18 cg17237881 chr20:61867533 0.59 
rs2276947 chr4:8233943 5.40E-18 cg25777912 chr4:8233394 0.45 
rs11248093 chr4:2276047 5.63E-18 cg22029856 chr4:2276003 0.24 
rs13147452 chr4:1078124 6.30E-18 cg13468214 chr4:1046988 0.93 
rs11688491 chr2:98167020 8.16E-18 cg26665480 chr2:98280029 0.92 
rs7710436 chr5:54056541 1.12E-17 cg06536806 chr5:54081633 0.2 
rs73494059 chr7:154468109 1.21E-17 cg15618646 chr7:154473202 0.64 
rs9390343 chr6:146010527 1.21E-17 cg25629118 chr6:146113270 0.5 
rs117194038 chr17:43927290 2.21E-17 cg12609785 chr17:43660871 0.51 
rs35037013 chr10:54656418 2.36E-17 cg05984115 chr10:54631212 0.47 
rs11633474 chr15:22939192 2.46E-17 cg26344513 chr15:22930613 0.58 
rs8082590 chr17:17958402 2.56E-17 cg04398451 chr17:18023971 0.27 
rs11995562 chr8:1427444 2.72E-17 cg16582891 chr8:1430303 0.09 
rs964757 chr2:183114225 3.16E-17 cg17054006 chr2:183107046 0.38 
rs56340588 chr7:127799341 4.36E-17 cg02301128 chr7:127792165 0.25 
rs62285061 chr4:1688981 4.82E-17 cg05026014 chr4:1749153 0.19 
rs6946060 chr7:157644761 5.48E-17 cg24524099 chr7:157643007 0.87 
rs74002504 chr2:241828338 5.49E-17 cg01588581 chr2:241832900 0.34 
rs887687 chr7:44185805 6.62E-17 cg18628255 chr7:44152333 0.32 
rs2666873 chr8:55090128 6.67E-17 cg20636351 chr8:55087400 0.31 
rs6503422 chr17:43163851 7.09E-17 cg25538415 chr17:43129957 0.5 
rs77841981 chr7:5231658 9.84E-17 cg16035714 chr7:5267749 0.91 
rs73494059 chr7:154468109 1.68E-16 cg23463533 chr7:154473289 0.9 
rs55674909 chr15:31525516 1.97E-16 cg03330558 chr15:31516127 0.3 
rs11123564 chr2:3683615 2.10E-16 cg14926093 chr2:3680421 0.55 
rs113661747 chr14:75894945 2.26E-16 cg22143352 chr14:75897841 0.26 
rs3861297 chr18:75380032 2.34E-16 cg27582240 chr18:75380514 0.76 
rs10271372 chr7:157793023 2.57E-16 cg12440927 chr7:157791721 0.64 
rs2978902 chr8:6690173 2.71E-16 cg11878365 chr8:6692387 1 
rs7455225 chr7:73241386 2.93E-16 cg02874145 chr7:73246406 0.36 
rs6968990 chr7:32552159 3.63E-16 cg06627557 chr7:32535165 0.01 
rs6514834 chr20:18010631 3.71E-16 cg02912291 chr20:17944845 0.8 
rs4959982 chr6:4464320 3.75E-16 cg12916580 chr6:4403020 0.35 
rs454759 chr12:125799159 4.45E-16 cg03923277 chr12:104359732 0.43 
rs55674909 chr15:31525516 4.89E-16 cg12689679 chr15:31516316 0.9 
rs890393 chr18:74102435 5.18E-16 cg24786174 chr18:74118243 0.35 
rs34228916 chr12:115942842 5.22E-16 cg18639984 chr12:115943877 0.46 
rs1476835 chr4:17665456 5.29E-16 cg04450456 chr4:17643702 0.36 
rs2244746 chr15:43695083 5.85E-16 cg05490132 chr15:43661835 0.12 
rs4689604 chr4:7129556 6.23E-16 cg13998369 chr4:7129440 0.89 
rs12342201 chr9:95894964 6.61E-16 cg13713821 chr9:95899302 0.05 
rs13147452 chr4:1078124 6.95E-16 cg09755784 chr4:1047097 0.49 
rs6946060 chr7:157644761 7.11E-16 cg22216157 chr7:157643037 0.81 
rs11675057 chr2:26399481 7.13E-16 cg22920501 chr2:26401640 0.85 
rs1058167 chr22:42538029 7.55E-16 cg11915388 chr22:42470451 0 
rs77841981 chr7:5231658 8.64E-16 cg01000248 chr7:5267360 0.77 
rs13008444 chr2:36909816 9.00E-16 cg21931986 chr2:36922916 0.16 
rs7018316 chr8:144630169 9.41E-16 cg16976870 chr8:144631524 0.73 
rs13147452 chr4:1078124 1.02E-15 cg01815783 chr4:1047043 0.84 
rs6711715 chr2:130330516 1.03E-15 cg05903289 chr2:130345205 0.67 
rs7018316 chr8:144630169 1.14E-15 cg18649319 chr8:144631768 0.68 
rs12129745 chr1:28572317 1.26E-15 cg04993605 chr1:28573052 0.73 
rs7514450 chr1:220991171 1.38E-15 cg15450098 chr1:221057561 0.04 
rs34474195 chr1:3178582 1.41E-15 cg26520908 chr1:3191876 0.64 
rs2968475 chr16:88976663 1.45E-15 cg08484992 chr16:88977278 0.88 
465 
 
rs74002504 chr2:241828338 1.53E-15 cg04034577 chr2:241836375 0.84 
rs74002504 chr2:241828338 1.53E-15 cg21187597 chr2:241846305 0.71 
rs9912302 chr17:44916982 1.62E-15 cg25836567 chr17:44929689 0.54 
rs13147452 chr4:1078124 1.71E-15 cg10407489 chr4:1043616 0.83 
rs8116218 chr20:44496330 1.80E-15 cg04807470 chr20:44452801 0 
rs1919784 chr7:33105268 2.04E-15 cg22798885 chr7:33102694 0.62 
rs7730045 chr5:56077993 2.17E-15 cg20203395 chr5:56204925 0.44 
rs7376288 chr4:741742 2.18E-15 cg14024328 chr4:719362 0.21 
rs3793202 chr7:6207142 2.40E-15 cg22849526 chr7:6199437 0.62 
rs7833924 chr8:144996029 2.52E-15 cg27082292 chr8:145001361 0.31 
rs72713299 chr15:34034124 2.85E-15 cg16888559 chr15:34031029 0.09 
rs56303414 chr16:67466435 3.04E-15 cg25341653 chr16:67233277 0.54 
rs3021270 chr22:40396409 3.14E-15 cg21771250 chr22:40406049 0.83 
rs2270115 chr17:9804724 3.29E-15 cg26853458 chr17:9805074 0.17 
rs3093182 chr19:15994924 3.49E-15 cg26851661 chr19:16045708 0.73 
rs7730045 chr5:56077993 3.53E-15 cg18230493 chr5:56204884 0.48 
rs2857851 chr4:3043512 4.44E-15 cg14003022 chr4:3043019 1 
rs62285061 chr4:1688981 5.82E-15 cg08488569 chr4:1749241 0.44 
rs137934836 chr17:16312563 6.28E-15 cg08466034 chr17:16318930 0.92 
rs72755098 chr15:64427587 6.84E-15 cg02848875 chr15:64387786 0.32 
rs7549293 chr1:205312280 7.42E-15 cg00407231 chr1:205312199 0.67 
rs732215 chr7:50544063 8.49E-15 cg00647317 chr7:50633725 0.12 
rs9902733 chr17:7271219 8.50E-15 cg25737411 chr17:7286288 0.36 
rs1350543 chr4:56014389 8.63E-15 cg09978860 chr4:56023921 0.86 
rs72634702 chr1:3661182 8.84E-15 cg19903298 chr1:3659644 0.84 
rs557888 chr11:94258480 9.91E-15 cg20289045 chr11:94270260 0.93 
rs557934 chr1:182548607 1.01E-14 cg27563952 chr1:182557982 0.22 
rs10079713 chr5:28692468 1.09E-14 cg07881623 chr6:80731107 0.38 
rs8116218 chr20:44496330 1.14E-14 cg12112556 chr20:44455373 0 
rs2221903 chr4:123538912 1.17E-14 cg10583651 chr4:123538969 0.71 
rs117194038 chr17:43927290 1.18E-14 cg05485769 chr17:44820573 0.93 
rs256881 chr5:16572798 1.20E-14 cg24531590 chr5:16559541 0.57 
rs117194038 chr17:43927290 1.28E-14 cg10780632 chr17:43973522 0.67 
rs55674909 chr15:31525516 1.32E-14 cg19666541 chr15:31516111 0.5 
rs6518257 chr21:47210107 1.37E-14 cg18931629 chr21:47287357 0.45 
rs4915215 chr1:201077212 1.44E-14 cg22815214 chr1:201083145 0.29 
rs9615062 chr22:45602573 1.46E-14 cg20078807 chr22:45608713 0.3 
rs9881242 chr3:134032225 1.46E-14 cg26387619 chr3:134032421 0.21 
rs13147452 chr4:1078124 1.52E-14 cg27284194 chr4:1044797 0.75 
rs16961809 chr19:29226299 1.61E-14 cg25267487 chr19:29217858 0.03 
rs7455225 chr7:73241386 1.62E-14 cg17787108 chr7:73246044 0.46 
rs6504120 chr17:60830725 1.67E-14 cg23831897 chr17:60827363 0.15 
rs62444320 chr7:5111830 1.70E-14 cg02215787 chr7:5107766 0.45 
rs4557742 chr8:145508113 1.71E-14 cg15151778 chr8:145502134 0.13 
rs571780 chr9:136001763 1.91E-14 cg13753488 chr9:136001623 0.85 
rs9826313 chr3:57943818 1.93E-14 cg07735586 chr3:57945651 0.18 
rs2062480 chr1:197905400 1.96E-14 cg00114966 chr1:197893920 0.09 
rs2872542 chr20:61664872 2.22E-14 cg16240275 chr20:61666158 0.86 
rs7539178 chr1:65383002 2.27E-14 cg09765463 chr1:65393430 0.43 
rs28676999 chr15:40569884 2.33E-14 cg19335742 chr15:40566880 0.43 
rs2637657 chr10:133993806 2.35E-14 cg18037376 chr10:134004552 0.82 
rs111543213 chr19:37642385 2.43E-14 cg08835041 chr19:37461278 0.55 
rs11230570 chr11:60782634 2.49E-14 cg27098804 chr11:60776124 0.28 
rs117194038 chr17:43927290 2.52E-14 cg01341218 chr17:43662625 0.08 
rs13724 chr8:142221032 2.64E-14 cg17525220 chr8:142204116 0.81 
rs1554948 chr17:7286326 2.72E-14 cg18632631 chr17:7284049 0.18 
rs903759 chr2:241078945 2.81E-14 cg03314473 chr2:241083794 0.39 
rs3907645 chr4:7338501 2.97E-14 cg19931925 chr4:7338730 0.72 
rs62014776 chr16:1339750 3.05E-14 cg03705235 chr16:1371463 0.94 
rs8053397 chr16:87573468 3.13E-14 cg16596957 chr16:87575150 0.91 
rs1554948 chr17:7286326 3.19E-14 cg25737411 chr17:7286288 0.36 
rs9627788 chr22:50300438 3.58E-14 cg15880211 chr22:50250494 0.55 
466 
 
rs12761857 chr10:7105868 3.74E-14 cg00998146 chr19:18284560 0.43 
rs2159397 chr17:14486205 3.93E-14 cg17334453 chr17:14479244 0.02 
rs1055150 chr19:18499784 4.00E-14 cg21088460 chr19:18499786 0.25 
rs67327962 chr16:89366932 4.06E-14 cg27251473 chr16:89359053 0.4 
rs11136381 chr8:1273538 4.41E-14 cg24513387 chr8:1273604 0.16 
rs7252903 chr19:16075619 4.61E-14 cg26851661 chr19:16045708 0.73 
rs9817966 chr3:46650540 4.72E-14 cg24524379 chr3:46600244 0.09 
rs1996370 chr11:35546199 4.84E-14 cg14642338 chr11:35547903 0.81 
rs2297776 chr9:34372931 5.03E-14 cg14096074 chr9:34255149 0.82 
rs7702622 chr5:122548721 5.23E-14 cg04547002 chr5:122551801 0.63 
rs2367209 chr3:160398885 6.09E-14 cg03789276 chr3:160170225 0.03 
rs73494059 chr7:154468109 6.11E-14 cg11537355 chr7:154473324 0.38 
rs7920264 chr10:134046083 6.53E-14 cg05225883 chr10:134043755 0.55 
rs12608939 chr19:3652680 6.99E-14 cg10996109 chr19:3637309 0.24 
rs340111 chr5:178773203 7.06E-14 cg27054655 chr5:178772969 0.35 
rs10773762 chr12:130765366 7.10E-14 cg14604444 chr12:130766091 0.29 
rs117194038 chr17:43927290 7.28E-14 cg08318660 chr17:44122580 0.64 
rs2665971 chr17:74010038 7.35E-14 cg00498401 chr17:74024829 0.23 
rs9615062 chr22:45602573 7.41E-14 cg02541592 chr22:45608686 0.09 
rs6959895 chr7:142434960 7.66E-14 cg02329916 chr7:142457299 0.71 
rs2290769 chr17:73826406 9.20E-14 cg06407111 chr17:73872650 0.63 
rs71559409 chr7:101006835 9.39E-14 cg15127702 chr7:101079617 0.41 
rs2475509 chr6:39890217 9.54E-14 cg10871120 chr6:39891273 0.03 
rs11738251 chr5:177819313 1.02E-13 cg06730250 chr5:177821870 0.57 
rs1557026 chr1:228383367 1.12E-13 cg24846680 chr1:228362309 0.43 
rs56303414 chr16:67466435 1.15E-13 cg19514469 chr16:67233432 0.36 
rs1072231 chr2:118634348 1.17E-13 cg24461052 chr2:118607738 0.89 
rs12473344 chr2:106959895 1.18E-13 cg24419520 chr2:106959257 0.55 
rs7730045 chr5:56077993 1.19E-13 cg24531977 chr5:56204891 0.84 
rs7305397 chr12:42850058 1.20E-13 cg19980929 chr12:42632907 0.89 
rs9365604 chr6:164171914 1.20E-13 cg18405330 chr6:164171960 0.53 
rs2317947 chr1:55431003 1.25E-13 cg15129052 chr1:55416755 0.62 
rs342778 chr13:53185730 1.25E-13 cg05335186 chr13:53173507 0.31 
rs13268456 chr8:28473911 1.29E-13 cg23665710 chr8:28476677 0.97 
rs66964681 chr2:242915902 1.42E-13 cg23069297 chr2:242833648 0.81 
rs7803698 chr7:64427895 1.43E-13 cg12143784 chr7:64541923 0.63 
rs36062268 chr9:27585697 1.45E-13 cg14297867 chr9:27526172 0.39 
rs11149799 chr16:75174049 1.48E-13 cg00897404 chr16:75182368 0.53 
rs1957841 chr14:89588834 1.61E-13 cg09271279 chr14:89588740 0.38 
rs135572 chr22:46527242 1.64E-13 cg00004775 chr22:46516503 0.32 
rs7514450 chr1:220991171 1.67E-13 cg26440142 chr1:221057573 0.21 
rs12976309 chr19:3864966 1.75E-13 cg22553301 chr19:3839231 0.66 
rs7018316 chr8:144630169 1.76E-13 cg10438391 chr8:144631915 0.79 
rs61821477 chr1:159383337 1.77E-13 cg25076881 chr1:159409836 0.41 
rs73210894 chr8:20019512 1.84E-13 cg09628359 chr8:20039283 0.75 
rs12433009 chr14:104196405 1.86E-13 cg01849466 chr14:104193079 0.02 
rs6754331 chr2:236441590 1.98E-13 cg00059854 chr2:236443857 0.76 
rs2816607 chr14:105718385 2.25E-13 cg10792982 chr14:105748885 0.32 
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Abstract
Background: Schizophrenia is a severe neuropsychiatric disorder that is hypothesized to result from disturbances in
early brain development. There is mounting evidence to support a role for developmentally regulated epigenetic
variation in the molecular etiology of the disorder. Here, we describe a systematic study of schizophrenia-associated
methylomic variation in the adult brain and its relationship to changes in DNA methylation across human fetal brain
development.
Results: We profile methylomic variation in matched prefrontal cortex and cerebellum brain tissue from
schizophrenia patients and controls, identifying disease-associated differential DNA methylation at multiple loci,
particularly in the prefrontal cortex, and confirming these differences in an independent set of adult brain samples.
Our data reveal discrete modules of co-methylated loci associated with schizophrenia that are enriched for genes
involved in neurodevelopmental processes and include loci implicated by genetic studies of the disorder. Methylomic
data from human fetal cortex samples, spanning 23 to 184 days post-conception, indicates that schizophrenia-associated
differentially methylated positions are significantly enriched for loci at which DNA methylation is dynamically altered
during human fetal brain development.
Conclusions: Our data support the hypothesis that schizophrenia has an important early neurodevelopmental
component, and suggest that epigenetic mechanisms may mediate these effects.
Background
Schizophrenia is a severe neuropsychiatric disorder charac-
terized by episodic psychosis and altered cognitive function.
With a lifetime prevalence of approximately 1%, schizo-
phrenia contributes significantly to the global burden
of disease [1]. Although schizophrenia does not typically
manifest until late adolescence or early adulthood, evi-
dence from neuroimaging, neuropathology and epi-
demiological studies has led to its conceptualization as
a neurodevelopmental disorder, with etiological origins
before birth [2]. To date, however, the neurobiological
mechanisms underlying the disorder remain largely
undefined, and molecular evidence for in utero disturbances
in schizophrenia is currently lacking.
Schizophrenia is known to have a substantial genetic
component, involving a large number of common variants
with individually small effects on risk for the disorder
[3], as well as rarer mutations [4] and copy number vari-
ants [5] of greater effect size. Of note, several of the
most robustly supported schizophrenia susceptibility genes
have known roles in early brain development and appear
to impact on schizophrenia risk during this period [6,7].
Epidemiological research suggests that prenatal environ-
mental insults are also important, with established associa-
tions between hypoxia [8], maternal infection [9], maternal
stress [10], and maternal malnutrition or famine [11] and
risk for developing schizophrenia. These observations have
led to a growing interest in the role of developmentally
regulated epigenetic variation in the molecular etiology of
schizophrenia [12]. The notion that epigenetic processes
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are involved in the onset of schizophrenia is supported by
recent methylomic studies of disease-discordant monozy-
gotic twins [13], clinical sample cohorts [14], and post-
mortem brain tissue [15].
Here, we describe a systematic study of schizophrenia-
associated methylomic variation in the adult brain and
its relationship to changes in DNA methylation during
human fetal brain development. We profiled DNA methy-
lation in matched prefrontal cortex (PFC) and cerebellum
brain tissue from schizophrenia patients and controls,
subsequently assessing disease-associated regions in
human fetal cortex samples spanning 23 to 184 days
post-conception. Our data support the hypothesis that
schizophrenia has an important early neurodevelop-
mental component, and suggest that epigenetic mecha-
nisms likely contribute to these disturbances.
Results and discussion
Identification of schizophrenia-associated differentially
methylated positions in the prefrontal cortex
Our ‘discovery’ cohort comprised PFC and cerebellum
samples from schizophrenia patients and matched (for
sex, age and sample quality markers (for example, pH))
control donors archived in the MRC London Brain Bank
for Neurodegenerative Diseases (LBBND; see Materials
and methods; Tables S1 and S2 in Additional file 1).
Genome-wide patterns of DNA methylation were quanti-
fied using the Illumina Infinium HumanMethylation450
BeadChip (450K array) (Illumina Inc., San Diego, CA,
USA), performing pre-processing, normalization and
stringent quality control as previously described [16]
(see Materials and methods; Table S3 in Additional file 1).
In total, data from 43 PFC (20 schizophrenia and 23
controls) and 44 cerebellum (21 schizophrenia and 23
controls) samples passed quality control metrics and
were used for analysis. The top-ranked differentially
methylated positions (DMPs) in each brain region are
shown in Tables S4 and S5 in Additional file 1. Most
notably, highly significant DMPs were identified in the
PFC (Table 1), with probes in four genes being signifi-
cantly associated with schizophrenia at a false discovery
rate (FDR) ≤0.05: GSDMD (cg26173173: control = 78.9 ± 3.0,
schizophrenia = 83.3 ± 1.3, FDR = 0.03); RASA3 (cg24803255:
control = 65.1 ± 4.7, schizophrenia = 56.4 ± 4.1, FDR = 0.03);
HTR5A (cg00903099: control = 11.5 ± 1.7, schizophrenia =
9.2 ± 1.2, FDR = 0.03); and PPFIA1 (cg08171022: control =
53.1 ± 3.2, schizophrenia = 47.6 ± 3.2, FDR = 0.03) (Figure 1A).
As epigenetic epidemiological research can be confounded
Table 1 Schizophrenia-associated differentially methylated positions in the prefrontal cortex
Probe ID Genomic position (hg19) Gene Gene region P-value FDR Mean SZ Mean control Beta difference
cg26173173 chr8:144642813 GSDMD Body 1.16E-07 0.03 0.83 0.79 0.04
cg24803255 chr13:114807060 RASA3 Body 1.25E-07 0.03 0.56 0.65 −0.09
cg00903099 chr7:154862441 HTR5A TSS200 2.40E-07 0.03 0.09 0.12 −0.02
cg08171022 chr11:70185278 PPFIA1 Body 2.85E-07 0.03 0.48 0.53 −0.05
cg02857643 chr17:48696108 CACNA1G Body 1.63E-06 0.1 0.87 0.92 −0.05
cg00236305 chr2:1796076 MYT1L Body 1.75E-06 0.1 0.67 0.73 −0.06
cg14966346 chr14:104152124 KLC1 Body 2.51E-06 0.1 0.72 0.77 −0.05
cg13079528 chr7:4027346 SDK1 Body 2.75E-06 0.1 0.71 0.79 −0.08
cg14429765 chr8:6492531 MCPH1 Body 2.79E-06 0.1 0.79 0.76 0.03
cg08602214 chr8:22864392 RHOBTB2 Body 2.87E-06 0.1 0.69 0.75 −0.07
cg19735533 chr2:241196887 - - 2.94E-06 0.1 0.76 0.81 −0.06
cg09507608 chr22:29873338 - - 2.95E-06 0.1 0.56 0.62 −0.06
cg23844013 chr1:57383752 C8A 3' UTR 3.20E-06 0.1 0.82 0.79 0.03
cg26578910 chr19:47204096 PRKD2 Body 3.47E-06 0.1 0.67 0.71 −0.04
cg21847368 chr13:113744010 MCF2L Body 3.70E-06 0.1 0.80 0.84 −0.03
cg03607729 chr16:25138698 LCMT1 Body 4.19E-06 0.1 0.70 0.75 −0.04
cg10248981 chr10:126157948 LHPP Body 4.32E-06 0.1 0.55 0.63 −0.07
cg03445663 chr2:242170236 HDLBP Body 4.59E-06 0.1 0.51 0.59 −0.08
cg15079231 chr3:42572745 VIPR1 Body 4.93E-06 0.1 0.76 0.80 −0.04
cg21341878 chr4:2278462 ZFYVE28 Body 5.14E-06 0.1 0.75 0.81 −0.05
cg04922803 chr12:104444418 GLT8D2 TSS1500 5.19E-06 0.1 0.68 0.62 0.06
cg18857062 chr6:43276478 CRIP3 Body 5.29E-06 0.1 0.21 0.26 −0.04
Listed are all probes associated with schizophrenia (SZ) with FDR ≤0.1. The 100 top-ranked DMPs are listed in Table S4 in Additional file 1.
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by cellular heterogeneity [17,18], we used an in silico algo-
rithm to assess the extent to which DMPs are influenced
by differences in neuronal proportions between individ-
uals [19]. Notably, all top-ranked PFC DMPs remained
significantly associated with schizophrenia after correction
for the estimated neuronal proportion in each sample
(Table S4 in Additional file 1). In contrast to the PFC, few
schizophrenia-associated DMPs (none at FDR ≤0.05) were
identified in the cerebellum (Table S5 in Additional file 1),
suggesting that disease-associated epigenetic differences
are likely to be brain region-specific.
Region-based analysis of altered DNA methylation in
schizophrenia
As DNA methylation is often correlated across adjacent
CpG sites [20,21], we used the Illumina Methylation Ana-
lyser (IMA) [22] package to aggregate and assess DNA
methylation across adjacent probes within annotated re-
gions of the genome. Again, we observe widespread evi-
dence for schizophrenia-associated DNA methylation
differences, occurring specifically in the PFC (Figure S1
and Table S6 in Additional file 1). Most notably we ob-
serve a large (approximately 8 kb) region spanning the
gene body of the Neuritin 1 (NRN1) gene across which
29 adjacent CpG sites are consistently hypomethylated
in schizophrenia patients compared with controls
(Figure 1B). The mean DNA methylation difference across
all 29 sites is -1.77% (FDR = 3.1e-2), with a notable region
of hypomethylation (-3.7%) spanning three consecutive
DMPs (FDR = 2.4e-2). This is of particular interest be-
cause NRN1 plays a well-established role in neurodevelop-
ment and synaptic plasticity [23], and genetic variation in
the gene has been linked to cognitive phenotypes in
schizophrenia [24].
Validation and replication of schizophrenia-associated
DNA methylation differences in the prefrontal cortex
To confirm the array data, bisulfite-pyrosequencing
was used to validate schizophrenia-associated DMPs in
the vicinity of three genes (NRN1 (cg00565348), C8A
(cg23844013), and RASA3 (cg24803255)) in the same
samples. Bisulfite-PCR amplification was performed in
duplicate using the primers and assay conditions in
Table S7 in Additional file 1. Fully methylated and fully
unmethylated control samples were included in all ex-
periments. For each amplicon we confirmed significant
DNA methylation differences in the same direction as
reported by the 450K array (Figure 1C; Figure S2 and
Table S8 in Additional file 1). We subsequently generated
a replication PFC (BA9) 450K dataset using schizophrenia
and control brains archived at the Douglas Bell-Canada
Brain Bank, Montreal, Canada (n = 33, 18 schizophrenia
and 15 controls; Tables S9 and S10 in Additional file 1)
using the Illumina 450K array as described above.
Strikingly, DNA methylation differences at the top-ranked
PFC DMPs identified in the ‘LBBND’ cohort (listed in
Table S11 in Additional file 1) were strongly correlated
with schizophrenia-associated differences at the same
probes in PFC tissue from the Montreal replication samples
(r = 0.54, P = 6.8e-09) with a consistent direction of effect
observed across both cohorts and significant differences ob-
served for top-ranked DMPs (Figure 1C,D).
Evidence for schizophrenia-associated gene co-methylated
modules in the prefrontal cortex
We next employed weighted gene co-methylation network
analysis (WGCNA) to undertake a systems-level view of
the DNA methylation differences associated with schi-
zophrenia in the PFC [25,26]. Using probe-wise DNA
methylation data we identified 110 modules (representing
discrete networks of co-methylated sites), and the first
principal component of each individual module (termed
the ‘eigengene’) was used to assess the relationship with
disease status. Twelve PFC modules were significantly
associated with schizophrenia, most notably the ‘black’
(n = 6,647 probes, r = -0.52, P = 0.0004) and ‘pink’ mod-
ules (n = 4,399 probes, r = -0.45, P = 0.002) (Figure 2A).
Module membership in both modules is strongly correlated
with probe-level disease significance (black module:
r =0.39, P <1e-200; pink module: r = 0.22, P = 2.4e-49)
(Figure 2B). Repeating WGCNA on the cerebellum data
yielded no schizophrenia-associated modules, provid-
ing further evidence of brain region-specific DNA
methylation differences in schizophrenia. Furthermore, a
comparison of modules across the two brain regions
showed that while a subset of 43 PFC modules correlated
strongly (r >0.8) with 51 cerebellum modules, none of the
PFC schizophrenia-associated modules were correlated
with modules in the cerebellum. Finally, despite the low
number of samples and lack of power for replicating
WGCNA associations in the Montreal replication dataset,
the modular structure of DNA methylation in the PFC
was found to be strongly preserved across both brain co-
horts (Figure S3 in Additional file 1), with both the black
and pink modules being highly conserved and negatively
correlated with schizophrenia (black module: r = -0.26;
pink module: r = -0.10).
Schizophrenia-associated co-methylated modules are
enriched for neurodevelopmental pathways and loci
previously implicated in the disorder
To test whether the identified schizophrenia-associated
modules were biologically meaningful, pathway and gene
ontology analyses were performed using Ingenuity Path-
way Analysis (IPA) and EASE (DAVID) software [28].
Enrichment for specific pathways and biological func-
tions was determined relative to the relevant microarray
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gene list using a right-tailed Fisher’s test. IPA of genes
associated with CpG sites in the top-ranked PFC modules
reveals a highly significant enrichment of disease pathways
related to ‘schizophrenia and other neuropsychiatric dis-
orders’ in the black module (P = 3.67e-15 to 1.27e-03;
Figure 2C), and ‘nervous system development and func-
tion’ in both the black (P = 3.80e-18 to 1.37e-03; Figure
S4 in Additional file 1) and pink (P = 4.04e-15 to 3.16e-
03; Figure S5 in Additional file 1) modules. Consistent
with the IPA results, gene ontology analysis using EASE
(DAVID) [28] shows that both modules are significantly
enriched for functions related to nervous system and
neuron development, synaptic transmission and calcium
ion binding (Table S12 in Additional file 1). An analysis of
co-methylation networks between the top-ranked ‘hub’
probes in the black and pink modules shows that they are
connected by DNA methylation in the vicinity of SHANK2,
a molecular scaffold protein that plays a critical role in neu-
rodevelopment and synaptogenesis, and has been widely
implicated in several neurodevelopmental disorders, includ-
ing schizophrenia [29] (Figure 2D). Furthermore, several
of the probes are located in genes that have been strongly
Figure 3 Schizophrenia associated DMPs are enriched for CpG sites undergoing epigenetic changes during fetal neocortex brain
development. (A) Correlation between DNA methylation and neurodevelopmental age (days post-conception) for 98 of the 100 top-ranked
schizophrenia-associated DMPs (blue) with corresponding FDR values (red). Dashed lines demarcate DMPs with FDR <0.01. (B) Distribution of the
number of CpG sites significantly associated with neocortex brain development (FDR <0.05) using 10,000 permutations of 98 randomly selected
CpG sites. The red arrow represents the number of significant (FDR <0.05) age-correlated CpG sites (n = 44) among the 100 top-ranked
schizophrenia-associated DMPs. (C,D) A CpG site in MYT1L, for example, significantly hypomethylated in schizophrenia (P = 0.00000175) (C) is
highly correlated with neocortical development (FDR = 1.39e-13) (D). Blue points represent male samples and pink points represent female samples.
Other examples of schizophrenia-associated DMPs correlated with neocortical development are shown in Figure S6 and Table S13 in Additional file 1.
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implicated in schizophrenia by a recent large collaborative
genome-wide association study (GWAS; for example,
CACNA1C, TSNARE1, PITPNM2, and HLA-L) [27].
Schizophrenia-associated DMPs are enriched for CpG sites
undergoing epigenetic changes during fetal neocortex
brain development
Given previous evidence for a neurodevelopmental basis
to schizophrenia [2], and our analyses demonstrating an
enrichment of neurodevelopmental pathways involved in
disease, we next investigated whether schizophrenia-
associated DMPs are enriched for CpG sites undergoing
dynamic DNA methylation changes during human fetal
brain development. For each of the top-ranked PFC
DMPs we assessed the correlation between DNA methy-
lation and days post-conception in a 450K DNA methy-
lation dataset generated by our lab using human fetal
brain tissue (n = 179, range = 23 to 184 days post-
conception, number of matching 450K probes in fetal data-
set after quality control and filtering = 98/100; HH Spiers et
al., in preparation). Strikingly, DNA methylation at 44% of
the schizophrenia-associated DMPs is significantly associ-
ated (at FDR <0.05) with post-conception age in the devel-
oping fetal brain (Figure 3A), reflecting a highly
significant enrichment for neurodevelopmental DMPs
(10,000 permutations, P = 8e-04) amongst schizophrenia-
associated loci (Figure 3B) and reinforcing the notion that
neurodevelopmental dysfunction is involved in schizophre-
nia. For example, one of the top-ranked schizophrenia-
associated DMPs (cg00236305), located in the gene body of
MYT1L, is significantly hypomethylated (P = 1.75e-6) in pa-
tients compared with controls (Figure 3C). MYT1L encodes
a potent transcription factor integral to neurodevelopment
[30], and the same probe is highly correlated with neocor-
tical development (FDR = 1.39e-13; Figure 3D). Other
examples of schizophrenia-associated DMPs strongly
correlated with neocortical development are shown in
Figure S6 and Table S13 in Additional file 1.
Conclusions
In this study we have found schizophrenia-associated vari-
ation in DNA methylation in the PFC, and identified
discrete modules of co-methylated loci associated with the
disorder that are significantly enriched for genes involved
in neurodevelopmental processes. Methylomic profiling
in human fetal cortex samples confirmed that disease-
associated DMPs are significantly enriched for loci at
which DNA methylation is dynamically altered during
human fetal brain development. These data strongly
support the hypothesis that schizophrenia has an important
early neurodevelopmental component, and suggest that epi-
genetic mechanisms may mediate the relationship between
neurodevelopmental disturbances and risk of disease.
Materials and methods
Samples and sample processing
London Brain Bank for Neurodegenerative Disorders
PFC and cerebellum samples were obtained from 47 brains
archived in the LBBND. Subjects were approached in life
for written consent for brain banking, and all tissue dona-
tions were collected and stored following legal and ethical
guidelines (NHS reference number 08/MRE09/38; the
HTA license number for the LBBND brain bank is 12293).
The study is also approved by the University of Exeter
Medical School Research Ethics Committee (reference
number 13/02/009). Samples were dissected by a trained
neuropathologist, snap-frozen and stored at -80°C. Schizo-
phrenia patients were diagnosed by trained psychiatrists
according to Diagnostic and Statistical Manual of Mental
Disorders (DSM) criteria. Demographic information
for the samples is summarized in Tables S1 and S2 in
Additional file 1. Samples were randomized with respect
to gender and disease status to avoid batch effects
throughout all experimental procedures. Genomic DNA
was isolated using a standard phenol-chloroform extrac-
tion protocol. DNA was tested for degradation and purity
using spectrophotometry and gel electrophoresis.
Douglas Bell-Canada Brain Bank, Montreal
PFC samples from 18 schizophrenia cases and 15 controls
were obtained from the Douglas Bell-Canada Brain
Bank (DBCBB) [31]. Brain specimens used in this study
were collected postmortem following consent obtained
with next of kin, according to tissue banking practices
regulated by the Quebec Health Research Fund [32], and
based on the OECD Guidelines on Human Biobanks and
Genetic Research Databases [33]. Samples were dissected
by neuropathology technicians, snap-frozen and stored at
-80°C. Psychiatric diagnoses were based on best-estimate
diagnostic procedures, following SCID I diagnostic interviews
conducted with informants, as described elsewhere [34].
Demographic information for the DBCBB samples is sum-
marized in Tables S8 and S9 in Additional file 1. Genomic
DNA was isolated using a standard phenol-chloroform
extraction protocol. DNA was tested for degradation and
purity using spectrophotometry and gel electrophoresis.
Genome-wide quantification of DNA methylation
Microarray processing
DNA (500 ng) from each sample was treated with sodium
bisulfite in duplicate, using the EZ-96 DNA methylation kit
(Zymo Research, Irvine, CA, USA). DNA methylation was
quantified using the Illumina Infinium HumanMethyla-
tion450 BeadChip (Illumina Inc.) run on an Illumina HiS-
can System (Illumina) using the manufacturers’ standard
protocol.
Pidsley et al. Genome Biology 2014, 15:483 Page 7 of 10
http://genomebiology.com/2014/15/10/483
Page number in thesis: 516
Data processing and quality control of discovery data
Signal intensities for each probe were extracted using Illu-
mina GenomeStudio software and imported into R [35]
using the methylumi and minfi packages [36,37]. Multi-
dimensional scaling plots of variable probes on the sex
chromosomes were used to check that the predicted
gender corresponded with the reported gender for each
individual. One sample showed a discrepancy between
measured and reported sex and was subsequently iden-
tified as having an XXY karyotype and removed from
the current study for independent investigation [38].
Comparison of non-CpG SNP probes on the array con-
firmed that matched PFC and cerebellum tissues were
sourced from the same individual. Raw beta values of
probes within brain region-specific DMRs (extracted
from [39]) were used to confirm the tissue identity of
each sample. Probes containing a SNP with minor allele
frequency >5% within 10 bp of the single base extension
site based on Illumina’s database and probes identified
by Chen and colleagues [40] (n = 34,548) were removed
from all analyses. Further data quality control and pro-
cessing steps were conducted using the wateRmelon
package [16] in R. The pfilter function was used to filter
data by beadcount and detection P-value. Samples with >1%
probes with a detection P-value >0.05 were removed
(PFC: n = 3 samples; cerebellum: n = 1 sample). Probes
with a detection P-value >0.05 in at least 1% of samples
and/or a beadcount <3 in 5% of samples were removed
across all samples to stringently control for poor quality
probes. Quality control sample exclusions are summa-
rized in Table S3 in Additional file 1. The dasen func-
tion was used to normalize the data as previously
described [16], with probes on the sex chromosomes re-
moved from all subsequent analysis.
Statistical analysis
First, analyses were performed to test for DNA methyla-
tion differences between schizophrenia cases and controls
at the individual probe level. To model the effect of
sample-specific variables we performed linear regression
for each probe using age, gender and disease status as
independent variables. Regression tests were performed
using the Limma [41] package in R, and prior to ana-
lyses β-values were log-transformed to M-values to im-
prove sensitivity. P-values were adjusted for multiple
testing according to the FDR procedure of Benjamini-
Hochberg. The CETS package in R [19] was used to
check that our top-ranked DMPs were not mediated by
the effect of differential neuronal cell proportions across
samples. To identify DMRs we used the Illumina Methyla-
tion Analyzer (IMA) [22] package to compute region-level
summaries of DNA methylation in the PFC and cerebel-
lum, which were then tested for association with disease
using Limma. P-values were adjusted for multiple testing
according to the FDR procedure of Benjamini-Hochberg.
Significant DMRs were selected at a 5% FDR and visual-
ized using RCircos [42] and Gviz [43] packages. To investi-
gate whether schizophrenia-associated DMPs are enriched
for sites undergoing epigenetic changes during neurodeve-
lopment, we used an unpublished 450K DNA methylation
dataset of fetal cortex brain samples (n = 179, range 23 to
184 days post-conception) collected as part of ongoing
work in our group (HH Spiers et al., in preparation). For
the top 100 schizophrenia-associated DMPs in our dataset,
we extracted β-values of 98 matched probes in the neuro-
developmental dataset (n = 2 probes removed during qual-
ity control of fetal dataset). We then used Pearson’s
correlation tests to assess the number of probes show-
ing a significant relationship (FDR <0.05) between DNA
methylation and days post-conception. To evaluate the
genome-wide significance of this result we compared
the above correlation with an estimated null distribution
from 10,000 randomizations of the data. On each
randomization we randomly selected 98 probes and
computed the number of probes with FDR <0.05, as
described above. One-tail significance was assessed by
comparing the original number of significant probes
(FDR <0.05) to the estimated null distribution.
Bisulfite-pyrosequencing
Independent verification analysis was performed on three
PFC schizophrenia-associated DMPs (in the vicinity of
NRN1, C8A, and RASA3), based on results from both
the probe-wise and region-level analysis. Pyrosequencing
assays were designed using the PyroMark Assay design
software (Qiagen, Hilden, Germany). Bisulfite-PCR ampli-
fication was performed in duplicate using the primers and
assay conditions in Table S7 in Additional file 1. Fully
methylated and fully unmethylated control samples were
included in all experiments.
Replication analysis
DNA samples from the Montreal cohort were analyzed
using the Illumina Infinium HumanMethylation450
BeadChip using the same processing and quality control
steps as described above. For the top 100 schizophrenia-
associated DMPs in the LBBND cohort (Table S4 in
Additional file 1), we extracted β-values for matched probes
in the Montreal dataset. Pearson’s correlation was used to
assess the relationship between disease-associated DNA
methylation differences in the two datasets at these probes.
Weighted gene co-methylation network analysis
Network analysis was performed on normalized probe-
wise DNA methylation data (PFC: n = 445,617 probes;
cerebellum: n = 440,836 probes) using WGCNA [26].
For each brain region pair-wise correlations were used
to identify modules of highly co-methylated probes,
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independent of disease status. Specifically, an unsigned
network was created with a soft threshold parameter of 6
using the blockwiseModules function based on a block size
of 20,000. Each module was then labeled with a unique
color name. The first principle component of the methyla-
tion matrix of each module was calculated to give a ‘mod-
ule eigengene’ (ME) for each module (a weighted average
methylation profile). To identify modules associated with
schizophrenia, each of the ME values was regressed on dis-
ease status, in addition to other sample-specific variables:
pH, age, gender, brain weight and cerebellum weight. To
test whether the identified schizophrenia-associated mod-
ules were biologically meaningful, pathway and gene ontol-
ogy analyses were performed using IPA [44] and EASE
(DAVID) [28,45]. Correlations were performed between
the ME and DNA methylation values to calculate the mod-
ule membership of each probe (the extent to which a given
probe contributes to the ME). This module membership
value was used to identify the ‘hub’ genes in each module.
The function modulePreservation in the WGCNA package
was used to calculate module preservation statistics for the
Montreal PFC data based on the PFC modules built from
the discovery dataset.
Accession numbers
The Gene Expression Omnibus accession numbers for
the 450K array data reported in this paper are GSE61431
(LBBND dataset) and GSE61380 (DBCBB dataset).
Additional file
Additional file 1: Supplementary Figures S1 to S6 and Supplementary
Tables S1 to S13.
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